TW202342649A - Composition, film, optical filter, solid-state imaging element, image display device, infrared sensor, camera module, and compound - Google Patents

Composition, film, optical filter, solid-state imaging element, image display device, infrared sensor, camera module, and compound Download PDF

Info

Publication number
TW202342649A
TW202342649A TW112109380A TW112109380A TW202342649A TW 202342649 A TW202342649 A TW 202342649A TW 112109380 A TW112109380 A TW 112109380A TW 112109380 A TW112109380 A TW 112109380A TW 202342649 A TW202342649 A TW 202342649A
Authority
TW
Taiwan
Prior art keywords
group
formula
heterocyclic
aryl
membered ring
Prior art date
Application number
TW112109380A
Other languages
Chinese (zh)
Inventor
荒山恭平
Original Assignee
日商富士軟片股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商富士軟片股份有限公司 filed Critical 日商富士軟片股份有限公司
Publication of TW202342649A publication Critical patent/TW202342649A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00Processes of polymerisation
    • C08F2/44Polymerisation in the presence of compounding ingredients, e.g. plasticisers, dyestuffs, fillers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/16Nitrogen-containing compounds
    • C08K5/34Heterocyclic compounds having nitrogen in the ring
    • C08K5/3412Heterocyclic compounds having nitrogen in the ring having one nitrogen atom in the ring
    • C08K5/3415Five-membered rings
    • C08K5/3417Five-membered rings condensed with carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/36Sulfur-, selenium-, or tellurium-containing compounds
    • C08K5/43Compounds containing sulfur bound to nitrogen
    • C08K5/435Sulfonamides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L101/00Compositions of unspecified macromolecular compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K3/00Materials not provided for elsewhere
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B5/00Optical elements other than lenses
    • G02B5/20Filters
    • G02B5/22Absorbing filters

Abstract

This composition includes an infrared absorbing agent, a curable compound, and a solvent, wherein the infrared absorbing agent includes a compound represented by formula (1). Provided are a film, an optical filter, a solid-state imaging element, an image display device, an infrared sensor, a camera module, and a compound.

Description

組成物、膜、光學濾波器、固體攝像元件、圖像顯示裝置、紅外線感測器、照相機膜組及化合物Compositions, films, optical filters, solid-state imaging devices, image display devices, infrared sensors, camera film groups and compounds

本發明係有關一種包含方酸菁化合物之組成物。又,本發明係有關一種使用組成物之膜、光學濾波器、固體攝像元件、圖像顯示裝置、紅外線感測器、照相機膜組及化合物。The present invention relates to a composition containing a squaraine compound. Furthermore, the present invention relates to a film, an optical filter, a solid-state imaging device, an image display device, an infrared sensor, a camera film assembly and a compound using the composition.

在視訊攝影機、數位相機、附相機功能之行動電話等中使用彩色圖像的固體攝像元件亦即CCD(電荷耦合元件)或CMOS(互補金屬氧化膜半導體)。該等固體攝像元件在其受光部使用對紅外線具有靈敏度之矽光二極體。因此,有時會設置紅外線截止濾波器進行光度因數(luminosity factor)校正。The solid-state imaging element that uses color images in video cameras, digital cameras, mobile phones with camera functions, etc. is CCD (Charge Coupled Device) or CMOS (Complementary Metal Oxide Semiconductor). These solid-state imaging devices use silicon photodiodes that are sensitive to infrared rays in their light-receiving portions. Therefore, an infrared cutoff filter is sometimes set for luminosity factor correction.

紅外線截止濾波器使用包含紅外線吸收劑之組成物製造。作為紅外線吸收劑,已知有方酸菁化合物等。The infrared cut filter is made of a composition containing an infrared absorber. As infrared absorbers, squaraine compounds and the like are known.

專利文獻1中記載有使用包含特定方酸菁化合物等之組成物來製造紅外線截止濾波器等之內容。Patent Document 1 describes the production of an infrared cut filter or the like using a composition containing a specific squaraine compound or the like.

[專利文獻1]國際公開第2014/088063號[Patent Document 1] International Publication No. 2014/088063

然而,方酸菁化合物的耐光性往往較低。因此,使用包含該等化合物之組成物來獲得之膜的耐光性存在進一步改善的餘地。However, squaraine compounds tend to have lower photostability. Therefore, there is room for further improvement in the light resistance of films obtained using compositions containing these compounds.

又,方酸菁化合物具有分子內鹽結構,因此在溶劑中的溶解性往往較低。因此,關於包含方酸菁化合物之組成物,方酸菁化合物在組成物的保管中容易析出,使用保管後的組成物來形成膜時,膜中容易產生異物等。因此,包含方酸菁化合物之組成物的保存穩定性存在進一步改善的餘地。In addition, since the squaraine compound has an intramolecular salt structure, its solubility in a solvent is often low. Therefore, regarding a composition containing a squaraine compound, the squaraine compound is likely to precipitate during storage of the composition, and when the composition after storage is used to form a film, foreign matter or the like is likely to be generated in the film. Therefore, there is room for further improvement in the storage stability of the composition containing the squaraine compound.

因此,本發明的目的在於提供一種能夠形成保存穩定性優異且耐光性優異的膜之組成物。又,本發明的目的在於提供一種膜、光學濾波器、固體攝像元件、圖像顯示裝置、紅外線感測器、照相機膜組及化合物。Therefore, an object of the present invention is to provide a composition capable of forming a film having excellent storage stability and excellent light resistance. Furthermore, an object of the present invention is to provide a film, an optical filter, a solid-state imaging device, an image display device, an infrared sensor, a camera film assembly, and a compound.

本發明提供以下內容。 <1>一種組成物,其包含紅外線吸收劑、硬化性化合物及溶劑, 上述紅外線吸收劑包含由式(1)表示之化合物; [化1] 式(1)中,A及B分別獨立地表示芳香族烴環或芳香族雜環, R aa1及R aa2分別獨立地表示鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基、烷基、芳基、雜環基、烷氧基、醯基、烷氧基羰基、-NR a11R a12、-SR a13、-SO 2R a14或-OSO 2R a15, R a11及R a12分別獨立地表示氫原子、烷基、芳基或雜環基, R a13~R a15分別獨立地表示烷基、芳基或雜環基, R b1~R b4分別獨立地表示氫原子、鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基、烷基、芳基、雜環基、烷氧基、醯基、烷氧基羰基、-NR b11R b12、-NHCOR b13、-NHSO 2R b14、-NHCSNHR b15、-SR b16、-SO 2R b17、-OSO 2R b18、-NHCSR b19、-NHCONHR b20或-NHCOOR b21, R b11及R b12分別獨立地表示氫原子、烷基、芳基或雜環基, R b13~R b21分別獨立地表示烷基、芳基或雜環基, Y 1~Y 4分別獨立地表示氫原子、烷基、芳基、雜環基或由式(Y-1)表示之基團, m1表示0~mA的整數,mA表示R aa1可取代A之最大的整數, m2表示0~mB的整數,mB表示R aa2可取代B之最大的整數, m1為2以上時,m1個R aa1中2個R aa1可以彼此鍵結而形成環, m2為2以上時,m2個R aa2中2個R aa2可以彼此鍵結而形成環, R aa1與Y 1可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, R aa1與Y 2可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, R aa2與Y 3可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, R aa2與Y 4可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, Y 1與Y 2可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, Y 3與Y 4可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環; 其中,Y 1~Y 4中的至少一個為由式(Y-1)表示之基團,且選自R aa1與Y 1、R aa1與Y 2、R aa2與Y 3及R aa2與Y 4中之至少一個鍵結而形成包含至少一個氮原子之5員環或6員環的雜環; [化2] 式(Y-1)中,波線表示鍵結鍵, Ry 1~Ry 4分別獨立地表示氫原子、烷基或芳基, X 1為單鍵、伸烷基、伸芳基、-O-、-S-、-NRx-、-CO-、-CS-、-SO-或-SO 2-,或者表示將選自伸烷基、伸芳基、-O-、-S-、-NRx-、-CO-、-CS-、-SO-及-SO 2-中之2個以上組合而成之基團,Rx表示氫原子、烷基或芳基, Z 1表示脂環式烴基、芳香族烴基、雜環基、由式(Z-1)~(Z-6)中的任一個表示之基團; 其中,Z 1為由式(Z-1)表示之基團或由式(Z-4)表示之基團時,X 1中的與Z 1連結之部分為伸烷基或伸芳基; [化3] 式(Z-1)~式(Z-6)中,波線表示鍵結鍵; 式(Z-1)中,Rz 11表示烷基或芳基; 式(Z-2)中,Rz 12表示氫原子、-COR 100或-COOR 100,R 100表示氫原子、烷基或芳基,Rz 12a表示烷基,mz表示0~4的整數; 式(Z-3)中,Rz 13~Rz 16分別獨立地表示烷基,Rz 17表示氫原子、烷基或氧自由基; 式(Z-4)中,Rz 18及Rz 19分別獨立地表示烷基或芳基; 式(Z-6)中,W 1表示單鍵、伸烷基、伸芳基或-CO-,Rz 20表示氫原子、烷基、芳基或-COR 101,R 101表示烷基或芳基。 <2>如<1>所述之組成物,其中 由上述式(1)表示之化合物為由式(2)表示之化合物; [化4] 式(2)中,R a1~R a4分別獨立地表示氫原子、鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基、烷基、芳基、雜環基、烷氧基、醯基、烷氧基羰基、-NR a11R a12、-SR a13、-SO 2R a14或-OSO 2R a15, R a11及R a12分別獨立地表示氫原子、烷基、芳基或雜環基, R a13~R a15分別獨立地表示烷基、芳基或雜環基, R b1~R b4分別獨立地表示氫原子、鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基、烷基、芳基、雜環基、烷氧基、醯基、烷氧基羰基、-NR b11R b12、-NHCOR b13、-NHSO 2R b14、-NHCSNHR b15、-SR b16、-SO 2R b17、-OSO 2R b18、-NHCSR b19、-NHCONHR b20或-NHCOOR b21, R b11及R b12分別獨立地表示氫原子、烷基、芳基或雜環基, R b13~R b21分別獨立地表示烷基、芳基或雜環基, Y 1~Y 4分別獨立地表示氫原子、烷基、芳基、雜環基或由上述式(Y-1)表示之基團, R a1與Y 1可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, R a2與Y 2可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, R a3與Y 3可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, R a4與Y 4可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, Y 1與Y 2可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, Y 3與Y 4可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環; 其中,Y 1~Y 4中的至少一個為由上述式(Y-1)表示之基團,且選自R a1與Y 1、R a2與Y 2、R a3與Y 3及R a4與Y 4中之至少一個鍵結而形成包含至少一個氮原子之5員環或6員環的雜環。 <3>如<1>所述之組成物,其中 由上述式(1)表示之化合物為由式(3)表示之化合物; [化5] 式(3)中,R 13~R 17、R 23~R 27分別獨立地表示氫原子、鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基、烷基、芳基、雜環基、烷氧基、醯基、烷氧基羰基、-NR a11R a12、-SR a13、-SO 2R a14或-OSO 2R a15, R a11及R a12分別獨立地表示氫原子、烷基、芳基或雜環基, R a13~R a15分別獨立地表示烷基、芳基或雜環基, R 11、R 12、R 21及R 22分別獨立地表示氫原子、鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基、烷基、芳基、雜環基、烷氧基、醯基、烷氧基羰基、-NR b11R b12、-NHCOR b13、-NHSO 2R b14、-NHCSNHR b15、-SR b16、-SO 2R b17、-OSO 2R b18、-NHCSR b19、-NHCONHR b20或-NHCOOR b21, R b11及R b12分別獨立地表示氫原子、烷基、芳基或雜環基, R b13~R b21分別獨立地表示烷基、芳基或雜環基, Y 11及Y 21分別獨立地表示氫原子、烷基、芳基、雜環基或由上述式(Y-1)表示之基團,Y 11及Y 21中的至少一個為由上述式(Y-1)表示之基團。 <4>如<3>所述之組成物,其中 上述式(3)的R 11及R 12中的至少一個和R 21及R 22中的至少一個分別獨立地為-NHCOR b13,R b13為烷基、芳基或雜環基。 <5>如<3>所述之組成物,其中 上述式(3)的R 11及R 12中的至少一個和R 21及R 22中的至少一個分別獨立地為-NHSO 2R b14,R b14為烷基、芳基或雜環基。 <6>如<1>至<5>之任一項所述之組成物,其中 上述硬化性化合物包含樹脂。 <7>如<1>至<6>之任一項所述之組成物,其中 上述紅外線吸收劑進一步包含由上述式(1)表示之化合物以外的紅外線吸收劑。 <8>如<1>至<7>之任一項所述之組成物,其進一步包含選自紫外線吸收劑及抗氧化劑中之至少1種。 <9>一種膜,其使用<1>至<8>之任一項所述之組成物來獲得。 <10>一種光學濾波器,其包含<9>所述之膜。 <11>一種固體攝像元件,其包含<9>所述之膜。 <12>一種圖像顯示裝置,其包含<9>所述之膜。 <13>一種紅外線感測器,其包含<9>所述之膜。 <14>一種照相機膜組,其包含<9>所述之膜。 <15>一種化合物,其由式(1)表示; [化6] 式(1)中,A及B分別獨立地表示芳香族烴環或芳香族雜環, R aa1及R aa2分別獨立地表示鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基、烷基、芳基、雜環基、烷氧基、醯基、烷氧基羰基、-NR a11R a12、-SR a13、-SO 2R a14或-OSO 2R a15, R a11及R a12分別獨立地表示氫原子、烷基、芳基或雜環基, R a13~R a15分別獨立地表示烷基、芳基或雜環基, R b1~R b4分別獨立地表示氫原子、鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基、烷基、芳基、雜環基、烷氧基、醯基、烷氧基羰基、-NR b11R b12、-NHCOR b13、-NHSO 2R b14、-NHCSNHR b15、-SR b16、-SO 2R b17、-OSO 2R b18、-NHCSR b19、-NHCONHR b20或-NHCOOR b21, R b11及R b12分別獨立地表示氫原子、烷基、芳基或雜環基, R b13~R b21分別獨立地表示烷基、芳基或雜環基, Y 1~Y 4分別獨立地表示氫原子、烷基、芳基、雜環基或由式(Y-1)表示之基團, m1表示0~mA的整數,mA表示R aa1可被A取代之最大的整數, m2表示0~mB的整數,mB表示R aa2可被B取代之最大的整數, m1為2以上時,m1個R aa1中2個R aa1可以彼此鍵結而形成環, m2為2以上時,m2個R aa2中2個R aa2可以彼此鍵結而形成環, R aa1與Y 1可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, R aa1與Y 2可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, R aa2與Y 3可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, R aa2與Y 4可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, Y 1與Y 2可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, Y 3與Y 4可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環; 其中,Y 1~Y 4中的至少一個為由式(Y-1)表示之基團,且選自R aa1與Y 1、R aa1與Y 2、R aa2與Y 3及R aa2與Y 4中之至少一個鍵結而形成包含至少一個氮原子之5員環或6員環的雜環; [化7] 式(Y-1)中,波線表示鍵結鍵, Ry 1~Ry 4分別獨立地表示氫原子、烷基或芳基, X 1為單鍵、伸烷基、伸芳基、-O-、-S-、-NRx-、-CO-、-CS-、-SO-或-SO 2-,或者表示將選自伸烷基、伸芳基、-O-、-S-、-NRx-、-CO-、-CS-、-SO-及-SO 2-中之2個以上組合而成之基團,Rx表示氫原子、烷基或芳基, Z 1表示脂環式烴基、芳香族烴基、雜環基、由式(Z-1)~(Z-6)中的任一個表示之基團; 其中,Z 1為由式(Z-1)表示之基團或由式(Z-4)表示之基團時,X 1中的與Z 1連結之部分為伸烷基或伸芳基; [化8] 式(Z-1)~式(Z-6)中,波線表示鍵結鍵; 式(Z-1)中,Rz 11表示烷基或芳基; 式(Z-2)中,Rz 12表示氫原子、-COR 100或-COOR 100,R 100表示氫原子、烷基或芳基,Rz 12a表示烷基,mz表示0~4的整數; 式(Z-3)中,Rz 13~Rz 16分別獨立地表示烷基,Rz 17表示氫原子、烷基或氧自由基; 式(Z-4)中,Rz 18及Rz 19分別獨立地表示烷基或芳基; 式(Z-6)中,W 1表示單鍵、伸烷基、伸芳基或-CO-,Rz 20表示氫原子、烷基、芳基或-COR 101,R 101表示烷基或芳基。 [發明效果] The present invention provides the following. <1> A composition containing an infrared absorber, a curable compound and a solvent, wherein the infrared absorber contains a compound represented by formula (1); [Chemical 1] In formula (1), A and B independently represent an aromatic hydrocarbon ring or an aromatic heterocyclic ring, and R aa1 and R aa2 independently represent a halogen atom, a sulfo group, a hydroxyl group, a cyano group, a nitro group, a carboxyl group, and a phosphate group. , alkyl, aryl, heterocyclyl, alkoxy, acyl, alkoxycarbonyl, -NR a11 R a12 , -SR a13 , -SO 2 R a14 or -OSO 2 R a15 , R a11 and R a12 Each independently represents a hydrogen atom, an alkyl group, an aryl group or a heterocyclic group, R a13 to R a15 each independently represents an alkyl group, an aryl group or a heterocyclic group, R b1 to R b4 each independently represents a hydrogen atom or a halogen atom , sulfo group, hydroxyl group, cyano group, nitro group, carboxyl group, phosphate group, alkyl group, aryl group, heterocyclic group, alkoxy group, hydroxyl group, alkoxycarbonyl group, -NR b11 R b12 , -NHCOR b13 , - NHSO 2 R b14 , -NHCSNHR b15 , -SR b16 , -SO 2 R b17 , -OSO 2 R b18 , -NHCSR b19 , -NHCONHR b20 or -NHCOOR b21 , R b11 and R b12 independently represent a hydrogen atom, an alkane group, aryl group or heterocyclic group, R b13 to R b21 independently represent an alkyl group, an aryl group or a heterocyclic group, Y 1 to Y 4 independently represent a hydrogen atom, an alkyl group, an aryl group, a heterocyclic group or A group represented by formula (Y-1), m1 represents an integer from 0 to mA, mA represents the largest integer that R aa1 can replace A, m2 represents an integer from 0 to mB, and mB represents the largest integer that R aa2 can replace B. Integer, when m1 is 2 or more, 2 R aa1 out of m1 R aa1 can bond with each other to form a ring. When m2 is 2 or more, 2 R aa2 out of m2 R aa2 can bond with each other to form a ring, R aa1 It can bond with Y 1 to form a heterocyclic ring containing a 5-membered ring or a 6-membered ring containing at least one nitrogen atom. R aa1 and Y 2 can bond to form a heterocyclic ring containing a 5-membered ring or a 6-membered ring containing at least one nitrogen atom. Ring, R aa2 and Y 3 can bond to form a 5-membered ring or a 6-membered heterocyclic ring containing at least one nitrogen atom, R aa2 and Y 4 can bond to form a 5-membered ring or 6-membered ring containing at least one nitrogen atom A heterocyclic ring with 5 members, Y 1 and Y 2 can be bonded to form a 5-membered ring or a 6-membered ring containing at least one nitrogen atom, Y 3 and Y 4 can be bonded to form a 5-membered ring containing at least one nitrogen atom. A membered ring or a 6-membered heterocyclic ring; wherein, at least one of Y 1 to Y 4 is a group represented by formula (Y-1), and is selected from R aa1 and Y 1 , R aa1 and Y 2 , R aa2 and at least one of Y 3 and R aa2 and Y 4 bond to form a 5-membered ring or a 6-membered ring heterocycle containing at least one nitrogen atom; [Chemical 2] In formula (Y-1), the wavy line represents a bond, Ry 1 to Ry 4 independently represent a hydrogen atom, an alkyl group or an aryl group, and X 1 is a single bond, an alkylene group, an aryl group, -O-, -S-, -NRx-, -CO-, -CS-, -SO- or -SO 2 -, or it will be selected from alkylene, aryl, -O-, -S-, -NRx-, A group composed of two or more of -CO-, -CS-, -SO- and -SO 2 -, Rx represents a hydrogen atom, an alkyl group or an aryl group, Z 1 represents an alicyclic hydrocarbon group or an aromatic hydrocarbon group , heterocyclic group, a group represented by any one of the formulas (Z-1) to (Z-6); wherein, Z 1 is a group represented by the formula (Z-1) or a group represented by the formula (Z-4 ) represents a group, the part in X 1 linked to Z 1 is an alkylene group or an aryl group; [Chemical 3] In formula (Z-1) to formula (Z-6), the wavy line represents a bond; in formula (Z-1), Rz 11 represents an alkyl group or an aryl group; in formula (Z-2), Rz 12 represents hydrogen atom, -COR 100 or -COOR 100 , R 100 represents a hydrogen atom, an alkyl group or an aryl group, Rz 12a represents an alkyl group, mz represents an integer from 0 to 4; in formula (Z-3), Rz 13 to Rz 16 respectively independently represents an alkyl group, and Rz 17 represents a hydrogen atom, an alkyl group or an oxygen radical; in formula (Z-4), Rz 18 and Rz 19 independently represent an alkyl group or an aryl group; in formula (Z-6), W 1 represents a single bond, an alkylene group, an aryl group or -CO-, Rz 20 represents a hydrogen atom, an alkyl group, an aryl group or -COR 101 , and R 101 represents an alkyl group or an aryl group. <2> The composition according to <1>, wherein the compound represented by the above formula (1) is a compound represented by the formula (2); [Chemical 4] In formula (2), R a1 to R a4 each independently represent a hydrogen atom, a halogen atom, a sulfo group, a hydroxyl group, a cyano group, a nitro group, a carboxyl group, a phosphate group, an alkyl group, an aryl group, a heterocyclic group, and an alkoxy group. , acyl group, alkoxycarbonyl group, -NR a11 R a12 , -SR a13 , -SO 2 R a14 or -OSO 2 R a15 , R a11 and R a12 respectively independently represent a hydrogen atom, an alkyl group, an aryl group or a hetero Ring group, R a13 to R a15 independently represent an alkyl group, an aryl group or a heterocyclic group, R b1 to R b4 respectively independently represent a hydrogen atom, a halogen atom, a sulfo group, a hydroxyl group, a cyano group, a nitro group, a carboxyl group, Phosphate group, alkyl group, aryl group, heterocyclyl group, alkoxy group, acyl group, alkoxycarbonyl group, -NR b11 R b12 , -NHCOR b13 , -NHSO 2 R b14 , -NHCSNHR b15 , -SR b16 , - SO 2 R b17 , -OSO 2 R b18 , -NHCSR b19 , -NHCONHR b20 or -NHCOOR b21 , R b11 and R b12 independently represent a hydrogen atom, an alkyl group, an aryl group or a heterocyclic group, R b13 ~ R b21 Each independently represents an alkyl group, an aryl group or a heterocyclic group, Y 1 to Y 4 each independently represents a hydrogen atom, an alkyl group, an aryl group, a heterocyclic group or a group represented by the above formula (Y-1), R a1 and Y 1 may bond to form a 5-membered ring or 6-membered heterocyclic ring containing at least one nitrogen atom, and R a2 and Y 2 may bond to form a 5-membered ring or 6-membered ring containing at least one nitrogen atom. Heterocycle, R a3 and Y 3 can bond to form a 5-membered ring or 6-membered ring containing at least one nitrogen atom, R a4 and Y 4 can bond to form a 5-membered ring containing at least one nitrogen atom or a 6-membered ring. A 6-membered heterocyclic ring, Y 1 and Y 2 can be bonded to form a 5-membered ring or a 6-membered ring heterocyclic containing at least one nitrogen atom, Y 3 and Y 4 can be bonded to form a 5-membered ring containing at least one nitrogen atom 5-membered ring or 6-membered ring heterocycle; wherein, at least one of Y 1 to Y 4 is a group represented by the above formula (Y-1), and is selected from R a1 and Y 1 , R a2 and Y 2 , R a3 and at least one of Y 3 and R a4 and Y 4 are bonded to form a 5-membered ring or a 6-membered ring heterocyclic ring containing at least one nitrogen atom. <3> The composition according to <1>, wherein the compound represented by the above formula (1) is a compound represented by the formula (3); [Chemical 5] In formula (3), R 13 to R 17 and R 23 to R 27 respectively independently represent a hydrogen atom, a halogen atom, a sulfo group, a hydroxyl group, a cyano group, a nitro group, a carboxyl group, a phosphate group, an alkyl group, an aryl group, a hetero group, and a hydrogen atom. Ring group, alkoxy group, acyl group, alkoxycarbonyl group, -NR a11 R a12 , -SR a13 , -SO 2 R a14 or -OSO 2 R a15 , R a11 and R a12 independently represent a hydrogen atom, an alkane group, aryl or heterocyclic group, R a13 to R a15 independently represent an alkyl group, an aryl group or a heterocyclic group, R 11 , R 12 , R 21 and R 22 respectively independently represent a hydrogen atom, a halogen atom, a sulfonate group, hydroxyl group, cyano group, nitro group, carboxyl group, phosphate group, alkyl group, aryl group, heterocyclic group, alkoxy group, acyl group, alkoxycarbonyl group, -NR b11 R b12 , -NHCOR b13 , -NHSO 2 R b14 , -NHCSNHR b15 , -SR b16 , -SO 2 R b17 , -OSO 2 R b18 , -NHCSR b19 , -NHCONHR b20 or -NHCOOR b21 , R b11 and R b12 independently represent a hydrogen atom, an alkyl group, Aryl or heterocyclic group, R b13 to R b21 independently represent an alkyl group, an aryl group or a heterocyclic group, Y 11 and Y 21 independently represent a hydrogen atom, an alkyl group, an aryl group, a heterocyclic group or a combination of the above The group represented by formula (Y-1), at least one of Y 11 and Y 21 is a group represented by the above formula (Y-1). <4> The composition according to <3>, wherein at least one of R 11 and R 12 and at least one of R 21 and R 22 of the above formula (3) are each independently -NHCOR b13 , and R b13 is Alkyl, aryl or heterocyclyl. <5> The composition according to <3>, wherein at least one of R 11 and R 12 and at least one of R 21 and R 22 of the above formula (3) are independently -NHSO 2 R b14 , R b14 is an alkyl group, an aryl group or a heterocyclic group. <6> The composition according to any one of <1> to <5>, wherein the curable compound contains a resin. <7> The composition according to any one of <1> to <6>, wherein the infrared absorber further contains an infrared absorber other than the compound represented by the above formula (1). <8> The composition according to any one of <1> to <7>, further comprising at least one selected from the group consisting of ultraviolet absorbers and antioxidants. <9> A film obtained using the composition according to any one of <1> to <8>. <10> An optical filter including the film according to <9>. <11> A solid-state imaging element including the film according to <9>. <12> An image display device including the film according to <9>. <13> An infrared sensor including the film according to <9>. <14> A camera film set including the film according to <9>. <15> A compound represented by formula (1); [Chemical 6] In formula (1), A and B independently represent an aromatic hydrocarbon ring or an aromatic heterocyclic ring, and R aa1 and R aa2 independently represent a halogen atom, a sulfo group, a hydroxyl group, a cyano group, a nitro group, a carboxyl group, and a phosphate group. , alkyl, aryl, heterocyclyl, alkoxy, acyl, alkoxycarbonyl, -NR a11 R a12 , -SR a13 , -SO 2 R a14 or -OSO 2 R a15 , R a11 and R a12 Each independently represents a hydrogen atom, an alkyl group, an aryl group or a heterocyclic group, R a13 to R a15 each independently represents an alkyl group, an aryl group or a heterocyclic group, R b1 to R b4 each independently represents a hydrogen atom or a halogen atom , sulfo group, hydroxyl group, cyano group, nitro group, carboxyl group, phosphate group, alkyl group, aryl group, heterocyclic group, alkoxy group, hydroxyl group, alkoxycarbonyl group, -NR b11 R b12 , -NHCOR b13 , - NHSO 2 R b14 , -NHCSNHR b15 , -SR b16 , -SO 2 R b17 , -OSO 2 R b18 , -NHCSR b19 , -NHCONHR b20 or -NHCOOR b21 , R b11 and R b12 independently represent a hydrogen atom, an alkane group, aryl group or heterocyclic group, R b13 to R b21 independently represent an alkyl group, an aryl group or a heterocyclic group, Y 1 to Y 4 independently represent a hydrogen atom, an alkyl group, an aryl group, a heterocyclic group or The group represented by formula (Y-1), m1 represents an integer from 0 to mA, mA represents the largest integer that R aa1 can be replaced by A, m2 represents an integer from 0 to mB, mB represents the maximum integer that R aa2 can be replaced by B The largest integer, when m1 is 2 or more, 2 R aa1 out of m1 R aa1 can bond with each other to form a ring. When m2 is 2 or more, 2 R aa2 out of m2 R aa2 can bond with each other to form a ring. R aa1 and Y 1 may bond to form a 5-membered ring or a 6-membered heterocyclic ring containing at least one nitrogen atom, and R aa1 and Y 2 may bond to form a 5-membered ring or 6-membered ring containing at least one nitrogen atom. A heterocyclic ring, R aa2 and Y 3 can bond to form a 5-membered ring or a 6-membered ring containing at least one nitrogen atom, R aa2 and Y 4 can bond to form a 5-membered ring containing at least one nitrogen atom Or a 6-membered heterocyclic ring, Y 1 and Y 2 can be bonded to form a 5-membered ring or a 6-membered ring heterocyclic containing at least one nitrogen atom, Y 3 and Y 4 can be bonded to form a 5-membered ring or a 6-membered ring containing at least one nitrogen atom. 5-membered ring or 6-membered ring heterocycle; wherein, at least one of Y 1 to Y 4 is a group represented by formula (Y-1), and is selected from R aa1 and Y 1 , R aa1 and Y 2 , R aa2 and at least one of Y 3 and R aa2 and Y 4 bond to form a 5-membered ring or a 6-membered ring heterocycle containing at least one nitrogen atom; [Chemical 7] In formula (Y-1), the wavy line represents a bond, Ry 1 to Ry 4 independently represent a hydrogen atom, an alkyl group or an aryl group, and X 1 is a single bond, an alkylene group, an aryl group, -O-, -S-, -NRx-, -CO-, -CS-, -SO- or -SO 2 -, or it will be selected from alkylene, aryl, -O-, -S-, -NRx-, A group composed of two or more of -CO-, -CS-, -SO- and -SO 2 -, Rx represents a hydrogen atom, an alkyl group or an aryl group, Z 1 represents an alicyclic hydrocarbon group or an aromatic hydrocarbon group , heterocyclic group, a group represented by any one of the formulas (Z-1) to (Z-6); wherein, Z 1 is a group represented by the formula (Z-1) or a group represented by the formula (Z-4 ) represents a group, the part in X 1 linked to Z 1 is an alkylene group or an aryl group; [Chemical 8] In formula (Z-1) to formula (Z-6), the wavy line represents a bond; in formula (Z-1), Rz 11 represents an alkyl group or an aryl group; in formula (Z-2), Rz 12 represents hydrogen atom, -COR 100 or -COOR 100 , R 100 represents a hydrogen atom, an alkyl group or an aryl group, Rz 12a represents an alkyl group, mz represents an integer from 0 to 4; in formula (Z-3), Rz 13 to Rz 16 respectively independently represents an alkyl group, and Rz 17 represents a hydrogen atom, an alkyl group or an oxygen radical; in formula (Z-4), Rz 18 and Rz 19 independently represent an alkyl group or an aryl group; in formula (Z-6), W 1 represents a single bond, an alkylene group, an aryl group or -CO-, Rz 20 represents a hydrogen atom, an alkyl group, an aryl group or -COR 101 , and R 101 represents an alkyl group or an aryl group. [Effects of the invention]

根據本發明,能夠提供一種能夠形成保存穩定性優異且耐光性優異的膜之組成物。又,本發明能夠提供一種膜、光學濾波器、固體攝像元件、圖像顯示裝置、紅外線感測器、照相機膜組及化合物。According to the present invention, it is possible to provide a composition capable of forming a film having excellent storage stability and excellent light resistance. Furthermore, the present invention can provide a film, an optical filter, a solid-state imaging device, an image display device, an infrared sensor, a camera film assembly, and a compound.

以下,對本發明的內容進行詳細說明。 本說明書中,“~”以將記載於其前後之數值作為下限值及上限值而包括之含義來使用。 本說明書中之基團(原子團)的標記中,未標有經取代及未經取代之標記包括不具有取代基之基團(原子團)的同時包括具有取代基之基團(原子團)。例如,“烷基”不僅包括不具有取代基之烷基(未經取代之烷基),亦包括具有取代基之烷基(經取代之烷基)。 本說明書中,“曝光”只要沒有特別指定,不僅包括使用光之曝光,使用電子束、離子束等粒子束之描畫亦包括在曝光中。又,作為曝光中所使用之光,可舉出水銀燈的明線光譜、以準分子雷射為代表之遠紫外線、極紫外線(EUV光)、X射線、電子束等活性光線或放射線。 本說明書中,“(甲基)丙烯酸酯”表示丙烯酸酯及甲基丙烯酸酯兩者或任一者,“(甲基)丙烯酸”表示丙烯酸及甲基丙烯酸兩者或任一者,“(甲基)丙烯醯基”表示丙烯醯基及甲基丙烯醯基兩者或任一者。 本說明書中,將重量平均分子量及數量平均分子量定義為利用凝膠滲透層析法(GPC)測定之聚苯乙烯換算值。 本說明書中,化學式中的Me表示甲基,Et表示乙基,Bu表示丁基,Ph表示苯基。 本說明書中,紅外線表示波長700~2500nm的光(電磁波)。 本說明書中,總固體成分係指從組成物的所有成分中去除溶劑之成分的總質量。 本說明書中,“步驟”這一用語,不僅包括獨立的步驟,即使在無法與其他步驟明確區分的情況下,只要實現該步驟所期待的作用,則亦包括在本用語中。 The contents of the present invention will be described in detail below. In this specification, "~" is used in the meaning of including the numerical value described before and after it as a lower limit value and an upper limit value. Among the symbols for groups (atomic groups) in this specification, the symbols not indicating substituted and unsubstituted include groups (atomic groups) without substituents and groups (atomic groups) with substituents. For example, "alkyl" includes not only alkyl groups without substituents (unsubstituted alkyl groups) but also alkyl groups with substituents (substituted alkyl groups). In this specification, "exposure" includes not only exposure using light but also drawing using particle beams such as electron beams and ion beams, unless otherwise specified. Examples of the light used for exposure include active light or radiation such as the bright line spectrum of a mercury lamp, far ultraviolet light, extreme ultraviolet light (EUV light), X-rays, and electron beams represented by excimer lasers. In this specification, "(meth)acrylate" means both or either acrylate and methacrylate, "(meth)acrylic acid" means both or either acrylic acid and methacrylic acid, and "(meth)acrylic acid" means both or either acrylic acid and methacrylic acid. "Base) acrylyl group" means both or any one of acrylyl group and methacrylyl group. In this specification, the weight average molecular weight and the number average molecular weight are defined as polystyrene-converted values measured by gel permeation chromatography (GPC). In this specification, Me in the chemical formula represents a methyl group, Et represents an ethyl group, Bu represents a butyl group, and Ph represents a phenyl group. In this specification, infrared rays represent light (electromagnetic waves) with a wavelength of 700 to 2500 nm. In this specification, the total solid content refers to the total mass of all components of the composition excluding the solvent. In this specification, the term "step" includes not only independent steps but also those that cannot be clearly distinguished from other steps as long as the expected effect of the step is achieved.

<組成物> 本發明的組成物的特徵為包含紅外線吸收劑、硬化性化合物及溶劑且上述紅外線吸收劑包含由式(1)表示之化合物。 <Composition> The composition of the present invention is characterized by including an infrared absorber, a curable compound and a solvent, and the infrared absorber includes a compound represented by formula (1).

本發明的組成物能夠形成保存穩定性優異且長期保管後異物等的產生仍得到抑制的膜。又,本發明能夠形成耐光性優異的膜。獲得此類效果之詳細理由尚不明確,但推測為如下。The composition of the present invention can form a film having excellent storage stability and suppressing the generation of foreign matter and the like even after long-term storage. Furthermore, the present invention can form a film excellent in light resistance. The detailed reason why such effects are obtained is not yet clear, but it is speculated as follows.

推測本發明的組成物所包含之由式(1)表示之化合物具有Y 1~Y 4中的至少一個為由式(Y-1)表示之基團且選自R aa1與Y 1、R aa1與Y 2、R aa2與Y 3及R aa2與Y 4中之至少一個鍵結而形成包含至少一個氮原子之5員環或6員環的雜環之結構,由此能夠提高與組成物所包含之溶劑或硬化性化合物的相溶性,其結果,能夠製成保存穩定性優異的組成物。 又,方酸菁化合物在製膜時往往容易在膜中形成H締合。H締合的形成往往容易導致耐光性降低,但推測由式(1)表示之化合物藉由具有上述結構,能夠抑制在膜中形成H締合。因此,藉由使用本發明的組成物,能夠形成耐光性優異的膜。 It is estimated that the compound represented by formula (1) contained in the composition of the present invention has at least one of Y 1 to Y 4 that is a group represented by formula (Y-1) and is selected from R aa1 and Y 1 , R aa1 It is bonded to at least one of Y 2 , R aa2 and Y 3 , and R aa2 and Y 4 to form a structure of a 5-membered ring or a 6-membered ring heterocyclic ring containing at least one nitrogen atom, thereby improving the relationship with the composition. The compatibility of the contained solvent or curable compound results in a composition having excellent storage stability. In addition, squaraine compounds tend to easily form H associations in the film during film production. The formation of H associations tends to cause a decrease in light resistance, but it is presumed that the compound represented by formula (1) can suppress the formation of H associations in the film by having the above structure. Therefore, by using the composition of the present invention, a film excellent in light resistance can be formed.

本發明的組成物能夠用作光學濾波器用組成物。作為光學濾波器的種類,可舉出紅外線截止濾波器及紅外線透射濾波器等。 由式(1)表示之化合物由於能夠抑制在膜中形成H締合,因此藉由使用本發明的組成物,亦能夠形成可見光透射性優異且紅外線遮蔽性優異的膜。因此,本發明的組成物特佳為用作紅外線截止濾波器用組成物。 The composition of the present invention can be used as an optical filter composition. Examples of types of optical filters include infrared cutoff filters, infrared transmission filters, and the like. Since the compound represented by formula (1) can suppress the formation of H association in the film, it is possible to form a film having excellent visible light transmittance and excellent infrared shielding property by using the composition of the present invention. Therefore, the composition of the present invention is particularly preferably used as a composition for an infrared cut filter.

以下,對本發明的組成物中所使用之各成分進行說明。Each component used in the composition of the present invention will be described below.

<<紅外線吸收劑>> 本發明的組成物包含紅外線吸收劑。本發明的組成物所包含之紅外線吸收劑包含由式(1)表示之化合物。由式(1)表示之化合物亦為本發明的化合物。以下,將由式(1)表示之化合物亦稱為特定化合物。 <<Infrared absorber>> The composition of the present invention contains an infrared absorber. The infrared absorber contained in the composition of the present invention contains a compound represented by formula (1). Compounds represented by formula (1) are also compounds of the present invention. Hereinafter, the compound represented by formula (1) is also called a specific compound.

(特定化合物(由式(1)表示之化合物)) [化9] (Specific compound (compound represented by formula (1))) [Chemical 9]

式(1)的A及B分別獨立地表示芳香族烴環或芳香族雜環。 構成芳香族烴環的環之碳數為6~48為較佳,6~22為更佳,6~12為特佳。芳香族烴環為單環或縮合數為2~8的縮合環為較佳,單環或縮合數為2~4的縮合環為更佳,單環或縮合數為2或3的縮合環為進一步較佳,單環或縮合數為2的縮合環為更進一步較佳,單環為特佳。 芳香族雜環為5員環或6員環為較佳。芳香族雜環為單環或縮合數為2~8的縮合環為較佳,單環或縮合數為2~4的縮合環為更佳,單環或縮合數為2或3的縮合環為進一步較佳,單環或縮合數為2的縮合環為更進一步較佳,單環為特佳。作為構成芳香族雜環的環之雜原子,可舉出氮原子、氧原子、硫原子,氮原子、硫原子為較佳。構成芳香族雜環的環之雜原子數為1~3為較佳,1~2為更佳。 A and B in Formula (1) each independently represent an aromatic hydrocarbon ring or an aromatic heterocyclic ring. The carbon number of the rings constituting the aromatic hydrocarbon ring is preferably 6 to 48, more preferably 6 to 22, and particularly preferably 6 to 12. It is preferred that the aromatic hydrocarbon ring is a single ring or a condensed ring with a condensation number of 2 to 8, a single ring or a condensed ring with a condensation number of 2 to 4 is even more preferred, a single ring or a condensed ring with a condensation number of 2 or 3 is preferred. More preferably, a single ring or a condensed ring with a condensation number of 2 is still more preferred, and a single ring is particularly preferred. The aromatic heterocyclic ring is preferably a 5-membered ring or a 6-membered ring. The aromatic heterocyclic ring is preferably a single ring or a condensed ring with a condensation number of 2 to 8, a single ring or a condensed ring with a condensation number of 2 to 4 is even more preferably, a single ring or a condensed ring with a condensation number of 2 or 3 is More preferably, a single ring or a condensed ring with a condensation number of 2 is still more preferred, and a single ring is particularly preferred. Examples of heteroatoms constituting the ring of the aromatic heterocyclic ring include nitrogen atoms, oxygen atoms, and sulfur atoms, with nitrogen atoms and sulfur atoms being preferred. The number of heteroatoms in the ring constituting the aromatic heterocyclic ring is preferably 1 to 3, more preferably 1 to 2.

式(1)中,A及B中的至少一個(較佳為A及B兩者)為苯環、噻吩環、呋喃環、吡咯環、吡啶環、薁環或包含該等環之縮合環為較佳。作為前述縮合環,可舉出萘環、苯并噻吩環、苯并呋喃環、異苯并呋喃環、苯并咪唑環、吲哚環、異吲哚環、喹啉環、異喹啉環、噻吩并吡咯環、吡咯并噻唑環等。A及B中的至少一個(較佳為A及B兩者)為苯環或萘環為較佳,苯環為更佳。In formula (1), at least one of A and B (preferably both A and B) is a benzene ring, a thiophene ring, a furan ring, a pyrrole ring, a pyridine ring, an azulene ring or a condensed ring containing these rings: Better. Examples of the condensed ring include naphthalene ring, benzothiophene ring, benzofuran ring, isobenzofuran ring, benzimidazole ring, indole ring, isoindole ring, quinoline ring, isoquinoline ring, Thienopyrrole ring, pyrrolothiazole ring, etc. At least one of A and B (preferably both A and B) is preferably a benzene ring or a naphthalene ring, and more preferably a benzene ring.

式(1)的R aa1及R aa2分別獨立地表示鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基、烷基、芳基、雜環基、烷氧基、醯基、烷氧基羰基、-NR a11R a12、-SR a13、-SO 2R a14或-OSO 2R a15, R a11及R a12分別獨立地表示氫原子、烷基、芳基或雜環基, R a13~R a15分別獨立地表示烷基、芳基或雜環基。 R aa1 and R aa2 in formula (1) each independently represent a halogen atom, a sulfo group, a hydroxyl group, a cyano group, a nitro group, a carboxyl group, a phosphate group, an alkyl group, an aryl group, a heterocyclic group, an alkoxy group, a hydroxyl group, Alkoxycarbonyl, -NR a11 R a12 , -SR a13 , -SO 2 R a14 or -OSO 2 R a15 , R a11 and R a12 respectively independently represent a hydrogen atom, an alkyl group, an aryl group or a heterocyclic group, R a13 to R a15 each independently represent an alkyl group, an aryl group or a heterocyclic group.

作為R aa1及R aa2所表示之鹵素原子,可舉出氟原子、氯原子、溴原子、碘原子。 Examples of the halogen atom represented by R aa1 and R aa2 include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.

R aa1、R aa2、R a11~R a15所表示之烷基的碳數為1~20為較佳,1~15為更佳,1~8為進一步較佳。烷基可以為直鏈、支鏈、環狀中的任一種,直鏈或支鏈為較佳。上述烷基可以具有取代基。作為取代基,可舉出後述取代基T中舉出的基團,選自包括芳基、雜環基、鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基及胺基之群組中之至少1種為較佳。 The number of carbon atoms in the alkyl group represented by R aa1 , R aa2 , and R a11 to R a15 is preferably 1 to 20, more preferably 1 to 15, and further preferably 1 to 8. The alkyl group may be linear, branched, or cyclic, with linear or branched chains being preferred. The above-mentioned alkyl group may have a substituent. Examples of the substituent include groups exemplified in the substituent T described below, and are selected from the group consisting of an aryl group, a heterocyclic group, a halogen atom, a sulfo group, a hydroxyl group, a cyano group, a nitro group, a carboxyl group, a phosphate group, and an amino group. At least one of the groups is preferred.

R aa1、R aa2、R a11~R a15所表示之芳基的碳數為6~48為較佳,6~22為更佳,6~12為進一步較佳。上述芳基可以具有取代基。作為取代基,可舉出後述取代基T中舉出的基團,選自包括烷基、雜環基、鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基及胺基之群組中之至少1種為較佳。 The number of carbon atoms in the aryl group represented by R aa1 , R aa2 , and R a11 to R a15 is preferably 6 to 48, more preferably 6 to 22, and further preferably 6 to 12. The above-mentioned aryl group may have a substituent. Examples of the substituent include the groups listed for the substituent T described below, and are selected from the group consisting of an alkyl group, a heterocyclic group, a halogen atom, a sulfo group, a hydroxyl group, a cyano group, a nitro group, a carboxyl group, a phosphate group, and an amino group. At least one of the groups is preferred.

R aa1、R aa2、R a11~R a15所表示之雜環基為5員環或6員環的雜環基為較佳。又,雜環基為單環的雜環基或縮合數為2~8的縮合環的雜環基為較佳,單環的雜環基或縮合數為2~4的縮合環的雜環基為更佳,單環的雜環基或縮合數為2或3的縮合環的雜環基為進一步較佳。構成雜環基的環之雜原子較佳為氮原子、氧原子或硫原子。構成雜環基的環之雜原子數為1~3為較佳,1~2為更佳。構成雜環基的環之碳原子數為1~30為較佳,1~18為更佳,1~12為進一步較佳。上述雜環基可以具有取代基。作為取代基,可舉出後述取代基T中舉出的基團,選自包括烷基、芳基、雜環基、鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基及胺基之群組中之至少1種為較佳。 The heterocyclic group represented by R aa1 , R aa2 , and R a11 to R a15 is preferably a 5-membered ring or a 6-membered ring heterocyclic group. Furthermore, the heterocyclic group is preferably a monocyclic heterocyclic group or a fused cyclic heterocyclic group with a condensation number of 2 to 8, and a monocyclic heterocyclic group or a fused cyclic heterocyclic group with a condensation number of 2 to 4 is preferred. More preferably, a monocyclic heterocyclic group or a fused cyclic heterocyclic group with a condensation number of 2 or 3 is still more preferable. The heteroatoms constituting the ring of the heterocyclyl group are preferably nitrogen atoms, oxygen atoms or sulfur atoms. The number of heteroatoms in the ring constituting the heterocyclyl group is preferably 1 to 3, more preferably 1 to 2. The number of carbon atoms of the ring constituting the heterocyclic group is preferably 1 to 30, more preferably 1 to 18, and further preferably 1 to 12. The above heterocyclic group may have a substituent. Examples of the substituent include the groups listed for the substituent T described below, and are selected from the group consisting of alkyl groups, aryl groups, heterocyclic groups, halogen atoms, sulfo groups, hydroxyl groups, cyano groups, nitro groups, carboxyl groups, phosphate groups, and At least one type from the group of amine groups is preferred.

R aa1、R aa2所表示之烷氧基的碳數為1~20為較佳,1~15為更佳,1~8為進一步較佳。烷氧基為直鏈或支鏈為較佳。上述烷氧基可以具有取代基。作為取代基,可舉出後述取代基T中舉出的基團,選自包括烷基、芳基、雜環基、鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基及胺基之群組中之至少1種為較佳。 The number of carbon atoms in the alkoxy group represented by R aa1 and R aa2 is preferably 1 to 20, more preferably 1 to 15, and further preferably 1 to 8. The alkoxy group is preferably straight chain or branched chain. The above-mentioned alkoxy group may have a substituent. Examples of the substituent include the groups listed for the substituent T described below, and are selected from the group consisting of alkyl groups, aryl groups, heterocyclic groups, halogen atoms, sulfo groups, hydroxyl groups, cyano groups, nitro groups, carboxyl groups, phosphate groups, and At least one type from the group of amine groups is preferred.

R aa1、R aa2所表示之醯基的碳數為2~30為較佳,2~15為更佳,2~8為進一步較佳。作為上述醯基,可舉出甲醯基、烷基羰基、芳基羰基。烷基羰基的碳數為2~30為較佳,2~15為更佳,2~8為進一步較佳。芳基羰基的碳數為7~30為較佳,7~20為更佳,7~12為進一步較佳。上述醯基可以具有取代基。作為取代基,可舉出後述取代基T中舉出的基團,選自包括烷基、芳基、雜環基、鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基及胺基之群組中之至少1種為較佳。 The carbon number of the acyl group represented by R aa1 and R aa2 is preferably 2 to 30, more preferably 2 to 15, and further preferably 2 to 8. Examples of the above-mentioned acyl group include a formyl group, an alkylcarbonyl group, and an arylcarbonyl group. The number of carbon atoms in the alkylcarbonyl group is preferably 2 to 30, more preferably 2 to 15, and still more preferably 2 to 8. The carbon number of the arylcarbonyl group is preferably 7 to 30, more preferably 7 to 20, and further preferably 7 to 12. The above-mentioned acyl group may have a substituent. Examples of the substituent include the groups listed for the substituent T described below, and are selected from the group consisting of alkyl groups, aryl groups, heterocyclic groups, halogen atoms, sulfo groups, hydroxyl groups, cyano groups, nitro groups, carboxyl groups, phosphate groups, and At least one type from the group of amine groups is preferred.

R aa1、R aa2所表示之烷氧基羰基的碳數為2~30為較佳,2~15為更佳,2~8為進一步較佳。上述烷氧基羰基可以具有取代基。作為取代基,可舉出後述取代基T中舉出的基團,選自包括烷基、芳基、雜環基、鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基及胺基之群組中之至少1種為較佳。 The carbon number of the alkoxycarbonyl group represented by R aa1 and R aa2 is preferably 2 to 30, more preferably 2 to 15, and further preferably 2 to 8. The alkoxycarbonyl group may have a substituent. Examples of the substituent include the groups listed for the substituent T described below, and are selected from the group consisting of alkyl groups, aryl groups, heterocyclic groups, halogen atoms, sulfo groups, hydroxyl groups, cyano groups, nitro groups, carboxyl groups, phosphate groups, and At least one type from the group of amine groups is preferred.

式(1)的m1表示0~mA的整數,mA表示R aa1可取代A之最大的整數, m2表示0~mB的整數,mB表示R aa2可取代B之最大的整數, m1為2以上時,m1個R aa1中2個R aa1可以彼此鍵結而形成環, m2為2以上時,m2個R aa2中2個R aa2可以彼此鍵結而形成環。 例如,A為苯環時,mA為2。m1及m2分別獨立地為0~2的整數為較佳,1或2為更佳。 m1 in formula (1) represents an integer from 0 to mA, mA represents the largest integer that R aa1 can replace A, m2 represents an integer from 0 to mB, mB represents the largest integer that R aa2 can replace B, when m1 is 2 or more , two R aa1 out of m1 R aa1 can bond with each other to form a ring, and when m2 is 2 or more, two R aa2 out of m2 R aa2 can bond with each other to form a ring. For example, when A is a benzene ring, mA is 2. It is preferable that m1 and m2 are each independently an integer of 0 to 2, and 1 or 2 is more preferable.

式(1)的R b1~R b4分別獨立地表示氫原子、鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基、烷基、芳基、雜環基、烷氧基、醯基、烷氧基羰基、-NR b11R b12、-NHCOR b13、-NHSO 2R b14、-NHCSNHR b15、-SR b16、-SO 2R b17、-OSO 2R b18、-NHCSR b19、-NHCONHR b20或-NHCOOR b21, R b11及R b12分別獨立地表示氫原子、烷基、芳基或雜環基, R b13~R b21分別獨立地表示烷基、芳基或雜環基。 R b1 to R b4 in the formula (1) each independently represent a hydrogen atom, a halogen atom, a sulfo group, a hydroxyl group, a cyano group, a nitro group, a carboxyl group, a phosphate group, an alkyl group, an aryl group, a heterocyclic group, an alkoxy group, Cyl group, alkoxycarbonyl group, -NR b11 R b12 , -NHCOR b13 , -NHSO 2 R b14 , -NHCSNHR b15 , -SR b16 , -SO 2 R b17 , -OSO 2 R b18 , -NHCSR b19 , -NHCONHR b20 or -NHCOOR b21 , R b11 and R b12 each independently represent a hydrogen atom, an alkyl group, an aryl group or a heterocyclic group, and R b13 to R b21 each independently represent an alkyl group, an aryl group or a heterocyclic group.

R b1~R b4所表示之鹵素原子、烷氧基、醯基及烷氧基羰基與R aa1及R aa2所表示之鹵素原子、烷氧基、醯基及烷氧基羰基相同,較佳範圍亦相同。 R b1~R b4及R b11~R b21所表示之烷基、芳基及雜環基與R aa1及R aa2所表示之烷基、芳基及雜環基相同,較佳範圍亦相同。 從能夠進一步提高可見光透射性及紅外線遮蔽性的理由考慮,R b11~R b21所表示之烷基為氟烷基亦較佳。 The halogen atoms, alkoxy groups, hydroxyl groups and alkoxycarbonyl groups represented by R b1 to R b4 are the same as the halogen atoms, alkoxy groups, hydroxyl groups and alkoxycarbonyl groups represented by R aa1 and R aa2 , and the preferred range is Same thing. The alkyl group, aryl group and heterocyclic group represented by R b1 to R b4 and R b11 to R b21 are the same as the alkyl group, aryl group and heterocyclic group represented by R aa1 and R aa2 , and the preferred ranges are also the same. It is also preferable that the alkyl group represented by R b11 to R b21 is a fluoroalkyl group because the visible light transmittance and the infrared shielding property can be further improved.

式(1)中,R b1及R b2中的至少一個和R b3及R b4中的至少一個分別獨立地表示-NHCOR b13、-NHSO 2R b14、-NHCSNHR b15、-SO 2R b17、-NHCSR b19、-NHCONHR b20或-NHCOOR b21為較佳,從能夠進一步提高可見光透射性及紅外線遮蔽性的理由考慮,-NHCOR b13或-NHSO 2R b14為更佳,-NHCOR b13為進一步較佳。R b13、R b14、R b15、R b17、R b19、R b20及R b21分別獨立地為烷基或芳基為較佳,烷基為更佳,從能夠進一步提高可見光透射性及紅外線遮蔽性的理由考慮,氟烷基為進一步較佳。 In formula (1), at least one of R b1 and R b2 and at least one of R b3 and R b4 independently represent -NHCOR b13 , -NHSO 2 R b14 , -NHCSNHR b15 , -SO 2 R b17 , - NHCSR b19 , -NHCONHR b20 or -NHCOOR b21 are preferred, and -NHCOR b13 or -NHSO 2 R b14 is more preferred, since it can further improve visible light transmittance and infrared shielding properties, and -NHCOR b13 is even more preferred. It is preferred that R b13 , R b14 , R b15 , R b17 , R b19 , R b20 and R b21 are each independently an alkyl group or an aryl group, and an alkyl group is more preferred, so that the visible light transmittance and infrared shielding properties can be further improved. Considering the reasons, fluoroalkyl group is further preferred.

式(1)中,R b1及R b2中的一個為-NHCOR b13、-NHSO 2R b14、-NHCSNHR b15、-SO 2R b17、-NHCSR b19、-NHCONHR b20或-NHCOOR b21,另一個為氫原子,且R b3及R b4中的一個為-NHCOR b13、-NHSO 2R b14、-NHCSNHR b15、-SO 2R b17、-NHCSR b19、-NHCONHR b20或-NHCOOR b21,另一個為氫原子為較佳,R b1及R b2中的一個為-NHCOR b13或-NHSO 2R b14,另一個為氫原子,且R b3及R b4中的一個為-NHCOR b13或-NHSO 2R b14,另一個為氫原子為更佳,R b1及R b2中的一個為-NHCOR b13,另一個為氫原子,且R b3及R b4中的一個為-NHCOR b13,另一個為氫原子為進一步較佳。 In formula (1), one of R b1 and R b2 is -NHCOR b13 , -NHSO 2 R b14 , -NHCSNHR b15 , -SO 2 R b17 , -NHCSR b19 , -NHCONHR b20 or -NHCOOR b21 , and the other is A hydrogen atom, and one of R b3 and R b4 is -NHCOR b13 , -NHSO 2 R b14 , -NHCSNHR b15 , -SO 2 R b17 , -NHCSR b19 , -NHCONHR b20 or -NHCOOR b21 , and the other is a hydrogen atom Preferably, one of R b1 and R b2 is -NHCOR b13 or -NHSO 2 R b14 , the other is a hydrogen atom, and one of R b3 and R b4 is -NHCOR b13 or -NHSO 2 R b14 , and the other is a hydrogen atom. It is more preferred that one is a hydrogen atom, one of R b1 and R b2 is -NHCOR b13 and the other is a hydrogen atom, and one of R b3 and R b4 is -NHCOR b13 and the other is a hydrogen atom. .

式(1)的Y 1~Y 4分別獨立地表示氫原子、烷基、芳基、雜環基或由式(Y-1)表示之基團, R aa1與Y 1可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, R aa1與Y 2可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, R aa2與Y 3可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, R aa2與Y 4可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, Y 1與Y 2可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, Y 3與Y 4可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環。 其中,Y 1~Y 4中的至少一個為由式(Y-1)表示之基團,且選自R aa1與Y 1、R aa1與Y 2、R aa2與Y 3及R aa2與Y 4中之至少一個鍵結而形成包含至少一個氮原子之5員環或6員環的雜環。 Y 1 to Y 4 in formula (1) each independently represent a hydrogen atom, an alkyl group, an aryl group, a heterocyclic group or a group represented by formula (Y-1), and R aa1 and Y 1 may be bonded to form a group consisting of A heterocyclic ring with a 5-membered ring or a 6-membered ring with at least one nitrogen atom, R aa1 and Y 2 may bond to form a heterocyclic ring with a 5-membered ring or a 6-membered ring containing at least one nitrogen atom, R aa2 and Y 3 may bond R aa2 and Y 4 can be bonded to form a heterocyclic ring containing a 5-membered ring or a 6-membered ring containing at least one nitrogen atom, and Y 1 and Y 2 can be bonded to form a heterocyclic ring containing a 5-membered ring or a 6-membered ring containing at least one nitrogen atom, and Y 3 and Y 4 can be bonded to form a heterocyclic ring containing a 5-membered ring or a 6-membered ring containing at least one nitrogen atom. . Among them, at least one of Y 1 to Y 4 is a group represented by formula (Y-1), and is selected from R aa1 and Y 1 , R aa1 and Y 2 , R aa2 and Y 3 and R aa2 and Y 4 At least one of them bonds to form a 5- or 6-membered heterocyclic ring containing at least one nitrogen atom.

式(1)的Y 1~Y 4所表示之烷基、芳基及雜環基與R aa1及R aa2所表示之烷基、芳基及雜環基相同,較佳範圍亦相同。 The alkyl group, aryl group and heterocyclic group represented by Y 1 to Y 4 in the formula (1) are the same as the alkyl group, aryl group and heterocyclic group represented by R aa1 and R aa2 , and the preferred ranges are also the same.

式(1)中,Y 1及Y 2中的至少一個和Y 3及Y 4中的至少一個分別獨立地為由式(Y-1)表示之基團為較佳。 In the formula (1), it is preferred that at least one of Y 1 and Y 2 and at least one of Y 3 and Y 4 be independently a group represented by the formula (Y-1).

對式(1)的Y 1~Y 4所表示之由式(Y-1)表示之基團進行說明。 [化10] The group represented by formula (Y-1) represented by Y 1 to Y 4 of formula (1) will be described. [Chemical 10]

式(Y-1)的波線表示鍵結鍵。The wavy lines in formula (Y-1) represent bonding bonds.

式(Y-1)的Ry 1~Ry 4分別獨立地表示氫原子、烷基或芳基。 Ry 1~Ry 4所表示之烷基的碳數為1~20為較佳,1~15為更佳,1~8為進一步較佳。烷基可以為直鏈、支鏈、環狀中的任一種,直鏈或支鏈為較佳。上述烷基可以具有取代基。作為取代基,可舉出在後述取代基T中舉出的基團。 Ry 1~Ry 4所表示之芳基的碳數為6~48為較佳,6~22為更佳,6~12為進一步較佳。上述芳基可以具有取代基。作為取代基,可舉出在後述取代基T中舉出的基團。 Ry 1~Ry 4為氫原子為較佳。 Ry 1 to Ry 4 in the formula (Y-1) each independently represent a hydrogen atom, an alkyl group or an aryl group. The number of carbon atoms in the alkyl group represented by Ry 1 to Ry 4 is preferably 1 to 20, more preferably 1 to 15, and further preferably 1 to 8. The alkyl group may be linear, branched, or cyclic, with linear or branched chains being preferred. The above-mentioned alkyl group may have a substituent. Examples of the substituent include groups exemplified by the substituent T described below. The number of carbon atoms in the aryl group represented by Ry 1 to Ry 4 is preferably 6 to 48, more preferably 6 to 22, and further preferably 6 to 12. The above-mentioned aryl group may have a substituent. Examples of the substituent include groups exemplified by the substituent T described below. Ry 1 to Ry 4 are preferably hydrogen atoms.

式(Y-1)的X 1為單鍵、伸烷基、伸芳基、-O-、-S-、-NRx-、-CO-、-CS-、-SO-或-SO 2-,或者表示將選自伸烷基、伸芳基、-O-、-S-、-NRx-、-CO-、-CS-、-SO-及-SO 2-中之2個以上組合而成之基團,Rx表示氫原子、烷基或芳基。其中,Z 1為由式(Z-1)表示之基團或由式(Z-4)表示之基團時,X 1中的與Z 1連結之部分為伸烷基或伸芳基。 X 1 of formula (Y-1) is a single bond, an alkylene group, an aryl group, -O-, -S-, -NRx-, -CO-, -CS-, -SO- or -SO 2 -, Or it means a combination of two or more selected from the group consisting of alkylene group, aryl group, -O-, -S-, -NRx-, -CO-, -CS-, -SO- and -SO 2 - Group, Rx represents a hydrogen atom, an alkyl group or an aryl group. When Z 1 is a group represented by formula (Z-1) or a group represented by formula (Z-4), the part in X 1 linked to Z 1 is an alkylene group or an aryl group.

X 1所表示之伸烷基的碳數為1~20為較佳,1~15為更佳,1~8為進一步較佳。 X 1所表示之伸芳基的碳數為6~48為較佳,6~22為更佳,6~12為進一步較佳。 Rx所表示之烷基的碳數為1~20為較佳,1~15為更佳,1~8為進一步較佳。烷基可以為直鏈、支鏈、環狀中的任一種,直鏈或支鏈為較佳。 Rx所表示之芳基的碳數為6~48為較佳,6~22為更佳,6~12為進一步較佳。 The number of carbon atoms in the alkylene group represented by X 1 is preferably 1 to 20, more preferably 1 to 15, and further preferably 1 to 8. The number of carbon atoms in the aryl group represented by X 1 is preferably 6 to 48, more preferably 6 to 22, and further preferably 6 to 12. The number of carbon atoms of the alkyl group represented by Rx is preferably 1 to 20, more preferably 1 to 15, and further preferably 1 to 8. The alkyl group may be linear, branched, or cyclic, with linear or branched chains being preferred. The number of carbon atoms of the aryl group represented by Rx is preferably 6 to 48, more preferably 6 to 22, and still more preferably 6 to 12.

式(Y-1)的X 1為由式(X-1)表示之基團為較佳。 *1-X 11-X 12-X 13- *2・・・・・・(X-1) *1*2表示鍵結鍵, *2為與Z 1的鍵結鍵。 X 11及X 13分別獨立地表示單鍵、-O-、-S-、-NRx-、-NRxCO-、-CONRx-、-CO-、-OCO-、-COO-、-CS-、-SO-或-SO 2-,Rx表示氫原子、烷基或芳基, X 12表示單鍵、伸烷基或伸芳基。 其中,式(Y-1)的Z 1為由式(Z-1)表示之基團或由式(Z-4)表示之基團時,X 12為伸烷基或伸芳基,X 13為單鍵。 X 1 of formula (Y-1) is preferably a group represented by formula (X-1). *1 -X 11 -X 12 -X 13 - *2 ・・・・・・ (X-1) *1 and *2 indicate bonding bonds, and *2 represents the bonding bond with Z 1 . X 11 and X 13 independently represent single bonds, -O-, -S-, -NRx-, -NRxCO-, -CONRx-, -CO-, -OCO-, -COO-, -CS-, -SO - or -SO 2 -, Rx represents a hydrogen atom, an alkyl group or an aryl group, X 12 represents a single bond, an alkyl group or an aryl group. Wherein, when Z 1 of the formula (Y-1) is a group represented by the formula (Z-1) or a group represented by the formula (Z-4), X 12 is an alkylene group or an aryl group, and X 13 is a single key.

X 11及X 13分別獨立地為單鍵、-O-、-NRx-、-NRxCO-、-CONRx-、-CO-、-OCO-或為較佳。 X 12為單鍵或伸烷基為較佳。 X 11 and X 13 are each independently a single bond, -O-, -NRx-, -NRxCO-, -CONRx-, -CO-, -OCO- or preferably. X 12 is preferably a single bond or an alkylene group.

式(Y-1)的Z 1為脂環式烴基、芳香族烴基或雜環基時,從保存穩定性、耐光性的觀點考慮,X 13為-O-為較佳。 When Z 1 in the formula (Y-1) is an alicyclic hydrocarbon group, an aromatic hydrocarbon group or a heterocyclic group, it is preferable that X 13 is -O- from the viewpoint of storage stability and light resistance.

式(Y-1)的Z 1為由式(Z-6)表示之基團且W 1為-CO-時,X 12為伸烷基或伸芳基,X 13為單鍵為較佳。 When Z 1 of formula (Y-1) is a group represented by formula (Z-6) and W 1 is -CO-, X 12 is an alkylene group or an aryl group, and X 13 is preferably a single bond.

式(Y-1)的Z 1表示脂環式烴基、芳香族烴基、雜環基、由式(Z-1)~(Z-6)中的任一個表示之基團。 Z 1 in formula (Y-1) represents an alicyclic hydrocarbon group, an aromatic hydrocarbon group, a heterocyclic group, or a group represented by any one of formulas (Z-1) to (Z-6).

Z 1所表示之脂環式烴基可以為單環的脂環式烴基,亦可以為多環的脂環式烴基。又,多環的脂環式烴基可以具有交聯結構,亦可以具有螺環結構。脂環式烴基可以具有取代基。作為取代基,可舉出後述取代基T中舉出的基團,烷基、芳基、烷氧基、芳氧基、烷氧基羰基、芳氧基羰基或醯氧基為較佳。 The alicyclic hydrocarbon group represented by Z 1 may be a monocyclic alicyclic hydrocarbon group or a polycyclic alicyclic hydrocarbon group. In addition, the polycyclic alicyclic hydrocarbon group may have a cross-linked structure or a spiro ring structure. The alicyclic hydrocarbon group may have a substituent. Examples of the substituent include the groups exemplified in the substituent T described below, and an alkyl group, an aryl group, an alkoxy group, an aryloxy group, an alkoxycarbonyl group, an aryloxycarbonyl group or a acyloxy group are preferred.

Z 1所表示之芳香族烴基可以為單環的芳香族烴基,亦可以為縮合環的芳香族烴基。芳香族烴基的碳數為6~48為較佳,6~22為更佳,6~12為進一步較佳。芳香族烴基可以具有取代基。作為取代基,可舉出後述取代基T中舉出的基團,烷基、芳基、烷氧基、芳氧基、烷氧基羰基、芳氧基羰基或醯氧基為較佳。 The aromatic hydrocarbon group represented by Z 1 may be a monocyclic aromatic hydrocarbon group or a condensed ring aromatic hydrocarbon group. The carbon number of the aromatic hydrocarbon group is preferably 6 to 48, more preferably 6 to 22, and still more preferably 6 to 12. The aromatic hydrocarbon group may have a substituent. Examples of the substituent include the groups exemplified in the substituent T described below, and an alkyl group, an aryl group, an alkoxy group, an aryloxy group, an alkoxycarbonyl group, an aryloxycarbonyl group or a acyloxy group are preferred.

Z 1所表示之雜環基為5員環或6員環的雜環基為較佳。雜環基為單環的雜環基或縮合數為2~8的縮合環的雜環基為較佳,單環的雜環基或縮合數為2~4的縮合環的雜環基為更佳,單環的雜環基或縮合數為2或3的縮合環的雜環基為進一步較佳。構成雜環基的環之雜原子較佳為氮原子、氧原子或硫原子。構成雜環基的環之雜原子數為1~3為較佳,1~2為更佳。構成雜環基的環之碳原子數為1~30為較佳,1~18為更佳,1~12為進一步較佳。雜環基可以具有取代基。作為取代基,可舉出在後述取代基T中舉出的基團。 The heterocyclic group represented by Z 1 is preferably a 5-membered ring or a 6-membered ring heterocyclic group. The heterocyclic group is preferably a monocyclic heterocyclic group or a fused cyclic heterocyclic group with a condensation number of 2 to 8, and more preferably a monocyclic heterocyclic group or a fused cyclic heterocyclic group with a condensation number of 2 to 4. Preferably, a monocyclic heterocyclic group or a fused cyclic heterocyclic group with a condensation number of 2 or 3 is further preferred. The heteroatoms constituting the ring of the heterocyclyl group are preferably nitrogen atoms, oxygen atoms or sulfur atoms. The number of heteroatoms in the ring constituting the heterocyclyl group is preferably 1 to 3, more preferably 1 to 2. The number of carbon atoms of the ring constituting the heterocyclic group is preferably 1 to 30, more preferably 1 to 18, and further preferably 1 to 12. The heterocyclic group may have a substituent. Examples of the substituent include groups exemplified by the substituent T described below.

[化11] [Chemical 11]

式(Z-1)~式(Z-6)中,波線表示鍵結鍵; 式(Z-1)中,Rz 11表示烷基或芳基; 式(Z-2)中,Rz 12表示氫原子、-COR 100或-COOR 100,R 100表示氫原子、烷基或芳基,Rz 12a表示烷基,mz表示0~4的整數; 式(Z-3)中,Rz 13~Rz 16分別獨立地表示烷基,Rz 17表示氫原子、烷基或氧自由基; 式(Z-4)中,Rz 18及Rz 19分別獨立地表示烷基或芳基; 式(Z-6)中,W 1表示單鍵、伸烷基、伸芳基或-CO-,Rz 20表示氫原子、烷基、芳基或-COR 101,R 101表示烷基或芳基。 In formula (Z-1) to formula (Z-6), the wavy line represents a bond; in formula (Z-1), Rz 11 represents an alkyl group or an aryl group; in formula (Z-2), Rz 12 represents hydrogen atom, -COR 100 or -COOR 100 , R 100 represents a hydrogen atom, an alkyl group or an aryl group, Rz 12a represents an alkyl group, mz represents an integer from 0 to 4; in formula (Z-3), Rz 13 to Rz 16 respectively independently represents an alkyl group, and Rz 17 represents a hydrogen atom, an alkyl group or an oxygen radical; in formula (Z-4), Rz 18 and Rz 19 independently represent an alkyl group or an aryl group; in formula (Z-6), W 1 represents a single bond, an alkylene group, an aryl group or -CO-, Rz 20 represents a hydrogen atom, an alkyl group, an aryl group or -COR 101 , and R 101 represents an alkyl group or an aryl group.

式(Z-1)的Rz 11表示烷基或芳基,烷基為較佳。烷基的碳數為1~20為較佳,1~15為更佳,1~8為進一步較佳。烷基可以為直鏈、支鏈、環狀中的任一種。又,烷基可以未經取代,亦可以具有取代基。作為取代基,可舉出在後述取代基T中舉出的基團。芳基的碳數為6~30為較佳,6~20為更佳,6~12為進一步較佳。又,芳基可以未經取代,亦可以具有取代基。作為取代基,可舉出在後述取代基T中舉出的基團。 Rz 11 in the formula (Z-1) represents an alkyl group or an aryl group, with an alkyl group being preferred. The number of carbon atoms in the alkyl group is preferably 1 to 20, more preferably 1 to 15, and further preferably 1 to 8. The alkyl group may be linear, branched, or cyclic. In addition, the alkyl group may be unsubstituted or may have a substituent. Examples of the substituent include groups exemplified by the substituent T described below. The aryl group preferably has 6 to 30 carbon atoms, more preferably 6 to 20 carbon atoms, and further preferably 6 to 12 carbon atoms. In addition, the aryl group may be unsubstituted or may have a substituent. Examples of the substituent include groups exemplified by the substituent T described below.

式(Z-2)的Rz 12表示氫原子、-COR 100或-COOR 100,R 100表示氫原子、烷基或芳基,Rz 12a表示烷基,mz表示0~4的整數。從耐光性的觀點考慮,Rz 12為氫原子為較佳。 關於R 100所表示之烷基及芳基,與Rz 11中說明的範圍相同。 mz表示0~4的整數,0~2的整數為較佳,1或2為更佳。 Rz 12a所表示之烷基的碳數為1~10為較佳,1~5為更佳。烷基可以為直鏈、支鏈、環狀中的任一種,直鏈或支鏈為較佳,支鏈為更佳。 Rz 12 in the formula (Z-2) represents a hydrogen atom, -COR 100 or -COOR 100 , R 100 represents a hydrogen atom, an alkyl group or an aryl group, Rz 12a represents an alkyl group, and mz represents an integer of 0 to 4. From the viewpoint of light resistance, Rz 12 is preferably a hydrogen atom. The alkyl group and aryl group represented by R 100 are in the same range as described for Rz 11 . mz represents an integer from 0 to 4, an integer from 0 to 2 is preferred, and 1 or 2 is more preferred. The number of carbon atoms in the alkyl group represented by Rz 12a is preferably 1 to 10, more preferably 1 to 5. The alkyl group can be any one of straight chain, branched chain, and cyclic. Straight chain or branched chain is preferred, and branched chain is more preferred.

式(Z-3)的Rz 13~Rz 16分別獨立地表示烷基,Rz 17表示氫原子、烷基或氧自由基(-O・)。Rz 13~Rz 17所表示之烷基的碳數為1~10為較佳,1~5為更佳。烷基可以為直鏈、支鏈、環狀中的任一種,直鏈或支鏈為較佳。 Rz 13 to Rz 16 in the formula (Z-3) each independently represent an alkyl group, and Rz 17 represents a hydrogen atom, an alkyl group or an oxygen radical (-O・). The number of carbon atoms in the alkyl group represented by Rz 13 to Rz 17 is preferably 1 to 10, more preferably 1 to 5. The alkyl group may be linear, branched, or cyclic, with linear or branched chains being preferred.

式(Z-4)中,Rz 18及Rz 19分別獨立地表示烷基或芳基,芳基為較佳。關於Rz 18及Rz 19所表示之烷基及芳基,與Rz 11中說明的範圍相同。 In formula (Z-4), Rz 18 and Rz 19 each independently represent an alkyl group or an aryl group, with an aryl group being preferred. The alkyl group and aryl group represented by Rz 18 and Rz 19 are in the same range as described for Rz 11 .

式(Z-6)的W 1表示單鍵、伸烷基、伸芳基或-CO-,Rz 20表示氫原子、烷基、芳基或-COR 101,R 101表示烷基或芳基。W 1所表示之伸烷基的碳數為1~20為較佳,1~15為更佳,1~8為進一步較佳。W 1所表示之伸芳基的碳數為6~48為較佳,6~22為更佳,6~12為進一步較佳。W 1為-CO-為較佳。Rz 20為氫原子、烷基或-COR 101為較佳,氫原子為更佳。關於R 101所表示之烷基及芳基,與Rz 11中說明的範圍相同。 W 1 in the formula (Z-6) represents a single bond, an alkylene group, an aryl group or -CO-, Rz 20 represents a hydrogen atom, an alkyl group, an aryl group or -COR 101 , and R 101 represents an alkyl group or an aryl group. The number of carbon atoms in the alkylene group represented by W 1 is preferably 1 to 20, more preferably 1 to 15, and further preferably 1 to 8. The number of carbon atoms in the aryl group represented by W 1 is preferably 6 to 48, more preferably 6 to 22, and still more preferably 6 to 12. It is preferred that W 1 is -CO-. Rz 20 is preferably a hydrogen atom, an alkyl group or -COR 101 , more preferably a hydrogen atom. The alkyl group and aryl group represented by R 101 are in the same range as described for Rz 11 .

從耐光性的觀點考慮,式(Y-1)的Z 1為由式(Z-1)~(Z-6)中的任一個表示之基團為較佳,由式(Z-1)~(Z-4)中的任一個表示之基團為更佳,由式(Z-2)或式(Z-4)表示之基團為進一步較佳,由式(Z-2)表示之基團為特佳。 From the viewpoint of light resistance, Z 1 of the formula (Y-1) is preferably a group represented by any one of the formulas (Z-1) to (Z-6), and the group represented by the formulas (Z-1) to A group represented by any one of (Z-4) is more preferred, a group represented by formula (Z-2) or formula (Z-4) is still more preferred, a group represented by formula (Z-2) The group is particularly good.

式(1)的Y 1及Y 2中的任一個和Y 3及Y 4中的任一個分別獨立地為由式(Y-1)表示之基團時,Y 1及Y 2中的任一個所表示之由式(Y-1)表示之基團中的Z 1與Y 3及Y 4中的任一個所表示之由式(Y-1)表示之基團中的Z 1可以相同,亦可以不同。不同基團時,從耐光性的觀點考慮,一個Z 1為由式(Z-1)或式(Z-4)表示之基團,另一個Z 1為式(Z-2)、式(Z-3)或式(Z-6)為較佳。 When any one of Y 1 and Y 2 and any one of Y 3 and Y 4 in the formula (1) are each independently a group represented by the formula (Y-1), either one of Y 1 and Y 2 Z 1 in the group represented by formula (Y-1) may be the same as Z 1 in the group represented by formula (Y- 1 ) represented by any one of Y 3 and Y 4 , or Can be different. When different groups are used, from the viewpoint of light resistance, one Z 1 is a group represented by formula (Z-1) or formula (Z-4), and the other Z 1 is a group represented by formula (Z-2) or formula (Z -3) or formula (Z-6) is better.

再者,有時特定化合物(由式(1)表示之化合物)中存在處於共振關係的化合物,本發明中,特定化合物(由式(1)表示之化合物)亦包含其共振結構。Furthermore, a specific compound (compound represented by formula (1)) may have a compound in a resonance relationship. In the present invention, the specific compound (compound represented by formula (1)) also includes its resonance structure.

特定化合物為由式(2)表示之化合物為較佳。 [化12] 式(2)中,R a1~R a4分別獨立地表示氫原子、鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基、烷基、芳基、雜環基、烷氧基、醯基、烷氧基羰基、-NR a11R a12、-SR a13、-SO 2R a14或-OSO 2R a15, R a11及R a12分別獨立地表示氫原子、烷基、芳基或雜環基, R a13~R a15分別獨立地表示烷基、芳基或雜環基, R b1~R b4分別獨立地表示氫原子、鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基、烷基、芳基、雜環基、烷氧基、醯基、烷氧基羰基、-NR b11R b12、-NHCOR b13、-NHSO 2R b14、-NHCSNHR b15、-SR b16、-SO 2R b17、-OSO 2R b18、-NHCSR b19、-NHCONHR b20或-NHCOOR b21, R b11及R b12分別獨立地表示氫原子、烷基、芳基或雜環基, R b13~R b21分別獨立地表示烷基、芳基或雜環基, Y 1~Y 4分別獨立地表示氫原子、烷基、芳基、雜環基或由式(Y-1)表示之基團, R a1與Y 1可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, R a2與Y 2可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, R a3與Y 3可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, R a4與Y 4可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, Y 1與Y 2可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, Y 3與Y 4可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環; 其中,Y 1~Y 4中的至少一個為由式(Y-1)表示之基團,且選自R a1與Y 1、R a2與Y 2、R a3與Y 3及R a4與Y 4中之至少一個鍵結而形成包含至少一個氮原子之5員環或6員環的雜環。 The specific compound is preferably a compound represented by formula (2). [Chemical 12] In formula (2), R a1 to R a4 each independently represent a hydrogen atom, a halogen atom, a sulfo group, a hydroxyl group, a cyano group, a nitro group, a carboxyl group, a phosphate group, an alkyl group, an aryl group, a heterocyclic group, and an alkoxy group. , acyl group, alkoxycarbonyl group, -NR a11 R a12 , -SR a13 , -SO 2 R a14 or -OSO 2 R a15 , R a11 and R a12 respectively independently represent a hydrogen atom, an alkyl group, an aryl group or a hetero Ring group, R a13 to R a15 independently represent an alkyl group, an aryl group or a heterocyclic group, R b1 to R b4 respectively independently represent a hydrogen atom, a halogen atom, a sulfo group, a hydroxyl group, a cyano group, a nitro group, a carboxyl group, Phosphate group, alkyl group, aryl group, heterocyclyl group, alkoxy group, acyl group, alkoxycarbonyl group, -NR b11 R b12 , -NHCOR b13 , -NHSO 2 R b14 , -NHCSNHR b15 , -SR b16 , - SO 2 R b17 , -OSO 2 R b18 , -NHCSR b19 , -NHCONHR b20 or -NHCOOR b21 , R b11 and R b12 independently represent a hydrogen atom, an alkyl group, an aryl group or a heterocyclic group, R b13 ~ R b21 Each independently represents an alkyl group, an aryl group or a heterocyclic group, Y 1 to Y 4 each independently represents a hydrogen atom, an alkyl group, an aryl group, a heterocyclic group or a group represented by formula (Y-1), R a1 It can bond with Y 1 to form a heterocyclic ring containing a 5-membered ring or a 6-membered ring containing at least one nitrogen atom. R a2 and Y 2 can bond to form a heterocyclic ring containing a 5-membered ring or a 6-membered ring containing at least one nitrogen atom. Ring, R a3 and Y 3 can bond to form a 5-membered ring or a 6-membered heterocyclic ring containing at least one nitrogen atom, R a4 and Y 4 can bond to form a 5-membered ring or 6-membered ring containing at least one nitrogen atom A heterocyclic ring with 5 members, Y 1 and Y 2 can be bonded to form a 5-membered ring or a 6-membered ring containing at least one nitrogen atom, Y 3 and Y 4 can be bonded to form a 5-membered ring containing at least one nitrogen atom. membered ring or 6-membered ring heterocycle; wherein, at least one of Y 1 to Y 4 is a group represented by formula (Y-1), and is selected from R a1 and Y 1 , R a2 and Y 2 , R a3 is bonded to at least one of Y 3 and R a4 to Y 4 to form a 5-membered or 6-membered heterocyclic ring containing at least one nitrogen atom.

式(2)的R b1~R b4與式(1)的R b1~R b4的含義相同。 式(2)的Y 1~Y 4與式(1)的Y 1~Y 4的含義相同。 R b1 to R b4 in the formula (2) have the same meaning as R b1 to R b4 in the formula (1). Y 1 to Y 4 in the formula (2) have the same meaning as Y 1 to Y 4 in the formula (1).

式(2)的R a1~R a4所表示之鹵素原子、烷氧基、醯基及烷氧基羰基與式(2)的R aa1及R aa2所表示之鹵素原子、烷氧基、醯基及烷氧基羰基相同,較佳範圍亦相同。 式(2)中的R a1~R a4、R a11~R a15所表示之烷基、芳基及雜環基與式(1)的R aa1及R aa2所表示之烷基、芳基及雜環基相同,較佳範圍亦相同。 The halogen atom, alkoxy group, hydroxyl group and alkoxycarbonyl group represented by R a1 to R a4 of the formula (2) and the halogen atom, alkoxy group and hydroxyl group represented by R aa1 and R aa2 of the formula (2) It is the same as alkoxycarbonyl group, and the preferable range is also the same. The alkyl group, aryl group and heterocyclic group represented by R a1 to R a4 and R a11 to R a15 in the formula (2) are the same as the alkyl group, aryl group and heterocyclic group represented by the R aa1 and R aa2 of the formula (1). The ring groups are the same and the preferred ranges are also the same.

式(2)中,R b1及R b2中的至少一個和R b3及R b4中的至少一個分別獨立地為-NHCOR b13、-NHSO 2R b14、-NHCSNHR b15、-SO 2R b17、-NHCSR b19、-NHCONHR b20或-NHCOOR b21為較佳,從能夠進一步提高可見光透射性及紅外線遮蔽性的理由考慮,-NHCOR b13或-NHSO 2R b14為更佳,-NHCOR b13為進一步較佳。R b13、R b14、R b15、R b17、R b19、R b20及R b21分別獨立地為烷基或芳基為較佳,烷基為更佳,從能夠進一步提高可見光透射性及紅外線遮蔽性的理由考慮,氟烷基為進一步較佳。 In the formula (2), at least one of R b1 and R b2 and at least one of R b3 and R b4 are independently -NHCOR b13 , -NHSO 2 R b14 , -NHCSNHR b15 , -SO 2 R b17 , - NHCSR b19 , -NHCONHR b20 or -NHCOOR b21 are preferred, and -NHCOR b13 or -NHSO 2 R b14 is more preferred, since it can further improve visible light transmittance and infrared shielding properties, and -NHCOR b13 is even more preferred. It is preferred that R b13 , R b14 , R b15 , R b17 , R b19 , R b20 and R b21 are each independently an alkyl group or an aryl group, and an alkyl group is more preferred, so that the visible light transmittance and infrared shielding properties can be further improved. Considering the reasons, fluoroalkyl group is further preferred.

式(2)中,R b1及R b2中的一個為-NHCOR b13、-NHSO 2R b14、-NHCSNHR b15、-SO 2R b17、-NHCSR b19、-NHCONHR b20或-NHCOOR b21,另一個為氫原子,且R b3及R b4中的一個為-NHCOR b13、-NHSO 2R b14、-NHCSNHR b15、-SO 2R b17、-NHCSR b19、-NHCONHR b20或-NHCOOR b21,另一個為氫原子為較佳,R b1及R b2中的一個為-NHCOR b13或-NHSO 2R b14,另一個為氫原子,且R b3及R b4中的一個為-NHCOR b13或-NHSO 2R b14,另一個為氫原子為更佳,R b1及R b2中的一個為-NHCOR b13,另一個為氫原子,且R b3及R b4中的一個為-NHCOR b13,另一個為氫原子為進一步較佳。 In formula (2), one of R b1 and R b2 is -NHCOR b13 , -NHSO 2 R b14 , -NHCSNHR b15 , -SO 2 R b17 , -NHCSR b19 , -NHCONHR b20 or -NHCOOR b21 , and the other is A hydrogen atom, and one of R b3 and R b4 is -NHCOR b13 , -NHSO 2 R b14 , -NHCSNHR b15 , -SO 2 R b17 , -NHCSR b19 , -NHCONHR b20 or -NHCOOR b21 , and the other is a hydrogen atom Preferably, one of R b1 and R b2 is -NHCOR b13 or -NHSO 2 R b14 , the other is a hydrogen atom, and one of R b3 and R b4 is -NHCOR b13 or -NHSO 2 R b14 , and the other is a hydrogen atom. It is more preferred that one is a hydrogen atom, one of R b1 and R b2 is -NHCOR b13 and the other is a hydrogen atom, and one of R b3 and R b4 is -NHCOR b13 and the other is a hydrogen atom. .

式(2)中,Y 1~Y 4中的至少一個為由式(Y-1)表示之基團,且選自R a1與Y 1、R a2與Y 2、R a3與Y 3及R a4與Y 4中之至少一個鍵結而形成包含至少一個氮原子之5員環或6員環的雜環。 In formula (2), at least one of Y 1 to Y 4 is a group represented by formula (Y-1), and is selected from R a1 and Y 1 , R a2 and Y 2 , R a3 and Y 3 and R a4 is bonded to at least one of Y 4 to form a 5- or 6-membered heterocyclic ring containing at least one nitrogen atom.

式(2)中,Y 1及Y 2中的至少一個和Y 3及Y 4中的至少一個分別獨立地為由式(Y-1)表示之基團為較佳。 In the formula (2), it is preferred that at least one of Y 1 and Y 2 and at least one of Y 3 and Y 4 be independently a group represented by the formula (Y-1).

式(2)中,R a2與Y 2鍵結而形成包含至少一個氮原子之5員環或6員環的雜環且R a4與Y 4鍵結而形成包含至少一個氮原子之5員環或6員環的雜環為較佳,R a2與Y 2鍵結而形成包含至少一個氮原子之5員環的雜環且R a4與Y 4鍵結而形成包含至少一個氮原子之5員環的雜環為更佳。 In formula (2), R a2 and Y 2 are bonded to form a 5-membered ring or a 6-membered ring heterocyclic ring containing at least one nitrogen atom, and R a4 and Y 4 are bonded to form a 5-membered ring containing at least one nitrogen atom. Or a 6-membered heterocyclic ring is preferred, R a2 and Y 2 are bonded to form a 5-membered heterocyclic ring containing at least one nitrogen atom, and R a4 and Y 4 are bonded to form a 5-membered ring containing at least one nitrogen atom. Heterocyclic rings are more preferred.

式(2)中,Y 1及Y 3中的至少一個為由式(Y-1)表示之基團(較佳為Y 1及Y 3分別獨立地為由式(Y-1)表示之基團),R a2與Y 2鍵結而形成包含至少一個氮原子之5員環或6員環的雜環(較佳為5員環的雜環),R a4與Y 4鍵結而形成包含至少一個氮原子之5員環或6員環的雜環(較佳為5員環的雜環)為較佳。 In formula (2), at least one of Y 1 and Y 3 is a group represented by formula (Y-1) (preferably, Y 1 and Y 3 are each independently a group represented by formula (Y-1) group), R a2 and Y 2 bond to form a 5-membered ring or a 6-membered ring heterocyclic ring containing at least one nitrogen atom (preferably a 5-membered ring heterocyclic ring), R a4 and Y 4 bond to form a 5-membered ring or 6-membered ring heterocyclic ring containing at least one nitrogen atom. A 5-membered ring or a 6-membered heterocyclic ring (preferably a 5-membered heterocyclic ring) with at least one nitrogen atom is preferred.

特定化合物為由式(3)表示之化合物為較佳。 [化13] The specific compound is preferably a compound represented by formula (3). [Chemical 13]

式(3)中,R 13~R 17、R 23~R 27分別獨立地表示氫原子、鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基、烷基、芳基、雜環基、烷氧基、醯基、烷氧基羰基、-NR a11R a12、-SR a13、-SO 2R a14或-OSO 2R a15, R a11及R a12分別獨立地表示氫原子、烷基、芳基或雜環基, R a13~R a15分別獨立地表示烷基、芳基或雜環基, R 11、R 12、R 21及R 22分別獨立地表示氫原子、鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基、烷基、芳基、雜環基、烷氧基、醯基、烷氧基羰基、-NR b11R b12、-NHCOR b13、-NHSO 2R b14、-NHCSNHR b15、-SR b16、-SO 2R b17、-OSO 2R b18、-NHCSR b19、-NHCONHR b20或-NHCOOR b21, R b11及R b12分別獨立地表示氫原子、烷基、芳基或雜環基, R b13~R b21分別獨立地表示烷基、芳基或雜環基, Y 11及Y 21分別獨立地表示氫原子、烷基、芳基、雜環基或由式(Y-1)表示之基團,Y 11及Y 21中的至少一個為由式(Y-1)表示之基團。 In formula (3), R 13 to R 17 and R 23 to R 27 respectively independently represent a hydrogen atom, a halogen atom, a sulfo group, a hydroxyl group, a cyano group, a nitro group, a carboxyl group, a phosphate group, an alkyl group, an aryl group, a hetero group, and a hydrogen atom. Ring group, alkoxy group, acyl group, alkoxycarbonyl group, -NR a11 R a12 , -SR a13 , -SO 2 R a14 or -OSO 2 R a15 , R a11 and R a12 independently represent a hydrogen atom, an alkane group, aryl or heterocyclic group, R a13 to R a15 independently represent an alkyl group, an aryl group or a heterocyclic group, R 11 , R 12 , R 21 and R 22 respectively independently represent a hydrogen atom, a halogen atom, a sulfonate group, hydroxyl group, cyano group, nitro group, carboxyl group, phosphate group, alkyl group, aryl group, heterocyclic group, alkoxy group, acyl group, alkoxycarbonyl group, -NR b11 R b12 , -NHCOR b13 , -NHSO 2 R b14 , -NHCSNHR b15 , -SR b16 , -SO 2 R b17 , -OSO 2 R b18 , -NHCSR b19 , -NHCONHR b20 or -NHCOOR b21 , R b11 and R b12 independently represent a hydrogen atom, an alkyl group, Aryl or heterocyclic group, R b13 ~ R b21 independently represent an alkyl group, an aryl group or a heterocyclic group, Y 11 and Y 21 independently represent a hydrogen atom, an alkyl group, an aryl group, a heterocyclic group or a formula (Y-1) is a group represented by formula (Y-1), and at least one of Y 11 and Y 21 is a group represented by formula (Y-1).

式(3)的R 13~R 17、R 23~R 27所表示之鹵素原子、烷氧基、醯基及烷氧基羰基與式(1)的R aa1及R aa2所表示之鹵素原子、烷氧基、醯基及烷氧基羰基相同,較佳範圍亦相同。 式(3)的R 13~R 17、R 23~R 27、R a11~R a15所表示之烷基、芳基及雜環基與式(1)的R aa1及R aa2所表示之烷基、芳基及雜環基相同,較佳範圍亦相同。 The halogen atom, alkoxy group, hydroxyl group and alkoxycarbonyl group represented by R 13 to R 17 and R 23 to R 27 of the formula (3) is the same as the halogen atom represented by R aa1 and R aa2 of the formula (1). The alkoxy group, acyl group and alkoxycarbonyl group are the same, and the preferred ranges are also the same. The alkyl group, aryl group and heterocyclic group represented by R 13 to R 17 , R 23 to R 27 and R a11 to R a15 of the formula (3) and the alkyl group represented by R aa1 and R aa2 of the formula (1) , aryl group and heterocyclic group are the same, and the preferred ranges are also the same.

式(3)的R 11、R 12、R 21及R 22所表示之鹵素原子、烷氧基、醯基及烷氧基羰基與式(1)的R b1~R b4所表示之鹵素原子、烷氧基、醯基及烷氧基羰基相同,較佳範圍亦相同。 式(3)的R 11、R 12、R 21、R 22、R b13~R b21所表示之烷基、芳基及雜環基與式(1)的R b1~R b4所表示之烷基、芳基及雜環基相同,較佳範圍亦相同。 The halogen atom, alkoxy group, hydroxyl group and alkoxycarbonyl group represented by R 11 , R 12 , R 21 and R 22 of the formula (3) and the halogen atom represented by R b1 to R b4 of the formula (1), The alkoxy group, acyl group and alkoxycarbonyl group are the same, and the preferred ranges are also the same. The alkyl group, aryl group and heterocyclic group represented by R 11 , R 12 , R 21 , R 22 , R b13 to R b21 of the formula (3) and the alkyl group represented by R b1 to R b4 of the formula (1) , aryl group and heterocyclic group are the same, and the preferred ranges are also the same.

式(3)中,R 11及R 12中的至少一個和R 21及R 22中的至少一個分別獨立地為-NHCOR b13或R 11及R 12中的至少一個和R 21及R 22中的至少一個分別獨立地為-NHSO 2R b14為較佳,R 11及R 12中的至少一個和R 21及R 22中的至少一個分別獨立地為-NHCOR b13為更佳。 其中,R 11及R 12中的一個為-NHCOR b13,另一個為氫原子,且R 21及R 22中的一個為-NHCOR b13,另一個為氫原子或者R 11及R 12中的一個為-NHSO 2R b14,另一個為氫原子,且R 21及R 22中的一個為-NHSO 2R b14,另一個為氫原子為較佳,R 11及R 12中的一個為-NHCOR b13,另一個為氫原子,且R 21及R 22中的一個為-NHCOR b13,另一個為氫原子為更佳。 In formula (3), at least one of R 11 and R 12 and at least one of R 21 and R 22 are independently -NHCOR b13 or at least one of R 11 and R 12 and R 21 and R 22 It is preferred that at least one of them is independently -NHSO 2 R b14 , and it is more preferred that at least one of R 11 and R 12 and at least one of R 21 and R 22 are independently -NHCOR b13 . Wherein, one of R 11 and R 12 is -NHCOR b13 and the other is a hydrogen atom, and one of R 21 and R 22 is -NHCOR b13 and the other is a hydrogen atom or one of R 11 and R 12 is -NHSO 2 R b14 , the other is a hydrogen atom, and one of R 21 and R 22 is -NHSO 2 R b14 , the other is preferably a hydrogen atom, and one of R 11 and R 12 is -NHCOR b13 , The other is a hydrogen atom, and one of R 21 and R 22 is -NHCOR b13 , and the other is more preferably a hydrogen atom.

式(3)的Y 11及Y 21所表示之烷基、芳基、雜環基及由式(Y-1)表示之基團與式(1)的Y 1~Y 4所表示之烷基、芳基、雜環基及由式(Y-1)表示之基團相同,較佳範圍亦相同。 式(3)的Y 11及Y 21分別獨立地為由式(Y-1)表示之基團為較佳。 The alkyl group, aryl group, heterocyclic group represented by Y 11 and Y 21 of the formula (3) and the group represented by the formula (Y-1) and the alkyl group represented by Y 1 to Y 4 of the formula (1) , aryl group, heterocyclic group and the group represented by formula (Y-1) are the same, and the preferred ranges are also the same. It is preferred that Y 11 and Y 21 of the formula (3) are each independently a group represented by the formula (Y-1).

式(3)的Y 11及Y 21分別獨立地為由式(Y-1)表示之基團時,兩者的式(Y-1)的Z 1可以相同,亦可以不同。不同基團時,從耐光性的觀點考慮,一個Z 1為由式(Z-1)或式(Z-4)表示之基團,另一個Z 1為式(Z-2)、式(Z-3)或式(Z-6)為較佳。 When Y 11 and Y 21 of the formula (3) are each independently a group represented by the formula (Y-1), Z 1 of the two formulas (Y-1) may be the same or different. When different groups are used, from the viewpoint of light resistance, one Z 1 is a group represented by formula (Z-1) or formula (Z-4), and the other Z 1 is a group represented by formula (Z-2) or formula (Z -3) or formula (Z-6) is better.

-關於取代基T- 作為取代基T,可舉出以下基團。鹵素原子(例如,氟原子、氯原子、溴原子、碘原子)、烷基(較佳為碳數1~30的烷基)、烯基(較佳為碳數2~30的烯基)、炔基(較佳為碳數2~30的炔基)、芳基(較佳為碳數6~30的芳基)、雜環基(較佳為碳數1~30的雜環基)、胺基(較佳為碳數0~30的胺基)、烷氧基(較佳為碳數1~30的烷氧基)、芳氧基(較佳為碳數6~30的芳氧基)、雜環氧基(較佳為碳數1~30的雜環氧基)、醯基(較佳為碳數2~30的醯基)、烷氧基羰基(較佳為碳數2~30的烷氧基羰基)、芳氧基羰基(較佳為碳數7~30的芳氧基羰基)、雜環氧基羰基(較佳為碳數2~30的雜環氧基羰基)、醯氧基(較佳為碳數2~30的醯氧基)、醯胺基(較佳為碳數2~30的醯胺基)、胺基羰基胺基(較佳為碳數2~30的胺基羰基胺基)、烷氧基羰基胺基(較佳為碳數2~30的烷氧基羰基胺基)、芳氧基羰基胺基(較佳為碳數7~30的芳氧基羰基胺基)、胺磺醯基(較佳為碳數0~30的胺磺醯基)、胺磺醯基胺基(較佳為碳數0~30的胺磺醯基胺基)、胺甲醯基(較佳為碳數1~30的胺甲醯基)、烷硫基(較佳為碳數1~30的烷硫基)、芳硫基(較佳為碳數6~30的芳硫基)、雜環硫基(較佳為碳數1~30的雜環硫基)、烷基磺醯基(較佳為碳數1~30的烷基磺醯基)、烷基磺醯基胺基(較佳為碳數1~30的烷基磺醯基胺基)、芳基磺醯基(較佳為碳數6~30的芳基磺醯基)、芳基磺醯基胺基(較佳為碳數6~30的芳基磺醯基胺基)、雜環磺醯基(較佳為碳數1~30的雜環磺醯基)、雜環磺醯基胺基(較佳為碳數1~30的雜環磺醯基胺基)、烷基亞磺醯基(較佳為碳數1~30的烷基亞磺醯基)、芳基亞磺醯基(較佳為碳數6~30的芳基亞磺醯基)、雜環亞磺醯基(較佳為碳數1~30的雜環亞磺醯基)、脲基(較佳為碳數1~30的脲基)、羥基、硝基、羧基、磺基、磷酸基、羧酸醯胺基、磺酸醯胺基、醯亞胺基、膦基、巰基、氰基、烷基亞磺酸基、芳基亞磺酸基、芳基偶氮基、雜環偶氮基、氧膦基、氧膦基氧基、氧膦基胺基、矽基、肼基、亞胺基。該等基團為能夠進一步取代之基團時,可以進一步具有取代基。作為取代基,可舉出在上述取代基T中說明之基團。 -About substituent T- Examples of the substituent T include the following groups. Halogen atom (for example, fluorine atom, chlorine atom, bromine atom, iodine atom), alkyl group (preferably an alkyl group having 1 to 30 carbon atoms), alkenyl group (preferably an alkenyl group having 2 to 30 carbon atoms), Alkynyl group (preferably an alkynyl group having 2 to 30 carbon atoms), aryl group (preferably an aryl group having 6 to 30 carbon atoms), heterocyclic group (preferably a heterocyclic group having 1 to 30 carbon atoms), Amino group (preferably an amine group having 0 to 30 carbon atoms), alkoxy group (preferably an alkoxy group having 1 to 30 carbon atoms), aryloxy group (preferably an aryloxy group having 6 to 30 carbon atoms) ), heterocyclic oxy group (preferably a heterocyclic oxy group having 1 to 30 carbon atoms), hydroxyl group (preferably a hydroxyl group having 2 to 30 carbon atoms), alkoxycarbonyl group (preferably a hydroxyl group having 2 to 30 carbon atoms) 30 alkoxycarbonyl group), aryloxycarbonyl group (preferably an aryloxycarbonyl group with 7 to 30 carbon atoms), heterocyclicoxycarbonyl group (preferably a heterocyclicoxycarbonyl group with 2 to 30 carbon atoms), acyloxy group (preferably a acyloxy group having 2 to 30 carbon atoms), amide group (preferably a amide group having 2 to 30 carbon atoms), aminocarbonylamino group (preferably having 2 to 30 carbon atoms) aminocarbonylamino group), alkoxycarbonylamino group (preferably alkoxycarbonylamino group having 2 to 30 carbon atoms), aryloxycarbonylamino group (preferably aryloxycarbonylamino group having 7 to 30 carbon atoms) (carbonylamino group), sulfonamide group (preferably sulfonamide group with 0 to 30 carbon atoms), sulfonamide group (preferably sulfonamide group with 0 to 30 carbon atoms), Aminomethyl group (preferably an aminomethyl group having 1 to 30 carbon atoms), alkylthio group (preferably an alkylthio group having 1 to 30 carbon atoms), arylthio group (preferably having 6 to 30 carbon atoms) arylthio group), heterocyclic thio group (preferably a heterocyclic thio group with 1 to 30 carbon atoms), alkylsulfonyl group (preferably an alkylsulfonyl group with 1 to 30 carbon atoms), alkyl group Sulfonylamine group (preferably an alkylsulfonylamine group having 1 to 30 carbon atoms), arylsulfonylamine group (preferably an arylsulfonylamine group having 6 to 30 carbon atoms), arylsulfonylamine group Amino group (preferably an arylsulfonylamine group with 6 to 30 carbon atoms), heterocyclic sulfonylamine group (preferably a heterocyclic sulfonylamine group with 1 to 30 carbon atoms), heterocyclic sulfonylamine group group (preferably a heterocyclic sulfenylamine group having 1 to 30 carbon atoms), an alkyl sulfinyl group (preferably an alkyl sulfinyl amine group having 1 to 30 carbon atoms), an aryl sulfenyl group (preferably an arylsulfenyl group having 6 to 30 carbon atoms), a heterocyclic sulfinyl group (preferably a heterocyclic sulfenyl group having 1 to 30 carbon atoms), ureido group (preferably an aryl sulfenyl group having a carbon number of 1 to 30 1 to 30 urea group), hydroxyl, nitro, carboxyl, sulfo, phosphate, carboxylic acid amide, sulfonyl amide, amide imide, phosphine, mercapto, cyano, alkyl sulfenyl Acid group, arylsulfinic acid group, aryl azo group, heterocyclic azo group, phosphinyl group, phosphinyloxy group, phosphinylamine group, silicon group, hydrazine group, imine group. When these groups are further substituted groups, they may further have a substituent. Examples of the substituent include the groups described for the substituent T described above.

-關於具體例- 作為特定化合物的具體例,可舉出以下所示之結構的化合物。作為特定化合物的具體例,亦可舉出該等化合物的共振結構體。 -About specific examples- Specific examples of the specific compound include compounds having the structures shown below. Specific examples of specific compounds include resonance structures of these compounds.

[化14] [化15] [化16] [化17] [化18] [化19] [化20] [化21] [化22] [化23] [化24] [化25] [化26] [化27] [化28] [化29] [化30] [Chemical 14] [Chemical 15] [Chemical 16] [Chemical 17] [Chemical 18] [Chemical 19] [Chemistry 20] [Chemistry 21] [Chemistry 22] [Chemistry 23] [Chemistry 24] [Chemical 25] [Chemical 26] [Chemical 27] [Chemical 28] [Chemical 29] [Chemical 30]

特定化合物的極大吸收波長存在於波長650~1500nm的範圍內為較佳,存在於波長680~1200的範圍內為更佳,存在於波長700~1000nm的範圍內為進一步較佳。It is preferable that the maximum absorption wavelength of the specific compound exists in the range of wavelength 650 to 1500 nm, more preferably it exists in the range of wavelength 680 to 1200 nm, and it is still more preferable that it exists in the range of wavelength 700 to 1000 nm.

(其他紅外線吸收劑) 本發明的組成物能夠含有上述特定化合物以外的紅外線吸收劑(其他紅外線吸收劑)。藉由進一步含有其他紅外線吸收劑,能夠形成能夠遮蔽更廣波長範圍的紅外線之膜。其他紅外線吸收劑可以為染料,亦可以為顏料(粒子)。作為其他紅外線吸收劑,可舉出吡咯并吡咯化合物、花青化合物、方酸菁化合物、聚次甲基化合物、酞菁化合物、萘酞菁化合物、夸特銳烯(quaterrylene)化合物、部花青化合物、克酮鎓化合物、氧雜菁化合物、亞銨化合物、二硫醇化合物、三芳基甲烷化合物、吡咯亞甲基化合物、甲亞胺化合物、蒽醌化合物、二苯并呋喃酮化合物、二硫烯金屬錯合物、金屬氧化物、金屬硼化物等。作為吡咯并吡咯化合物,可舉出日本特開2009-263614號公報的0016~0058段中記載之化合物、日本特開2011-068731號公報的0037~0052段中記載之化合物、國際公開第2015/166873號的0010~0033段中記載之化合物等。作為方酸菁化合物,可舉出日本特開2011-208101號公報的0044~0049段中記載之化合物、日本專利第6065169號公報的0060~0061段中記載之化合物、國際公開第2016/181987號的0040段中記載之化合物、日本特開2015-176046號公報中記載之化合物、國際公開第2016/190162號的0072段中記載之化合物、日本特開2016-074649號公報的0196~0228段中記載之化合物、日本特開2017-067963號公報的0124段中記載之化合物、國際公開第2017/135359號中記載之化合物、日本特開2017-114956號公報中記載之化合物、日本專利6197940號公報中記載之化合物、國際公開第2016/120166號中記載之化合物等。作為花青化合物,可舉出日本特開2009-108267號公報的0044~0045段中記載之化合物、日本特開2002-194040號公報的0026~0030段中記載之化合物、日本特開2015-172004號公報中記載之化合物、日本特開2015-172102號公報中記載之化合物、日本特開2008-088426號公報中記載之化合物、國際公開第2016/190162號的0090段中記載之化合物、日本特開2017-031394號公報中記載之化合物等。作為聚次甲基化合物,可舉出日本特開2021-134350號公報中記載之化合物、國際公開第2021/085372號中記載之化合物等。作為克酮鎓化合物,可舉出日本特開2017-082029號公報中記載之化合物。作為亞銨化合物,例如可舉出日本特表2008-528706號公報中記載之化合物、日本特開2012-012399號公報中記載之化合物、日本特開2007-092060號公報中記載之化合物、國際公開第2018/043564號的0048~0063段中記載之化合物。作為酞菁化合物,可舉出日本特開2012-077153號公報的0093段中記載之化合物、日本特開2006-343631號公報中記載之酞菁氧鈦、日本特開2013-195480號公報的0013~0029段中記載之化合物、日本專利第6081771號公報中記載之釩酞菁化合物、國際公開第2020/071470號中記載之化合物。作為萘酞菁化合物,可舉出日本特開2012-077153號公報的0093段中記載之化合物。作為二硫烯金屬錯合物,可舉出日本專利第5733804號公報中記載之化合物。作為金屬氧化物,例如可舉出氧化銦錫、氧化銻錫、氧化鋅、Al摻雜氧化鋅、氟摻雜二氧化錫、鈮摻雜二氧化鈦、氧化鎢等。關於氧化鎢的詳細內容,能夠參考日本特開2016-006476號公報的0080段,該內容編入本說明書中。作為金屬硼化物,可舉出硼化鑭等。作為硼化鑭的市售品,可舉出LaB 6-F(Japan New Metals Co.,Ltd.製)等。又,作為金屬硼化物,亦能夠使用國際公開第2017/119394號中記載之化合物。作為氧化銦錫的市售品,可舉出F-ITO(DOWA HIGHTECH CO.,LTD.製)等。 (Other infrared absorbers) The composition of the present invention can contain infrared absorbers other than the above-mentioned specific compounds (other infrared absorbers). By further containing other infrared absorbers, a film capable of blocking infrared rays in a wider wavelength range can be formed. Other infrared absorbers can be dyes or pigments (particles). Examples of other infrared absorbers include pyrrolopyrrole compounds, cyanine compounds, squaraine compounds, polymethine compounds, phthalocyanine compounds, naphthalocyanine compounds, quaterrylene compounds, and merocyanine compounds. Compounds, ketonium compounds, oxocyanine compounds, iminium compounds, dithiol compounds, triarylmethane compounds, pyrrromethylene compounds, methimine compounds, anthraquinone compounds, dibenzofuranone compounds, disulfide compounds Alkene metal complexes, metal oxides, metal borides, etc. Examples of the pyrrolopyrrole compound include compounds described in paragraphs 0016 to 0058 of Japanese Patent Application Laid-Open No. 2009-263614, compounds described in paragraphs 0037 to 0052 of Japanese Patent Application Laid-Open No. 2011-068731, and International Publication No. 2015/ Compounds described in paragraphs 0010 to 0033 of No. 166873, etc. Examples of the squaraine compound include compounds described in paragraphs 0044 to 0049 of Japanese Patent Publication No. 2011-208101, compounds described in paragraphs 0060 to 0061 of Japanese Patent Publication No. 6065169, and International Publication No. 2016/181987. Compounds described in paragraph 0040 of Japanese Patent Application Laid-Open No. 2015-176046, compounds described in paragraph 0072 of International Publication No. 2016/190162, compounds described in paragraphs 0196 to 0228 of Japanese Patent Application Laid-Open No. 2016-074649 Compounds described, compounds described in paragraph 0124 of Japanese Patent Application Laid-Open No. 2017-067963, compounds described in International Publication No. 2017/135359, compounds described in Japanese Patent Application Publication No. 2017-114956, Japanese Patent Application No. 6197940 Compounds described in, Compounds described in International Publication No. 2016/120166, etc. Examples of the cyanine compound include compounds described in paragraphs 0044 to 0045 of Japanese Patent Application Laid-Open No. 2009-108267, compounds described in paragraphs 0026 to 0030 of Japanese Patent Application Publication No. 2002-194040, and compounds described in Japanese Patent Application Laid-Open No. 2015-172004. Compounds described in Japanese Patent Application Publication No. 2015-172102, Compounds described in Japanese Patent Application Publication No. 2008-088426, Compounds described in Paragraph 0090 of International Publication No. 2016/190162, Japanese Patent Application Publication No. 2016/190162 Compounds etc. described in the publication No. 2017-031394. Examples of the polymethine compound include compounds described in Japanese Patent Application Laid-Open No. 2021-134350, compounds described in International Publication No. 2021/085372, and the like. Examples of the crotonium compound include compounds described in Japanese Patent Application Laid-Open No. 2017-082029. Examples of the immonium compound include compounds described in Japanese Patent Application Publication No. 2008-528706, compounds described in Japanese Patent Application Publication No. 2012-012399, compounds described in Japanese Patent Application Publication No. 2007-092060, and International Publications. Compounds described in paragraphs 0048 to 0063 of No. 2018/043564. Examples of the phthalocyanine compound include the compound described in paragraph 0093 of Japanese Patent Application Laid-Open No. 2012-077153, titanyl phthalocyanine described in Japanese Patent Application Laid-Open No. 2006-343631, and 0013 of Japanese Patent Application Laid-Open No. 2013-195480. The compound described in paragraph ~0029, the vanadium phthalocyanine compound described in Japanese Patent No. 6081771, and the compound described in International Publication No. 2020/071470. Examples of the naphthalocyanine compound include compounds described in paragraph 0093 of Japanese Patent Application Laid-Open No. 2012-077153. Examples of the disulfene metal complex include compounds described in Japanese Patent No. 5733804. Examples of metal oxides include indium tin oxide, antimony tin oxide, zinc oxide, Al-doped zinc oxide, fluorine-doped tin dioxide, niobium-doped titanium dioxide, tungsten oxide, and the like. For details about tungsten oxide, you can refer to paragraph 0080 of Japanese Patent Application Laid-Open No. 2016-006476, and this content is incorporated into this specification. Examples of the metal boride include lanthanum boride and the like. Examples of commercially available lanthanum boride include LaB 6 -F (manufactured by Japan New Metals Co., Ltd.). In addition, as the metal boride, the compound described in International Publication No. 2017/119394 can also be used. Examples of commercially available products of indium tin oxide include F-ITO (manufactured by DOWA HIGHTECH CO., LTD.).

又,作為紅外線吸收劑,亦能夠使用日本特開2017-197437號公報中記載之方酸菁化合物、日本特開2017-025311號公報中記載之方酸菁化合物、國際公開第2016/154782號中記載之方酸菁化合物、日本專利第5884953號公報中記載之方酸菁化合物、日本專利第6036689號公報中記載之方酸菁化合物、日本專利第5810604號公報中記載之方酸菁化合物、國際公開第2017/213047號的0090~0107段中記載之方酸菁化合物、日本特開2018-054760號公報的0019~0075段中記載之含吡咯環化合物、日本特開2018-040955號公報的0078~0082段中記載之含吡咯環化合物、日本特開2018-002773號公報的0043~0069段中記載之含吡咯環化合物、日本特開2018-041047號公報的0024~0086段中記載之在醯胺α位具有芳香環之方酸菁化合物、日本特開2017-179131號公報中記載之醯胺連結型方酸菁化合物、日本特開2017-141215號公報中記載之具有吡咯雙型方酸菁骨架或克酮鎓骨架之化合物、日本特開2017-082029號公報中記載之二氫咔唑雙型方酸菁化合物、日本特開2017-068120號公報的0027~0114段中記載之非對稱型化合物、日本特開2017-067963號公報中記載之含吡咯環化合物(咔唑型)、日本專利第6251530號公報中記載之酞菁化合物等。Moreover, as an infrared absorber, the squarylium compound described in Japanese Patent Application Laid-Open No. 2017-197437, the squarylium compound described in Japanese Patent Application Laid-Open No. 2017-025311, and the squarylium compound described in International Publication No. 2016/154782 can also be used. Squarylium compounds described in Japanese Patent No. 5884953, squarylyanine compounds described in Japanese Patent No. 6036689, squarylyanine compounds described in Japanese Patent No. 5810604, International Squarylium compounds described in paragraphs 0090 to 0107 of Publication No. 2017/213047, pyrrole ring-containing compounds described in paragraphs 0019 to 0075 of Japanese Patent Application Laid-Open No. 2018-054760, and 0078 of Japanese Patent Application Laid-Open No. 2018-040955 Pyrrole ring-containing compounds described in paragraphs 0082 to 0082, pyrrole ring-containing compounds described in paragraphs 0043 to 0069 of Japanese Patent Application Laid-Open No. 2018-002773, and pyrrole ring-containing compounds described in paragraphs 0024 to 0086 of Japanese Patent Application Laid-Open No. 2018-041047 Squarylyanine compounds having an aromatic ring at the α position of the amine, amide-linked squarylyanine compounds described in Japanese Patent Application Laid-Open No. 2017-179131, squarylyanine compounds having a pyrrole double type described in Japanese Patent Application Publication No. 2017-141215 Compounds with skeleton or ketonium skeleton, dihydrocarbazole bisquaryl cyanine compound described in Japanese Patent Application Laid-Open No. 2017-082029, asymmetric type described in paragraphs 0027 to 0114 of Japanese Patent Application Laid-Open No. 2017-068120 Compounds, pyrrole ring-containing compounds (carbazole type) described in Japanese Patent Publication No. 2017-067963, phthalocyanine compounds described in Japanese Patent No. 6251530, etc.

作為其他紅外線吸收劑,亦能夠使用歐洲專利第3628645號說明書的0025段中記載之由下述式表示之氧化鎢。 M 1 aM 2 bW cO d(P(O) nR meM 1、M 2表示銨陽離子或金屬陽離子,a為0.01~0.5,b為0~0.5,c為1,d為2.5~3,e為0.01~0.75,n為1、2或3,m為1、2或3,R表示可具有取代基之烴基。 As another infrared absorber, tungsten oxide represented by the following formula described in paragraph 0025 of European Patent No. 3628645 can also be used. M 1 a M 2 b W c O d (P(O) n R m ) e M 1 and M 2 represent ammonium cations or metal cations, a is 0.01 to 0.5, b is 0 to 0.5, c is 1, and d is 2.5 to 3, e is 0.01 to 0.75, n is 1, 2 or 3, m is 1, 2 or 3, and R represents a hydrocarbon group which may have a substituent.

在組成物的總固體成分中,紅外線吸收劑的含量為0.1質量%以上為較佳,0.5質量%以上為更佳,3質量%以上為進一步較佳,5質量%以上為特佳。又,紅外線吸收劑的含量的上限為50質量%以下為較佳,40質量%以下為更佳,30質量%以下為進一步較佳。 在組成物的總固體成分中,上述特定化合物的含量為0.1質量%以上為較佳,0.5質量%以上為更佳,3質量%以上為進一步較佳,5質量%以上為特佳。又,上述特定化合物的含量的上限為50質量%以下為較佳,40質量%以下為更佳,30質量%以下為進一步較佳。本發明的組成物可以僅含有1種特定化合物,亦可以包含2種以上。包含2種以上時,該等的合計量在上述範圍內為較佳。 本發明的組成物含有其他紅外線吸收劑時,相對於上述特定化合物的100質量份,其他紅外線吸收劑的含量為1~1000質量份為較佳,3~500質量份為更佳,5~300質量份為進一步較佳。本發明的組成物可以僅含有1種其他紅外線吸收劑,亦可以包含2種以上。包含2種以上時,該等的合計量在上述範圍內為較佳。 In the total solid content of the composition, the content of the infrared absorber is preferably 0.1 mass% or more, more preferably 0.5 mass% or more, further preferably 3 mass% or more, and particularly preferably 5 mass% or more. Moreover, the upper limit of the content of the infrared absorber is preferably 50 mass% or less, more preferably 40 mass% or less, and further preferably 30 mass% or less. In the total solid content of the composition, the content of the specific compound is preferably 0.1 mass% or more, more preferably 0.5 mass% or more, further preferably 3 mass% or more, and particularly preferably 5 mass% or more. Furthermore, the upper limit of the content of the specific compound is preferably 50 mass% or less, more preferably 40 mass% or less, and still more preferably 30 mass% or less. The composition of the present invention may contain only one specific compound, or may contain two or more types. When two or more types are included, the total amount is preferably within the above range. When the composition of the present invention contains other infrared absorbers, the content of the other infrared absorbers is preferably 1 to 1000 parts by mass, more preferably 3 to 500 parts by mass, and 5 to 300 parts by mass relative to 100 parts by mass of the above-mentioned specific compound. Parts by mass are more preferable. The composition of the present invention may contain only one type of other infrared absorber, or may contain two or more types. When two or more types are included, the total amount is preferably within the above range.

<<硬化性化合物>> 本發明的組成物含有硬化性化合物。作為硬化性化合物,可舉出聚合性化合物、樹脂等。樹脂可以為非聚合性樹脂(不具有聚合性基之樹脂),亦可以為聚合性樹脂(具有聚合性基之樹脂)。作為聚合性基,可舉出含有乙烯性不飽和鍵之基團、環狀醚基、羥甲基、烷氧基甲基等。作為含有乙烯性不飽和鍵之基團,可舉出乙烯基、乙烯基苯基、(甲基)烯丙基、(甲基)丙烯醯基、(甲基)丙烯醯氧基、(甲基)丙烯醯基醯胺基等,(甲基)烯丙基、(甲基)丙烯醯基及(甲基)丙烯醯氧基為較佳,(甲基)丙烯醯氧基為更佳。作為環狀醚基,可舉出環氧基、氧環丁烷基等,環氧基為較佳。 <<Hardening compound>> The composition of the present invention contains a curable compound. Examples of curable compounds include polymerizable compounds, resins, and the like. The resin may be a non-polymerizable resin (a resin without a polymerizable group) or a polymerizable resin (a resin with a polymerizable group). Examples of the polymerizable group include a group containing an ethylenically unsaturated bond, a cyclic ether group, a hydroxymethyl group, an alkoxymethyl group, and the like. Examples of the group containing an ethylenically unsaturated bond include vinyl, vinylphenyl, (meth)allyl, (meth)acrylyl, (meth)acryloxy, and (meth)acrylyl. ) acrylamide group, etc., (meth)allyl, (meth)acrylyl and (meth)acryloxy groups are preferred, and (meth)acryloxy group is more preferred. Examples of the cyclic ether group include an epoxy group, an oxybutanyl group, and the like, with an epoxy group being preferred.

作為硬化性化合物,使用至少含有樹脂者為較佳。又,將本發明的組成物作為光微影用組成物時,作為硬化性化合物,使用樹脂和聚合性化合物(較佳為作為單體類型聚合性化合物的聚合性單體)為較佳,使用樹脂和具有含有乙烯性不飽和鍵之基團之聚合性單體(單體類型聚合性化合物)為更佳。As the curing compound, it is preferable to use one containing at least resin. Furthermore, when the composition of the present invention is used as a composition for photolithography, it is preferable to use a resin and a polymerizable compound (preferably a polymerizable monomer as a monomer type polymerizable compound) as the curable compound. Resins and polymerizable monomers (monomer type polymerizable compounds) having a group containing an ethylenically unsaturated bond are more preferred.

(聚合性化合物) 作為聚合性化合物,可舉出具有含有乙烯性不飽和鍵之基團之化合物、具有環狀醚基之化合物、具有羥甲基之化合物、具有烷氧基甲基之化合物等。具有含有乙烯性不飽和鍵之基團之化合物能夠較佳地用作自由基聚合性化合物。又,具有環狀醚基之化合物能夠較佳地用作陽離子聚合性化合物。 (polymeric compound) Examples of the polymerizable compound include compounds having an ethylenically unsaturated bond-containing group, compounds having a cyclic ether group, compounds having a hydroxymethyl group, and compounds having an alkoxymethyl group. A compound having an ethylenically unsaturated bond-containing group can be preferably used as a radically polymerizable compound. Moreover, the compound which has a cyclic ether group can be suitably used as a cationic polymerizable compound.

作為樹脂類型聚合性化合物,可舉出包含具有聚合性基之重複單元之樹脂等。Examples of resin-type polymerizable compounds include resins containing repeating units having a polymerizable group.

單體類型聚合性化合物(聚合性單體)的分子量未達2000為較佳,1500以下為更佳。聚合性單體的分子量的下限為100以上為較佳,200以上為更佳。樹脂類型的聚合性化合物的重量平均分子量(Mw)為2000~2000000為較佳。重量平均分子量的上限為1000000以下為較佳,500000以下為更佳。重量平均分子量的下限為3000以上為較佳,5000以上為更佳。The molecular weight of the monomer-type polymerizable compound (polymerizable monomer) is preferably less than 2,000, and more preferably not more than 1,500. The lower limit of the molecular weight of the polymerizable monomer is preferably 100 or more, and more preferably 200 or more. The weight average molecular weight (Mw) of the resin type polymerizable compound is preferably 2,000 to 2,000,000. The upper limit of the weight average molecular weight is preferably 1,000,000 or less, more preferably 500,000 or less. The lower limit of the weight average molecular weight is preferably 3,000 or more, and more preferably 5,000 or more.

又,作為聚合性單體的具有含有乙烯性不飽和鍵之基團之化合物為3~15官能的(甲基)丙烯酸酯化合物為較佳,3~6官能的(甲基)丙烯酸酯化合物為更佳。作為具體例,可舉出日本特開2009-288705號公報的0095~0108段、日本特開2013-029760號公報的0227段、日本特開2008-292970號公報的0254~0257段、日本特開2013-253224號公報的0034~0038段、日本特開2012-208494號公報的0477段、日本特開2017-048367號公報、日本專利第6057891號公報、日本專利第6031807號公報、日本特開2017-194662號公報中記載之化合物,該等內容編入本說明書中。Furthermore, the compound having an ethylenically unsaturated bond-containing group as the polymerizable monomer is preferably a 3- to 15-functional (meth)acrylate compound, and a 3- to 6-functional (meth)acrylate compound is preferably Better. Specific examples include Paragraphs 0095 to 0108 of Japanese Patent Application Laid-Open No. 2009-288705, Paragraph 0227 of Japanese Patent Application Laid-Open No. 2013-029760, Paragraphs 0254 to 0257 of Japanese Patent Application Laid-Open No. 2008-292970, and Paragraphs 0254 to 0257 of Japanese Patent Application Laid-Open No. 2008-292970. Paragraphs 0034 to 0038 of Publication No. 2013-253224, Paragraph 0477 of Japanese Patent Publication No. 2012-208494, Japanese Patent Publication No. 2017-048367, Japanese Patent Publication No. 6057891, Japanese Patent Publication No. 6031807, Japanese Patent Publication No. 2017 -Compounds described in Publication No. 194662, the contents of which are incorporated into this specification.

作為具有含有乙烯性不飽和鍵之基團之化合物,可舉出二新戊四醇三(甲基)丙烯酸酯(市售品為KAYARAD D-330;Nippon Kayaku Co.,Ltd.製)、二新戊四醇四(甲基)丙烯酸酯(市售品為KAYARAD D-320;Nippon Kayaku Co.,Ltd.製)、二新戊四醇五(甲基)丙烯酸酯(市售品為KAYARAD D-310;Nippon Kayaku Co.,Ltd.製)、二新戊四醇六(甲基)丙烯酸酯(市售品為KAYARAD DPHA;Nippon Kayaku Co.,Ltd.製,NK ESTER A-DPH-12E;SHIN-NAKAMURA CHEMICAL Co.,Ltd.製)及該等化合物的(甲基)丙烯醯基經由乙二醇及/或丙二醇殘基鍵結之結構的化合物(例如,SARTOMER Company,Inc.的市售品SR454、SR499)等。又,作為具有含有乙烯性不飽和鍵之基團之化合物,亦能夠使用二甘油EO(環氧乙烷)改質(甲基)丙烯酸酯(市售品為M-460;TOAGOSEI CO.,LTD.製)、新戊四醇四丙烯酸酯(SHIN-NAKAMURA CHEMICAL Co.,Ltd.製,NK ESTER A-TMMT)、1,6-己二醇二丙烯酸酯(Nippon Kayaku Co.,Ltd.製,KAYARAD HDDA)、RP-1040(Nippon Kayaku Co.,Ltd.製)、ARONIX TO-2349(TOAGOSEI CO.,LTD.製)、NK Oligo UA-7200(SHIN-NAKAMURA CHEMICAL Co.,Ltd.製)、8UH-1006、8UH-1012(Taisei Fine Chemical Co.,Ltd.製)、LIGHT ACRYLATE POB-A0(KYOEISHA CHEMICAL Co.,LTD.製)等。Examples of the compound having an ethylenically unsaturated bond-containing group include dipenterythritol tri(meth)acrylate (commercially available as KAYARAD D-330; manufactured by Nippon Kayaku Co., Ltd.), Neopenterythritol tetra(meth)acrylate (commercially available as KAYARAD D-320; manufactured by Nippon Kayaku Co., Ltd.), dineopenterythritol penta(meth)acrylate (commercially available as KAYARAD D -310; manufactured by Nippon Kayaku Co., Ltd.), dipenterythritol hexa(meth)acrylate (commercially available product is KAYARAD DPHA; manufactured by Nippon Kayaku Co., Ltd., NK ESTER A-DPH-12E; SHIN-NAKAMURA CHEMICAL Co., Ltd.) and compounds in which the (meth)acrylyl groups of these compounds are bonded via ethylene glycol and/or propylene glycol residues (for example, commercially available from SARTOMER Company, Inc. Products SR454, SR499), etc. Furthermore, as a compound having an ethylenically unsaturated bond-containing group, diglycerol EO (ethylene oxide) modified (meth)acrylate (commercially available as M-460; TOAGOSEI CO., LTD. .), neopentyl tetraacrylate (manufactured by SHIN-NAKAMURA CHEMICAL Co., Ltd., NK ESTER A-TMMT), 1,6-hexanediol diacrylate (manufactured by Nippon Kayaku Co., Ltd., KAYARAD HDDA), RP-1040 (manufactured by Nippon Kayaku Co., Ltd.), ARONIX TO-2349 (manufactured by TOAGOSEI CO., LTD.), NK Oligo UA-7200 (manufactured by SHIN-NAKAMURA CHEMICAL Co., Ltd.), 8UH-1006, 8UH-1012 (manufactured by Taisei Fine Chemical Co., Ltd.), LIGHT ACRYLATE POB-A0 (manufactured by KYOEISHA CHEMICAL Co., Ltd.), etc.

又,作為具有含有乙烯性不飽和鍵之基團之化合物,使用三羥甲基丙烷三(甲基)丙烯酸酯、三羥甲基丙烷環氧丙烷改質三(甲基)丙烯酸酯、三羥甲基丙烷環氧乙烷改質三(甲基)丙烯酸酯、異三聚氰酸環氧乙烷改質三(甲基)丙烯酸酯、新戊四醇三(甲基)丙烯酸酯等3官能(甲基)丙烯酸酯化合物亦較佳。作為3官能(甲基)丙烯酸酯化合物的市售品,可舉出ARONIX M-309、M-310、M-321、M-350、M-360、M-313、M-315、M-306、M-305、M-303、M-452、M-450(TOAGOSEI CO.,LTD.製)、NK ESTER A9300、A-GLY-9E、A-GLY-20E、A-TMM-3、A-TMM-3L、A-TMM-3LM-N、A-TMPT、TMPT(SHIN-NAKAMURA CHEMICAL Co.,Ltd.製)、KAYARAD GPO-303、TMPTA、THE-330、TPA-330、PET-30(Nippon Kayaku Co.,Ltd.製)等。Furthermore, as the compound having an ethylenically unsaturated bond-containing group, trimethylolpropane tri(meth)acrylate, trimethylolpropane epoxypropane-modified tri(meth)acrylate, and trihydroxypropane tri(meth)acrylate are used. Methylpropane ethylene oxide modified tri(meth)acrylate, isocyanuric acid ethylene oxide modified tri(meth)acrylate, neopentylerythritol tri(meth)acrylate, etc. 3 functional (Meth)acrylate compounds are also preferred. Commercially available products of trifunctional (meth)acrylate compounds include ARONIX M-309, M-310, M-321, M-350, M-360, M-313, M-315, and M-306 , M-305, M-303, M-452, M-450 (manufactured by TOAGOSEI CO., LTD.), NK ESTER A9300, A-GLY-9E, A-GLY-20E, A-TMM-3, A- TMM-3L, A-TMM-3LM-N, A-TMPT, TMPT (manufactured by SHIN-NAKAMURA CHEMICAL Co., Ltd.), KAYARAD GPO-303, TMPTA, THE-330, TPA-330, PET-30 (Nippon Made by Kayaku Co., Ltd.) etc.

具有含有乙烯性不飽和鍵之基團之化合物可以進一步具有羧基、磺基、磷酸基等酸基。作為此類化合物的市售品,可舉出ARONIX M-305、M-510、M-520、ARONIX TO-2349(TOAGOSEI CO.,LTD.製)等。The compound having an ethylenically unsaturated bond-containing group may further have an acid group such as a carboxyl group, a sulfo group, or a phosphate group. Commercially available products of such compounds include ARONIX M-305, M-510, M-520, ARONIX TO-2349 (manufactured by TOAGOSEI CO., LTD.), and the like.

作為具有含有乙烯性不飽和鍵之基團之化合物,亦能夠使用具有己內酯結構之化合物。關於具有己內酯結構之化合物,能夠參考日本特開2013-253224號公報的0042~0045段的記載,該內容編入本說明書中。關於具有己內酯結構之化合物,例如,可舉出Nippon Kayaku Co.,Ltd.的市售品DPCA-20、DPCA-30、DPCA-60、DPCA-120等。As the compound having an ethylenically unsaturated bond-containing group, a compound having a caprolactone structure can also be used. Regarding the compound having a caprolactone structure, the description in paragraphs 0042 to 0045 of Japanese Patent Application Laid-Open No. 2013-253224 can be referred to, and the content is incorporated into this specification. Examples of compounds having a caprolactone structure include commercially available products DPCA-20, DPCA-30, DPCA-60, and DPCA-120 from Nippon Kayaku Co., Ltd.

作為具有含有乙烯性不飽和鍵之基團之化合物,亦能夠使用具有含有乙烯性不飽和鍵之基團及伸烷氧基之化合物。此類化合物為具有含有乙烯性不飽和鍵之基團及乙烯氧基和/或伸丙基氧基之化合物為較佳,具有含有乙烯性不飽和鍵之基團及乙烯氧基之化合物為更佳,具有4~20個乙烯氧基之3~6官能(甲基)丙烯酸酯化合物為進一步較佳。作為市售品,例如可舉出SARTOMER Company,Inc.製具有4個乙烯氧基之4官能(甲基)丙烯酸酯SR-494、Nippon Kayaku Co.,Ltd.製具有3個伸異丁氧基之3官能(甲基)丙烯酸酯KAYARAD TPA-330等。As the compound having an ethylenically unsaturated bond-containing group, a compound having an ethylenically unsaturated bond-containing group and an alkyloxy group can also be used. Such compounds are preferably compounds having a group containing an ethylenically unsaturated bond and a vinyloxy group and/or a propyleneoxy group, and more preferably a compound having a group containing an ethylenically unsaturated bond and an vinyloxy group. Preferable, 3-6 functional (meth)acrylate compounds having 4-20 vinyloxy groups are further preferred. Examples of commercially available products include SR-494, a tetrafunctional (meth)acrylate having four vinyloxy groups manufactured by SARTOMER Company, Inc., and SR-494, a tetrafunctional (meth)acrylate having three isobutoxy groups manufactured by Nippon Kayaku Co., Ltd. 3-functional (meth)acrylate KAYARAD TPA-330, etc.

作為具有含有乙烯性不飽和鍵之基團之化合物,亦能夠使用具有茀骨架之聚合性化合物。作為市售品,可舉出OGSOL EA-0200、EA-0300(Osaka Gas Chemicals Co.,Ltd.製,具有茀骨架之(甲基)丙烯酸酯單體)等。As the compound having an ethylenically unsaturated bond-containing group, a polymerizable compound having a fluorine skeleton can also be used. Examples of commercially available products include OGSOL EA-0200 and EA-0300 ((meth)acrylate monomer having a fluorine skeleton, manufactured by Osaka Gas Chemicals Co., Ltd.).

作為具有含有乙烯性不飽和鍵之基團之化合物,使用實質上不含有甲苯等環境管制物質之化合物亦較佳。作為此類化合物的市售品,可舉出KAYARAD DPHA LT、KAYARAD DPEA-12 LT(Nippon Kayaku Co.,Ltd.製)等。As the compound having an ethylenically unsaturated bond-containing group, it is also preferred to use a compound that does not substantially contain environmentally controlled substances such as toluene. Commercially available products of such compounds include KAYARAD DPHA LT, KAYARAD DPEA-12 LT (manufactured by Nippon Kayaku Co., Ltd.), and the like.

作為具有環狀醚基之化合物,可舉出具有環氧基之化合物、具有氧環丁烷基之化合物等,較佳為具有環氧基之化合物。作為具有環氧基之化合物,可舉出在1分子內具有1~100個環氧基之化合物。環氧基數的上限例如能夠設定為10個以下,亦能夠設定為5個以下。環氧基數的下限較佳為2個以上。Examples of the compound having a cyclic ether group include compounds having an epoxy group, compounds having an oxybutanyl group, and the like, and compounds having an epoxy group are preferred. Examples of the compound having an epoxy group include compounds having 1 to 100 epoxy groups in one molecule. The upper limit of the number of epoxy groups can be set to 10 or less, for example, or 5 or less. The lower limit of the number of epoxy groups is preferably 2 or more.

具有環狀醚基之化合物可以為低分子化合物(例如,分子量未達1000),亦可以為高分子化合物(macromolecule)(例如,分子量為1000以上,聚合物的情況下,重量平均分子量為1000以上)。環狀醚基的重量平均分子量為200~100000為較佳,500~50000為更佳。重量平均分子量的上限為10000以下為較佳,5000以下為更佳,3000以下為進一步較佳。The compound with a cyclic ether group may be a low molecular compound (for example, the molecular weight is less than 1000), or it may be a macromolecule compound (for example, the molecular weight is 1000 or more, and in the case of a polymer, the weight average molecular weight is 1000 or more ). The weight average molecular weight of the cyclic ether group is preferably 200 to 100,000, more preferably 500 to 50,000. The upper limit of the weight average molecular weight is preferably 10,000 or less, more preferably 5,000 or less, and still more preferably 3,000 or less.

作為具有環狀醚基之化合物,亦能夠使用日本特開2013-011869號公報的0034~0036段中記載之化合物、日本特開2014-043556號公報的0147~0156段中記載之化合物、日本特開2014-089408號公報的0085~0092段中記載之化合物、日本特開2017-179172號公報中記載之化合物。As the compound having a cyclic ether group, compounds described in paragraphs 0034 to 0036 of Japanese Patent Application Publication No. 2013-011869, compounds described in paragraphs 0147 to 0156 of Japanese Patent Application Publication No. 2014-043556, and compounds described in Japanese Patent Application Publication No. 2014-043556 can also be used. Compounds described in paragraphs 0085 to 0092 of Japanese Patent Application Publication No. 2014-089408, and compounds described in Japanese Patent Application Publication No. 2017-179172.

作為具有環狀醚基之化合物的市售品,可舉出DENACOL EX-212L、EX-212、EX-214L、EX-214、EX-216L、EX-216、EX-321L、EX-321、EX-850L、EX-850(以上為Nagase ChemteX Corporation製)、ADEKA RESIN EP-4000S、EP-4003S、EP-4010S、EP-4011S(以上為ADEKA CORPORATION製)、NC-2000、NC-3000、NC-7300、XD-1000、EPPN-501、EPPN-502(以上為ADEKA CORPORATION製)、CELLOXIDE 2021P、CELLOXIDE 2081、CELLOXIDE 2083、CELLOXIDE 2085、EHPE3150、EPOLEAD PB 3600、PB 4700(以上為Daicel Corporation製)、CYCLOMER P ACA 200M、ACA 230AA、ACA Z250、ACA Z251、ACA Z300、ACA Z320(以上為Daicel Corporation製)、jER1031S、jER157S65、jER152、jER154、jER157S70(以上為Mitsubishi Chemical Corporation製)、ARONE OXETANE OXT-121、OXT-221、OX-SQ、PNOX(以上為TOAGOSEI CO.,LTD.製)、ADEKA GLYCIROL ED-505(ADEKA CORPORATION製,含環氧基單體)、Marproof G-0150M、G-0105SA、G-0130SP、G-0250SP、G-1005S、G-1005SA、G-1010S、G-2050M、G-01100、G-01758(NOF CORPORATION製,含環氧基聚合物)、OXT-101、OXT-121、OXT-212、OXT-221(以上為TOAGOSEI CO.,LTD.製,含氧環丁烷基單體)、OXE-10、OXE-30(以上為OSAKA ORGANIC CHEMICAL INDUSTRY LTD.製,含氧環丁烷基單體)等。Examples of commercially available compounds having a cyclic ether group include DENACOL EX-212L, EX-212, EX-214L, EX-214, EX-216L, EX-216, EX-321L, EX-321, EX -850L, EX-850 (the above are made by Nagase ChemteX Corporation), ADEKA RESIN EP-4000S, EP-4003S, EP-4010S, EP-4011S (the above are made by ADEKA CORPORATION), NC-2000, NC-3000, NC- 7300, P ACA 200M, ACA 230AA, ACA Z250, ACA Z251, ACA Z300, ACA Z320 (the above are made by Daicel Corporation), jER1031S, jER157S65, jER152, jER154, jER157S70 (the above are made by Mitsubishi Chemical Corporation), ARONE OXETANE OXT-121, OXT-221, OX-SQ, PNOX (the above are manufactured by TOAGOSEI CO., LTD.), ADEKA GLYCIROL ED-505 (manufactured by ADEKA CORPORATION, containing epoxy monomer), Marproof G-0150M, G-0105SA, G- 0130SP, G-0250SP, G-1005S, G-1005SA, G-1010S, G-2050M, G-01100, G-01758 (manufactured by NOF CORPORATION, containing epoxy polymer), OXT-101, OXT-121, OXT-212, OXT-221 (the above are manufactured by TOAGOSEI CO., LTD., oxygen-containing cyclobutane monomer), OXE-10, OXE-30 (the above are manufactured by OSAKA ORGANIC CHEMICAL INDUSTRY LTD., oxygen-containing cyclobutane) alkyl monomer), etc.

作為具有羥甲基之化合物(以下,亦稱為羥甲基化合物),可舉出羥甲基與氮原子或形成芳香族環之碳原子鍵結之化合物。又,作為具有烷氧基甲基之化合物(以下,亦稱為烷氧基甲基化合物),可舉出烷氧基甲基與氮原子或形成芳香族環之碳原子鍵結之化合物。作為烷氧基甲基或羥甲基與氮原子鍵結之化合物,烷氧基甲基化三聚氰胺、羥甲基化三聚氰胺、烷氧基甲基化苯并胍胺、羥甲基化苯并胍胺、烷氧基甲基化甘脲、羥甲基化甘脲、烷氧基甲基化脲及羥甲基化脲等為較佳。又,亦能夠使用日本特開2004-295116號公報的0134~0147段、日本特開2014-089408號公報的0095~0126段中記載之化合物。Examples of the compound having a hydroxymethyl group (hereinafter also referred to as a hydroxymethyl compound) include a compound in which a hydroxymethyl group is bonded to a nitrogen atom or a carbon atom forming an aromatic ring. Examples of the compound having an alkoxymethyl group (hereinafter also referred to as an alkoxymethyl compound) include a compound in which an alkoxymethyl group is bonded to a nitrogen atom or a carbon atom forming an aromatic ring. As a compound in which alkoxymethyl or hydroxymethyl is bonded to a nitrogen atom, alkoxymethylated melamine, hydroxymethylated melamine, alkoxymethylated benzoguanamine, hydroxymethylated benzoguanamine Amine, alkoxymethylated glycoluril, hydroxymethylated glycoluril, alkoxymethylated urea, hydroxymethylated urea, etc. are preferred. In addition, compounds described in paragraphs 0134 to 0147 of Japanese Patent Application Laid-Open No. 2004-295116 and paragraphs 0095 to 0126 of Japanese Patent Application Laid-Open No. 2014-089408 can also be used.

(樹脂) 本發明的組成物能夠使用樹脂作為硬化性化合物。硬化性化合物使用至少包含樹脂者為較佳。樹脂例如以在組成物中分散顏料等之用途、黏合劑的用途配合。再者,將主要用於在組成物中分散顏料等之樹脂亦稱為分散劑。然而,樹脂的此類用途為一例,亦能夠以此類用途以外的用途為目的使用樹脂。再者,具有聚合性基之樹脂亦相當於聚合性化合物。 (resin) The composition of the present invention can use resin as the curable compound. It is preferable to use a curable compound containing at least resin. The resin is used, for example, to disperse pigments in the composition and to be used as a binder. Furthermore, resins mainly used to disperse pigments and the like in compositions are also called dispersants. However, this type of use of the resin is an example, and the resin can be used for purposes other than such uses. Furthermore, a resin having a polymerizable group also corresponds to a polymerizable compound.

樹脂的重量平均分子量較佳為3000~2000000。上限為1000000以下為較佳,500000以下為更佳。下限為4000以上為較佳,5000以上為更佳。The weight average molecular weight of the resin is preferably 3,000 to 2,000,000. The upper limit is preferably 1,000,000 or less, and even more preferably 500,000 or less. A lower limit of 4,000 or more is preferred, and a lower limit of 5,000 or more is even better.

作為樹脂,可舉出(甲基)丙烯酸樹脂、環氧樹脂、烯-硫醇樹脂、聚碳酸酯樹脂、聚醚樹脂、聚芳酯樹脂、聚碸樹脂、聚醚碸樹脂、聚苯樹脂、聚伸芳基醚氧化膦樹脂、聚醯亞胺樹脂、聚醯胺樹脂、聚醯胺醯亞胺樹脂、聚烯烴樹脂、環烯烴樹脂、聚酯樹脂、苯乙烯樹脂、乙酸乙烯酯樹脂、聚乙烯醇樹脂、聚乙烯縮醛樹脂、聚胺酯樹脂、聚脲樹脂等。在該等樹脂中,可以單獨使用1種,亦可以混合使用2種以上。作為環烯烴樹脂,從提高耐熱性的觀點考慮,降莰烯樹脂為較佳。作為降莰烯樹脂的市售品,例如可舉出JSR Corporation製ARTON系列(例如,ARTON F4520)等。又,作為樹脂,亦能夠使用國際公開第2016/088645號的實施例中記載之樹脂、日本特開2017-057265號公報中記載之樹脂、日本特開2017-032685號公報中記載之樹脂、日本特開2017-075248號公報中記載之樹脂、日本特開2017-066240號公報中記載之樹脂、日本特開2017-167513號公報中記載之樹脂、日本特開2017-173787號公報中記載之樹脂、日本特開2017-206689號公報的0041~0060段中記載之樹脂、日本特開2018-010856號公報的0022~0071段中記載之樹脂、日本特開2016-222891號公報中記載之封端聚異氰酸酯樹脂、日本特開2020-122052號公報中記載之樹脂、日本特開2020-111656號公報中記載之樹脂、日本特開2020-139021號公報中記載之樹脂、日本特開2017-138503號公報中記載之包含主鏈具有環結構之結構單元及側鏈具有聯苯基之結構單元之樹脂。又,作為樹脂,亦能夠較佳地使用具有茀骨架之樹脂。關於具有茀骨架之樹脂,能夠參考美國專利申請公開第2017/0102610號說明書的記載,該內容編入本說明書中。又,作為樹脂,亦能夠使用日本特開2020-186373號公報的0199~0233段中記載之樹脂、日本特開2020-186325號公報中記載之鹼可溶性樹脂、韓國公開專利第10-2020-0078339號公報中記載之由式1表示之樹脂、日本特開2021-134350號公報中記載之樹脂。Examples of the resin include (meth)acrylic resin, epoxy resin, ene-thiol resin, polycarbonate resin, polyether resin, polyarylate resin, polystyrene resin, polyetherstyrene resin, polyphenylene resin, Polyarylene ether phosphine oxide resin, polyimide resin, polyamide resin, polyamide imine resin, polyolefin resin, cycloolefin resin, polyester resin, styrene resin, vinyl acetate resin, poly Vinyl alcohol resin, polyvinyl acetal resin, polyurethane resin, polyurea resin, etc. Among these resins, one type may be used alone, or two or more types may be mixed and used. As the cyclic olefin resin, norbornene resin is preferred from the viewpoint of improving heat resistance. Examples of commercially available norbornene resins include the ARTON series (for example, ARTON F4520) manufactured by JSR Corporation. In addition, as the resin, the resin described in the Examples of International Publication No. 2016/088645, the resin described in Japanese Patent Application Laid-Open No. 2017-057265, the resin described in Japanese Patent Application Laid-Open No. 2017-032685, and the Japanese Patent Application Publication No. 2017-032685 can also be used. The resin described in Japanese Patent Application Publication No. 2017-075248, the resin described in Japanese Patent Application Publication No. 2017-066240, the resin described in Japanese Patent Application Publication No. 2017-167513, the resin described in Japanese Patent Application Publication No. 2017-173787 , the resin described in paragraphs 0041 to 0060 of Japanese Patent Application Laid-Open No. 2017-206689, the resin described in paragraphs 0022 to 0071 of Japanese Patent Application Publication No. 2018-010856, and the capping described in Japanese Patent Application Laid-Open No. 2016-222891 Polyisocyanate resin, resin described in Japanese Patent Application Publication No. 2020-122052, resin described in Japanese Patent Application Publication No. 2020-111656, resin described in Japanese Patent Application Publication No. 2020-139021, Japanese Patent Application Publication No. 2017-138503 The resin described in the publication contains a structural unit having a ring structure in the main chain and a structural unit having a biphenyl group in the side chain. In addition, as the resin, a resin having a skeleton can also be suitably used. Regarding the resin having a tungsten skeleton, reference can be made to the description of U.S. Patent Application Publication No. 2017/0102610, which content is incorporated into this specification. In addition, as the resin, the resin described in paragraphs 0199 to 0233 of Japanese Patent Application Laid-Open No. 2020-186373, the alkali-soluble resin described in Japanese Patent Application Laid-Open No. 2020-186325, and Korean Patent Publication No. 10-2020-0078339 can also be used. The resin represented by Formula 1 described in the Japanese Patent Application Publication No. 2021-134350.

作為樹脂,使用具有酸基之樹脂為較佳。作為酸基,例如,可舉出羧基、磷酸基、磺基、酚性羥基等。該等酸基可僅為1種,亦可以為2種以上。具有酸基之樹脂亦能夠用作分散劑。具有酸基之樹脂的酸值為30~500mgKOH/g為較佳。下限為50mgKOH/g以上為較佳,70mgKOH/g以上為更佳。上限為400mgKOH/g以下為較佳,200mgKOH/g以下為更佳,150mgKOH/g以下為進一步較佳,120mgKOH/g以下為最佳。As the resin, it is preferable to use a resin having an acid group. Examples of acidic groups include carboxyl groups, phosphate groups, sulfo groups, phenolic hydroxyl groups, and the like. There may be only one type of these acid groups, or two or more types. Resins with acid groups can also be used as dispersants. The acid value of the resin with acid groups is preferably 30 to 500 mgKOH/g. The lower limit is preferably 50 mgKOH/g or more, and more preferably 70 mgKOH/g or more. The upper limit is preferably 400 mgKOH/g or less, more preferably 200 mgKOH/g or less, further preferably 150 mgKOH/g or less, and most preferably 120 mgKOH/g or less.

作為樹脂,包括含有源自由式(ED1)表示之化合物及/或由式(ED2)表示之化合物(以下,有時將該等化合物亦稱為“醚二聚體”。)之重複單元之樹脂亦較佳。The resin includes a resin containing a repeating unit derived from a compound represented by formula (ED1) and/or a compound represented by formula (ED2) (hereinafter, these compounds may also be referred to as "ether dimers"). Also better.

[化31] [Chemical 31]

式(ED1)中,R 1及R 2分別獨立地表示氫原子或可以具有取代基之碳數1~25的烴基。 [化32] 式(ED2)中,R表示氫原子或碳數1~30的有機基。作為式(ED2)的具體例,能夠參考日本特開2010-168539號公報的記載。 In the formula (ED1), R 1 and R 2 each independently represent a hydrogen atom or a hydrocarbon group having 1 to 25 carbon atoms which may have a substituent. [Chemical 32] In formula (ED2), R represents a hydrogen atom or an organic group having 1 to 30 carbon atoms. As a specific example of the formula (ED2), reference can be made to the description of Japanese Patent Application Laid-Open No. 2010-168539.

關於醚二聚體的具體例,能夠參考日本特開2013-029760號公報的0317段,該內容編入本說明書中。Regarding specific examples of the ether dimer, reference can be made to paragraph 0317 of Japanese Patent Application Laid-Open No. 2013-029760, and this content is incorporated into this specification.

作為樹脂,使用具有聚合性基之樹脂亦較佳。聚合性基為含有乙烯性不飽和鍵之基團及環狀醚基為較佳,含有乙烯性不飽和鍵之基團為更佳。As the resin, it is also preferable to use a resin having a polymerizable group. The polymerizable group is preferably a group containing an ethylenically unsaturated bond and a cyclic ether group, and more preferably a group containing an ethylenically unsaturated bond.

作為樹脂,使用包含源自由式(X)表示之化合物之重複單元之樹脂亦較佳。 [化33] 式中,R 1表示氫原子或甲基,R 21及R 22分別獨立地表示伸烷基,n表示0~15的整數。R 21及R 22所表示之伸烷基的碳數為1~10為較佳,1~5為更佳,1~3為進一步較佳,2或3為特佳。n表示0~15的整數,0~5的整數為較佳,0~4的整數為更佳,0~3的整數為進一步較佳。 As the resin, it is also preferable to use a resin containing a repeating unit derived from a compound represented by formula (X). [Chemical 33] In the formula, R 1 represents a hydrogen atom or a methyl group, R 21 and R 22 each independently represent an alkylene group, and n represents an integer of 0 to 15. The number of carbon atoms in the alkylene group represented by R 21 and R 22 is preferably from 1 to 10, more preferably from 1 to 5, further preferably from 1 to 3, and particularly preferably 2 or 3. n represents an integer of 0 to 15, and an integer of 0 to 5 is preferred, an integer of 0 to 4 is more preferred, and an integer of 0 to 3 is further preferred.

作為由式(X)表示之化合物,可舉出對枯基苯酚(para-cumyl phenol)的環氧乙烷或環氧丙烷改質(甲基)丙烯酸酯等。作為市售品,可舉出ARONIX M-110(TOAGOSEI CO.,LTD.製)等。Examples of the compound represented by formula (X) include ethylene oxide or propylene oxide modified (meth)acrylate of para-cumyl phenol. Examples of commercially available products include ARONIX M-110 (manufactured by TOAGOSEI CO., LTD.) and the like.

樹脂包含作為分散劑的樹脂為較佳。作為分散劑,可舉出酸性分散劑(酸性樹脂)、鹼性分散劑(鹼性樹脂)。在此,酸性分散劑(酸性樹脂)表示酸基的量多於鹼基的量之樹脂。作為酸性分散劑(酸性樹脂),將酸基的量和鹼基的量的總量設定為100莫耳%時,酸基的量為70莫耳%以上之樹脂為較佳。酸性分散劑(酸性樹脂)所具有之酸基較佳為羧基。酸性分散劑(酸性樹脂)的酸值為10~105mgKOH/g為較佳。又,鹼性分散劑(鹼性樹脂)表示鹼基的量多於酸基的量之樹脂。作為鹼性分散劑(鹼性樹脂),將酸基的量與鹼基的量的合計量設定為100莫耳%時,鹼基的量超過50莫耳%以上的樹脂為較佳。鹼性分散劑所具有之鹼基為胺基為較佳。The resin preferably contains a resin as a dispersant. Examples of the dispersant include acidic dispersants (acidic resins) and alkaline dispersants (basic resins). Here, the acidic dispersant (acidic resin) means a resin in which the amount of acid groups is greater than the amount of base groups. As an acidic dispersant (acidic resin), when the total amount of acid groups and base amounts is 100 mol%, a resin having an acid group amount of 70 mol% or more is preferred. The acid group of the acidic dispersant (acidic resin) is preferably a carboxyl group. The acid value of the acidic dispersant (acidic resin) is preferably 10 to 105 mgKOH/g. In addition, the alkaline dispersant (alkaline resin) means a resin in which the amount of base groups is greater than the amount of acid groups. As an alkaline dispersant (alkaline resin), when the total amount of acid groups and bases is 100 mol%, a resin in which the amount of bases exceeds 50 mol% or more is preferred. The alkaline dispersant preferably has an amine group as its base.

用作分散劑之樹脂為接枝樹脂亦較佳。關於接枝樹脂的詳細內容,能夠參考日本特開2012-255128號公報的0025~0094段的記載,該內容編入本說明書中。It is also preferred that the resin used as the dispersant is a graft resin. Regarding the details of the graft resin, reference can be made to the description in paragraphs 0025 to 0094 of Japanese Patent Application Laid-Open No. 2012-255128, and this content is incorporated into this specification.

用作分散劑之樹脂為在主鏈及側鏈中的至少一個上包含氮原子之聚亞胺系分散劑亦較佳。作為聚亞胺系分散劑,具有主鏈及側鏈且在主鏈及側鏈中的至少一個上具有鹼性氮原子之樹脂為較佳,該主鏈包含具有pKa14以下的官能基之部分結構,該側鏈的原子數為40~10000。鹼性氮原子只要為呈鹼性之氮原子,則並沒有特別限制。聚亞胺系分散劑能夠參考日本特開2012-255128號公報的0102~0166段的記載,該內容編入本說明書中。The resin used as a dispersant is also preferably a polyimine-based dispersant containing a nitrogen atom in at least one of the main chain and side chain. As the polyimine-based dispersant, a resin having a main chain and a side chain and having a basic nitrogen atom in at least one of the main chain and the side chain is preferred, and the main chain includes a partial structure having a functional group of pKa14 or less. , the number of atoms in the side chain is 40 to 10,000. The basic nitrogen atom is not particularly limited as long as it is a basic nitrogen atom. Regarding the polyimine-based dispersant, the descriptions in paragraphs 0102 to 0166 of Japanese Patent Application Laid-Open No. 2012-255128 can be referred to, and this content is incorporated into this specification.

用作分散劑之樹脂為在核部鍵結有複數個聚合物鏈之結構的樹脂亦較佳。作為此類樹脂,例如,可舉出樹枝狀聚合物(包括星型聚合物)。又,作為樹枝狀聚合物的具體例,可舉出日本特開2013-043962號公報的0196~0209段中記載之高分子化合物C-1~C-31等。It is also preferred that the resin used as the dispersant has a structure in which a plurality of polymer chains are bonded to the core. Examples of such resins include dendritic polymers (including star polymers). Specific examples of dendrimers include polymer compounds C-1 to C-31 described in paragraphs 0196 to 0209 of Japanese Patent Application Laid-Open No. 2013-043962.

用作分散劑之樹脂為包含側鏈具有含有乙烯性不飽和鍵之基團之重複單元之樹脂亦較佳。側鏈具有含有乙烯性不飽和鍵之基團之重複單元的含量在樹脂的所有重複單元中為10莫耳%以上為較佳,10~80莫耳%為更佳,20~70莫耳%為進一步較佳。The resin used as a dispersant is also preferably a resin containing a repeating unit having a group containing an ethylenically unsaturated bond in the side chain. The content of the repeating unit having an ethylenically unsaturated bond-containing group in the side chain among all the repeating units of the resin is preferably 10 mol% or more, more preferably 10 to 80 mol%, and 20 to 70 mol%. For further improvement.

又,作為分散劑,亦能夠使用日本特開2018-087939號公報中記載之樹脂、日本專利第6432077號公報的0219~0221段中記載之嵌段共聚物(EB-1)~(EB-9)、國際公開第2016/104803號中記載之具有聚酯側鏈之聚乙烯亞胺、國際公開第2019/125940號中記載之嵌段共聚物、日本特開2020-066687號公報中記載之具有丙烯醯胺結構單元之嵌段聚合物、日本特開2020-066688號公報中記載之具有丙烯醯胺結構單元之嵌段聚合物等。In addition, as the dispersant, the resin described in Japanese Patent Application Laid-Open No. 2018-087939 and the block copolymers (EB-1) to (EB-9) described in paragraphs 0219 to 0221 of Japanese Patent No. 6432077 can also be used. ), the polyethyleneimine having a polyester side chain described in International Publication No. 2016/104803, the block copolymer described in International Publication No. 2019/125940, the polyethylene imine described in Japanese Patent Application Laid-Open No. 2020-066687 Block polymers with acrylamide structural units, block polymers with acrylamide structural units described in Japanese Patent Application Laid-Open No. 2020-066688, etc.

分散劑亦能夠作為市售品獲得,作為此類具體例,可舉出BYK-Chemie GmbH製DISPERBYK系列、Japan Lubrizol Corporation製SOLSPERSE系列、BASF公司製Efka系列、Ajinomoto Fine-Techno Co.,Inc.製Ajispar系列等。又,亦能夠使用日本特開2012-137564號公報的0129段中記載之產品、日本特開2017-194662號公報的0235段中記載之產品作為分散劑。Dispersants are also available as commercial products, and specific examples thereof include DISPERBYK series manufactured by BYK-Chemie GmbH, SOLSPERSE series manufactured by Japan Lubrizol Corporation, Efka series manufactured by BASF Corporation, and Ajinomoto Fine-Techno Co., Inc. Ajispar series etc. In addition, the products described in Paragraph 0129 of Japanese Patent Application Laid-Open No. 2012-137564 and the products described in Paragraph 0235 of Japanese Patent Application Laid-Open No. 2017-194662 can also be used as the dispersant.

在組成物的總固體成分中,硬化性化合物的含量為1~95質量%為較佳。下限為2質量%以上為較佳,5質量%以上為更佳,7質量%以上為進一步較佳,10質量%以上為特佳。上限為94質量%以下為較佳,90質量%以下為更佳,85質量%以下為進一步較佳,80質量%以下為特佳。The content of the curable compound is preferably 1 to 95% by mass in the total solid content of the composition. The lower limit is preferably 2 mass% or more, more preferably 5 mass% or more, further preferably 7 mass% or more, and 10 mass% or more is particularly preferred. The upper limit is preferably 94 mass% or less, more preferably 90 mass% or less, further preferably 85 mass% or less, and particularly preferably 80 mass% or less.

本發明的組成物包含聚合性化合物作為硬化性化合物時,聚合性化合物的含量在組成物的總固體成分中為1~85質量%為較佳。下限為2質量%以上為較佳,3質量%以上為更佳,5質量%以上為進一步較佳。上限為80質量%以下為較佳,70質量%以下為更佳。When the composition of the present invention contains a polymerizable compound as a curable compound, the content of the polymerizable compound is preferably 1 to 85% by mass in the total solid content of the composition. The lower limit is preferably 2 mass% or more, more preferably 3 mass% or more, and still more preferably 5 mass% or more. The upper limit is preferably 80 mass% or less, and more preferably 70 mass% or less.

本發明的組成物包含聚合性單體作為硬化性化合物時,聚合性單體的含量在組成物的總固體成分中為1~50質量%為較佳。下限為2質量%以上為較佳,3質量%以上為更佳,5質量%以上為進一步較佳。上限為30質量%以下為較佳,20質量%以下為更佳。When the composition of the present invention contains a polymerizable monomer as a curable compound, the content of the polymerizable monomer is preferably 1 to 50% by mass in the total solid content of the composition. The lower limit is preferably 2 mass% or more, more preferably 3 mass% or more, and still more preferably 5 mass% or more. The upper limit is preferably 30 mass% or less, and more preferably 20 mass% or less.

本發明的組成物包含具有含有乙烯性不飽和鍵之基團之化合物作為硬化性化合物時,具有含有乙烯性不飽和鍵之基團之化合物的含量在組成物的總固體成分中為1~70質量%為較佳。下限為2質量%以上為較佳,3質量%以上為更佳,5質量%以上為進一步較佳。上限為65質量%以下為較佳,60質量%以下為更佳。When the composition of the present invention contains a compound having an ethylenically unsaturated bond-containing group as the curing compound, the content of the compound having an ethylenically unsaturated bond-containing group in the total solid content of the composition is 1 to 70 Mass% is better. The lower limit is preferably 2 mass% or more, more preferably 3 mass% or more, and still more preferably 5 mass% or more. The upper limit is preferably 65 mass% or less, and more preferably 60 mass% or less.

本發明的組成物包含具有環狀醚基之化合物作為硬化性化合物時,具有環狀醚基之化合物的含量在組成物的總固體成分中為1~95質量%為較佳。下限為2質量%以上為較佳,3質量%以上為更佳,5質量%以上為進一步較佳。上限為80質量%以下為較佳,70質量%以下為更佳,60質量%以下為進一步較佳。When the composition of the present invention contains a compound having a cyclic ether group as the curing compound, the content of the compound having a cyclic ether group is preferably 1 to 95% by mass in the total solid content of the composition. The lower limit is preferably 2 mass% or more, more preferably 3 mass% or more, and still more preferably 5 mass% or more. The upper limit is preferably 80 mass% or less, more preferably 70 mass% or less, and still more preferably 60 mass% or less.

本發明的組成物包含樹脂作為硬化性化合物時,樹脂的含量在組成物的總固體成分中為1~85質量%為較佳。下限為2質量%以上為較佳,5質量%以上為更佳,7質量%以上為進一步較佳,10質量%以上為特佳。上限為80質量%以下為較佳,75質量%以下為更佳,70質量%以下為進一步較佳,40質量%以下為特佳。When the composition of the present invention contains a resin as a curable compound, the content of the resin is preferably 1 to 85% by mass of the total solid content of the composition. The lower limit is preferably 2 mass% or more, more preferably 5 mass% or more, further preferably 7 mass% or more, and 10 mass% or more is particularly preferred. The upper limit is preferably 80 mass% or less, more preferably 75 mass% or less, further preferably 70 mass% or less, and particularly preferably 40 mass% or less.

本發明的組成物含有作為分散劑的樹脂時,作為分散劑的樹脂的含量在組成物的總固體成分中為0.1~40質量%為較佳。上限為25質量%以下為較佳,20質量%以下為進一步較佳。下限為0.5質量%以上為較佳,1質量%以上為進一步較佳。又,作為分散劑的樹脂的含量相對於顏料100質量份為1~100質量份為較佳。上限為80質量份以下為較佳,75質量份以下為更佳。下限為2.5質量份以上為較佳,5質量份以上為更佳。When the composition of the present invention contains a resin as a dispersant, the content of the resin as a dispersant is preferably 0.1 to 40% by mass in the total solid content of the composition. The upper limit is preferably 25% by mass or less, and further preferably 20% by mass or less. It is more preferable that the lower limit is 0.5 mass % or more, and it is further more preferable that it is 1 mass % or more. In addition, the content of the resin as a dispersant is preferably 1 to 100 parts by mass relative to 100 parts by mass of the pigment. The upper limit is preferably 80 parts by mass or less, and more preferably 75 parts by mass or less. The lower limit is preferably 2.5 parts by mass or more, and more preferably 5 parts by mass or more.

本發明的組成物可以僅包含1種硬化性化合物,亦可以包含2種以上。包含2種以上的硬化性化合物時,該等的合計量在上述範圍內為較佳。The composition of the present invention may contain only one type of curable compound, or may contain two or more types. When two or more types of curable compounds are contained, the total amount is preferably within the above range.

<<溶劑>> 本發明的組成物含有溶劑。作為溶劑,可舉出水、有機溶劑,有機溶劑為較佳。作為有機溶劑,可舉出酯系溶劑、酮系溶劑、醇系溶劑、醯胺系溶劑、醚系溶劑、烴系溶劑等。關於該等的詳細內容,能夠參考國際公開第2015/166779號的0223段,該內容編入本說明書中。又,亦能夠較佳地使用經環狀烷基取代之酯系溶劑、經環狀烷基取代之酮系溶劑。作為有機溶劑的具體例,可舉出聚乙二醇單甲醚、二氯甲烷、3-乙氧基丙酸甲酯、3-乙氧基丙酸乙酯、乙基賽路蘇乙酸酯、乳酸乙酯、二乙二醇二甲醚、乙酸丁酯、3-甲氧基丙酸甲酯、2-庚酮、2-戊酮、3-戊酮、4-庚酮、環己酮、2-甲基環己酮、3-甲基環己酮、4-甲基環己酮、環庚酮、環辛酮、乙酸環己酯、環戊酮、乙基卡必醇乙酸酯、丁基卡必醇乙酸酯、丙二醇單甲醚、丙二醇單甲醚乙酸酯、3-甲氧基-N,N-二甲基丙醯胺、3-丁氧基-N,N-二甲基丙醯胺、丙二醇二乙酸酯、3-甲氧基丁醇、甲基乙基酮、γ-丁內酯、環丁碸、苯甲醚、1,4-二乙醯氧基丁烷、二乙二醇單乙醚乙酸酯、1,3-丁二醇二乙酸酯、二丙二醇甲醚乙酸酯、二丙酮醇(亦稱為4-羥基-4-甲基-2-戊酮)、2-甲氧基丙基乙酸酯、2-甲氧基-1-丙醇、異丙醇等。然而,有時出於環境方面等原因,減少作為有機溶劑之芳香族烴類(苯、甲苯、二甲苯、乙苯等)為較佳(例如,相對於有機溶劑總量,能夠設定為50質量ppm(parts per million:百萬分率)以下,亦能夠設定為10質量ppm以下,亦能夠設定為1質量ppm以下)。 <<Solvent>> The composition of the present invention contains a solvent. Examples of the solvent include water and organic solvents, with organic solvents being preferred. Examples of the organic solvent include ester solvents, ketone solvents, alcohol solvents, amide solvents, ether solvents, hydrocarbon solvents, and the like. For details, please refer to paragraph 0223 of International Publication No. 2015/166779, which is incorporated into this specification. Furthermore, ester-based solvents substituted with cyclic alkyl groups and ketone-based solvents substituted with cyclic alkyl groups can also be suitably used. Specific examples of the organic solvent include polyethylene glycol monomethyl ether, methylene chloride, methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, and ethylcelusacetate. , Ethyl lactate, diglyme, butyl acetate, methyl 3-methoxypropionate, 2-heptanone, 2-pentanone, 3-pentanone, 4-heptanone, cyclohexanone , 2-methylcyclohexanone, 3-methylcyclohexanone, 4-methylcyclohexanone, cycloheptanone, cyclooctanone, cyclohexyl acetate, cyclopentanone, ethyl carbitol acetate , butyl carbitol acetate, propylene glycol monomethyl ether, propylene glycol monomethyl ether acetate, 3-methoxy-N,N-dimethylpropylamide, 3-butoxy-N,N- Dimethylpropamide, propylene glycol diacetate, 3-methoxybutanol, methyl ethyl ketone, γ-butyrolactone, cycloterine, anisole, 1,4-diethyloxy Butane, diethylene glycol monoethyl ether acetate, 1,3-butanediol diacetate, dipropylene glycol methyl ether acetate, diacetone alcohol (also known as 4-hydroxy-4-methyl-2 -pentanone), 2-methoxypropyl acetate, 2-methoxy-1-propanol, isopropyl alcohol, etc. However, sometimes it is better to reduce the number of aromatic hydrocarbons (benzene, toluene, xylene, ethylbenzene, etc.) used as organic solvents for environmental reasons (for example, it can be set to 50 mass based on the total amount of organic solvents). ppm (parts per million: parts per million) or less, it can also be set to 10 mass ppm or less, or it can be set to 1 mass ppm or less).

本發明中,使用金屬含量少的有機溶劑為較佳,有機溶劑的金屬含量例如為10質量ppb(parts per billion:十億分率)以下為較佳。可以根據需要使用質量ppt(parts per trillion:兆分率)級別的有機溶劑,此類有機溶劑例如由Toyo Gosei Co.,Ltd提供(化學工業日報,2015年11月13日)。In the present invention, it is preferable to use an organic solvent with a small metal content. It is preferable that the metal content of the organic solvent is, for example, 10 mass ppb (parts per billion: parts per billion) or less. Organic solvents of ppt (parts per trillion) quality level can be used as needed, and such organic solvents are provided by Toyo Gosei Co., Ltd., for example (Chemical Industry Daily, November 13, 2015).

作為從有機溶劑中去除金屬等雜質之方法,例如能夠舉出蒸餾(分子蒸餾、薄膜蒸餾等)或使用了過濾器之過濾。作為用於過濾之過濾器的過濾器孔徑,10μm以下為較佳,5μm以下為更佳,3μm以下為進一步較佳。過濾器的材質較佳為聚四氟乙烯、聚乙烯或尼龍。Examples of methods for removing impurities such as metals from organic solvents include distillation (molecular distillation, thin film distillation, etc.) or filtration using a filter. The filter pore size of the filter used for filtration is preferably 10 μm or less, more preferably 5 μm or less, and further preferably 3 μm or less. The filter material is preferably polytetrafluoroethylene, polyethylene or nylon.

有機溶劑可以包含異構物(原子數相同,但結構不同的化合物)。又,異構物可以僅包含1種,亦可以包含複數種。Organic solvents can contain isomers (compounds with the same number of atoms but different structures). In addition, the isomer may contain only one type or a plurality of types.

過氧化物在有機溶劑中的含有率為0.8mmol/L以下為較佳,實質上不包含過氧化物為更佳。It is preferable that the content rate of peroxide in the organic solvent is 0.8 mmol/L or less, and it is more preferable that it does not contain peroxide substantially.

溶劑在組成物中的含量為10~97質量%為較佳。下限為30質量%以上為較佳,40質量%以上為更佳,50質量%以上為進一步較佳,60質量%以上為更進一步較佳,70質量%以上為特佳。上限為96質量%以下為較佳,95質量%以下為更佳。組成物可以僅含有1種溶劑,亦可以含有2種以上。包含2種以上時,該等的合計量在上述範圍內為較佳。The content of the solvent in the composition is preferably 10 to 97% by mass. The lower limit is preferably 30% by mass or more, more preferably 40% by mass or more, more preferably 50% by mass or more, still more preferably 60% by mass or more, and particularly preferably 70% by mass or more. The upper limit is preferably 96 mass% or less, and more preferably 95 mass% or less. The composition may contain only one type of solvent, or may contain two or more types of solvents. When two or more types are included, the total amount is preferably within the above range.

<<色素衍生物>> 本發明的組成物能夠進一步含有色素衍生物。色素衍生物可用作分散助劑。作為色素衍生物,可舉出具有色素骨架上鍵結了酸基或鹼基之結構之化合物。 <<Pigment Derivatives>> The composition of the present invention can further contain a pigment derivative. Pigment derivatives can be used as dispersing aids. Examples of dye derivatives include compounds having a structure in which an acid group or a base is bonded to the dye skeleton.

作為構成色素衍生物之色素骨架,可舉出方酸菁色素骨架、吡咯并吡咯色素骨架、二酮吡咯并吡咯色素骨架、喹吖酮色素骨架、蒽醌色素骨架、聯蒽酮色素骨架、苯并異吲哚色素骨架、噻𠯤靛藍色素骨架、偶氮色素骨架、喹啉黃色素骨架、酞菁色素骨架、萘酞菁色素骨架、二㗁𠯤色素骨架、苝色素骨架、紫環酮色素骨架、苯并咪唑酮色素骨架、苯并噻唑色素骨架、苯并咪唑色素骨架及苯并㗁唑色素骨架,方酸菁色素骨架、吡咯并吡咯色素骨架、二酮吡咯并吡咯色素骨架、酞菁色素骨架、喹吖酮色素骨架及苯并咪唑酮色素骨架為較佳,方酸菁色素骨架及吡咯并吡咯色素骨架為更佳。Examples of the pigment skeleton constituting the pigment derivative include squarylyanine pigment skeleton, pyrrolopyrrole pigment skeleton, diketopyrrolopyrrole pigment skeleton, quinacridone pigment skeleton, anthraquinone pigment skeleton, bisanthrone pigment skeleton, and benzene pigment skeleton. Isoindole pigment skeleton, thi𠯤indigo pigment skeleton, azo pigment skeleton, quinoline yellow pigment skeleton, phthalocyanine pigment skeleton, naphthalocyanine pigment skeleton, di-㗁𠯤 pigment skeleton, perylene pigment skeleton, purpurone pigment skeleton , benzimidazolone pigment skeleton, benzothiazole pigment skeleton, benzimidazole pigment skeleton and benzoethazole pigment skeleton, squaraine pigment skeleton, pyrrolopyrrole pigment skeleton, diketopyrrolopyrrole pigment skeleton, phthalocyanine pigment The skeleton, quinacridone pigment skeleton and benzimidazolone pigment skeleton are preferred, and the squaraine pigment skeleton and pyrrolopyrrole pigment skeleton are even better.

作為酸基,可舉出羧基、磺基、磷酸基、硼酸基、羧酸醯胺基、磺醯胺基、醯亞胺酸基及該等的鹽等。作為構成鹽之原子或原子團,可舉出鹼金屬離子(Li +、Na +、K +等)、鹼土類金屬離子(Ca 2+、Mg 2+等)、銨離子、咪唑鎓離子、吡啶鎓離子、鏻離子等。作為羧酸醯胺基,由-NHCOR A1表示之基團為較佳。作為磺醯胺基,由-NHSO 2R A2表示之基團為較佳。作為醯亞胺酸基,由-SO 2NHSO 2R A3、-CONHSO 2R A4、-CONHCOR A5或-SO 2NHCOR A6表示之基團為較佳,-SO 2NHSO 2R A3為更佳。R A1~R A6分別獨立地表示烷基或芳基。R A1~R A6所表示之烷基及芳基可以具有取代基。作為取代基,鹵素原子為較佳,氟原子為更佳。 Examples of the acid group include a carboxyl group, a sulfo group, a phosphoric acid group, a boric acid group, a carboxylic acid amide group, a sulfonamide group, a amide acid group, and salts thereof. Examples of atoms or atomic groups constituting the salt include alkali metal ions (Li + , Na + , K + , etc.), alkaline earth metal ions (Ca 2+ , Mg 2+ , etc.), ammonium ions, imidazolium ions, and pyridinium ions, phosphonium ions, etc. As the carboxylic acid amide group, a group represented by -NHCOR A1 is preferred. As the sulfonamide group, a group represented by -NHSO 2 R A2 is preferred. As the amide acid group, a group represented by -SO 2 NHSO 2 R A3 , -CONHSO 2 R A4 , -CONHCOR A5 or -SO 2 NHCOR A6 is preferred, and -SO 2 NHSO 2 R A3 is more preferred. R A1 to R A6 each independently represent an alkyl group or an aryl group. The alkyl group and aryl group represented by R A1 to R A6 may have a substituent. As the substituent, a halogen atom is preferred, and a fluorine atom is more preferred.

作為鹼基,可舉出胺基、吡啶基及其鹽、銨基的鹽以及酞醯亞胺甲基。作為構成鹽之原子或原子團,可舉出氫氧化物離子、鹵素離子、羧酸離子、磺酸離子、苯氧離子等。Examples of the base include an amino group, a pyridyl group and a salt thereof, a salt of an ammonium group, and a phthalimide methyl group. Examples of atoms or atomic groups constituting the salt include hydroxide ions, halogen ions, carboxylate ions, sulfonate ions, phenoxide ions, and the like.

作為色素衍生物的具體例,可舉出後述實施例中記載之化合物。又,亦可舉出日本特開昭56-118462號公報、日本特開昭63-264674號公報、日本特開平01-217077號公報、日本特開平03-009961號公報、日本特開平03-026767號公報、日本特開平03-153780號公報、日本特開平03-045662號公報、日本特開平04-285669號公報、日本特開平06-145546號公報、日本特開平06-212088號公報、日本特開平06-240158號公報、日本特開平10-030063號公報、日本特開平10-195326號公報、國際公開第2011/024896號的0086~0098段、國際公開第2012/102399號的0063~0094段中記載之化合物,該等內容編入本說明書中。Specific examples of the dye derivatives include compounds described in the Examples described below. Furthermore, Japanese Patent Application Laid-Open No. Sho 56-118462, Japanese Patent Application Laid-Open No. Sho 63-264674, Japanese Patent Application Laid-Open No. 01-217077, Japanese Patent Application Laid-Open No. 03-009961, and Japanese Patent Application Laid-Open No. 03-026767 can also be cited. Japanese Patent Application Publication No. 03-153780, Japanese Patent Application Publication No. 03-045662, Japanese Patent Application Publication No. 04-285669, Japanese Patent Application Publication No. 06-145546, Japanese Patent Application Publication No. 06-212088, Japanese Patent Application Publication No. 06-212088, Kaihei Publication No. 06-240158, Japanese Patent Application Publication No. 10-030063, Japanese Patent Application Publication No. 10-195326, paragraphs 0086 to 0098 of International Publication No. 2011/024896, paragraphs 0063 to 0094 of International Publication No. 2012/102399 The compounds described in are incorporated into this specification.

色素衍生物的含量相對於顏料100質量份為1~50質量份為較佳。下限值為3質量份以上為較佳,5質量份以上為更佳。上限值為40質量份以下為較佳,30質量份以下為更佳。色素衍生物可以僅使用1種,亦可以使用2種以上。使用2種以上時,合計量在上述範圍內為較佳。The content of the pigment derivative is preferably 1 to 50 parts by mass based on 100 parts by mass of the pigment. The lower limit value is preferably 3 parts by mass or more, and more preferably 5 parts by mass or more. The upper limit is preferably 40 parts by mass or less, and more preferably 30 parts by mass or less. Only one type of pigment derivative may be used, or two or more types may be used. When two or more types are used, the total amount is preferably within the above range.

<<光聚合起始劑>> 本發明的組成物包含聚合性化合物時,本發明的組成物進一步含有光聚合起始劑為較佳。作為光聚合起始劑,並沒有特別限制,能夠適當地選自公知的光聚合起始劑。例如,對紫外線區域至可見區域的光線具有感光性之化合物為較佳。光聚合起始劑為光自由基聚合起始劑為較佳。 <<Photopolymerization initiator>> When the composition of the present invention contains a polymerizable compound, it is preferred that the composition of the present invention further contains a photopolymerization initiator. The photopolymerization initiator is not particularly limited and can be appropriately selected from known photopolymerization initiators. For example, compounds that are photosensitive to light in the ultraviolet range to the visible range are preferred. The photopolymerization initiator is preferably a photoradical polymerization initiator.

作為光聚合起始劑,可舉出鹵化烴衍生物(例如,具有三𠯤骨架之化合物、具有㗁二唑骨架之化合物等)、醯基膦化合物、六芳基雙咪唑化合物、肟化合物、有機過氧化物、硫化合物、酮化合物、芳香族鎓鹽、α-羥基酮化合物、α-胺基酮化合物等。從曝光靈敏度的觀點考慮,光聚合起始劑為三鹵甲基三𠯤化合物、苄基二甲基縮酮化合物、α-羥基酮化合物、α-胺基酮化合物、醯基膦化合物、氧化膦化合物、茂金屬化合物、肟化合物、六芳基雙咪唑化合物、鎓化合物、苯并噻唑化合物、二苯甲酮化合物、苯乙酮化合物、環戊二烯-苯-鐵錯合物、鹵甲基㗁二唑化合物及3-芳基取代香豆素化合物為較佳,選自肟化合物、α-羥基酮化合物、α-胺基酮化合物及醯基膦化合物中之化合物為更佳,肟化合物為進一步較佳。又,作為光聚合起始劑,可舉出日本特開2014-130173號公報的0065~0111段中記載之化合物、日本專利第6301489號公報中記載之化合物、MATERIAL STAGE 37~60p,vol.19,No.3,2019中記載之過氧化物系光聚合起始劑、國際公開第2018/221177號中記載之光聚合起始劑、國際公開第2018/110179號中記載之光聚合起始劑、日本特開2019-043864號公報中記載之光聚合起始劑、日本特開2019-044030號公報中記載之光聚合起始劑、日本特開2019-167313號公報中記載之過氧化物系起始劑、日本特開2020-055992號公報中記載之具有㗁唑啶基之胺基苯乙酮系起始劑、日本特開2013-190459號公報中記載之肟系光聚合起始劑、日本特開2020-172619號公報中記載之聚合物、國際公開第2020/152120號中記載之由式1表示之化合物等,該等內容編入本說明書中。Examples of the photopolymerization initiator include halogenated hydrocarbon derivatives (for example, compounds having a trioxadiazole skeleton, compounds having an oxadiazole skeleton, etc.), acylphosphine compounds, hexaarylbisimidazole compounds, oxime compounds, organic Peroxides, sulfur compounds, ketone compounds, aromatic onium salts, α-hydroxyketone compounds, α-aminoketone compounds, etc. From the viewpoint of exposure sensitivity, photopolymerization initiators include trihalomethyl trisulfide compounds, benzyldimethyl ketal compounds, α-hydroxyketone compounds, α-aminoketone compounds, acylphosphine compounds, and phosphine oxides. Compounds, metallocene compounds, oxime compounds, hexaarylbisimidazole compounds, onium compounds, benzothiazole compounds, benzophenone compounds, acetophenone compounds, cyclopentadiene-benzene-iron complexes, halomethyl compounds The oxadiazole compound and the 3-aryl substituted coumarin compound are preferred, and the compound selected from the group consisting of oxime compounds, α-hydroxyketone compounds, α-aminoketone compounds and acylphosphine compounds is more preferred, and the oxime compound is Better still. Examples of the photopolymerization initiator include compounds described in paragraphs 0065 to 0111 of Japanese Patent Application Laid-Open No. 2014-130173, compounds described in Japanese Patent Publication No. 6301489, and MATERIAL STAGE 37 to 60p, vol. 19 , the peroxide-based photopolymerization initiator described in No. 3, 2019, the photopolymerization initiator described in International Publication No. 2018/221177, the photopolymerization initiator described in International Publication No. 2018/110179 , the photopolymerization initiator described in Japanese Patent Application Publication No. 2019-043864, the photopolymerization initiator described in Japanese Patent Application Publication No. 2019-044030, the peroxide system described in Japanese Patent Application Publication No. 2019-167313 Initiator, the aminoacetophenone-based initiator having an oxazolidinyl group described in Japanese Patent Application Laid-Open No. 2020-055992, the oxime-based photopolymerization initiator described in Japanese Patent Application Publication No. 2013-190459, The polymer described in Japanese Patent Application Laid-Open No. 2020-172619, the compound represented by Formula 1 described in International Publication No. 2020/152120, and the like are incorporated in this specification.

作為六芳基雙咪唑化合物的具體例,可舉出2,2’,4-三(2-氯苯基)-5-(3,4-二甲氧基苯基)-4,5-二苯基-1,1’-雙咪唑等。Specific examples of hexaarylbisimidazole compounds include 2,2',4-tris(2-chlorophenyl)-5-(3,4-dimethoxyphenyl)-4,5-di Phenyl-1,1'-bisimidazole, etc.

作為α-羥基酮化合物的市售品,可舉出Omnirad 184、Omnirad 1173、Omnirad 2959、Omnirad 127(以上為IGM Resins B.V.公司製)、Irgacure 184、Irgacure 1173、Irgacure 2959、Irgacure 127(以上為BASF公司製)等。作為α-胺基酮化合物的市售品,可舉出Omnirad 907、Omnirad 369、Omnirad 369E、Omnirad 379EG(以上為IGM Resins B.V.公司製)、Irgacure 907、Irgacure 369、Irgacure 369E、Irgacure 379EG(以上為BASF公司製)等。作為醯基膦化合物的市售品,可舉出Omnirad 819、Omnirad TPO(以上為IGM Resins B.V.公司製)、Irgacure 819、Irgacure TPO(以上為BASF公司製)等。Commercially available α-hydroxyketone compounds include Omnirad 184, Omnirad 1173, Omnirad 2959, and Omnirad 127 (the above products are manufactured by IGM Resins B.V.), Irgacure 184, Irgacure 1173, Irgacure 2959, and Irgacure 127 (the above products are manufactured by BASF). company system), etc. Commercially available α-aminoketone compounds include Omnirad 907, Omnirad 369, Omnirad 369E, and Omnirad 379EG (the above are manufactured by IGM Resins B.V.), Irgacure 907, Irgacure 369, Irgacure 369E, and Irgacure 379EG (the above are manufactured by IGM Resins B.V.). BASF Corporation), etc. Examples of commercially available acylphosphine compounds include Omnirad 819, Omnirad TPO (the above products are manufactured by IGM Resins B.V.), Irgacure 819, and Irgacure TPO (the above products are manufactured by BASF Corporation), and the like.

作為肟化合物,可舉出日本特開2001-233842號公報中記載之化合物、日本特開2000-080068號公報中記載之化合物、日本特開2006-342166號公報中記載之化合物、J.C.S.Perkin II(1979年,第1653-1660頁)中記載之化合物、J.C.S.Perkin II(1979年,第156-162頁)中記載之化合物、Journal of Photopolymer Science and Technology(1995年,第202-232頁)中記載之化合物、日本特開2000-066385號公報中記載之化合物、日本特表2004-534797號公報中記載之化合物、日本特開2006-342166號公報中記載之化合物、日本特開2017-019766號公報中記載之化合物、日本專利第6065596號公報中記載之化合物、國際公開第2015/152153號中記載之化合物、國際公開第2017/051680號中記載之化合物、日本特開2017-198865號公報中記載之化合物、國際公開第2017/164127號的0025~0038段中記載之化合物、國際公開第2013/167515號中記載之化合物、國際公開第2017/169819號、日本特開2019-168654號公報的0029~0044中記載之化合物等。作為肟化合物的具體例,可舉出3-苯甲醯氧基亞胺基丁-2-酮、3-乙醯氧基亞胺基丁-2-酮、3-丙醯氧基亞胺基丁-2-酮、2-乙醯氧基亞胺基戊-3-酮、2-乙醯氧基亞胺基-1-苯基丙-1-酮、2-苯甲醯氧基亞胺基-1-苯基丙-1-酮、3-(4-甲苯磺醯氧基)亞胺基丁-2-酮及2-乙氧基羰氧基亞胺基-1-苯基丙-1-酮等、1-[4-(苯硫基)苯基]-3-環己烷-丙-1,2-二酮-2-(O-乙醯肟)。作為市售品,可舉出Irgacure OXE01、Irgacure OXE02、Irgacure OXE03、Irgacure OXE04(以上為BASF公司製)、TR-PBG-304、TR-PBG-327(TRONLY公司製)、Adeka Optomer N-1919(ADEKA CORPORATION製,日本特開2012-014052號公報中記載之光聚合起始劑2)。又,作為肟化合物,使用沒有著色性之化合物或透明性高且不易變色的化合物亦較佳。作為市售品,可舉出ADEKA ARKLS NCI-730、NCI-831、NCI-930(以上為ADEKA CORPORATION製)等。Examples of the oxime compound include compounds described in Japanese Patent Application Publication No. 2001-233842, compounds described in Japanese Patent Application Publication No. 2000-080068, compounds described in Japanese Patent Application Publication No. 2006-342166, and J.C.S. Perkin II ( Compounds described in J.C.S. Perkin II (1979, pp. 156-162), Journal of Photopolymer Science and Technology (1995, pp. 202-232) Compounds, compounds described in Japanese Patent Application Publication No. 2000-066385, compounds described in Japanese Patent Application Publication No. 2004-534797, compounds described in Japanese Patent Application Publication No. 2006-342166, Japanese Patent Application Publication No. 2017-019766 Compounds described in, Compounds described in Japanese Patent Publication No. 6065596, Compounds described in International Publication No. 2015/152153, Compounds described in International Publication No. 2017/051680, Compounds described in Japanese Patent Publication No. 2017-198865 Compounds, compounds described in paragraphs 0025 to 0038 of International Publication No. 2017/164127, compounds described in International Publication No. 2013/167515, compounds described in International Publication No. 2017/169819, and 0029 of Japanese Patent Application Publication No. 2019-168654 Compounds described in ~0044, etc. Specific examples of the oxime compound include 3-benzoyloxyiminobutan-2-one, 3-acetyloxyiminobutan-2-one, and 3-propionyloxyiminobutan-2-one. Butan-2-one, 2-acetyloxyiminopentan-3-one, 2-acetyloxyimino-1-phenylpropan-1-one, 2-benzyloxyimine 1-phenylpropan-1-one, 3-(4-toluenesulfonyloxy)iminobutan-2-one and 2-ethoxycarbonyloxyimino-1-phenylpropan- 1-one, etc., 1-[4-(phenylthio)phenyl]-3-cyclohexane-propan-1,2-dione-2-(O-acetyl oxime). Examples of commercially available products include Irgacure OXE01, Irgacure OXE02, Irgacure OXE03, Irgacure OXE04 (the above are manufactured by BASF), TR-PBG-304, TR-PBG-327 (manufactured by TRONLY), Adeka Optomer N-1919 ( Photopolymerization initiator 2) manufactured by ADEKA CORPORATION and described in Japanese Patent Application Publication No. 2012-014052. In addition, as the oxime compound, it is also preferable to use a compound that has no coloring properties or a compound that is highly transparent and difficult to change color. Examples of commercially available products include ADEKA ARKLS NCI-730, NCI-831, NCI-930 (the above are manufactured by ADEKA CORPORATION), and the like.

作為光聚合起始劑,亦能夠使用具有茀環之肟化合物。作為具有茀環之肟化合物的具體例,可舉出日本特開2014-137466號公報中記載之化合物、日本專利6636081號公報中記載之化合物、韓國公開專利第10-2016-0109444號公報中記載之化合物。As the photopolymerization initiator, an oxime compound having a fluorine ring can also be used. Specific examples of the oxime compound having a fluorine ring include the compounds described in Japanese Patent Application Laid-Open No. 2014-137466, the compounds described in Japanese Patent Publication No. 6636081, and the compounds described in Korean Patent Publication No. 10-2016-0109444. of compounds.

作為光聚合起始劑,亦能夠使用具有咔唑環的至少一個苯環成為萘環之骨架之肟化合物。作為此類肟化合物的具體例,可舉出國際公開第2013/083505號中記載之化合物。As the photopolymerization initiator, an oxime compound having at least one benzene ring of a carbazole ring serving as the skeleton of a naphthalene ring can also be used. Specific examples of such oxime compounds include compounds described in International Publication No. 2013/083505.

作為光聚合起始劑,亦能夠使用具有氟原子之肟化合物。作為具有氟原子之肟化合物的具體例,可舉出日本特開2010-262028號公報中記載之化合物、日本特表2014-500852號公報中記載之化合物24、36~40、日本特開2013-164471號公報中記載之化合物(C-3)等。As the photopolymerization initiator, an oxime compound having a fluorine atom can also be used. Specific examples of the oxime compound having a fluorine atom include compounds described in Japanese Patent Application Publication No. 2010-262028, compounds 24, 36 to 40 described in Japanese Patent Application Publication No. 2014-500852, and Japanese Patent Application Publication No. 2013- Compound (C-3) described in Publication No. 164471, etc.

作為光聚合起始劑,能夠使用具有硝基之肟化合物。具有硝基之肟化合物設定為二聚體亦較佳。作為具有硝基之肟化合物的具體例,可舉出日本特開2013-114249號公報的0031~0047段、日本特開2014-137466號公報的0008~0012、0070~0079段中記載之化合物、日本專利4223071號公報的0007~0025段中記載之化合物、ADEKA ARKLS NCI-831(ADEKA CORPORATION製)。As the photopolymerization initiator, an oxime compound having a nitro group can be used. It is also preferable that the oxime compound having a nitro group is a dimer. Specific examples of the oxime compound having a nitro group include compounds described in paragraphs 0031 to 0047 of Japanese Patent Application Laid-Open No. 2013-114249 and paragraphs 0008 to 0012 and 0070 to 0079 of Japanese Patent Application Laid-Open No. 2014-137466, The compound described in paragraphs 0007 to 0025 of Japanese Patent No. 4223071, ADEKA ARKLS NCI-831 (manufactured by ADEKA CORPORATION).

作為光聚合起始劑,亦能夠使用具有苯并呋喃骨架之肟化合物。作為具體例,可舉出國際公開第2015/036910號中記載之OE-01~OE-75。As the photopolymerization initiator, an oxime compound having a benzofuran skeleton can also be used. Specific examples include OE-01 to OE-75 described in International Publication No. 2015/036910.

作為光聚合起始劑,亦能夠使用咔唑骨架上鍵結了具有羥基之取代基之肟化合物。作為此類光聚合起始劑,可舉出國際公開第2019/088055號中記載之化合物等。As the photopolymerization initiator, an oxime compound in which a substituent having a hydroxyl group is bonded to the carbazole skeleton can also be used. Examples of such photopolymerization initiators include compounds described in International Publication No. 2019/088055.

以下示出可較佳地用於本發明之肟化合物的具體例,但本發明並不限定於該等。Specific examples of oxime compounds that can be preferably used in the present invention are shown below, but the present invention is not limited to these.

[化34] [化35] [化36] [化37] [Chemical 34] [Chemical 35] [Chemical 36] [Chemical 37]

肟化合物為在波長350~500nm的範圍內具有極大吸收波長之化合物為較佳,在波長360~480nm的範圍內具有極大吸收波長之化合物為更佳。又,從靈敏度的觀點考慮,肟化合物在波長365nm或波長405nm處的莫耳吸光係數高為較佳,1000~300000為更佳,2000~300000為進一步較佳,5000~200000為特佳。化合物的莫耳吸光係數能夠使用公知的方法測定。例如,藉由分光光度計(Varian公司製Cary-5分光光度計(spectrophotometer)),使用乙酸乙酯溶劑,以0.01g/L的濃度測定為較佳。The oxime compound is preferably a compound having a maximum absorption wavelength in the wavelength range of 350 to 500 nm, and more preferably a compound having a maximum absorption wavelength in the wavelength range of 360 to 480 nm. In addition, from the viewpoint of sensitivity, the oxime compound preferably has a high Mohr absorption coefficient at a wavelength of 365 nm or a wavelength of 405 nm, more preferably 1,000 to 300,000, further preferably 2,000 to 300,000, and particularly preferably 5,000 to 200,000. The molar absorption coefficient of a compound can be measured using a known method. For example, it is preferably measured with a spectrophotometer (Cary-5 spectrophotometer manufactured by Varian Corporation) using an ethyl acetate solvent at a concentration of 0.01 g/L.

作為光聚合起始劑,可以使用2官能或3官能以上的光自由基聚合起始劑。藉由使用此類光自由基聚合起始劑,從光自由基聚合起始劑的一分子產生2個以上的自由基,因此可獲得良好的靈敏度。又,在使用了非對稱結構的化合物時,結晶性下降而在溶劑等中的溶解性變高,隨時間的經過變得難以析出,藉此能夠提高組成物的經時穩定性。作為2官能或3官能以上的光自由基聚合起始劑的具體例,可舉出日本特表2010-527339號公報、日本特表2011-524436號公報、國際公開第2015/004565號、日本特表2016-532675號公報的0407~0412段、國際公開第2017/033680號的0039~0055段中記載之肟化合物的二聚體、日本特表2013-522445號公報中記載之化合物(E)及化合物(G)、國際公開第2016/034963號中記載之Cmpd1~7、日本特表2017-523465號公報的0007段中記載之肟酯系起始劑、日本特開2017-167399號公報的0020~0033段中記載之光起始劑、日本特開2017-151342號公報的0017~0026段中記載之光聚合起始劑(A)、日本專利第6469669號公報中記載之肟酯系起始劑等。As the photopolymerization initiator, a bifunctional or trifunctional or higher photoradical polymerization initiator can be used. By using such a photoradical polymerization initiator, two or more radicals are generated from one molecule of the photoradical polymerization initiator, so good sensitivity can be obtained. In addition, when a compound with an asymmetric structure is used, the crystallinity decreases and the solubility in a solvent or the like increases, making it difficult to precipitate over time, thereby improving the stability of the composition over time. Specific examples of the bifunctional or trifunctional or higher-functional photoradical polymerization initiator include Japanese Patent Application Publication No. 2010-527339, Japanese Patent Application Publication No. 2011-524436, International Publication No. 2015/004565, and Japanese Patent Application Publication No. 2015/004565. The dimer of the oxime compound described in paragraphs 0407 to 0412 of Table 2016-532675, paragraphs 0039 to 0055 of International Publication No. 2017/033680, the compound (E) described in Japanese Patent Publication No. 2013-522445, and Compound (G), Cmpd1 to 7 described in International Publication No. 2016/034963, oxime ester-based initiator described in paragraph 0007 of Japanese Patent Application Publication No. 2017-523465, and 0020 of Japanese Patent Application Publication No. 2017-167399 The photoinitiator described in paragraphs 0033 to 0033, the photopolymerization initiator (A) described in paragraphs 0017 to 0026 of Japanese Patent Application Laid-Open No. 2017-151342, the oxime ester-based initiator described in Japanese Patent No. 6469669 Agents, etc.

在組成物的總固體成分中,光聚合起始劑的含量為0.1~40質量%為較佳,0.5~35質量%為更佳,1~30質量%為進一步較佳。組成物可以僅含有1種光聚合起始劑,亦可以含有2種以上。包含2種以上時,該等的合計量在上述範圍內為較佳。In the total solid content of the composition, the content of the photopolymerization initiator is preferably 0.1 to 40 mass%, more preferably 0.5 to 35 mass%, and further preferably 1 to 30 mass%. The composition may contain only one type of photopolymerization initiator, or may contain two or more types. When two or more types are included, the total amount is preferably within the above range.

<<硬化劑>> 本發明的組成物包含具有環狀醚基之化合物時,進一步包含硬化劑為較佳。作為硬化劑,例如,可舉出胺系化合物、酸酐系化合物、醯胺系化合物、酚化合物、多元羧酸、硫醇化合物等。作為硬化劑的具體例,可舉出琥珀酸、偏苯三甲酸、焦蜜石酸、N,N-二甲基-4-胺吡啶、新戊四醇四(3-巰基丙酸酯)等。硬化劑亦能夠使用日本特開2016-075720號公報的0072~0078段中記載之化合物、日本特開2017-036379號公報中記載之化合物。相對於具有環狀醚基之化合物的100質量份,硬化劑的含量為0.01~20質量份為較佳,0.01~10質量份為更佳,0.1~6.0質量份為進一步較佳。 <<Hardening agent>> When the composition of the present invention contains a compound having a cyclic ether group, it is preferred to further contain a hardener. Examples of the curing agent include amine compounds, acid anhydride compounds, amide compounds, phenol compounds, polycarboxylic acids, thiol compounds, and the like. Specific examples of the hardening agent include succinic acid, trimellitic acid, pyromelonic acid, N,N-dimethyl-4-aminepyridine, neopentylerythritol tetrakis(3-mercaptopropionate), etc. . As the curing agent, the compounds described in paragraphs 0072 to 0078 of Japanese Patent Application Laid-Open No. 2016-075720 and the compounds described in Japanese Patent Application Laid-Open No. 2017-036379 can also be used. The content of the hardener is preferably 0.01 to 20 parts by mass, more preferably 0.01 to 10 parts by mass, and further preferably 0.1 to 6.0 parts by mass relative to 100 parts by mass of the compound having a cyclic ether group.

<<彩色著色劑>> 本發明的組成物能夠含有彩色著色劑。本發明中,彩色著色劑係指除了白色著色劑及黑色著色劑以外的著色劑。彩色著色劑為在波長400nm以上且未達650nm的範圍內具有吸收之著色劑為較佳。 <<Color colorant>> The composition of the present invention can contain a colorant. In the present invention, color colorants refer to colorants other than white colorants and black colorants. It is preferable that the colorant has absorption in a wavelength range of 400 nm or more and less than 650 nm.

作為彩色著色劑,可舉出紅色著色劑、綠色著色劑、藍色著色劑、黃色著色劑、紫色著色劑及橙色著色劑。彩色著色劑可以為顏料,亦可以為染料。可以同時使用顏料和染料。又,顏料可以為無機顏料、有機顏料中的任一種。又,顏料亦能夠使用將無機顏料或有機-無機顏料的一部分用有機發色團取代之材料。藉由將無機顏料或有機-無機顏料用有機發色團取代,能夠容易進行色相設計。Examples of color colorants include red colorants, green colorants, blue colorants, yellow colorants, purple colorants, and orange colorants. The colorant can be a pigment or a dye. Pigments and dyes can be used together. Moreover, the pigment may be either an inorganic pigment or an organic pigment. In addition, the pigment may be a material in which a part of an inorganic pigment or an organic-inorganic pigment is replaced with an organic chromophore. By replacing inorganic pigments or organic-inorganic pigments with organic chromophores, hue design can be easily performed.

顏料的平均一次粒徑為1~200nm為較佳。下限為5nm以上為較佳,10nm以上為更佳。上限為180nm以下為較佳,150nm以下為更佳,100nm以下為進一步較佳。只要顏料的平均一次粒徑在上述範圍內,則組成物中的顏料的分散穩定性良好。再者,在本發明中,顏料的一次粒徑能夠藉由透射式電子顯微鏡觀察顏料的一次粒子,並根據所獲得之圖像照片來求出。具體而言,求出顏料的一次粒子的投影面積,並計算與其相對應之等效圓直徑作為顏料的一次粒徑。又,將本發明中的平均一次粒徑設定為針對400個顏料的一次粒子的一次粒徑的算數平均值。又,顏料的一次粒子係指未凝聚的獨立粒子。The average primary particle size of the pigment is preferably 1 to 200 nm. The lower limit is preferably 5 nm or more, and more preferably 10 nm or more. The upper limit is preferably 180 nm or less, more preferably 150 nm or less, and still more preferably 100 nm or less. As long as the average primary particle diameter of the pigment is within the above range, the dispersion stability of the pigment in the composition is good. Furthermore, in the present invention, the primary particle diameter of the pigment can be determined from the obtained image photograph by observing the primary particles of the pigment with a transmission electron microscope. Specifically, the projected area of the primary particles of the pigment is determined, and the equivalent circle diameter corresponding thereto is calculated as the primary particle size of the pigment. In addition, the average primary particle diameter in the present invention is set as the arithmetic mean value of the primary particle diameters of 400 primary particles of the pigment. In addition, the primary particles of the pigment refer to independent particles that are not agglomerated.

彩色著色劑包含顏料為較佳。顏料在彩色著色劑中的含量為50質量%以上為較佳,70質量%以上為更佳,80質量%以上為進一步較佳,90質量%以上為特佳。作為顏料,可舉出以下所示者。The colorant preferably contains a pigment. The content of the pigment in the colorant is preferably 50 mass% or more, more preferably 70 mass% or more, further preferably 80 mass% or more, and particularly preferably 90 mass% or more. Examples of pigments include those shown below.

顏料索引(C.I.)顏料黃1、2、3、4、5、6、10、11、12、13、14、15、16、17、18、20、24、31、32、34、35、35:1、36、36:1、37、37:1、40、42、43、53、55、60、61、62、63、65、73、74、77、81、83、86、93、94、95、97、98、100、101、104、106、108、109、110、113、114、115、116、117、118、119、120、123、125、126、127、128、129、137、138、139、147、148、150、151、152、153、154、155、156、161、162、164、166、167、168、169、170、171、172、173、174、175、176、177、179、180、181、182、185、187、188、193、194、199、213、214、215、228、231、232(次甲基系)、233(喹啉系)、234(胺基酮系)、235(胺基酮系)、236(胺基酮系)等(以上為黃色顏料)、 C.I.顏料橙2、5、13、16、17:1、31、34、36、38、43、46、48、49、51、52、55、59、60、61、62、64、71、73等(以上為橙色顏料)、 C.I.顏料紅1、2、3、4、5、6、7、9、10、14、17、22、23、31、38、41、48:1、48:2、48:3、48:4、49、49:1、49:2、52:1、52:2、53:1、57:1、60:1、63:1、66、67、81:1、81:2、81:3、83、88、90、105、112、119、122、123、144、146、149、150、155、166、168、169、170、171、172、175、176、177、178、179、184、185、187、188、190、200、202、206、207、208、209、210、216、220、224、226、242、246、254、255、264、269、270、272、279、291、294(𠮿口星系,Organo Ultramarine(有機群青)、Bluish Red(藍紅))、295(單偶氮系)、296(二偶氮系)、297(胺基酮)等(以上為紅色顏料)、 C.I.顏料綠7、10、36、37、58、59、62、63、64(酞菁系)、65(酞菁系)、66(酞菁系)等(以上為綠色顏料)、 C.I.顏料紫1、19、23、27、32、37、42、60(三芳基甲烷系)、61(𠮿口星系)等(以上為紫色顏料)、 C.I.顏料藍1、2、15、15:1、15:2、15:3、15:4、15:6、16、22、29、60、64、66、79、80、87(單偶氮系)、88(次甲基系)等(以上為藍色顏料)。 Pigment Index (C.I.) Pigment Yellow 1, 2, 3, 4, 5, 6, 10, 11, 12, 13, 14, 15, 16, 17, 18, 20, 24, 31, 32, 34, 35, 35 :1, 36, 36:1, 37, 37:1, 40, 42, 43, 53, 55, 60, 61, 62, 63, 65, 73, 74, 77, 81, 83, 86, 93, 94 ,95,97,98,100,101,104,106,108,109,110,113,114,115,116,117,118,119,120,123,125,126,127,128,129,137 ,138,139,147,148,150,151,152,153,154,155,156,161,162,164,166,167,168,169,170,171,172,173,174,175,176 , 177, 179, 180, 181, 182, 185, 187, 188, 193, 194, 199, 213, 214, 215, 228, 231, 232 (methine series), 233 (quinoline series), 234 ( Amino ketone series), 235 (amino ketone series), 236 (amino ketone series), etc. (the above are yellow pigments), C.I. Pigment Orange 2, 5, 13, 16, 17: 1, 31, 34, 36, 38, 43, 46, 48, 49, 51, 52, 55, 59, 60, 61, 62, 64, 71, 73 etc. (the above is orange pigment), C.I. Pigment Red 1, 2, 3, 4, 5, 6, 7, 9, 10, 14, 17, 22, 23, 31, 38, 41, 48:1, 48:2, 48:3, 48:4 , 49, 49:1, 49:2, 52:1, 52:2, 53:1, 57:1, 60:1, 63:1, 66, 67, 81:1, 81:2, 81:3 ,83,88,90,105,112,119,122,123,144,146,149,150,155,166,168,169,170,171,172,175,176,177,178,179,184 ,185,187,188,190,200,202,206,207,208,209,210,216,220,224,226,242,246,254,255,264,269,270,272,279,291 , 294 (𠮿kou galaxy, Organo Ultramarine (organic ultramarine), Bluish Red (blue-red)), 295 (monoazo series), 296 (diazo series), 297 (amino ketone), etc. (the above are red pigments ), C.I. Pigment Green 7, 10, 36, 37, 58, 59, 62, 63, 64 (phthalocyanine series), 65 (phthalocyanine series), 66 (phthalocyanine series), etc. (the above are green pigments), C.I. Pigment Purple 1, 19, 23, 27, 32, 37, 42, 60 (triarylmethane series), 61 (𠮿kou galaxy), etc. (the above are purple pigments), C.I. Pigment Blue 1, 2, 15, 15:1, 15:2, 15:3, 15:4, 15:6, 16, 22, 29, 60, 64, 66, 79, 80, 87 (monoazo series), 88 (methine series), etc. (the above are blue pigments).

又,作為綠色顏料,亦能夠使用在一分子中的鹵素原子數平均為10~14個、溴原子數平均為8~12個、氯原子數平均為2~5個之鹵化鋅酞菁顏料。作為具體例,可舉出國際公開第2015/118720號中記載之化合物。又,作為綠色顏料,亦能夠使用中國專利申請第106909027號說明書中記載之化合物、國際公開第2012/102395號中記載之具有磷酸酯作為配位體之酞菁化合物、日本特開2019-008014號公報中記載之酞菁化合物、日本特開2018-180023號公報中記載之酞菁化合物、日本特開2019-038958號公報中記載之化合物、日本特開2020-076995號公報中記載之核殼型色素等。Furthermore, as the green pigment, it is also possible to use a halide zinc phthalocyanine pigment having an average number of halogen atoms in one molecule of 10 to 14, an average number of bromine atoms in a molecule of 8 to 12, and an average number of chlorine atoms in a molecule of 2 to 5. Specific examples include compounds described in International Publication No. 2015/118720. In addition, as the green pigment, the compound described in Chinese Patent Application No. 106909027, the phthalocyanine compound having a phosphate ester as a ligand described in International Publication No. 2012/102395, and Japanese Patent Application Laid-Open No. 2019-008014 can also be used. Phthalocyanine compounds described in the publication, phthalocyanine compounds described in Japanese Patent Application Publication No. 2018-180023, compounds described in Japanese Patent Application Publication No. 2019-038958, core-shell type described in Japanese Patent Application Publication No. 2020-076995 Pigments, etc.

又,作為藍色顏料,亦能夠使用具有磷原子之鋁酞菁化合物。作為具體例,可舉出日本特開2012-247591號公報的0022~0030段、日本特開2011-157478號公報的0047段中記載之化合物。Furthermore, as the blue pigment, an aluminum phthalocyanine compound having a phosphorus atom can also be used. Specific examples include compounds described in paragraphs 0022 to 0030 of Japanese Patent Application Laid-Open No. 2012-247591 and paragraph 0047 of Japanese Patent Application Laid-Open No. 2011-157478.

又,作為黃色顏料,亦能夠使用日本特開2017-201003號公報中記載之化合物、日本特開2017-197719號公報中記載之化合物、日本特開2017-171912號公報的0011~0062、0137~0276段中記載之化合物、日本特開2017-171913號公報的0010~0062、0138~0295段中記載之化合物、日本特開2017-171914號公報的0011~0062、0139~0190段中記載之化合物、日本特開2017-171915號公報的0010~0065、0142~0222段中記載之化合物、日本特開2013-054339號公報的0011~0034段中記載之喹啉黃化合物、日本特開2014-026228號公報的0013~0058段中記載之喹啉黃化合物、日本特開2018-062644號公報中記載之異吲哚啉化合物、日本特開2018-203798號公報中記載之喹啉黃化合物、日本特開2018-062578號公報中記載之喹啉黃化合物、日本專利第6432076號公報中記載之喹啉黃化合物、日本特開2018-155881號公報中記載之喹啉黃化合物、日本特開2018-111757號公報中記載之喹啉黃化合物、日本特開2018-040835號公報中記載之喹啉黃化合物、日本特開2017-197640號公報中記載之喹啉黃化合物、日本特開2016-145282號公報中記載之喹啉黃化合物、日本特開2014-085565號公報中記載之喹啉黃化合物、日本特開2014-021139號公報中記載之喹啉黃化合物、日本特開2013-209614號公報中記載之喹啉黃化合物、日本特開2013-209435號公報中記載之喹啉黃化合物、日本特開2013-181015號公報中記載之喹啉黃化合物、日本特開2013-061622號公報中記載之喹啉黃化合物、日本特開2013-032486號公報中記載之喹啉黃化合物、日本特開2012-226110號公報中記載之喹啉黃化合物、日本特開2008-074987號公報中記載之喹啉黃化合物、日本特開2008-081565號公報中記載之喹啉黃化合物、日本特開2008-074986號公報中記載之喹啉黃化合物、日本特開2008-074985號公報中記載之喹啉黃化合物、日本特開2008-050420號公報中記載之喹啉黃化合物、日本特開2008-031281號公報中記載之喹啉黃化合物、日本特公昭48-032765號公報中記載之喹啉黃化合物、日本特開2019-008014號公報中記載之喹啉黃化合物、日本專利第6607427號公報中記載之喹啉黃化合物、韓國公開專利第10-2014-0034963號公報中記載之化合物、日本特開2017-095706號公報中記載之化合物、台灣專利申請公開第201920495號公報中記載之化合物、日本專利第6607427號公報中記載之化合物、日本特開2020-033525號公報中記載之化合物、日本特開2020-033524號公報中記載之化合物、日本特開2020-033523號公報中記載之化合物、日本特開2020-033522號公報中記載之化合物、日本特開2020-033521號公報中記載之化合物、國際公開第2020/045200號中記載之化合物、國際公開第2020/045199號中記載之化合物、國際公開第2020/045197號中記載之化合物。又,從提高色值的觀點考慮,亦可較佳地使用對該等化合物進行了多聚體化者。In addition, as the yellow pigment, compounds described in Japanese Patent Application Laid-Open No. 2017-201003, compounds described in Japanese Patent Application Laid-Open No. 2017-197719, and compounds 0011 to 0062 and 0137 to Japanese Patent Application Laid-Open No. 2017-171912 can also be used. Compounds described in paragraph 0276, compounds described in paragraphs 0010 to 0062 and 0138 to 0295 of Japanese Patent Application Laid-Open No. 2017-171913, compounds described in paragraphs 0011 to 0062 and 0139 to 0190 of Japanese Patent Application Publication No. 2017-171914 , the compounds described in paragraphs 0010 to 0065 and 0142 to 0222 of Japanese Patent Application Laid-Open No. 2017-171915, the quinoline yellow compounds described in paragraphs 0011 to 0034 of Japanese Patent Application Publication No. 2013-054339, and the compounds described in Japanese Patent Application Laid-Open No. 2014-026228 Quinoline compounds described in paragraphs 0013 to 0058 of Japanese Patent Application Publication No., isoindoline compounds described in Japanese Patent Application Laid-Open No. 2018-062644, quinoline yellow compounds described in Japanese Patent Application Publication No. 2018-203798, Japanese Patent Application Publication No. 2018-203798 Quinophthalone compounds described in Japanese Patent Application Publication No. 2018-062578, quinophthaline compounds described in Japanese Patent Application Publication No. 6432076, quinophthaline compounds described in Japanese Patent Application Publication No. 2018-155881, Japanese Patent Application Publication No. 2018-111757 Quinophthalone compound described in Japanese Patent Application Laid-Open No. 2018-040835, Quinophthalone compound described in Japanese Patent Application Laid-Open No. 2017-197640, Japanese Patent Application Laid-Open No. 2016-145282 Quinophthalone compound described in Japanese Patent Application Laid-Open No. 2014-085565, Quinophthalone compound described in Japanese Patent Application Laid-Open No. 2014-021139, Japanese Patent Application Laid-Open No. 2013-209614 The quinophthalone compound described in Japanese Patent Application Laid-Open No. 2013-209435, the quinophthalate compound described in Japanese Patent Application Laid-Open No. 2013-181015, and the quinoline yellow compound described in Japanese Patent Application Laid-Open No. 2013-061622 Quinophthal compounds, quinophthal compounds described in Japanese Patent Application Laid-Open No. 2013-032486, quinophthal compounds described in Japanese Patent Application Laid-Open No. 2012-226110, quinophthal compounds described in Japanese Patent Application Laid-Open No. 2008-074987 Compounds, quinophthalone compounds described in Japanese Patent Application Laid-Open No. 2008-081565, quinophthaline compounds described in Japanese Patent Application Laid-Open No. 2008-074986, quinophthaline compounds described in Japanese Patent Application Laid-Open No. 2008-074985, Quinophthalone compounds described in Japanese Patent Publication No. 2008-050420, quinophthaline compounds described in Japanese Patent Publication No. 2008-031281, quinophthaline compounds described in Japanese Patent Publication No. 48-032765, Japanese Patent Publication No. 48-032765 Quinophthalone compounds described in Japanese Patent Publication No. 2019-008014, quinophthalone compounds described in Japanese Patent Publication No. 6607427, compounds described in Korean Patent Publication No. 10-2014-0034963, Japanese Patent Publication No. 2017-095706 Compounds described in Japanese Patent Application Publication No. 201920495, Compounds described in Japanese Patent Application Publication No. 6607427, Compounds described in Japanese Patent Application Publication No. 2020-033525, Japanese Patent Application Publication No. 2020-033524 Compounds described in Japanese Patent Application Publication No. 2020-033523, Compounds described in Japanese Patent Application Publication No. 2020-033522, Compounds described in Japanese Patent Application Publication No. 2020-033521, International Publication No. 2020 Compounds described in /045200, compounds described in International Publication No. 2020/045199, and compounds described in International Publication No. 2020/045197. In addition, from the viewpoint of improving the color value, those in which these compounds are polymerized can also be preferably used.

作為紅色顏料,亦能夠使用日本特開2017-201384號公報中記載之結構中至少一個溴原子被取代之二酮吡咯并吡咯化合物、日本專利第6248838號的0016~0022段中記載之二酮吡咯并吡咯化合物、國際公開第2012/102399號中記載之二酮吡咯并吡咯化合物、國際公開第2012/117965號中記載之二酮吡咯并吡咯化合物、日本特開2012-229344號公報中記載之萘酚偶氮化合物、日本專利第6516119號公報中記載之紅色顏料、日本專利第6525101號公報中記載之紅色顏料、日本特開2020-090632號公報的0229段中記載之溴化二酮吡咯并吡咯化合物、韓國公開專利第10-2019-0140741號公報中記載之蒽醌化合物、韓國公開專利第10-2019-0140744號公報中記載之蒽醌化合物、日本特開2020-079396號公報中記載之苝化合物等。又,作為紅色顏料,亦能夠使用具有如下結構之化合物:對芳香族環導入了鍵結有氧原子、硫原子或氮原子之基團之芳香族環基鍵結於二酮吡咯并吡咯骨架。As the red pigment, diketopyrrolopyrrole compounds described in Japanese Patent Application Laid-Open No. 2017-201384 in which at least one bromine atom is substituted in the structure and diketopyrrolopyrrole compounds described in paragraphs 0016 to 0022 of Japanese Patent No. 6248838 can also be used. Pyrrolopyrrole compound, diketopyrrolopyrrole compound described in International Publication No. 2012/102399, diketopyrrolopyrrole compound described in International Publication No. 2012/117965, naphthalene described in Japanese Patent Application Laid-Open No. 2012-229344 Phenolic azo compound, red pigment described in Japanese Patent No. 6516119, red pigment described in Japanese Patent No. 6525101, brominated diketopyrrolopyrrole described in paragraph 0229 of Japanese Patent Application Laid-Open No. 2020-090632 Compounds, anthraquinone compounds described in Korean Patent Publication No. 10-2019-0140741, anthraquinone compounds described in Korean Patent Publication No. 10-2019-0140744, perylene compounds described in Japanese Patent Application Laid-Open No. 2020-079396 Compounds etc. Furthermore, as the red pigment, a compound having a structure in which a group to which an oxygen atom, a sulfur atom or a nitrogen atom is bonded is introduced into an aromatic ring and an aromatic ring group is bonded to a diketopyrrolopyrrole skeleton can also be used.

關於各種顏料具有為較佳之衍射角,能夠參考日本專利第6561862號公報、日本專利第6413872號公報、日本專利第6281345號公報、日本特開2020-026503號公報的記載,該等內容編入本說明書中。又,作為吡咯并吡咯系顏料,使用在晶格面中(±1±1±1)的8個面中與X射線衍射圖案中的最大峰對應之面方向的微晶尺寸為140Å以下者亦較佳。又,關於吡咯并吡咯系顏料的物性,設定為如日本特開2020-097744號公報的0028~0073段中所記載亦較佳。Regarding the preferred diffraction angles of various pigments, you can refer to the records of Japanese Patent No. 6561862, Japanese Patent No. 6413872, Japanese Patent No. 6281345, and Japanese Patent Application Laid-Open No. 2020-026503, and these contents are incorporated into this specification. middle. In addition, as the pyrrolopyrrole-based pigment, those having a crystallite size of 140 Å or less in the direction of the plane corresponding to the maximum peak in the X-ray diffraction pattern among the eight planes of the lattice plane (±1±1±1) may also be used. Better. In addition, the physical properties of the pyrrolopyrrole-based pigment are preferably as described in paragraphs 0028 to 0073 of Japanese Patent Application Laid-Open No. 2020-097744.

彩色著色劑亦能夠使用染料。作為染料,並沒有特別限制,能夠使用公知的染料。例如,可舉出吡唑偶氮系染料、苯胺基偶氮系染料、三芳基甲烷系染料、蒽醌系染料、蒽吡啶酮系染料、亞苄基系染料、氧雜菁系染料、吡唑并三唑偶氮系染料、吡啶酮偶氮系染料、花青系染料、啡噻𠯤系染料、吡咯并吡唑甲亞胺系染料、𠮿口星系染料、酞菁系染料、苯并哌喃系染料、靛藍系染料、吡咯亞甲基系染料等。Dyes can also be used as colorants. The dye is not particularly limited and known dyes can be used. Examples include pyrazole azo dyes, anilinoazo dyes, triarylmethane dyes, anthraquinone dyes, anthrapyridone dyes, benzylidene dyes, oxocyanine dyes, and pyrazole dyes. Triazole azo dyes, pyridone azo dyes, cyanine dyes, thiophene dyes, pyrrolopyrazole imine dyes, star dyes, phthalocyanine dyes, benzopyrans dyes, indigo dyes, pyrromethene dyes, etc.

彩色著色劑亦能夠使用色素多聚體。色素多聚體為溶解於溶劑中使用的染料為較佳。又,色素多聚體可以形成粒子。色素多聚體為粒子時,通常以分散在溶劑中的狀態使用。粒子狀態的色素多聚體例如能夠藉由乳化聚合獲得,可舉出日本特開2015-214682號公報中記載之化合物及製造方法作為具體例。色素多聚體為在一分子中具有2個以上色素結構者,具有3個以上色素結構為較佳。上限並沒有特別限定,亦能夠設定為100以下。一分子中所具有之複數個色素結構可以為相同的色素結構,亦可以為不同的色素結構。色素多聚體的重量平均分子量(Mw)為2000~50000為較佳。下限為3000以上為更佳,6000以上為進一步較佳。上限為30000以下為更佳,20000以下為進一步較佳。色素多聚體亦能夠使用日本特開2011-213925號公報、日本特開2013-041097號公報、日本特開2015-028144號公報、日本特開2015-030742號公報、國際公開第2016/031442號等中記載之化合物。Pigment polymers can also be used as colorants. It is preferable that the pigment polymer is a dye that is dissolved in a solvent. In addition, the dye multimer may form particles. When the pigment polymer is in the form of particles, it is usually used in a state dispersed in a solvent. The dye multimer in the particle state can be obtained by, for example, emulsion polymerization. Specific examples include the compound and the production method described in Japanese Patent Application Laid-Open No. 2015-214682. The pigment multimer has two or more pigment structures in one molecule, preferably three or more pigment structures. The upper limit is not particularly limited and can be set to 100 or less. The plurality of pigment structures in one molecule may be the same pigment structure or may be different pigment structures. The weight average molecular weight (Mw) of the dye multimer is preferably 2,000 to 50,000. It is more preferable that the lower limit is 3,000 or more, and it is further more preferable that it is 6,000 or more. It is more preferable that the upper limit is 30,000 or less, and it is further more preferable that it is 20,000 or less. The dye multimer can also be used as Japanese Patent Application Laid-Open Nos. 2011-213925, 2013-041097, 2015-028144, 2015-030742, and International Publication No. 2016/031442. Compounds described in etc.

又,彩色著色劑能夠使用日本特開2012-158649號公報中記載之噻唑化合物、日本特開2011-184493號公報中記載之偶氮化合物、日本特開2011-145540號公報中記載之偶氮化合物、韓國公開專利第10-2020-0028160號公報中記載之三芳基甲烷染料聚合物、日本特開2020-117638號公報中記載之𠮿口星化合物、國際公開第2020/174991號中記載之酞菁化合物、日本特開2020-160279號公報中記載之異吲哚啉化合物或該等的鹽。In addition, the colorant can use the thiazole compound described in Japanese Patent Application Publication No. 2012-158649, the azo compound described in Japanese Patent Application Publication No. 2011-184493, and the azo compound described in Japanese Patent Application Publication No. 2011-145540. , the triarylmethane dye polymer described in Korean Patent Publication No. 10-2020-0028160, the triarylmethane compound described in Japanese Patent Application Publication No. 2020-117638, and the phthalocyanine described in International Publication No. 2020/174991 Compounds, isoindoline compounds described in Japanese Patent Application Laid-Open No. 2020-160279, or salts thereof.

本發明的組成物含有彩色著色劑時,彩色著色劑的含量在本發明的組成物的總固體成分中為1~50質量%為較佳。本發明的組成物含有2種以上的彩色著色劑時,該等的合計量在上述範圍內為較佳。When the composition of the present invention contains a colorant, the content of the colorant is preferably 1 to 50% by mass in the total solid content of the composition of the present invention. When the composition of the present invention contains two or more colorants, the total amount is preferably within the above range.

將本發明的組成物用作紅外線截止濾波器用途時,本發明的組成物實質上不含有彩色著色劑為較佳。再者,本發明的組成物實質上不含有彩色著色劑係指本發明的組成物的總固體成分中的彩色著色劑的含量為0.5質量%以下,0.1質量%以下為較佳,不含有彩色著色劑為更佳。When the composition of the present invention is used as an infrared cut filter, it is preferred that the composition of the present invention contains substantially no colorant. Furthermore, the composition of the present invention substantially does not contain a colorant means that the content of the colorant in the total solid content of the composition of the present invention is 0.5% by mass or less, preferably 0.1% by mass or less, and does not contain a colorant. Colorants are even better.

<<使紅外線透射且遮蔽可見光之色材>> 本發明的組成物亦能夠含有使紅外線透射且遮蔽可見光之色材(以下,亦稱為遮蔽可見光之色材)。包含遮蔽可見光之色材之組成物可較佳地用作紅外線透射濾波器形成用組成物。 <<Color material that transmits infrared rays and blocks visible light>> The composition of the present invention may also contain a color material that transmits infrared rays and blocks visible light (hereinafter, also referred to as a color material that blocks visible light). A composition containing a color material that blocks visible light can be preferably used as a composition for forming an infrared transmission filter.

遮蔽可見光之色材為吸收紫色至紅色的波長區域的光之色材為較佳。又,遮蔽可見光之色材為遮蔽波長450~650nm的波長區域的光之色材為較佳。又,遮蔽可見光之色材為使波長900~1500nm的光透射之色材為較佳。遮蔽可見光之色材滿足以下(A)及(B)中至少一個必要條件為較佳。 (A):含有2種以上的彩色著色劑,以2種以上的彩色著色劑的組合形成黑色。 (B):包含有機系黑色著色劑。 The color material that blocks visible light is preferably a color material that absorbs light in the wavelength range from purple to red. Furthermore, the color material that blocks visible light is preferably a color material that blocks light in a wavelength range of 450 to 650 nm. In addition, the color material that blocks visible light is preferably a color material that transmits light with a wavelength of 900 to 1500 nm. It is preferable that the color material that blocks visible light meets at least one of the following necessary conditions (A) and (B). (A): Contains two or more colorants, and the combination of two or more colorants forms black. (B): Contains organic black colorant.

作為彩色著色劑,可舉出上述者。作為有機系黑色著色劑,例如,可舉出雙苯并呋喃酮化合物、甲亞胺化合物、苝化合物、偶氮化合物等,雙苯并呋喃酮化合物、苝化合物為較佳。作為雙苯并呋喃酮化合物,可舉出日本特表2010-534726號公報、日本特表2012-515233號公報、日本特表2012-515234號公報等中記載之化合物,例如,能夠作為BASF公司製“Irgaphor Black”獲得。作為苝化合物,可舉出日本特開2017-226821號公報的0016~0020段中記載之化合物、C.I.顏料黑31、32等。作為甲亞胺化合物,可舉出本日本特開平01-170601號公報、日本特開平02-034664號公報等中記載之化合物,例如能夠作為Dainichiseika Color & Chemicals Mfg.Co.,Ltd.製“CHROMO FINE BLACK A1103”獲得。Examples of the coloring agent include those mentioned above. Examples of the organic black colorant include dibenzofuranone compounds, methimine compounds, perylene compounds, azo compounds, and the like, with dibenzofuranone compounds and perylene compounds being preferred. Examples of the dibenzofuranone compound include compounds described in Japanese Patent Application Publication No. 2010-534726, Japanese Patent Application Publication No. 2012-515233, Japanese Patent Application Publication No. 2012-515234, and the like. For example, it can be used as a dibenzofuranone compound manufactured by BASF Corporation. "Irgaphor Black" obtained. Examples of the perylene compound include the compounds described in paragraphs 0016 to 0020 of Japanese Patent Application Laid-Open No. 2017-226821, C.I. Pigment Black 31, 32, and the like. Examples of the methimine compound include compounds described in Japanese Patent Application Laid-Open No. 01-170601, Japanese Patent Application Laid-Open No. 02-034664, etc., for example, "CHROMO" manufactured by Dainichiseika Color & Chemicals Mfg. Co., Ltd. FINE BLACK A1103” obtained.

作為以2種以上的彩色著色劑的組合形成黑色時的彩色著色劑的組合,例如可舉出以下(1)~(8)的態樣。 (1)含有黃色著色劑、藍色著色劑、紫色著色劑及紅色著色劑之態樣。 (2)含有黃色著色劑、藍色著色劑及紅色著色劑之態樣。 (3)含有黃色著色劑、紫色著色劑及紅色著色劑之態樣。 (4)含有黃色著色劑及紫色著色劑之態樣。 (5)含有綠色著色劑、藍色著色劑、紫色著色劑及紅色著色劑之態樣。 (6)含有紫色著色劑及橙色著色劑之態樣。 (7)含有綠色著色劑、紫色著色劑及紅色著色劑之態樣。 (8)含有綠色著色劑及紅色著色劑之態樣。 Examples of combinations of color colorants used to form black by a combination of two or more color colorants include the following aspects (1) to (8). (1) Contains yellow colorant, blue colorant, purple colorant and red colorant. (2) Contains yellow colorant, blue colorant and red colorant. (3) Contains yellow colorant, purple colorant and red colorant. (4) Contains yellow coloring agent and purple coloring agent. (5) Containing green colorant, blue colorant, purple colorant and red colorant. (6) Contains purple coloring agent and orange coloring agent. (7) Contains green colorant, purple colorant and red colorant. (8) Contains green colorant and red colorant.

本發明的組成物含有遮蔽可見光之色材時,遮蔽可見光之色材的含量在組成物的總固體成分中為1~50質量%為較佳。下限為5質量%以上為較佳,10質量%以上為更佳,20質量%以上為進一步較佳,30質量%以上為特佳。When the composition of the present invention contains a color material that blocks visible light, the content of the color material that blocks visible light is preferably 1 to 50% by mass in the total solid content of the composition. It is preferable that the lower limit is 5 mass % or more, more preferably 10 mass % or more, 20 mass % or more is still more preferred, and 30 mass % or more is particularly preferred.

將本發明的組成物用作紅外線截止濾波器用途時,本發明的組成物實質上不含有遮蔽可見光之色材為較佳。再者,本發明的組成物實質上不含有遮蔽可見光之色材係指本發明的組成物的總固體成分中的遮蔽可見光之色材的含量為0.5質量%以下,0.1質量%以下為較佳,不含有遮蔽可見光之色材為更佳。When the composition of the present invention is used as an infrared cut filter, it is preferred that the composition of the present invention substantially does not contain a color material that blocks visible light. Furthermore, the composition of the present invention substantially does not contain a color material that blocks visible light means that the content of a color material that blocks visible light in the total solid content of the composition of the present invention is 0.5% by mass or less, preferably 0.1% by mass or less. , it is better if it does not contain color materials that block visible light.

<<界面活性劑>> 本發明的組成物含有界面活性劑為較佳。作為界面活性劑,能夠使用氟系界面活性劑、非離子性界面活性劑、陽離子性界面活性劑、陰離子性界面活性劑、聚矽氧系界面活性劑等各種界面活性劑。界面活性劑為聚矽氧系界面活性劑或氟系界面活性劑為較佳。關於界面活性劑,可舉出國際公開第2015/166779號的0238~0245段中記載之界面活性劑,該內容編入本說明書中。 <<Surfactant>> The composition of the present invention preferably contains a surfactant. As the surfactant, various surfactants such as fluorine-based surfactants, nonionic surfactants, cationic surfactants, anionic surfactants, and polysiloxane-based surfactants can be used. The surfactant is preferably a polysiloxane-based surfactant or a fluorine-based surfactant. Examples of the surfactant include those described in paragraphs 0238 to 0245 of International Publication No. 2015/166779, and this content is incorporated into this specification.

作為氟系界面活性劑,可舉出日本特開2014-041318號公報的0060~0064段(對應之國際公開第2014/017669號的0060~0064段)等中記載之界面活性劑、日本特開2011-132503號公報的0117~0132段中記載之界面活性劑、日本特開2020-008634號公報中記載之界面活性劑,該內容編入本說明書中。作為氟系界面活性劑的市售品,例如,可舉出MEGAFACE F-171、F-172、F-173、F-176、F-177、F-141、F-142、F-143、F-144、F-437、F-475、F-477、F-479、F-482、F-554、F-555-A、F-556、F-557、F-558、F-559、F-560、F-561、F-563、F-565、F-568、F-575、F-780、EXP、MFS-330、R-01、R-40、R-40-LM、R-41、R-41-LM、RS-43、TF-1956、RS-90、R-94、RS-72-K、DS-21(以上為DIC Corporation製)、FLUORAD FC430、FC431、FC171(以上為Sumitomo 3M Limited製)、SURFLON S-382、SC-101、SC-103、SC-104、SC-105、SC-1068、SC-381、SC-383、S-393、KH-40(以上為AGC INC.製)、PolyFox PF636、PF656、PF6320、PF6520、PF7002(以上為OMNOVA SOLUTIONS INC.製)、Futurgent 208G、215M、245F、601AD、601ADH2、602A、610FM、710FL、710FM、710FS、FTX-218(以上為NEOS COMPANY LIMITED製)等。Examples of the fluorine-based surfactant include surfactants described in paragraphs 0060 to 0064 of Japanese Patent Application Laid-Open No. 2014-041318 (corresponding to paragraphs 0060 to 0064 of International Publication No. 2014/017669), Japanese Patent Application Laid-Open No. 2014/017669, etc. The surfactants described in paragraphs 0117 to 0132 of Publication No. 2011-132503 and the surfactants described in Japanese Patent Application Laid-Open No. 2020-008634 are incorporated in this specification. Examples of commercially available fluorine-based surfactants include MEGAFACE F-171, F-172, F-173, F-176, F-177, F-141, F-142, F-143, F -144, F-437, F-475, F-477, F-479, F-482, F-554, F-555-A, F-556, F-557, F-558, F-559, F -560, F-561, F-563, F-565, F-568, F-575, F-780, EXP, MFS-330, R-01, R-40, R-40-LM, R-41 , R-41-LM, RS-43, TF-1956, RS-90, R-94, RS-72-K, DS-21 (the above are made by DIC Corporation), FLUORAD FC430, FC431, FC171 (the above are made by Sumitomo 3M Limited), SURFLON S-382, SC-101, SC-103, SC-104, SC-105, SC-1068, SC-381, SC-383, S-393, KH-40 (the above is AGC INC .), PolyFox PF636, PF656, PF6320, PF6520, PF7002 (the above are made by OMNOVA SOLUTIONS INC.), Futurgent 208G, 215M, 245F, 601AD, 601ADH2, 602A, 610FM, 710FL, 710FM, 710FS, FTX-218 (the above Made by NEOS COMPANY LIMITED), etc.

又,作為氟系界面活性劑,亦能夠較佳地使用丙烯酸系化合物,該丙烯酸系化合物具有包含含有氟原子之官能基之分子結構,且在加熱時含有氟原子之官能基的部分被切斷而氟原子揮發。作為此類氟系界面活性劑,可舉出DIC Corporation製MEGAFACE DS系列(化學工業日報(2016年2月22日)、日經產業新聞(2016年2月23日)),例如可舉出MEGAFACE DS-21。In addition, as the fluorine-based surfactant, an acrylic compound having a molecular structure including a functional group containing a fluorine atom and in which the portion of the functional group containing the fluorine atom is cleaved during heating can also be suitably used. The fluorine atoms volatilize. Examples of such fluorine-based surfactants include the MEGAFACE DS series manufactured by DIC Corporation (Chemical Industry Daily (February 22, 2016), Nikkei Sangyo Shimbun (February 23, 2016)). For example, MEGAFACE DS-21.

又,作為氟系界面活性劑,使用具有氟化烷基或氟化伸烷基醚基之含氟原子乙烯基醚化合物與親水性乙烯基醚化合物的聚合物亦較佳。此類氟系界面活性劑可舉出日本特開2016-216602號公報中記載之氟系界面活性劑,該內容編入本說明書中。Furthermore, as the fluorine-based surfactant, it is also preferable to use a polymer of a fluorine atom-containing vinyl ether compound having a fluorinated alkyl group or a fluorinated alkylene ether group and a hydrophilic vinyl ether compound. Examples of such fluorine-based surfactants include the fluorine-based surfactants described in Japanese Patent Application Laid-Open No. 2016-216602, the contents of which are incorporated in this specification.

作為氟系界面活性劑,亦能夠使用嵌段聚合物。作為氟系界面活性劑,亦能夠較佳地使用含氟高分子化合物,該含氟高分子化合物包含:源自具有氟原子之(甲基)丙烯酸酯化合物之重複單元;及源自具有2個以上(較佳為5個以上)伸烷氧基(較佳為乙烯氧基、伸丙氧基)之(甲基)丙烯酸酯化合物之重複單元。又,日本特開2010-032698號公報的0016~0037段中記載之含氟界面活性劑、下述化合物亦例示為本發明中使用之氟系界面活性劑。 [化38] 上述化合物的重量平均分子量較佳為3000~50000,例如為14000。上述化合物中,表示重複單元的比例之%為莫耳%。 As the fluorine-based surfactant, a block polymer can also be used. As the fluorine-based surfactant, a fluorine-containing polymer compound containing: a repeating unit derived from a (meth)acrylate compound having a fluorine atom; and a fluorine-containing polymer compound derived from a (meth)acrylate compound having 2 The repeating unit of the above (preferably 5 or more) (meth)acrylate compound having an alkyleneoxy group (preferably an vinyloxy group or a propyleneoxy group). In addition, the fluorine-containing surfactants described in paragraphs 0016 to 0037 of Japanese Patent Application Laid-Open No. 2010-032698 and the following compounds are also exemplified as fluorine-based surfactants used in the present invention. [Chemical 38] The weight average molecular weight of the above compound is preferably 3,000 to 50,000, for example, 14,000. In the above compounds, the percentage expressed as the proportion of repeating units is molar %.

又,作為氟系界面活性劑,亦能夠使用側鏈具有含有乙烯性不飽和鍵之基團之含氟聚合物。作為具體例,可舉出日本特開2010-164965號公報的0050~0090段及0289~0295段中記載之化合物、DIC Corporation製MEGAFACE RS-101、RS-102、RS-718K、RS-72-K等。又,作為氟系界面活性劑,亦能夠使用日本特開2015-117327號公報的0015~0158段中記載之化合物。Furthermore, as the fluorine-based surfactant, a fluorine-containing polymer having a group containing an ethylenically unsaturated bond in the side chain can also be used. Specific examples include compounds described in paragraphs 0050 to 0090 and paragraphs 0289 to 0295 of Japanese Patent Application Laid-Open No. 2010-164965, MEGAFACE RS-101, RS-102, RS-718K, and RS-72- manufactured by DIC Corporation. K et al. In addition, as the fluorine-based surfactant, compounds described in paragraphs 0015 to 0158 of Japanese Patent Application Laid-Open No. 2015-117327 can also be used.

又,將國際公開第2020/084854號中記載之界面活性劑用作具有碳數6以上的全氟烷基之界面活性劑的替代物,從環境管制的觀點考慮亦較佳。In addition, it is also preferable from the viewpoint of environmental control to use the surfactant described in International Publication No. 2020/084854 as a substitute for the surfactant having a perfluoroalkyl group with a carbon number of 6 or more.

又,將由式(fi-1)表示之含氟醯亞胺鹽化合物用作界面活性劑亦較佳。 [化39] 式(fi-1)中,m表示1或2,n表示1~4的整數,a表示1或2,X a+表示a價金屬離子、一級銨離子、二級銨離子、三級銨離子、四級銨離子或NH 4 +Furthermore, it is also preferable to use a fluoride-containing imine salt compound represented by formula (fi-1) as a surfactant. [Chemical 39] In formula (fi-1), m represents 1 or 2, n represents an integer from 1 to 4, a represents 1 or 2, X a+ represents a-valent metal ion, primary ammonium ion, secondary ammonium ion, tertiary ammonium ion, Quaternary ammonium ion or NH 4 + .

作為非離子性界面活性劑,可舉出丙三醇、三羥甲基丙烷、三羥甲基乙烷及該等的乙氧基化物及丙氧基化物(例如,丙三醇丙氧基化物、丙三醇乙氧基化物等)、聚氧乙烯月桂基醚、聚氧乙烯硬脂基醚、聚氧乙烯油基醚、聚氧乙烯辛基苯基醚、聚氧乙烯壬基苯基醚、聚乙二醇二月桂酸酯、聚乙二醇二硬脂酸酯、山梨糖醇脂肪酸酯、Pluronic L10、L31、L61、L62、10R5、17R2、25R2(BASF公司製)、Tetronic 304、701、704、901、904、150R1(BASF公司製)、SOLSPERSE 20000(Japan Lubrizol Corporation製)、NCW-101、NCW-1001、NCW-1002(FUJIFILM Wako Pure Chemical Corporation製)、PIONIN D-6112、D-6112-W、D-6315(Takemoto Oil & Fat Co.,Ltd.製)、OLFIN E1010、Surfynol 104、400、440(Nissin Chemical Co.,Ltd.製)等。Examples of nonionic surfactants include glycerol, trimethylolpropane, trimethylolethane, and their ethoxylates and propoxylates (for example, glycerol propoxylate , glycerol ethoxylate, etc.), polyoxyethylene lauryl ether, polyoxyethylene stearyl ether, polyoxyethylene oleyl ether, polyoxyethylene octylphenyl ether, polyoxyethylene nonylphenyl ether , polyethylene glycol dilaurate, polyethylene glycol distearate, sorbitol fatty acid ester, Pluronic L10, L31, L61, L62, 10R5, 17R2, 25R2 (manufactured by BASF), Tetronic 304, 701, 704, 901, 904, 150R1 (manufactured by BASF Corporation), SOLSPERSE 20000 (manufactured by Japan Lubrizol Corporation), NCW-101, NCW-1001, NCW-1002 (manufactured by FUJIFILM Wako Pure Chemical Corporation), PIONIN D-6112, D -6112-W, D-6315 (manufactured by Takemoto Oil & Fat Co., Ltd.), OLFIN E1010, Surfynol 104, 400, 440 (manufactured by Nissin Chemical Co., Ltd.), etc.

作為陽離子性界面活性劑,可舉出四烷基銨鹽、烷基胺鹽、苄烷銨鹽、烷基吡啶鎓鹽、咪唑鎓鹽等。作為具體例,可舉出二羥基乙基硬脂胺、2-十七烯基-羥基乙基咪唑啉、月桂基二甲基苄基氯化銨、氯化十六烷基吡啶、硬脂醯胺甲基氯化吡啶等。Examples of cationic surfactants include tetraalkylammonium salts, alkylamine salts, benzalkylammonium salts, alkylpyridinium salts, and imidazolium salts. Specific examples include dihydroxyethyl stearylamine, 2-heptadecenyl-hydroxyethyl imidazoline, lauryldimethylbenzyl ammonium chloride, cetylpyridinium chloride, and stearyl chloride. Aminomethylpyridinium chloride, etc.

作為陰離子性界面活性劑,可舉出十二基苯磺酸、十二基苯磺酸鈉、月桂基硫酸鈉、烷基二苯基醚二磺酸鈉、烷基萘磺酸鈉、二烷基磺基琥珀酸鈉、硬脂酸鈉、油酸鉀、二辛基磺基琥珀酸鈉、聚氧乙烯烷基醚硫酸鈉、聚氧乙烯烷基醚硫酸鈉、聚氧乙烯烷基苯基醚硫酸鈉、二烷基磺基琥珀酸鈉、硬脂酸鈉、油酸鈉、三級辛基苯氧基乙氧基聚乙氧基乙基硫酸鈉鹽等。Examples of the anionic surfactant include dodecyl benzene sulfonic acid, sodium dodecyl benzene sulfonate, sodium lauryl sulfate, sodium alkyl diphenyl ether disulfonate, sodium alkyl naphthalene sulfonate, and dioxane. Sodium sulfosuccinate, sodium stearate, potassium oleate, sodium dioctyl sulfosuccinate, sodium polyoxyethylene alkyl ether sulfate, sodium polyoxyethylene alkyl ether sulfate, polyoxyethylene alkyl phenyl Sodium ether sulfate, sodium dialkyl sulfosuccinate, sodium stearate, sodium oleate, tertiary octylphenoxyethoxypolyethoxyethyl sulfate sodium salt, etc.

作為聚矽氧系界面活性劑,例如,可舉出SH8400、SH8400 FLUID、FZ-2122、67 Additive、74 Additive、M Additive、SF 8419 OIL(以上為Dow Corning Toray Co.,Ltd.製)、TSF-4440、TSF-4300、TSF-4445、TSF-4460、TSF-4452(以上為Momentive Performance Materials Inc.製)、KP-341、KF-6000、KF-6001、KF-6002、KF-6003(以上為Shin-Etsu Chemical Co.,Ltd.製)、BYK-307、BYK-322、BYK-323、BYK-330、BYK-3760、BYK-UV3510(以上為BYK-Chemie GmbH製)等。Examples of polysilicone-based surfactants include SH8400, SH8400 FLUID, FZ-2122, 67 Additive, 74 Additive, M Additive, SF 8419 OIL (the above are manufactured by Dow Corning Toray Co., Ltd.), TSF -4440, TSF-4300, TSF-4445, TSF-4460, TSF-4452 (the above are made by Momentive Performance Materials Inc.), KP-341, KF-6000, KF-6001, KF-6002, KF-6003 (the above (manufactured by Shin-Etsu Chemical Co., Ltd.), BYK-307, BYK-322, BYK-323, BYK-330, BYK-3760, BYK-UV3510 (the above are manufactured by BYK-Chemie GmbH), etc.

又,聚矽氧系界面活性劑亦能夠使用下述結構的化合物。 [化40] Moreover, the compound of the following structure can also be used as a polysiloxane surfactant. [Chemical 40]

在組成物的總固體成分中,界面活性劑的含量為0.001~1質量%為較佳,0.001~0.5質量%為更佳,0.001~0.2質量%為進一步較佳。組成物可以僅含有1種界面活性劑,亦可以含有2種以上。包含2種以上時,該等的合計量在上述範圍內為較佳。In the total solid content of the composition, the surfactant content is preferably 0.001 to 1% by mass, more preferably 0.001 to 0.5% by mass, and further preferably 0.001 to 0.2% by mass. The composition may contain only one type of surfactant, or may contain two or more types. When two or more types are included, the total amount is preferably within the above range.

<<聚合抑制劑>> 本發明的組成物能夠含有聚合抑制劑。作為聚合抑制劑,可舉出氫醌、對甲氧基苯酚、二-三級丁基-對甲酚、五倍子酚、三級丁基鄰苯二酚、苯醌、4,4’-硫代雙(3-甲基-6-三級丁基苯酚)、2,2’-亞甲基雙(4-甲基-6-三級丁基苯酚)、N-亞硝基苯基羥胺鹽(銨鹽、第一鈰鹽等),對甲氧基苯酚為較佳。 在組成物的總固體成分中,聚合抑制劑的含量為0.0001~5質量%為較佳。組成物可以僅含有1種聚合抑制劑,亦可以含有2種以上。包含2種以上時,該等的合計量在上述範圍內為較佳。 <<Polymerization inhibitor>> The composition of the present invention can contain a polymerization inhibitor. Examples of polymerization inhibitors include hydroquinone, p-methoxyphenol, di-tertiary butyl-p-cresol, gallic acid, tertiary butylcatechol, benzoquinone, and 4,4'-thio Bis(3-methyl-6-tertiary butylphenol), 2,2'-methylenebis(4-methyl-6-tertiary butylphenol), N-nitrosophenylhydroxylamine salt ( ammonium salt, first cerium salt, etc.), p-methoxyphenol is preferred. The content of the polymerization inhibitor is preferably 0.0001 to 5% by mass of the total solid content of the composition. The composition may contain only one type of polymerization inhibitor, or may contain two or more types. When two or more types are included, the total amount is preferably within the above range.

<<矽烷偶合劑>> 本發明的組成物能夠含有矽烷偶合劑。本說明書中,矽烷偶合劑係指具有水解性基及其以外的官能基之矽烷化合物。又,水解性基係指與矽原子直接鍵結,並能夠藉由水解反應及縮合反應中的至少一種而產生矽氧烷鍵之取代基。作為水解性基,可舉出鹵素原子、烷氧基、醯氧基等,烷氧基為較佳。亦即,矽烷偶合劑為具有烷氧基矽基之化合物為較佳。又,作為水解性基以外的官能基,例如,可舉出乙烯基、(甲基)丙烯醯基、巰基、環氧基、氧環丁烷基、胺基、脲基、硫醚基、異氰酸酯基、苯基等,(甲基)丙烯醯基及環氧基為較佳。矽烷偶合劑可舉出日本特開2009-288703號公報的0018~0036段中記載之化合物、日本特開2009-242604號公報的0056~0066段中記載之化合物,該等內容編入本說明書中。在組成物的總固體成分中,矽烷偶合劑的含量為0.01~15.0質量%為較佳,0.05~10.0質量%為更佳。組成物可以僅含有1種矽烷偶合劑,亦可以含有2種以上。包含2種以上時,該等的合計量在上述範圍內為較佳。 <<Silane Coupling Agent>> The composition of the present invention can contain a silane coupling agent. In this specification, a silane coupling agent refers to a silane compound having a hydrolyzable group and other functional groups. In addition, the hydrolyzable group refers to a substituent that is directly bonded to a silicon atom and can generate a siloxane bond through at least one of a hydrolysis reaction and a condensation reaction. Examples of the hydrolyzable group include a halogen atom, an alkoxy group, a hydroxyl group, and the like, with an alkoxy group being preferred. That is, the silane coupling agent is preferably a compound having an alkoxysilyl group. Examples of functional groups other than the hydrolyzable group include a vinyl group, a (meth)acrylyl group, a mercapto group, an epoxy group, an oxybutanyl group, an amino group, a urea group, a thioether group, and an isocyanate group. group, phenyl group, etc., (meth)acrylyl group and epoxy group are preferred. Examples of the silane coupling agent include the compounds described in paragraphs 0018 to 0036 of Japanese Patent Application Laid-Open No. 2009-288703 and the compounds described in paragraphs 0056 to 0066 of Japanese Patent Application Laid-Open No. 2009-242604, and these contents are incorporated in this specification. In the total solid content of the composition, the content of the silane coupling agent is preferably 0.01 to 15.0 mass%, and more preferably 0.05 to 10.0 mass%. The composition may contain only one type of silane coupling agent, or may contain two or more types. When two or more types are included, the total amount is preferably within the above range.

<<紫外線吸收劑>> 本發明的組成物能夠含有紫外線吸收劑。作為紫外線吸收劑,可舉出共軛二烯化合物、胺基二烯化合物、水楊酸酯化合物、二苯甲酮化合物、苯并三唑化合物、丙烯腈化合物、羥苯基三𠯤化合物、吲哚化合物、三𠯤化合物、二苯甲醯基等。作為此類化合物的具體例,可舉出日本特開2009-217221號公報的0038~0052段、日本特開2012-208374號公報的0052~0072段、日本特開2013-068814號公報的0317~0334段、日本特開2016-162946號公報的0061~0080段、國際公開第2021/131355號的0052、0074段、國際公開第2021/132247號的0022~0024段中記載之化合物,該等內容編入本說明書中。作為紫外線吸收劑的市售品,可舉出BASF公司製Tinuvin系列、Uvinul系列等。又,作為苯并三唑化合物,可舉出MIYOSHI OIL & FAT CO.,LTD.製MYUA系列(化學工業日報,2016年2月1日)。紫外線吸收劑亦能夠使用後述實施例中記載之化合物、日本專利第6268967號公報的0049~0059段、國際公開第2016/181987號的0059~0076段中記載之化合物。在組成物的總固體成分中,紫外線吸收劑的含量為0.01~30質量%為較佳,0.05~25質量%為更佳。組成物可以僅含有1種紫外線吸收劑,亦可以含有2種以上。包含2種以上時,該等的合計量在上述範圍內為較佳。 <<UV absorber>> The composition of the present invention can contain an ultraviolet absorber. Examples of the ultraviolet absorber include conjugated diene compounds, aminodiene compounds, salicylate compounds, benzophenone compounds, benzotriazole compounds, acrylonitrile compounds, hydroxyphenyl trisulfonate compounds, and indepine compounds. Indole compounds, tribenzoyl compounds, benzyl compounds, etc. Specific examples of such compounds include paragraphs 0038 to 0052 of Japanese Patent Application Laid-Open No. 2009-217221, paragraphs 0052 to 0072 of Japanese Patent Application Laid-Open No. 2012-208374, and paragraphs 0317 to 0317 of Japanese Patent Application Laid-Open No. 2013-068814. Compounds described in Paragraph 0334, Paragraphs 0061 to 0080 of Japanese Patent Application Laid-Open No. 2016-162946, Paragraphs 0052 and 0074 of International Publication No. 2021/131355, Paragraphs 0022 to 0024 of International Publication No. 2021/132247, etc. incorporated into this manual. Commercially available products of ultraviolet absorbers include BASF's Tinuvin series, Uvinul series, and the like. Examples of benzotriazole compounds include the MYUA series manufactured by MIYOSHI OIL & FAT CO., LTD. (Chemical Industry Daily, February 1, 2016). As the ultraviolet absorber, the compounds described in the examples described below, and the compounds described in paragraphs 0049 to 0059 of Japanese Patent No. 6268967 and paragraphs 0059 to 0076 of International Publication No. 2016/181987 can also be used. In the total solid content of the composition, the content of the ultraviolet absorber is preferably 0.01 to 30% by mass, and more preferably 0.05 to 25% by mass. The composition may contain only one type of ultraviolet absorber, or may contain two or more types. When two or more types are included, the total amount is preferably within the above range.

<<抗氧化劑>> 本發明的組成物能夠含有抗氧化劑。作為抗氧化劑,可舉出酚系抗氧化劑、胺系抗氧化劑、磷系抗氧化劑、硫系抗氧化劑等。作為酚系抗氧化劑,可舉出受阻酚化合物。酚系抗氧化劑在與酚性羥基相鄰之部位(鄰位)具有取代基之化合物為較佳。作為前述取代基,碳數1~22的經取代或未經取代之烷基為較佳。抗氧化劑為在同一分子內具有苯酚基和亞磷酸酯基之化合物亦較佳。作為磷系抗氧化劑,可舉出三[2-[[2,4,8,10-四(1,1-二甲基乙基)二苯并[d,f][1,3,2]二氧雜膦雜環庚二烯-6-基]氧基]乙基]胺、三[2-[(4,6,9,11-四-三級丁基二苯并[d,f][1,3,2]二氧雜膦雜環庚二烯-2-基)氧基]乙基]胺、亞磷酸雙(2,4-二-三級丁基-6-甲基苯基)乙酯、三(2,4-二-三級丁基苯基)亞磷酸酯等。作為抗氧化劑的市販品,例如,可舉出ADEKA STAB AO-20、ADEKA STAB AO-30、ADEKA STAB AO-40、ADEKA STAB AO-50、ADEKA STAB AO-50F、ADEKA STAB AO-60、ADEKA STAB AO-60G、ADEKA STAB AO-80、ADEKA STAB AO-330、ADEKA STAB AO-412S、ADEKA STAB 2112、ADEKA STAB PEP-36、ADEKA STAB HP-10(以上為ADEKA CORPORATION製)、JP-650(JOHOKU CHEMICAL CO.,LTD.製)等。抗氧化劑亦能夠使用日本專利第6268967號公報的0023~0048段中記載之化合物、國際公開第2017/006600號中記載之化合物、國際公開第2017/164024號中記載之化合物、韓國公開專利第10-2019-0059371號公報中記載之化合物。在組成物的總固體成分中,抗氧化劑的含量為0.01~20質量%為較佳,0.3~15質量%為更佳。組成物可以僅含有1種抗氧化劑,亦可以含有2種以上。包含2種以上時,該等的合計量在上述範圍內為較佳。 <<Antioxidants>> The composition of the present invention can contain antioxidants. Examples of antioxidants include phenol-based antioxidants, amine-based antioxidants, phosphorus-based antioxidants, sulfur-based antioxidants, and the like. Examples of phenolic antioxidants include hindered phenol compounds. The phenolic antioxidant is preferably a compound having a substituent at the position adjacent to the phenolic hydroxyl group (ortho position). As the substituent, a substituted or unsubstituted alkyl group having 1 to 22 carbon atoms is preferred. It is also preferable that the antioxidant is a compound having a phenol group and a phosphite group in the same molecule. Examples of phosphorus-based antioxidants include tris[2-[[2,4,8,10-tetrakis(1,1-dimethylethyl)dibenzo[d,f][1,3,2] Dioxaphosphineheterocycloheptadien-6-yl]oxy]ethyl]amine, tris[2-[(4,6,9,11-tetra-tertiary butyldibenzo[d,f] [1,3,2]dioxaphosphineheterocycloheptadien-2-yl)oxy]ethyl]amine, bis(2,4-di-tertiary butyl-6-methylphenyl phosphite) ) ethyl ester, tris (2,4-di-tertiary butylphenyl) phosphite, etc. Examples of commercially available antioxidants include ADEKA STAB AO-20, ADEKA STAB AO-30, ADEKA STAB AO-40, ADEKA STAB AO-50, ADEKA STAB AO-50F, ADEKA STAB AO-60, and ADEKA STAB. AO-60G, ADEKA STAB AO-80, ADEKA STAB AO-330, ADEKA STAB AO-412S, ADEKA STAB 2112, ADEKA STAB PEP-36, ADEKA STAB HP-10 (the above are made by ADEKA CORPORATION), JP-650 (JOHOKU CHEMICAL CO., LTD.) etc. As antioxidants, compounds described in paragraphs 0023 to 0048 of Japanese Patent No. 6268967, compounds described in International Publication No. 2017/006600, compounds described in International Publication No. 2017/164024, and Korean Patent Publication No. 10 can also be used. -Compounds described in Publication No. 2019-0059371. In the total solid content of the composition, the antioxidant content is preferably 0.01 to 20 mass%, and more preferably 0.3 to 15 mass%. The composition may contain only one type of antioxidant, or may contain two or more types. When two or more types are included, the total amount is preferably within the above range.

<<其他成分>> 本發明的組成物可以根據需要含有增感劑、硬化促進劑、填料、熱硬化促進劑、可塑劑及其他助劑類(例如,導電性粒子、消泡劑、阻燃劑、調平劑、剝離促進劑、香料、表面張力調節劑、鏈轉移劑等)。藉由適當地含有該等成分,能夠調節膜物性等性質。關於該等成分,例如,能夠參考日本特開2012-003225號公報的0183段以後(對應之美國專利申請公開第2013/0034812號說明書的0237段)的記載、日本特開2008-250074號公報的0101~0104、0107~0109段等的記載,該等內容編入本說明書中。又,本發明的組成物可根據需要含有潛在抗氧化劑。作為潛在抗氧化劑,可舉出如下化合物:作為抗氧化劑發揮作用之部位被保護基保護且藉由以100~250℃加熱或在酸/鹼觸媒存在下以80~200℃加熱而保護基脫離並作為抗氧化劑發揮作用。作為潛在抗氧化劑,可舉出國際公開第2014/021023號、國際公開第2017/030005號、日本特開2017-008219號公報中記載之化合物。作為潛在抗氧化劑的市售品,可舉出ADEKA ARKLS GPA-5001(ADEKA CORPORATION製)等。 <<Other ingredients>> The composition of the present invention may contain sensitizers, hardening accelerators, fillers, thermal hardening accelerators, plasticizers and other auxiliaries (for example, conductive particles, defoaming agents, flame retardants, leveling agents, Peeling accelerators, fragrances, surface tension regulators, chain transfer agents, etc.). By appropriately containing these components, film physical properties and other properties can be adjusted. Regarding these components, for example, reference can be made to the descriptions of paragraphs 0183 and onwards of Japanese Patent Application Laid-Open No. 2012-003225 (corresponding to paragraph 0237 of the specification of U.S. Patent Application Publication No. 2013/0034812), and the descriptions of Japanese Patent Application Laid-Open No. 2008-250074. The descriptions in paragraphs 0101 to 0104, 0107 to 0109, etc. are incorporated into this manual. Furthermore, the composition of the present invention may contain latent antioxidants if necessary. Examples of potential antioxidants include compounds in which a site functioning as an antioxidant is protected by a protective group and the protective group is detached by heating at 100 to 250°C or heating at 80 to 200°C in the presence of an acid/alkali catalyst. and acts as an antioxidant. Examples of potential antioxidants include compounds described in International Publication No. 2014/021023, International Publication No. 2017/030005, and Japanese Patent Application Laid-Open No. 2017-008219. Examples of commercially available latent antioxidants include ADEKA ARKLS GPA-5001 (manufactured by ADEKA CORPORATION).

<收容容器> 作為本發明的組成物的收容容器,並沒有特別限制,能夠使用公知的收容容器。又,作為收容容器,以抑制雜質混入原材料、組成物中為目的,使用由6種6層的樹脂構成容器內壁之多層瓶、將6種樹脂設定為7層結構之瓶亦較佳。作為此類容器,例如,可舉出日本特開2015-123351號公報中記載之容器。又,容器內壁以防止金屬從容器內壁溶出,提高組成物的經時穩定性或抑制成分變質等為目的,設定為玻璃製、不鏽鋼製等亦較佳。 <Container> There is no particular limitation on the container for storing the composition of the present invention, and a known container can be used. In addition, as a storage container, in order to prevent impurities from being mixed into raw materials and compositions, it is also preferable to use a multi-layer bottle with an inner wall composed of six types of six-layer resins or a bottle with a seven-layer structure using six types of resins. Examples of such a container include the container described in Japanese Patent Application Laid-Open No. 2015-123351. In addition, the inner wall of the container is preferably made of glass, stainless steel, etc. for the purpose of preventing elution of metal from the inner wall of the container, improving the stability of the composition over time, or suppressing deterioration of components.

<組成物的製備方法> 本發明的組成物能夠混合前述成分來製備。製備組成物時,可以將所有成分同時溶解或分散於溶劑中而製備組成物,亦可以根據需要預先製備適當配合了各成分之2份以上的溶液或分散液,並在使用時(塗佈時)將該等混合而製備組成物。 <Preparation method of composition> The composition of the present invention can be prepared by mixing the aforementioned components. When preparing a composition, all the components can be dissolved or dispersed in a solvent at the same time to prepare the composition. Alternatively, a solution or dispersion containing 2 or more parts of each component can be prepared in advance as needed and used (when coating). ) are mixed to prepare a composition.

製備組成物時,可以包括顏料分散製程。在顏料分散製程中,作為用於分散顏料的機械力,可舉出壓縮、擠壓、衝擊、剪斷、孔蝕等。作為該等製程的具體例,可舉出珠磨、砂磨、輥磨、球磨、塗料攪拌、微射流、高速葉輪、混砂、噴流混合、高壓濕式微粒化、超聲波分散等。又,顏料在砂磨機(珠磨機)中的粉碎中,在藉由使用直徑小的微珠、增加微珠的填充率等來提高粉碎效率之條件下進行處理為較佳。又,粉碎處理後,藉由過濾、離心分離等去除粗粒子為較佳。又,關於顏料分散製程及分散機,能夠較佳地使用“分散技術大全集,JOHOKIKO CO.,LTD.發行,2005年7月15日”或“以懸浮液(固體/液體分散體系)為中心之分散技術與工業上的實際應用 綜合資料集,經營開發中心出版部發行,1978年10月10日”、日本特開2015-157893號公報的0022段中記載之製程及分散機。又,在顏料分散製程中,可以藉由鹽磨步驟進行顏料的微細化處理。例如,在鹽磨步驟中使用之材料、裝置、處理條件等能夠參考日本特開2015-194521號公報、日本特開2012-046629號公報的記載。作為用於分散的珠子材料,可舉出二氧化鋯、瑪瑙、石英、二氧化鈦、碳化鎢、氮化矽、氧化鋁、不鏽鋼及玻璃。又,珠子亦能夠使用莫氏硬度為2以上的無機化合物。可以在組成物中包含1~10000ppm的上述珠子。When preparing the composition, a pigment dispersion process may be included. In the pigment dispersion process, examples of mechanical forces used to disperse pigments include compression, extrusion, impact, shearing, pitting, and the like. Specific examples of these processes include bead milling, sand milling, roller milling, ball milling, paint stirring, micro-jet flow, high-speed impeller, sand mixing, jet mixing, high-pressure wet micronization, ultrasonic dispersion, and the like. In addition, when the pigment is pulverized in a sand mill (bead mill), it is preferable to perform the treatment under conditions that improve the pulverization efficiency by using microbeads with small diameters, increasing the filling rate of microbeads, etc. In addition, after the grinding process, it is preferable to remove coarse particles by filtration, centrifugation, etc. In addition, regarding the pigment dispersion process and dispersion machine, it is better to use "Encyclopedia of Dispersion Technology, published by JOHOKIKO CO., LTD., July 15, 2005" or "Centering on Suspension (Solid/Liquid Dispersion System)" "A Comprehensive Data Collection of Dispersion Technology and Industrial Applications, published by the Publishing Department of the Business Development Center, October 10, 1978" and the process and dispersion machine described in paragraph 0022 of Japanese Patent Application Publication No. 2015-157893. In addition, in the pigment dispersion process, the pigment can be refined through a salt grinding step. For example, the materials, equipment, processing conditions, etc. used in the salt grinding step can be referred to the descriptions of Japanese Patent Application Laid-Open No. 2015-194521 and Japanese Patent Application Laid-Open No. 2012-046629. Examples of bead materials used for dispersion include zirconium dioxide, agate, quartz, titanium dioxide, tungsten carbide, silicon nitride, alumina, stainless steel, and glass. In addition, an inorganic compound having a Mohs hardness of 2 or more can also be used for the beads. The above beads may be included in the composition at 1 to 10,000 ppm.

製備組成物時,以去除異物、減少缺陷等為目的,用過濾器過濾組成物為較佳。作為過濾器,只要為一直以來用於過濾用途等之過濾器,則能夠沒有特別限定地使用。例如可舉出使用聚四氟乙烯(PTFE)等氟樹脂、尼龍(例如尼龍-6、尼龍-6,6)等聚醯胺樹脂、聚乙烯、聚丙烯(PP)等聚烯烴樹脂(包括高密度、超高分子量的聚烯烴樹脂)等材料之過濾器。在該等材料之中,聚丙烯(包括高密度聚丙烯)及尼龍為較佳。When preparing the composition, it is preferable to filter the composition with a filter for the purpose of removing foreign matter, reducing defects, etc. The filter can be used without particular limitation as long as it is a filter that has been conventionally used for filtration purposes. Examples include the use of fluororesins such as polytetrafluoroethylene (PTFE), polyamide resins such as nylon (for example, nylon-6, nylon-6,6), and polyolefin resins (including high-resin resins such as polyethylene and polypropylene (PP)). density, ultra-high molecular weight polyolefin resin) and other materials. Among these materials, polypropylene (including high-density polypropylene) and nylon are preferred.

過濾器的孔徑為0.01~7.0μm為較佳,0.01~3.0μm為更佳,0.05~0.5μm為進一步較佳。只要過濾器的孔徑在上述範圍內,則能夠更確實地去除微細的異物。關於過濾器的孔徑值,能夠參考過濾器廠商的標稱值。關於過濾器,能夠使用由Nihon Pall Ltd.(DFA4201NXEY、DFA4201NAEY、DFA4201J006P等)、Advantec Toyo Kaisha,Ltd.、Nihon Entegris K.K.(Formerly Nippon Mykrolis Corporation)及KITZ MICROFILTER Corporation等提供之各種過濾器。The pore diameter of the filter is preferably 0.01 to 7.0 μm, more preferably 0.01 to 3.0 μm, and further preferably 0.05 to 0.5 μm. As long as the pore size of the filter is within the above range, fine foreign matter can be removed more reliably. Regarding the pore size of the filter, you can refer to the nominal value of the filter manufacturer. As for the filter, various filters provided by Nihon Pall Ltd. (DFA4201NXEY, DFA4201NAEY, DFA4201J006P, etc.), Advantec Toyo Kaisha, Ltd., Nihon Entegris K.K. (Formerly Nippon Mykrolis Corporation), KITZ MICROFILTER Corporation, etc. can be used.

又,作為過濾器,使用纖維狀濾材亦較佳。作為纖維狀濾材,例如可舉出聚丙烯纖維、尼龍纖維、玻璃纖維等。作為市售品,可舉出ROKI TECHNO CO.,LTD.製SBP型系列(SBP008等)、TPR型系列(TPR002、TPR005等)、SHPX型系列(SHPX003等)。In addition, it is also preferable to use a fibrous filter material as the filter. Examples of fibrous filter materials include polypropylene fiber, nylon fiber, glass fiber, and the like. Commercially available products include SBP type series (SBP008, etc.), TPR type series (TPR002, TPR005, etc.), and SHPX type series (SHPX003, etc.) manufactured by ROKI TECHNO CO., LTD.

在使用過濾器時,可以組合不同的過濾器(例如,第1過濾器和第2過濾器等)。此時,使用各過濾器之過濾可以僅進行1次,亦可以進行2次以上。又,可以在上述範圍內組合不同孔徑的過濾器。又,使用第1過濾器之過濾僅對分散液進行,在混合其他成分之後可以用第2過濾器進行過濾。When using filters, you can combine different filters (e.g. 1st filter and 2nd filter, etc.). At this time, filtration using each filter may be performed only once, or may be performed two or more times. Furthermore, filters with different pore sizes can be combined within the above range. In addition, filtration using the first filter is performed only on the dispersion, and filtration can be performed using the second filter after mixing other components.

<膜> 接著,對本發明的膜進行說明。本發明的膜為由上述本發明的組成物獲得之膜。本發明的膜能夠較佳地用作光學濾波器。光學濾波器的用途並沒有特別限定,可舉出紅外線截止濾波器、紅外線透射濾波器等。作為紅外線截止濾波器,例如,可舉出固體攝像元件的受光側的紅外線截止濾波器(例如,針對晶圓級別透鏡之紅外線截止濾波器用等)、固體攝像元件的背面側(與受光側相反的一側)的紅外線截止濾波器、環境光感測器用紅外線截止濾波器(例如,感知放置了情報終端裝置之環境的照度、色調而調整顯示器的色調之照度感測器、調整色調之色彩校正用感測器)等。尤其,能夠較佳地用作固體攝像元件的受光側的紅外線截止濾波器。作為紅外線透射濾波器,可舉出遮蔽可見光且能夠使特定波長以上的紅外線選擇性透射之濾波器。 <Membrane> Next, the film of the present invention will be described. The film of the present invention is a film obtained from the composition of the present invention described above. The film of the present invention can be preferably used as an optical filter. The use of the optical filter is not particularly limited, and examples include infrared cut filters, infrared transmission filters, and the like. Examples of the infrared cut filter include an infrared cut filter on the light-receiving side of the solid-state imaging element (for example, an infrared cut-off filter for a wafer-level lens), and an infrared cut-off filter on the back side of the solid-state imaging element (opposite to the light-receiving side). Infrared cut filter for one side), infrared cut filter for ambient light sensor (for example, an illumination sensor that senses the illumination and hue of the environment where the information terminal device is placed and adjusts the hue of the display, and a color correction filter that adjusts the hue sensor) etc. In particular, it can be suitably used as an infrared cut filter on the light-receiving side of a solid-state imaging element. Examples of the infrared transmission filter include a filter that blocks visible light and can selectively transmit infrared rays having a specific wavelength or above.

本發明的膜可以具有圖案,亦可以為不具有圖案之膜(平坦膜)。又,本發明的膜可以積層於支撐體上來使用,亦可以將本發明的膜從支撐體剝離來使用。作為支撐體,可舉出矽基板等半導體基材或透明基材。The film of the present invention may have a pattern, or may be a film without a pattern (flat film). Furthermore, the film of the present invention can be laminated on a support and used, or the film of the present invention can be peeled off from the support and used. Examples of the support include semiconductor base materials such as silicon substrates and transparent base materials.

可以在用作支撐體之半導體基材上形成有電荷耦合元件(CCD)、互補金屬氧化膜半導體(CMOS)、透明導電膜等。又,可以在半導體基材上形成有隔離各像素之黑矩陣。又,可以根據需要在半導體基材上設置有用於改善與上部層的密接性、防止物質的擴散或基板表面平坦化之底塗層。A charge coupled device (CCD), a complementary metal oxide film semiconductor (CMOS), a transparent conductive film, etc. can be formed on the semiconductor substrate used as a support. In addition, a black matrix that isolates each pixel may be formed on the semiconductor substrate. In addition, if necessary, a primer layer may be provided on the semiconductor base material for improving adhesion with the upper layer, preventing diffusion of substances, or flattening the substrate surface.

作為可用作支撐體之透明基材,只要由至少能夠使可見光透射之材料構成,則並沒有特別限定。例如,可舉出由玻璃、樹脂等材質構成之基材。作為樹脂,可舉出聚對苯二甲酸乙二醇酯、聚對苯二甲酸丁二醇酯等聚酯樹脂、聚乙烯、聚丙烯、乙烯/乙酸乙烯酯共聚物等聚烯烴樹脂、降莰烯樹脂、聚丙烯酸酯、聚甲基丙烯酸甲酯等丙烯酸樹脂、胺基甲酸酯樹脂、氯乙烯樹脂、氟樹脂、聚碳酸酯樹脂、聚乙烯醇縮丁醛樹脂、聚乙烯醇樹脂等。作為玻璃,可舉出鈉鈣玻璃、硼矽酸玻璃、無鹼玻璃、石英玻璃、含銅玻璃等。作為含銅玻璃,可舉出含銅磷酸鹽玻璃、含銅氟磷酸鹽玻璃等。含銅玻璃亦能夠使用市售品。作為含銅玻璃的市售品,可舉出NF-50(AGC TECHNO GLASS Co.,Ltd.製)等。The transparent base material that can be used as a support is not particularly limited as long as it is made of a material that can transmit at least visible light. For example, a base material made of glass, resin, etc. can be mentioned. Examples of the resin include polyester resins such as polyethylene terephthalate and polybutylene terephthalate, polyolefin resins such as polyethylene, polypropylene, and ethylene/vinyl acetate copolymers, and norbornene resins. Acrylic resin, polyacrylate, polymethyl methacrylate and other acrylic resins, urethane resin, vinyl chloride resin, fluorine resin, polycarbonate resin, polyvinyl butyral resin, polyvinyl alcohol resin, etc. Examples of glass include soda-lime glass, borosilicate glass, alkali-free glass, quartz glass, copper-containing glass, and the like. Examples of copper-containing glass include copper-containing phosphate glass, copper-containing fluorophosphate glass, and the like. Commercially available copper-containing glass can also be used. Examples of commercially available copper-containing glass include NF-50 (manufactured by AGC TECHNO GLASS Co., Ltd.).

本發明的膜的厚度能夠根據目的適當調整。膜的厚度能夠設定為200μm以下,亦能夠設定為150μm以下,亦能夠設定為120μm以下,亦能夠設定為20μm以下,亦能夠設定為10μm以下,亦能夠設定為5μm以下。膜的厚度的下限為0.1μm以上為較佳,0.2μm以上為更佳。The thickness of the film of the present invention can be appropriately adjusted depending on the purpose. The thickness of the film can be set to 200 μm or less, to 150 μm or less, to 120 μm or less, to 20 μm or less, to 10 μm or less, or to 5 μm or less. The lower limit of the thickness of the film is preferably 0.1 μm or more, and more preferably 0.2 μm or more.

將本發明的膜用作紅外線截止濾波器時,本發明的膜在波長650~1500nm(較佳為波長660~1200nm,更佳為波長660~1000nm)的範圍內存在極大吸收波長為較佳。又,波長420~550nm的光的平均透射率為50%以上為較佳,70%以上為更佳,80%以上為進一步較佳,85%以上為特佳。又,在波長420~550nm的所有範圍內的透射率為50%以上為較佳,70%以上為更佳,80%以上為進一步較佳。又,本發明的膜在波長650~1500nm(較佳為波長660~1200nm,更佳為波長660~1000nm)的範圍內的至少1處的透射率為15%以下為較佳,10%以下為更佳,5%以下為進一步較佳。又,在將極大吸收波長處的吸光度設定為1時,本發明的膜在波長420~550nm的範圍內的平均吸光度未達0.030為較佳,未達0.025為更佳。When the film of the present invention is used as an infrared cut filter, it is preferable that the film of the present invention has a maximum absorption wavelength in the range of wavelength 650 to 1500 nm (preferably wavelength 660 to 1200 nm, more preferably wavelength 660 to 1000 nm). In addition, the average transmittance of light with a wavelength of 420 to 550 nm is preferably 50% or more, more preferably 70% or more, further preferably 80% or more, and particularly preferably 85% or more. In addition, the transmittance in the entire wavelength range of 420 to 550 nm is preferably 50% or more, more preferably 70% or more, and still more preferably 80% or more. In addition, the transmittance of the film of the present invention at at least one point within the wavelength range of 650 to 1500 nm (preferably 660 to 1200 nm, more preferably 660 to 1000 nm) is preferably 15% or less, and 10% or less. Better still, 5% or less is even better. Furthermore, when the absorbance at the maximum absorption wavelength is set to 1, the average absorbance of the film of the present invention in the wavelength range of 420 to 550 nm is preferably less than 0.030, and more preferably less than 0.025.

將本發明的膜用作紅外線透射濾波器時,本發明的膜例如具有以下(i1)~(i3)中的任一種分光特性為較佳。 (i1):在波長400~850nm的範圍內的透射率的最大值為20%以下(較佳為15%以下,更佳為10%以下)且在波長1000~1500nm的範圍內的透射率的最小值為70%以上(較佳為75%以上,更佳為80%以上)之濾波器。具有此類分光特性之膜能夠遮蔽波長400~850nm的範圍內的光,使波長大於950nm的光透射。 (i2):在波長400~950nm的範圍內的透射率的最大值為20%以下(較佳為15%以下,更佳為10%以下)且在波長1100~1500nm的範圍內的透射率的最小值為70%以上(較佳為75%以上,更佳為80%以上)之濾波器。具有此類分光特性之膜能夠遮蔽波長400~950nm的範圍內的光且透射波長大於1050nm的光。 (i3):在波長400~1050nm的範圍內的透射率的最大值為20%以下(較佳為15%以下,更佳為10%以下)且在波長1200~1500nm的範圍內的透射率的最小值為70%以上(較佳為75%以上,更佳為80%以上)之濾波器。具有此類分光特性之膜能夠遮蔽波長400~1050nm的範圍內的光且透射波長大於1150nm的光。 When the film of the present invention is used as an infrared transmission filter, it is preferable that the film of the present invention has any one of the following spectral characteristics (i1) to (i3), for example. (i1): The maximum value of the transmittance in the wavelength range of 400 to 850 nm is 20% or less (preferably 15% or less, more preferably 10% or less) and the transmittance in the wavelength range of 1000 to 1500 nm A filter with a minimum value of 70% or more (preferably 75% or more, more preferably 80% or more). A film with such spectroscopic characteristics can block light in the wavelength range of 400 to 850 nm and transmit light with wavelengths greater than 950 nm. (i2): The maximum value of the transmittance in the wavelength range of 400 to 950 nm is 20% or less (preferably 15% or less, more preferably 10% or less) and the transmittance in the wavelength range of 1100 to 1500 nm A filter with a minimum value of 70% or more (preferably 75% or more, more preferably 80% or more). A film with such spectroscopic characteristics can block light with a wavelength in the range of 400 to 950 nm and transmit light with a wavelength greater than 1050 nm. (i3): The maximum value of the transmittance in the wavelength range of 400 to 1050 nm is 20% or less (preferably 15% or less, more preferably 10% or less) and the transmittance in the wavelength range of 1200 to 1500 nm A filter with a minimum value of 70% or more (preferably 75% or more, more preferably 80% or more). A film with such spectroscopic characteristics can block light with a wavelength in the range of 400 to 1050 nm and transmit light with a wavelength greater than 1150 nm.

本發明的膜亦可以與包含彩色著色劑之濾色器組合使用。濾色器能夠使用包含彩色著色劑之著色組成物來製造。將本發明的膜用作紅外線截止濾波器,且組合使用本發明的膜與濾色器時,本發明的膜的光徑上配置有濾色器為較佳。例如,將本發明的膜與濾色器積層而用作積層體為較佳。在積層體中,本發明的膜與濾色器兩者在厚度方向上可以相鄰,亦可以不相鄰。本發明的膜與濾色器在厚度方向上不相鄰時,可以在與形成有濾色器之支撐體不同的支撐體上形成有本發明的膜,亦可以在本發明的膜與濾色器之間夾有構成固體攝像元件之其他構件(例如,微透鏡、平坦化層等)。The films of the invention may also be used in combination with color filters containing colored colorants. The color filter can be produced using a coloring composition containing a color colorant. When the film of the present invention is used as an infrared cut filter, and the film of the present invention is used in combination with a color filter, it is preferable that the color filter is arranged on the optical path of the film of the present invention. For example, it is preferable to laminate the film of the present invention and a color filter to use as a laminate. In the laminate, the film of the present invention and the color filter may or may not be adjacent to each other in the thickness direction. When the film of the present invention and the color filter are not adjacent to each other in the thickness direction, the film of the present invention may be formed on a support different from the support on which the color filter is formed, or the film of the present invention may be formed on a different support than the support on which the color filter is formed. Other components constituting the solid-state imaging element (for example, microlenses, planarization layers, etc.) are sandwiched between the components.

本發明的膜能夠用於CCD(電荷耦合元件)、CMOS(互補金屬氧化膜半導體)等固體攝像元件、紅外線感測器、圖像顯示裝置等各種裝置。The film of the present invention can be used in various devices such as solid-state imaging elements such as CCD (charge coupled device) and CMOS (complementary metal oxide semiconductor), infrared sensors, and image display devices.

<膜的製造方法> 本發明的膜能夠經過塗佈本發明的組成物之步驟來製造。 <Membrane manufacturing method> The film of the present invention can be produced by applying the composition of the present invention.

作為支撐體,可舉出上述者。作為組成物的塗佈方法,能夠使用公知的方法。例如,可舉出滴加法(滴鑄);狹縫塗佈法;噴霧法;輥塗法;旋轉塗佈法(旋塗);流延塗佈法;狹縫旋塗法;預濕法(例如,日本特開2009-145395號公報中記載之方法);噴墨(例如按需方式、壓電方式、熱方式)、噴嘴噴射等噴出系印刷、柔版印刷、網版印刷、凹版印刷、逆轉偏移印刷、金屬遮罩印刷等各種印刷法;使用模具等之轉印法;奈米壓印法等。作為噴墨中的適用方法並沒有特別限定,例如可舉出“噴墨的拓展、使用-專利中出現之無限可能性-,2005年2月發行,Sumitbe Techon Research Co.,Ltd.”所示之方法(尤其第115頁~第133頁)或日本特開2003-262716號公報、日本特開2003-185831號公報、日本特開2003-261827號公報、日本特開2012-126830號公報、日本特開2006-169325號公報等中記載之方法。Examples of the support include those mentioned above. As a method of applying the composition, a known method can be used. Examples include dropping method (drip casting); slit coating method; spray method; roll coating method; spin coating method (spin coating); cast coating method; slit spin coating method; prewet method ( For example, the method described in Japanese Patent Application Laid-Open No. 2009-145395); inkjet (for example, drop-on-demand method, piezoelectric method, thermal method), nozzle jet printing, flexographic printing, screen printing, gravure printing, Various printing methods such as reverse offset printing and metal mask printing; transfer printing methods using molds, etc.; nanoimprinting methods, etc. There are no particular limitations on the applicable method for inkjet. For example, "Expansion and Usage of Inkjet - Infinite Possibilities Appeared in Patents -", published in February 2005, Sumitbe Techon Research Co., Ltd. method (especially pages 115 to 133) or Japanese Patent Application Publication No. 2003-262716, Japanese Patent Application Publication No. 2003-185831, Japanese Patent Application Publication No. 2003-261827, Japanese Patent Application Publication No. 2012-126830, Japan The method described in Japanese Patent Application Publication No. 2006-169325, etc.

可以對塗佈組成物形成之組成物層進行乾燥(預烘烤)。進行預烘烤時,預烘烤溫度為150℃以下為較佳,120℃以下為更佳,110℃以下為進一步較佳。下限例如能夠設定為50℃以上,亦能夠設定為80℃以上。預烘烤時間為10秒~3000秒為較佳,40~2500秒為更佳,80~220秒為進一步較佳。乾燥能夠利用加熱板、烘箱等來進行。The composition layer formed by applying the composition may be dried (prebaked). When prebaking is performed, the prebaking temperature is preferably 150°C or lower, more preferably 120°C or lower, and further preferably 110°C or lower. The lower limit can be set to 50°C or higher, for example, or to 80°C or higher. The prebaking time is preferably 10 to 3000 seconds, more preferably 40 to 2500 seconds, and further preferably 80 to 220 seconds. Drying can be performed using a heating plate, an oven, etc.

膜的製造方法可以進一步包括圖案形成步驟。作為圖案形成方法,可舉出利用光微影法之圖案形成方法、利用乾式蝕刻法之圖案形成方法,利用光微影法之圖案形成方法為較佳。再者,將本發明的膜用作平坦膜時,可以不進行圖案形成步驟。以下,對圖案形成步驟進行詳細說明。The film manufacturing method may further include a pattern forming step. Examples of the pattern forming method include a pattern forming method using photolithography and a pattern forming method using dry etching. The pattern forming method using photolithography is preferred. Furthermore, when the film of the present invention is used as a flat film, the pattern forming step does not need to be performed. The pattern forming steps will be described in detail below.

(利用光微影法形成圖案的情況) 利用光微影法之圖案形成方法包括對塗佈本發明的組成物形成之組成物層進行圖案狀曝光之步驟(曝光步驟)和顯影去除未曝光部的組成物層而形成圖案之步驟(顯影步驟)為較佳。可以根據需要設置對經顯影之圖案進行烘烤之步驟(後烘烤步驟)。以下,對各步驟進行說明。 (Pattern formation using photolithography) The pattern forming method using photolithography includes a step of exposing a composition layer formed by applying the composition of the present invention in a pattern (exposure step) and a step of developing and removing the unexposed portions of the composition layer to form a pattern (development step). steps) are better. The step of baking the developed pattern (post-baking step) can be set as needed. Each step is explained below.

在曝光步驟中對組成物層進行圖案狀曝光。例如,使用步進曝光機或掃描曝光機等,隔著具有規定遮罩圖案之遮罩,對組成物層進行曝光,由此能夠以圖案狀進行曝光。藉此,能夠硬化曝光部分。In the exposure step, the composition layer is exposed in a pattern. For example, the composition layer can be exposed in a pattern by using a stepper exposure machine, a scanning exposure machine, or the like through a mask having a predetermined mask pattern. Thereby, the exposed portion can be hardened.

作為能夠在曝光時使用之放射線(光),可舉出g射線、i射線等。又,亦能夠使用波長300nm以下的光(較佳為波長180~300nm的光)。作為波長300nm以下的光,可舉出KrF射線(波長248nm)、ArF射線(波長193nm)等,KrF射線(波長248nm)為較佳。又,亦能夠利用300nm以上的長波光源。Examples of radiation (light) that can be used during exposure include g-rays, i-rays, and the like. In addition, light with a wavelength of 300 nm or less (preferably light with a wavelength of 180 to 300 nm) can also be used. Examples of light having a wavelength of 300 nm or less include KrF rays (wavelength: 248 nm), ArF rays (wavelength: 193 nm), and KrF rays (wavelength: 248 nm) are preferred. In addition, long-wavelength light sources of 300 nm or more can also be used.

又,在曝光時,可以連續照射光而進行曝光,亦可以實施脈衝式照射而進行曝光(脈衝曝光)。再者,脈衝曝光係指以短時間(例如,毫秒級以下)週期,反覆進行光的照射和暫停而進行曝光之方式的曝光方法。In addition, during exposure, light may be continuously irradiated for exposure, or pulse irradiation may be performed for exposure (pulse exposure). In addition, pulse exposure refers to an exposure method in which light is irradiated and paused repeatedly for a short period of time (for example, milliseconds or less) to perform exposure.

照射量(曝光量)例如為0.03~2.5J/cm 2為較佳,0.05~1.0J/cm 2為更佳。曝光時的氧濃度能夠適當選擇,除了在大氣下進行以外,例如亦可以在氧濃度為19體積%以下的低氧環境下(例如,15體積%、5體積%或實質上無氧)進行曝光,亦可以在氧濃度超過21體積%之高氧環境下(例如,22體積%、30體積%或50體積%)進行曝光。又,曝光照度能夠適當設定,通常能夠從1000W/m 2~100000W/m 2(例如,5000W/m 2、15000W/m 2或35000W/m 2)的範圍內選擇。氧濃度和曝光照度的條件可以適當組合,例如能夠設定為氧濃度為10體積%且照度為10000W/m 2、氧濃度為35體積%且照度為20000W/m 2等。 The irradiation amount (exposure amount) is, for example, preferably 0.03 to 2.5 J/cm 2 , and more preferably 0.05 to 1.0 J/cm 2 . The oxygen concentration during exposure can be appropriately selected. In addition to performing the exposure in the atmosphere, for example, the exposure can also be performed in a low-oxygen environment with an oxygen concentration of 19% by volume or less (for example, 15% by volume, 5% by volume, or substantially no oxygen). , it can also be exposed in a high oxygen environment with an oxygen concentration exceeding 21 volume % (for example, 22 volume %, 30 volume % or 50 volume %). In addition, the exposure illuminance can be appropriately set, and can usually be selected from the range of 1000W/m 2 to 100000W/m 2 (for example, 5000W/m 2 , 15000W/m 2 or 35000W/m 2 ). The conditions of oxygen concentration and exposure illumination can be appropriately combined. For example, the oxygen concentration can be set to 10 volume % and the illumination intensity is 10000 W/m 2 , the oxygen concentration can be set to 35 volume % and the illumination intensity is 20000 W/m 2 , etc.

接著,顯影去除曝光後的組成物層的未曝光部的組成物層來形成圖案。未曝光部的組成物層的顯影去除能夠使用顯影液進行。藉此,曝光步驟中的未曝光部的組成物層溶出至顯影液中,在支撐體上僅殘留光硬化部分。顯影液的溫度例如為20~30℃為較佳。顯影時間為20~180秒為較佳。又,為了提高殘渣去除性,可以反覆進行複數次如下步驟:每隔60秒甩掉顯影液,進而供給新的顯影液之步驟。Next, the composition layer is developed to remove the unexposed portions of the exposed composition layer to form a pattern. The composition layer of the unexposed portion can be removed by development using a developer. Thereby, the composition layer of the unexposed portion in the exposure step is eluted into the developer, and only the photohardened portion remains on the support. The temperature of the developer is preferably 20 to 30°C, for example. The development time is preferably 20 to 180 seconds. In addition, in order to improve the residue removal performance, the following steps can be repeated several times: the step of shaking off the developer every 60 seconds and then supplying new developer.

顯影液可舉出有機溶劑、鹼顯影液等,可較佳地使用鹼顯影液。作為鹼顯影液,用純水稀釋鹼劑而得之鹼性水溶液(鹼顯影液)為較佳。作為鹼劑,例如可舉出氨、乙胺、二乙胺、二甲基乙醇胺、二乙二醇胺、二乙醇胺、羥胺、乙二胺、氫氧化四甲銨、氫氧化四乙銨、氫氧化四丙銨、氫氧化四丁基銨、氫氧化乙基三甲銨、氫氧化苄基三甲銨、氫氧化二甲基雙(2-羥基乙基)銨、膽鹼、吡咯、哌啶、1,8-二氮雜雙環[5.4.0]-7-十一碳烯等有機鹼性化合物或者氫氧化鈉、氫氧化鉀、碳酸鈉、碳酸氫鈉、矽酸鈉、偏矽酸鈉等無機鹼性化合物。從環境方面及安全方面考慮,鹼劑為分子量大的化合物為較佳。鹼性水溶液的鹼劑的濃度為0.001~10質量%為較佳,0.01~1質量%為更佳。又,顯影液可以進一步含有界面活性劑。作為界面活性劑,非離子性界面活性劑為較佳。從便於運輸、保管等觀點考慮,顯影液可以先製造成濃縮液而在使用時稀釋成所需濃度。稀釋倍率並沒有特別限定,例如能夠設定在1.5~100倍的範圍內。又,顯影後用純水進行清洗(沖洗)亦較佳。又,如下進行沖洗為較佳:一邊使形成有顯影後的組成物層之支撐體旋轉,一邊向顯影後的組成物層供給沖洗液。又,藉由使噴出沖洗液之噴嘴從支撐體的中心部向支撐體的周緣部移動來進行亦較佳。此時,使噴嘴從支撐體中心部向周緣部移動時,可以使噴嘴逐漸降低移動速度的同時移動。藉由如此進行沖洗,能夠抑制沖洗的面內不均。又,使噴嘴從支撐體中心部向周緣部移動的同時逐漸降低支撐體的轉速亦可獲得相同的效果。Examples of the developer include organic solvents, alkali developers, and the like, and an alkali developer is preferably used. As an alkali developer, an alkaline aqueous solution (alkali developer) obtained by diluting an alkali agent with pure water is preferred. Examples of the alkaline agent include ammonia, ethylamine, diethylamine, dimethylethanolamine, diethyleneglycolamine, diethanolamine, hydroxylamine, ethylenediamine, tetramethylammonium hydroxide, tetraethylammonium hydroxide, hydrogen Tetrapropylammonium oxide, tetrabutylammonium hydroxide, ethyltrimethylammonium hydroxide, benzyltrimethylammonium hydroxide, dimethylbis(2-hydroxyethyl)ammonium hydroxide, choline, pyrrole, piperidine, 1 , 8-diazabicyclo[5.4.0]-7-undecene and other organic alkaline compounds or inorganic compounds such as sodium hydroxide, potassium hydroxide, sodium carbonate, sodium bicarbonate, sodium silicate, sodium metasilicate, etc. Basic compounds. From environmental and safety considerations, it is better for the alkaline agent to be a compound with a large molecular weight. The concentration of the alkali agent in the alkaline aqueous solution is preferably 0.001 to 10% by mass, and more preferably 0.01 to 1% by mass. Moreover, the developer may further contain a surfactant. As the surfactant, nonionic surfactants are preferred. From the viewpoint of convenience in transportation and storage, the developer can be first produced as a concentrated solution and then diluted to a required concentration when used. The dilution ratio is not particularly limited, but can be set in the range of 1.5 to 100 times, for example. In addition, it is also preferable to wash (rinse) with pure water after development. Moreover, it is preferable to perform rinsing as follows: while rotating the support on which the developed composition layer is formed, a rinsing liquid is supplied to the developed composition layer. It is also preferable to move the nozzle that sprays the rinse liquid from the center of the support body to the peripheral edge of the support body. At this time, when moving the nozzle from the center part of the support body to the peripheral part, the nozzle may be moved while gradually reducing the moving speed. By performing flushing in this manner, in-plane unevenness of flushing can be suppressed. In addition, the same effect can also be obtained by gradually reducing the rotation speed of the support body while moving the nozzle from the center part of the support body to the peripheral part.

顯影後,在實施乾燥之後進行追加曝光處理或加熱處理(後烘烤)為較佳。追加曝光處理或後烘烤為用於製成完全硬化者之顯影後硬化處理。例如,後烘烤中的加熱溫度為100~240℃為較佳,200~240℃為更佳。能夠以成為上述條件之方式,使用加熱板或對流烘箱(熱風循環式乾燥機)、高頻加熱機等加熱機構,以連續式或間歇式,對顯影後的膜進行後烘烤。進行追加曝光處理時,用於曝光之光為波長400nm以下的光為較佳。又,追加曝光處理可以藉由韓國公開專利第10-2017-0122130號公報中記載之方法進行。After development, it is preferable to perform additional exposure processing or heat processing (post-baking) after drying. Additional exposure processing or post-baking is a post-development hardening process used to achieve complete hardening. For example, the heating temperature in post-baking is preferably 100 to 240°C, and more preferably 200 to 240°C. The developed film can be post-baked in a continuous or intermittent manner using a heating mechanism such as a heating plate, a convection oven (hot air circulation dryer), or a high-frequency heating machine so that the above conditions are met. When performing additional exposure processing, it is preferable that the light used for exposure is light with a wavelength of 400 nm or less. In addition, the additional exposure process can be performed by the method described in Korean Patent Publication No. 10-2017-0122130.

(利用乾式蝕刻法形成圖案之情況) 藉由乾式蝕刻法形成圖案時,能夠藉由以下方法進行:對在支撐體上塗佈上述組成物形成之組成物層進行硬化而形成硬化物層,接著在該硬化物層上形成經圖案化之光阻層,接著將經圖案化之光阻層作為遮罩,使用蝕刻氣體對硬化物層進行乾式蝕刻等。形成光阻層時,實施預烘烤處理為較佳。關於藉由乾式蝕刻法形成圖案的內容,能夠參考日本特開2013-064993號公報的0010~0067段的記載,該內容編入本說明書中。 (When pattern formation using dry etching method) When forming a pattern by a dry etching method, the composition layer formed by applying the above composition on a support is cured to form a cured product layer, and then a patterned layer is formed on the cured product layer. The photoresist layer is then used as a mask, and etching gas is used to dry-etch the hardened material layer. When forming the photoresist layer, it is better to perform a pre-baking process. Regarding the content of pattern formation by dry etching, the description in paragraphs 0010 to 0067 of Japanese Patent Application Laid-Open No. 2013-064993 can be referred to, and the content is incorporated into this specification.

<光學濾波器> 本發明的光學濾波器具有上述本發明的膜。作為光學濾波器的種類,可舉出紅外線截止濾波器及紅外線透射濾波器等。 <Optical Filter> The optical filter of the present invention has the film of the present invention described above. Examples of types of optical filters include infrared cutoff filters, infrared transmission filters, and the like.

本發明的光學濾波器除了具有上述本發明的膜以外,可以進一步具有含銅層、介電體多層膜、紫外線吸收層等。作為紫外線吸收層,例如,可舉出國際公開第2015/099060號的0040~0070、0119~0145段中記載之吸收層。作為介電體多層膜,可舉出日本特開2014-041318號公報的0255~0259段中記載之介電體多層膜。作為含銅層,亦能夠使用由含銅玻璃構成之玻璃基板(含銅玻璃基板)、包含銅錯合物之層(含銅錯合物層)。作為含銅玻璃基板,可舉出含銅磷酸鹽玻璃、含銅氟磷酸鹽玻璃等。作為含銅玻璃的市售品,可舉出NF-50(AGC TECHNO GLASS Co.,Ltd.製)、BG-60、BG-61(以上,Schott AG製)、CD5000(HOYA CORPORATION製)等。The optical filter of the present invention may further include a copper-containing layer, a dielectric multilayer film, an ultraviolet absorbing layer, etc., in addition to the film of the present invention. Examples of the ultraviolet absorbing layer include the absorbing layers described in paragraphs 0040 to 0070 and 0119 to 0145 of International Publication No. 2015/099060. Examples of the dielectric multilayer film include those described in paragraphs 0255 to 0259 of Japanese Patent Application Laid-Open No. 2014-041318. As the copper-containing layer, a glass substrate made of copper-containing glass (copper-containing glass substrate) or a layer containing a copper complex (copper complex-containing layer) can also be used. Examples of the copper-containing glass substrate include copper-containing phosphate glass, copper-containing fluorophosphate glass, and the like. Examples of commercially available copper-containing glass include NF-50 (manufactured by AGC TECHNO GLASS Co., Ltd.), BG-60, BG-61 (the above, manufactured by Schott AG), CD5000 (manufactured by HOYA CORPORATION), and the like.

<固體攝像元件> 本發明的固體攝像元件包含上述本發明的膜。作為固體攝像元件的結構,只要是具有本發明的膜之結構且作為固體攝像元件發揮作用之結構,則並沒有特別限定。例如,可舉出如下結構。 <Solid-state imaging device> The solid-state imaging element of the present invention includes the film of the present invention described above. The structure of the solid-state imaging element is not particularly limited as long as it has the structure of the film of the present invention and functions as a solid-state imaging element. For example, the following structures are mentioned.

上述結構為在支撐體上具有構成固體攝像元件的受光區域之由複數個光二極體及多晶矽等構成之傳輸電極、在光二極體及傳輸電極上具有僅在光二極體的受光部開口之由鎢等構成之遮光膜,在遮光膜上具有以覆蓋遮光膜整體及光二極體受光部之方式形成之由氮化矽等構成之元件保護膜,在元件保護膜上具有本發明的膜。進而,亦可以為在元件保護膜上且在本發明的膜的下方(靠近支撐體側)具有聚光機構(例如,微透鏡等。以下相同)之結構、或在本發明的膜上具有聚光機構之結構等。又,濾色器亦可以具有如下結構:例如在藉由隔壁分隔成方格狀之空間嵌入有形成各像素之膜。此時的隔壁的折射率比各像素低為較佳。作為具有此類結構之攝像裝置的例子,可舉出日本特開2012-227478號公報、日本特開2014-179577號公報中記載之裝置。The above-mentioned structure has a transmission electrode composed of a plurality of photodiodes, polycrystalline silicon, etc., which constitutes the light-receiving area of the solid-state imaging element, on the support body, and the photodiode and the transmission electrode have an opening in the light-receiving part only of the photodiode. A light-shielding film made of tungsten or the like, an element protective film made of silicon nitride or the like formed to cover the entire light-shielding film and the light-receiving part of the photodiode, and the film of the present invention on the element protective film. Furthermore, the element protection film may be provided with a light condensing mechanism (for example, a microlens, etc.; the same applies below) below (near the support side) the film of the present invention, or the film of the present invention may be provided with a condensing mechanism. The structure of the light mechanism, etc. Furthermore, the color filter may have a structure in which, for example, a film forming each pixel is embedded in a space divided into a grid shape by partition walls. At this time, it is preferable that the refractive index of the partition wall is lower than that of each pixel. Examples of imaging devices having such a structure include devices described in Japanese Patent Application Laid-Open No. 2012-227478 and Japanese Patent Application Laid-Open No. 2014-179577.

<圖像顯示裝置> 本發明的圖像顯示裝置包含本發明的膜。作為圖像顯示裝置,可舉出液晶顯示裝置、有機電致發光(有機EL)顯示裝置等。關於圖像顯示裝置的定義、詳細內容,例如記載於“電子顯示裝置(佐佐木昭夫著,Kogyo Chosakai Publishing Co.,Ltd.,1990年發行)”、“顯示裝置(伊吹順章著,Sangyo Tosho Publishing Co.,Ltd.,1989年發行)”等。又,關於液晶顯示裝置,例如記載於“下一代液晶顯示技術(內田龍男編輯,Kogyo Chosakai Publishing Co.,Ltd.,1994年發行)”。能夠適用本發明之液晶顯示裝置並沒有特別限制,例如能夠適用於上述“下一代液晶顯示技術”中記載之各種方式的液晶顯示裝置。圖像顯示裝置可以具有白色有機EL元件。作為白色有機EL元件,串聯結構為較佳。關於有機EL元件的串聯結構,記載於日本特開2003-045676號公報、三上明義監修,“有機EL技術開發的最前沿-高亮度・高精度・長壽命化・技術集-”,TECHNICAL INFORMATION INSTITUTE CO.,LTD.,326~328頁,2008年等。有機EL元件發出之白色光的光譜在藍色區域(430~485nm)、綠色區域(530~580nm)及黃色區域(580~620nm)具有較強的極大發光峰為較佳。除了該等發光峰以外,進一步在紅色區域(650~700nm)具有極大發光峰為更佳。 <Image display device> The image display device of the present invention includes the film of the present invention. Examples of image display devices include liquid crystal display devices, organic electroluminescence (organic EL) display devices, and the like. The definition and details of the image display device are described in, for example, "Electronic Display Device (by Akio Sasaki, published by Kogyo Chosakai Publishing Co., Ltd., 1990)" and "Display Device (by Junaki Ibuki, Sangyo Tosho Publishing)" Co., Ltd., issued in 1989)" etc. Further, the liquid crystal display device is described in, for example, "Next Generation Liquid Crystal Display Technology (edited by Tatsuo Uchida, published by Kogyo Chosakai Publishing Co., Ltd., 1994)". The liquid crystal display device to which the present invention can be applied is not particularly limited. For example, it can be applied to various types of liquid crystal display devices described in the above-mentioned “Next Generation Liquid Crystal Display Technology”. The image display device may have a white organic EL element. As a white organic EL element, a series structure is preferred. Regarding the series structure of organic EL elements, it is described in Japanese Patent Application Laid-Open No. 2003-045676, supervised by Mikami Akiyoshi, "The Frontier of Organic EL Technology Development - High Brightness, High Precision, Long Lifetime, and Technology Collection-", TECHNICAL INFORMATION INSTITUTE CO.,LTD., pages 326~328, 2008, etc. The spectrum of the white light emitted by the organic EL element is preferably one with strong maximum luminescence peaks in the blue region (430-485nm), green region (530-580nm) and yellow region (580-620nm). In addition to these luminescence peaks, it is more preferable to have a maximum luminescence peak in the red region (650 to 700 nm).

<紅外線感測器> 本發明的紅外線感測器包含上述本發明的膜。作為紅外線感測器的結構,只要是作為紅外線感測器發揮作用之結構,則並沒有特別限定。以下,利用附圖對本發明的紅外線感測器的一實施形態進行說明。 <Infrared sensor> The infrared sensor of the present invention includes the film of the present invention described above. The structure of the infrared sensor is not particularly limited as long as it functions as an infrared sensor. Hereinafter, an embodiment of the infrared sensor of the present invention will be described with reference to the drawings.

圖1中,符號110為固體攝像元件。在固體攝像元件110的攝像區域上配置有紅外線截止濾波器111和紅外線透射濾波器114。又,在紅外線截止濾波器111上配置有濾色器112。在濾色器112及紅外線透射濾波器114的入射光hν側配置有微透鏡115。以覆蓋微透鏡115之方式形成有平坦化層116。In FIG. 1 , reference numeral 110 denotes a solid-state imaging element. An infrared cut filter 111 and an infrared transmitting filter 114 are arranged in the imaging area of the solid-state imaging element 110 . Furthermore, a color filter 112 is arranged on the infrared cut filter 111 . Microlenses 115 are arranged on the incident light hν side of the color filter 112 and the infrared transmission filter 114 . A planarization layer 116 is formed to cover the microlens 115 .

紅外線截止濾波器111能夠使用本發明的組成物形成。濾色器112為形成有透射並吸收可見區域內的特定波長的光之像素之濾色器,並沒有特別限定,能夠使用以往公知的像素形成用濾色器。例如,可以使用形成有紅色(R)、綠色(G)、藍色(B)的像素之濾色器等。例如,能夠參考日本特開2014-043556號公報的0214~0263段的記載,該內容編入本說明書中。紅外線透射濾波器114可根據所使用之紅外LED的發光波長來選擇其特性。紅外線透射濾波器114能夠使用本發明的組成物來形成。The infrared cut filter 111 can be formed using the composition of the present invention. The color filter 112 is a color filter formed with pixels that transmit and absorb light of a specific wavelength in the visible range, and is not particularly limited, and conventionally known color filters for forming pixels can be used. For example, a color filter in which red (R), green (G), and blue (B) pixels are formed may be used. For example, the description in paragraphs 0214 to 0263 of Japanese Patent Application Laid-Open No. 2014-043556 can be referred to, and this content is incorporated into this specification. The characteristics of the infrared transmission filter 114 can be selected according to the emission wavelength of the infrared LED used. The infrared transmission filter 114 can be formed using the composition of the present invention.

圖1所示之紅外線感測器中,可以在平坦化層116上進一步配置有與紅外線截止濾波器111不同的紅外線截止濾波器(其他紅外線截止濾波器)。作為其他紅外線截止濾波器,可舉出具有含銅層及/或介電體多層膜者等。關於該等的詳細內容,可舉出上述者。又,作為其他紅外線截止濾波器,可以使用雙帶通濾波器。In the infrared sensor shown in FIG. 1 , an infrared cutoff filter (other infrared cutoff filter) different from the infrared cutoff filter 111 may be further disposed on the planarization layer 116 . Examples of other infrared cut filters include those having a copper-containing layer and/or a dielectric multilayer film. Details of these include those mentioned above. In addition, as another infrared cut filter, a double bandpass filter can be used.

<照相機膜組> 本發明的照相機膜組包含固體攝像元件及上述本發明的膜。照相機膜組進一步具有透鏡及用於處理從固體攝像元件獲得之影像之電路為較佳。作為在照相機膜組中使用之固體攝像元件,可以為上述本發明之固體攝像元件,亦可以為公知的固體攝像元件。又,作為在照相機膜組中使用之透鏡及處理從上述固體攝像元件獲得之影像之電路,能夠使用公知者。作為照相機膜組的例子,能夠參考日本特開2016-006476號公報及日本特開2014-197190號公報中記載之照相機膜組,該等內容編入本說明書中。 [實施例] <Camera Film Set> The camera film set of the present invention includes a solid-state imaging element and the film of the present invention. The camera film assembly preferably further has a lens and a circuit for processing images obtained from the solid-state imaging element. The solid-state imaging element used in the camera film group may be the above-mentioned solid-state imaging element of the present invention or a known solid-state imaging element. In addition, known ones can be used as the lens used in the camera film group and the circuit for processing the image obtained from the above-mentioned solid-state imaging element. As an example of a camera film set, reference can be made to the camera film set described in Japanese Patent Application Laid-Open No. 2016-006476 and Japanese Patent Application Laid-Open No. 2014-197190, the contents of which are incorporated into this specification. [Example]

以下,舉出實施例對本發明進行進一步詳細的說明。以下實施例所示之材料、使用量、比例、處理內容、處理順序等,只要不脫離本發明的主旨,則能夠適當變更。Hereinafter, the present invention will be described in further detail with reference to examples. The materials, usage amounts, proportions, treatment contents, treatment procedures, etc. shown in the following examples can be appropriately changed as long as they do not deviate from the gist of the present invention.

<合成例> (合成例1)化合物A-e-1的合成 按照以下合成方案合成了化合物A-e-1。 [化41] <Synthesis Example> (Synthesis Example 1) Synthesis of Compound Ae-1 Compound Ae-1 was synthesized according to the following synthesis scheme. [Chemical 41]

中間體1藉由美國專利出願公開第2014/0061505號說明書中記載之方法進行了合成。中間體2藉由國際公開第2011/107501號中記載之方法進行了合成。中間體3藉由國際公開第2014/088063號中記載之方法進行了合成。中間體4藉由Bioconjugate Chemistry(2017),28(5),1552-1559中記載之方法進行了合成。中間體5藉由Organic and Biomolecular Chemistry,2011,vol.9,#23,8122-8129頁中記載之方法進行了合成。 在正丁醇/甲苯(26mL/60mL)中將中間體5(4.4g,7.0mmol)和方酸(0.36g,3.1mmol)共沸脫水的同時使其加熱回流12小時。將反應液冷卻後減壓蒸餾去除溶劑,藉由矽膠柱層析法(展開溶劑:氯仿)對殘渣進行了純化。減壓蒸餾去除氯仿之後,在甲醇中對固體進行超音波分散並吸附過濾固體,由此獲得了目標化合物(化合物A-e-1)(綠色結晶,1.3g,產率31%)。 化合物A-e-1的鑑定資料:MALDI TOF-MASS(飛行時間型質量分析法)Calc.for[M+H]+:1332.5 found:1332.5 Intermediate 1 was synthesized by the method described in US Patent Application Publication No. 2014/0061505. Intermediate 2 was synthesized by the method described in International Publication No. 2011/107501. Intermediate 3 was synthesized by the method described in International Publication No. 2014/088063. Intermediate 4 was synthesized by the method described in Bioconjugate Chemistry (2017), 28(5), 1552-1559. Intermediate 5 was synthesized by the method described in Organic and Biomolecular Chemistry, 2011, vol.9, #23, pages 8122-8129. Intermediate 5 (4.4 g, 7.0 mmol) and squaric acid (0.36 g, 3.1 mmol) were azeotropically dehydrated in n-butanol/toluene (26 mL/60 mL) and heated to reflux for 12 hours. The reaction solution was cooled and the solvent was evaporated under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent: chloroform). After the chloroform was removed by distillation under reduced pressure, the solid was ultrasonically dispersed in methanol and filtered by adsorption to obtain the target compound (compound A-e-1) (green crystal, 1.3 g, yield 31%). Identification data of compound A-e-1: MALDI TOF-MASS (time-of-flight mass analysis method) Calc.for[M+H]+: 1332.5 found: 1332.5

<組成物的製造> 將下述表中記載之成分分別以下述表中記載之質量份混合並攪拌之後,利用孔徑0.45μm的尼龍製過濾器(Nihon Pall Ltd.製)過濾,由此製造了組成物。 <Manufacture of composition> The components described in the following table were mixed and stirred in the mass parts described in the following table, and then filtered through a nylon filter (manufactured by Nihon Pall Ltd.) with a pore size of 0.45 μm, thereby producing a composition.

[表1]    紅外線吸收劑 (特定化合物) 紅外線吸收劑 (其他) 樹脂 紫外線 吸收劑 抗氧化劑 溶劑 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 實施例1 A-a-1 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例2 A-a-2 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例3 A-a-3 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例4 A-b-1 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例5 A-b-2 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例6 A-b-3 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例7 A-b-4 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例8 A-b-5 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例9 A-b-6 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例10 A-b-7 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例11 A-b-8 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例12 A-b-9 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例13 A-b-10 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例14 A-b-11 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例15 A-b-12 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例16 A-b-13 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例17 A-b-14 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例18 A-b-15 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例19 A-c-1 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例20 A-c-2 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例21 A-c-3 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例22 A-c-4 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例23 A-d-1 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例24 A-d-2 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例25 A-d-3 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例26 A-e-1 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例27 A-e-2 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例28 A-e-3 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例29 A-e-4 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例30 A-e-5 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例31 A-e-6 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例32 A-e-7 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例33 A-e-8 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例34 A-e-9 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例35 A-e-10 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例36 A-e-11 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例37 A-e-12 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例38 A-e-13 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例39 A-e-14 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例40 A-e-15 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例41 A-e-16 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例42 A-f-1 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例43 A-f-2 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例44 A-f-3 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例45 A-f-4 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 [表2]    紅外線吸收劑 (特定化合物) 紅外線吸收劑 (其他) 樹脂 紫外線 吸收劑 抗氧化劑 溶劑 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 實施例46 A-g-1 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例47 A-g-2 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例48 A-g-3 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例49 A-g-4 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例50 A-h-1 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例51 A-h-2 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例52 A-i-1 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例53 A-i-2 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例54 A-i-3 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例55 A-i-4 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例56 A-i-5 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例57 A-i-6 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例58 A-k-1 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例59 A-k-2 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例60 A-k-3 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例61 A-k-4 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例62 A-k-5 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例63 A-k-6 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例64 A-e-1 A-g-4 0.02 0.02 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例65 A-e-1 0.04 B-a-2 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例66 A-e-1 0.04 B-a-3 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例67 A-e-1 0.035 B-a-1 B-b-1 0.02 0.1 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例68 A-e-1 0.035 B-a-1 B-b-2 0.02 0.1 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例69 A-e-1 0.035 B-a-1 B-b-3 0.02 0.1 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例70 A-e-1 0.035 B-a-1 B-b-4 0.02 0.1 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例71 A-e-1 0.035 B-a-1 B-b-5 0.02 0.1 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例72 A-e-1 0.038 B-a-1 B-b-6 0.075 0.2 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例73 A-e-1 0.038 B-a-1 B-b-7 0.075 0.2 C-1 99.2 D-1 0.17 E-1 0.3 F-1 400 實施例74 A-e-1 0.038 B-a-1 B-b-8 0.075 0.2 C-1 99.2 D-1 0.17 E-1 0.3 F-1 400 實施例75 A-e-1 0.05 B-a-1 B-c-1 0.12 0.05 C-1 99.2 D-1 0.17 E-1 0.3 F-1 400 實施例76 A-e-1 0.05 B-a-1 B-c-1 B-c-2 0.12 0.05 0.04 C-1 99.3 D-1 0.17 E-1 0.3 F-1 400 實施例77 A-e-1 0.04 B-a-1 B-c-3 0.09 0.005 C-1 99.3 D-1 0.17 E-1 0.3 F-1 400 [表3]    紅外線吸收劑 (特定化合物) 紅外線吸收劑 (其他) 樹脂 紫外線 吸收劑 抗氧化劑 溶劑 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 實施例78 A-e-1 0.06 B-a-1 B-d-1 0.07 0.04 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例79 A-e-1 0.06 B-a-1 B-d-2 0.07 0.04 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例80 A-e-1 0.06 B-a-1 B-d-3 0.07 0.05 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例81 A-e-1 0.06 B-a-1 B-d-4 0.07 0.05 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例82 A-e-1 0.04 B-a-1 B-e-1 0.09 0.08 C-1 99.3 D-1 0.17 E-1 0.3 F-1 400 實施例83 A-e-1 0.04 B-a-1 0.09 C-2 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例84 A-e-1 0.04 B-a-1 0.09 C-3 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例85 A-e-1 0.04 B-a-1 0.09 C-4 99.4 D-1 0.17 E-1 0.3 F-1 400 實施例86 A-e-1 0.04 B-a-1 0.09 C-1 99.4 D-2 0.17 E-1 0.3 F-1 400 實施例87 A-e-1 0.04 B-a-1 0.09 C-1 99.4 D-3 0.17 E-1 0.3 F-1 400 實施例88 A-e-1 0.04 B-a-1 0.09 C-1 99.4 D-4 0.17 E-1 0.3 F-1 400 實施例89 A-e-1 0.04 B-a-1 0.09 C-1 99.4 D-5 0.17 E-1 0.3 F-1 400 實施例90 A-e-1 0.04 B-a-1 0.09 C-1 99.4 D-6 0.17 E-1 0.3 F-1 400 實施例91 A-e-1 0.04 B-a-1 0.09 C-1 99.4 D-7 0.17 E-1 0.3 F-1 400 實施例92 A-e-1 0.04 B-a-1 0.09 C-1 99.4 D-8 0.17 E-1 0.3 F-1 400 實施例93 A-e-1 0.04 B-a-1 0.09 C-1 99.4 D-9 0.17 E-1 0.3 F-1 400 實施例94 A-e-1 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-2 0.3 F-1 400 實施例95 A-e-1 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-3 0.3 F-1 400 實施例96 A-e-1 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-4 0.3 F-1 400 實施例97 A-e-1 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-5 0.3 F-1 400 實施例98 A-e-1 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-6 0.3 F-1 400 實施例99 A-e-1 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-7 0.3 F-1 400 實施例100 A-e-1 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 E-5 0.15 0.15 F-1 400 實施例101 A-e-1 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-2 400 實施例102 A-e-l 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-3 F-4 280 120 比較例1 X-1 0.04 B-a-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 [表4]    紅外線吸收劑 (特定化合物) 紅外線吸收劑 (其他) 樹脂 硬化劑 紫外線 吸收劑 抗氧化劑 界面活性劑 溶劑 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 實施例201 A-a-1 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例202 A-a-2 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例203 A-a-3 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例204 A-b-1 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例205 A-b-2 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例206 A-b-3 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例207 A-b-4 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例208 A-b-5 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例209 A-b-6 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例210 A-b-7 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例211 A-b-8 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例212 A-b-9 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例213 A-b-10 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例214 A-b-11 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例215 A-b-12 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例216 A-b-13 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例217 A-b-14 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例218 A-b-15 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例219 A-c-1 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例220 A-c-2 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例221 A-c-3 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例222 A-c-4 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例223 A-d-1 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例224 A-d-2 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例225 A-d-3 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例226 A-e-1 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例227 A-e-2 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 [表5]    紅外線吸收劑 (特定化合物) 紅外線吸收劑 (其他) 樹脂 硬化劑 紫外線 吸收劑 抗氧化劑 界面活性劑 溶劑 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 實施例228 A-e-3 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例229 A-e-4 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例230 A-e-5 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例231 A-e-6 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例232 A-e-7 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例233 A-e-8 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例234 A-e-9 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例235 A-e-10 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例236 A-e-11 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例237 A-e-12 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例238 A-e-13 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例239 A-e-14 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例240 A-e-15 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例241 A-e-16 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例242 A-f-1 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例243 A-f-2 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例244 A-f-3 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例245 A-f-4 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例246 A-g-1 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例247 A-g-2 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例248 A-g-3 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例249 A-g-4 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例250 A-h-1 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例251 A-h-2 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例252 A-i-1 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例253 A-i-2 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例254 A-i-3 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 [表6]    紅外線吸收劑 (特定化合物) 紅外線吸收劑 (其他) 樹脂 硬化劑 紫外線 吸收劑 抗氧化劑 界面活性劑 溶劑 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 實施例255 A-i-4 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例256 A-i-5 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例257 A-i-6 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例258 A-k-1 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例259 A-k-2 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例260 A-k-3 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例261 A-k-4 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例262 A-k-5 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例263 A-k-6 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例264 A-e-1 A-g-4 0.40 0.40 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例265 A-e-1 0.80 B-a-2 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例266 A-e-1 0.80 B-a-3 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例267 A-e-1 0.70 B-a-1 B-b-1 0.40 2.00 C-5 92.7 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例268 A-e-1 0.70 B-a-1 B-b-2 0.40 2.00 C-5 92.7 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例269 A-e-1 0.70 B-a-1 B-b-3 0.40 2.00 C-5 92.7 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例270 A-e-1 0.70 B-a-1 B-b-4 0.40 2.00 C-5 92.7 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例271 A-e-1 0.70 B-a-1 B-b-5 0.40 2.00 C-5 92.7 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例272 A-e-1 0.76 B-a-1 B-b-6 1.50 4.00 C-5 89.6 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例273 A-e-1 0.76 B-a-1 B-b-7 1.50 4.00 C-5 89.6 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 [表7]    紅外線吸收劑 (特定化合物) 紅外線吸收劑 (其他) 樹脂 硬化劑 紫外線 吸收劑 抗氧化劑 界面活性劑 溶劑 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 實施例274 A-e-1 0.76 B-a-1 B-b-8 1.50 4.00 C-5 89.6 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例275 A-e-1 1.00 B-a-1 B-c-1 2.40 1.00 C-5 91.4 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例276 A-e-1 1.00 B-a-1 B-c-1 B-c-2 2.40 1.00 0.80 C-5 90.6 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例277 A-e-1 0.80 B-a-1 B-c-3 1.80 0.10 C-5 93.1 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例278 A-e-1 1.20 B-a-1 B-d-1 1.40 0.80 C-5 92.4 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例279 A-e-1 1.20 B-a-1 B-d-2 1.40 0.80 C-5 92.4 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例280 A-e-1 1.20 B-a-1 B-d-3 1.40 1.00 C-5 92.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例281 A-e-1 1.20 B-a-1 B-d-4 1.40 1.00 C-5 92.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例282 A-e-1 0.80 B-a-1 B-e-1 1.80 1.60 C-5 91.6 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例283 A-e-1 0.80 B-a-1 1.80 C-6 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例284 A-e-1 0.80 B-a-1 1.80 C-7 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例285 A-e-1 0.80 B-a-1 1.80 C-8 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例286 A-e-1 0.80 B-a-1 1.80 C-9 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例287 A-e-1 0.80 B-a-1 1.80 C-10 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例288 A-e-1 0.80 B-a-1 1.80 C-11 C-13 46.6 46.6 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例289 A-e-1 0.80 B-a-1 1.80 C-12 C-13 46.6 46.6 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 [表8]    紅外線吸收劑 (特定化合物) 紅外線吸收劑 (其他) 樹脂 硬化劑 紫外線 吸收劑 抗氧化劑 界面活性劑 溶劑 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 實施例290 A-e-1 0.80 B-a-1 1.80 C-5 93.2 - - D-2 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例291 A-e-1 0.80 B-a-1 1.80 C-11 C-13 74.1 - - D-2 20 E-1 3.3 G-1 0.01 F-5 233 實施例292 A-e-1 0.80 B-a-1 1.80 C-5 93.2 - - D-3 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例293 A-e-1 0.80 B-a-1 1.80 C-5 93.2 - - D-4 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例294 A-e-1 0.80 B-a-1 1.80 C-5 93.2 - - D-5 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例295 A-e-1 0.80 B-a-1 1.80 C-5 93.2 - - D-6 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例296 A-e-1 0.80 B-a-1 1.80 C-5 93.2 - - D-7 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例297 A-e-1 0.80 B-a-1 1.80 C-5 93.2 - - D-8 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例298 A-e-1 0.80 B-a-1 1.80 C-5 93.2 - - D-9 0.85 E-1 3.3 G-1 0.01 F-5 233 實施例299 A-e-1 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-2 3.3 G-1 0.01 F-5 233 實施例300 A-e-1 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-3 3.3 G-1 0.01 F-5 233 實施例301 A-e-1 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-4 3.3 G-1 0.01 F-5 233 實施例302 A-e-1 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-5 3.3 G-1 0.01 F-5 233 實施例303 A-e-1 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-6 3.3 G-1 0.01 F-5 233 實施例304 A-e-1 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-7 3.3 G-1 0.01 F-5 233 實施例305 A-e-1 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 E-5 1.7 1.6 G-1 0.01 F-5 233 實施例306 A-e-1 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-2 0.01 F-5 233 實施例307 A-e-1 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-3 0.01 F-5 233 實施例308 A-e-1 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-4 0.01 F-5 233 實施例309 A-e-1 0.80 B-a-1 1.80 C-5 90.2 H-1 3 D-1 0.85 E-2 3.3 G-1 0.01 F-5 233 實施例310 A-e-1 0.80 B-a-1 1.80 C-5 90.2 H-2 3 D-1 0.85 E-2 3.3 G-1 0.01 F-5 233 實施例311 A-e-1 0.80 B-a-1 1.80 C-5 90.2 H-3 3 D-1 0.85 E-2 3.3 G-1 0.01 F-5 233 實施例312 A-e-1 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-6 233 實施例313 A-e-1 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 F-7 117 116 比較例2 X-1 0.80 B-a-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 [表9]    紅外線吸收劑 (特定化合物) 紅外線吸收劑 (其他) 樹脂 聚合性 化合物 光聚合 起始劑 紫外線 吸收劑 抗氧化劑 界面活性劑 聚合抑制劑 密接劑 溶劑 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 實施例401 A-a-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例402 A-a-2 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例403 A-a-3 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例404 A-b-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例405 A-b-2 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例406 A-b-3 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例407 A-b-4 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例408 A-b-5 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例409 A-b-6 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例410 A-b-7 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例411 A-b-8 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例412 A-b-9 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例413 A-b-10 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例414 A-b-11 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例415 A-b-12 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例416 A-b-13 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例417 A-b-14 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例418 A-b-15 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例419 A-c-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例420 A-c-2 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例421 A-c-3 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例422 A-c-4 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例423 A-d-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例424 A-d-2 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例425 A-d-3 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例426 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例427 A-e-2 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例428 A-e-3 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例429 A-e-4 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 [表10]    紅外線吸收劑 (特定化合物) 紅外線吸收劑 (其他) 樹脂 聚合性 化合物 光聚合 起始劑 紫外線 吸收劑 抗氧化劑 界面活性劑 聚合抑制劑 密接劑 溶劑 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 實施例430 A-e-5 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例431 A-e-6 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例432 A-e-7 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例433 A-e-8 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例434 A-e-9 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例435 A-e-10 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例436 A-e-11 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例437 A-e-12 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例438 A-e-13 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例439 A-e-14 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例440 A-e-15 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例441 A-e-16 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例442 A-f-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例443 A-f-2 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例444 A-f-3 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例445 A-f-4 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例446 A-g-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例447 A-g-2 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例448 A-g-3 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例449 A-g-4 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例450 A-h-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例451 A-h-2 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例452 A-i-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例453 A-i-2 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例454 A-i-3 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例455 A-i-4 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例456 A-i-5 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例457 A-i-6 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例458 A-k-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 [表11]    紅外線吸收劑 (特定化合物) 紅外線吸收劑 (其他) 樹脂 聚合性 化合物 光聚合 起始劑 紫外線 吸收劑 抗氧化劑 界面活性劑 聚合抑制劑 密接劑 溶劑 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 實施例459 A-k-2 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例460 A-k-3 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例461 A-k-4 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例462 A-k-5 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例463 A-k-6 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例464 A-e-1 A-g-4 2.0 2.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例465 A-e-1 4.0 B-a-2 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例466 A-e-1 4.0 B-a-3 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例467 A-e-1 3.5 B-a-1 B-b-1 2.0 10 C-14 46.5 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 01003 F-5 400 實施例468 A-e-1 3.5 B-a-1 B-b-2 2.0 10 C-14 46.5 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例469 A-e-1 3.5 B-a-1 B-b-3 2.0 10 C-14 46.5 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例470 A-e-1 3.5 B-a-1 B-b-4 2.0 10 C-14 46.5 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例471 A-e-1 3.5 B-a-1 B-b-5 2.0 10 C-14 46.5 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例472 A-e-1 3.8 B-a-1 B-b-6 7.5 20 C-14 30.7 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例473 A-e-1 3.8 B-a-1 B-b-7 7.5 20 C-14 30.7 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例474 A-e-1 3.8 B-a-1 B-b-8 7.5 20 C-14 30.7 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例475 A-e-1 5.0 B-a-1 B-c-1 12 5.0 C-14 40.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例476 A-e-1 5.0 B-a-1 B-c-1 B-c-2 12 5.0 4.0 C-14 36.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 [表12]    紅外線吸收劑 (特定化合物) 紅外線吸收劑 (其他) 樹脂 聚合性 化合物 光聚合 起始劑 紫外線 吸收劑 抗氧化劑 界面活性劑 聚合抑制劑 密接劑 溶劑 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 實施例477 A-e-1 4.0 B-a-1 B-c-3 9.0 0.5 C-14 48.5 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例478 A-e-1 6.0 B-a-1 B-d-1 7.0 4.0 C-14 45.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例479 A-e-1 6.0 B-a-1 B-d-2 7.0 4.0 C-14 45.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例480 A-e-1 6.0 B-a-1 B-d-3 7.0 5.0 C-14 44.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例481 A-e-1 6.0 B-a-1 B-d-4 7.0 5.0 C-14 44.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例482 A-e-1 4.0 B-a-1 B-e-1 9.0 8.0 C-14 41.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例483 A-e-1 4.0 B-a-1 9.0 C-10 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例484 A-e-1 4.0 B-a-1 9.0 C-15 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例485 A-e-1 4.0 B-a-1 9.0 C-16 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例486 A-e-1 4.0 B-a-1 9.0 C-17 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例487 A-e-1 4.0 B-a-1 9.0 C-18 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例488 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-2 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例489 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-3 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例490 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-2 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例491 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-3 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例492 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-4 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例493 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-5 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例494 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-2 J-3 5 5 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例495 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-2 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 [表13]    紅外線吸收劑 (特定化合物) 紅外線吸收劑 (其他) 樹脂 聚合性 化合物 光聚合 起始劑 紫外線 吸收劑 抗氧化劑 界面活性劑 聚合抑制劑 密接劑 溶劑 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 種類 質量份 實施例496 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-3 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例497 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-4 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例498 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-5 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例499 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-6 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例500 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-7 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例501 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-8 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例502 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-9 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 實施例503 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-2 3 G-1 0.01 K-1 0.003 F-5 400 實施例504 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-3 3 G-1 0.01 K-1 0.003 F-5 400 實施例505 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-4 3 G-1 0.01 K-1 0.003 F-5 400 實施例506 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-5 3 G-1 0.01 K-1 0.003 F-5 400 實施例507 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-6 3 G-1 0.01 K-1 0.003 F-5 400 實施例508 A-e-1 4.0 B-a-1 9.0 C-14 49.0 1-1 20 J-1 10 D-1 5 E-7 3 G-1 0.01 K-1 0.003 F-5 400 實施例509 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 E-5 1.5 1.5 G-1 0.01 K-1 0.003 F-5 400 實施例510 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-2 0.01 K-1 0.003 F-5 400 實施例511 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-3 0.01 K-1 0.003 F-5 400 實施例512 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-4 0.01 K-1 0.003 F-5 400 實施例513 A-e-1 4.0 B-a-1 9.0 C-14 46.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 L-1 0.003 3 F-5 400 實施例514 A-e-1 4.0 B-a-1 9.0 C-14 46.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 L-2 0.003 3 F-5 400 實施例515 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-6 400 實施例516 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 F-7 200 200 實施例517 A-e-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 F-8 200 200 比較例3 X-1 4.0 B-a-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 [Table 1]    Infrared absorbers (specific compounds) Infrared absorber (other) Resin UV absorber Antioxidants Solvent Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Example 1 Aa-1 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 2 Aa-2 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 3 Aa-3 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 4 Ab-1 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 5 Ab-2 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 6 Ab-3 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 7 Ab-4 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 8 Ab-5 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 9 Ab-6 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 10 Ab-7 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 11 Ab-8 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 12 Ab-9 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 13 Ab-10 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 14 Ab-11 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 15 Ab-12 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 16 Ab-13 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 17 Ab-14 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 18 Ab-15 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 19 Ac-1 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 20 Ac-2 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 21 Ac-3 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 22 Ac-4 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 23 Ad-1 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 24 Ad-2 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 25 Ad-3 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 26 Ae-1 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 27 Ae-2 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 28 Ae-3 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 29 Ae-4 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 30 Ae-5 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 31 Ae-6 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 32 Ae-7 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 33 Ae-8 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 34 Ae-9 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 35 Ae-10 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 36 Ae-11 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 37 Ae-12 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 38 Ae-13 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 39 Ae-14 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 40 Ae-15 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 41 Ae-16 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 42 Af-1 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 43 Af-2 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 44 Af-3 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 45 Af-4 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 [Table 2]    Infrared absorbers (specific compounds) Infrared absorber (other) Resin UV absorber Antioxidants Solvent Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Example 46 Ag-1 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 47 Ag-2 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 48 Ag-3 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 49 Ag-4 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 50 Ah-1 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 51 Ah-2 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 52 Ai-1 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 53 Ai-2 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 54 Ai-3 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 55 Ai-4 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 56 Ai-5 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 57 Ai-6 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 58 Ak-1 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 59 Ak-2 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 60 Ak-3 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 61 Ak-4 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 62 Ak-5 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 63 Ak-6 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 64 Ae-1 Ag-4 0.02 0.02 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 65 Ae-1 0.04 Ba-2 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 66 Ae-1 0.04 Ba-3 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 67 Ae-1 0.035 Ba-1 Bb-1 0.02 0.1 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 68 Ae-1 0.035 Ba-1 Bb-2 0.02 0.1 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 69 Ae-1 0.035 Ba-1 Bb-3 0.02 0.1 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 70 Ae-1 0.035 Ba-1 Bb-4 0.02 0.1 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 71 Ae-1 0.035 Ba-1 Bb-5 0.02 0.1 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 72 Ae-1 0.038 Ba-1 Bb-6 0.075 0.2 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 73 Ae-1 0.038 Ba-1 Bb-7 0.075 0.2 C-1 99.2 D-1 0.17 E-1 0.3 F-1 400 Example 74 Ae-1 0.038 Ba-1 Bb-8 0.075 0.2 C-1 99.2 D-1 0.17 E-1 0.3 F-1 400 Example 75 Ae-1 0.05 Ba-1 Bc-1 0.12 0.05 C-1 99.2 D-1 0.17 E-1 0.3 F-1 400 Example 76 Ae-1 0.05 Ba-1 Bc-1 Bc-2 0.12 0.05 0.04 C-1 99.3 D-1 0.17 E-1 0.3 F-1 400 Example 77 Ae-1 0.04 Ba-1 Bc-3 0.09 0.005 C-1 99.3 D-1 0.17 E-1 0.3 F-1 400 [table 3]    Infrared absorbers (specific compounds) Infrared absorber (other) Resin UV absorber Antioxidants Solvent Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Example 78 Ae-1 0.06 Ba-1 Bd-1 0.07 0.04 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 79 Ae-1 0.06 Ba-1 Bd-2 0.07 0.04 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 80 Ae-1 0.06 Ba-1 Bd-3 0.07 0.05 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 81 Ae-1 0.06 Ba-1 Bd-4 0.07 0.05 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 82 Ae-1 0.04 Ba-1 Be-1 0.09 0.08 C-1 99.3 D-1 0.17 E-1 0.3 F-1 400 Example 83 Ae-1 0.04 Ba-1 0.09 C-2 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 84 Ae-1 0.04 Ba-1 0.09 C-3 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 85 Ae-1 0.04 Ba-1 0.09 C-4 99.4 D-1 0.17 E-1 0.3 F-1 400 Example 86 Ae-1 0.04 Ba-1 0.09 C-1 99.4 D-2 0.17 E-1 0.3 F-1 400 Example 87 Ae-1 0.04 Ba-1 0.09 C-1 99.4 D-3 0.17 E-1 0.3 F-1 400 Example 88 Ae-1 0.04 Ba-1 0.09 C-1 99.4 D-4 0.17 E-1 0.3 F-1 400 Example 89 Ae-1 0.04 Ba-1 0.09 C-1 99.4 D-5 0.17 E-1 0.3 F-1 400 Example 90 Ae-1 0.04 Ba-1 0.09 C-1 99.4 D-6 0.17 E-1 0.3 F-1 400 Example 91 Ae-1 0.04 Ba-1 0.09 C-1 99.4 D-7 0.17 E-1 0.3 F-1 400 Example 92 Ae-1 0.04 Ba-1 0.09 C-1 99.4 D-8 0.17 E-1 0.3 F-1 400 Example 93 Ae-1 0.04 Ba-1 0.09 C-1 99.4 D-9 0.17 E-1 0.3 F-1 400 Example 94 Ae-1 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-2 0.3 F-1 400 Example 95 Ae-1 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-3 0.3 F-1 400 Example 96 Ae-1 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-4 0.3 F-1 400 Example 97 Ae-1 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-5 0.3 F-1 400 Example 98 Ae-1 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-6 0.3 F-1 400 Example 99 Ae-1 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-7 0.3 F-1 400 Example 100 Ae-1 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 E-5 0.15 0.15 F-1 400 Example 101 Ae-1 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-2 400 Example 102 Ael 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-3 F-4 280 120 Comparative example 1 X-1 0.04 Ba-1 0.09 C-1 99.4 D-1 0.17 E-1 0.3 F-1 400 [Table 4]    Infrared absorbers (specific compounds) Infrared absorber (other) Resin Hardener UV absorber Antioxidants surfactant Solvent Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Example 201 Aa-1 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 202 Aa-2 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 203 Aa-3 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 204 Ab-1 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 205 Ab-2 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 206 Ab-3 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 207 Ab-4 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 208 Ab-5 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 209 Ab-6 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 210 Ab-7 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 211 Ab-8 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 212 Ab-9 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 213 Ab-10 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 214 Ab-11 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 215 Ab-12 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 216 Ab-13 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 217 Ab-14 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 218 Ab-15 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 219 Ac-1 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 220 Ac-2 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 221 Ac-3 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 222 Ac-4 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 223 Ad-1 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 224 Ad-2 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 225 Ad-3 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 226 Ae-1 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 227 Ae-2 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 [table 5]    Infrared absorbers (specific compounds) Infrared absorber (other) Resin Hardener UV absorber Antioxidants surfactant Solvent Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Example 228 Ae-3 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 229 Ae-4 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 230 Ae-5 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 231 Ae-6 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 232 Ae-7 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 233 Ae-8 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 234 Ae-9 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 235 Ae-10 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 236 Ae-11 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 237 Ae-12 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 238 Ae-13 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 239 Ae-14 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 240 Ae-15 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 241 Ae-16 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 242 Af-1 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 243 Af-2 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 244 Af-3 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 245 Af-4 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 246 Ag-1 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 247 Ag-2 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 248 Ag-3 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 249 Ag-4 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 250 Ah-1 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 251 Ah-2 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 252 Ai-1 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 253 Ai-2 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 254 Ai-3 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 [Table 6]    Infrared absorbers (specific compounds) Infrared absorber (other) Resin Hardener UV absorber Antioxidants surfactant Solvent Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Example 255 Ai-4 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 256 Ai-5 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 257 Ai-6 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 258 Ak-1 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 259 Ak-2 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 260 Ak-3 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 261 Ak-4 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 262 Ak-5 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 263 Ak-6 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 264 Ae-1 Ag-4 0.40 0.40 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 265 Ae-1 0.80 Ba-2 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 266 Ae-1 0.80 Ba-3 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 267 Ae-1 0.70 Ba-1 Bb-1 0.40 2.00 C-5 92.7 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 268 Ae-1 0.70 Ba-1 Bb-2 0.40 2.00 C-5 92.7 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 269 Ae-1 0.70 Ba-1 Bb-3 0.40 2.00 C-5 92.7 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 270 Ae-1 0.70 Ba-1 Bb-4 0.40 2.00 C-5 92.7 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 271 Ae-1 0.70 Ba-1 Bb-5 0.40 2.00 C-5 92.7 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 272 Ae-1 0.76 Ba-1 Bb-6 1.50 4.00 C-5 89.6 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 273 Ae-1 0.76 Ba-1 Bb-7 1.50 4.00 C-5 89.6 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 [Table 7]    Infrared absorbers (specific compounds) Infrared absorber (other) Resin Hardener UV absorber Antioxidants surfactant Solvent Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Example 274 Ae-1 0.76 Ba-1 Bb-8 1.50 4.00 C-5 89.6 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 275 Ae-1 1.00 Ba-1 Bc-1 2.40 1.00 C-5 91.4 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 276 Ae-1 1.00 Ba-1 Bc-1 Bc-2 2.40 1.00 0.80 C-5 90.6 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 277 Ae-1 0.80 Ba-1 Bc-3 1.80 0.10 C-5 93.1 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 278 Ae-1 1.20 Ba-1 Bd-1 1.40 0.80 C-5 92.4 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 279 Ae-1 1.20 Ba-1 Bd-2 1.40 0.80 C-5 92.4 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 280 Ae-1 1.20 Ba-1 Bd-3 1.40 1.00 C-5 92.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 281 Ae-1 1.20 Ba-1 Bd-4 1.40 1.00 C-5 92.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 282 Ae-1 0.80 Ba-1 Be-1 1.80 1.60 C-5 91.6 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 283 Ae-1 0.80 Ba-1 1.80 C-6 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 284 Ae-1 0.80 Ba-1 1.80 C-7 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 285 Ae-1 0.80 Ba-1 1.80 C-8 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 286 Ae-1 0.80 Ba-1 1.80 C-9 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 287 Ae-1 0.80 Ba-1 1.80 C-10 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 288 Ae-1 0.80 Ba-1 1.80 C-11 C-13 46.6 46.6 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 289 Ae-1 0.80 Ba-1 1.80 C-12 C-13 46.6 46.6 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 [Table 8]    Infrared absorbers (specific compounds) Infrared absorber (other) Resin Hardener UV absorber Antioxidants surfactant Solvent Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Example 290 Ae-1 0.80 Ba-1 1.80 C-5 93.2 - - D-2 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 291 Ae-1 0.80 Ba-1 1.80 C-11 C-13 74.1 - - D-2 20 E-1 3.3 G-1 0.01 F-5 233 Example 292 Ae-1 0.80 Ba-1 1.80 C-5 93.2 - - D-3 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 293 Ae-1 0.80 Ba-1 1.80 C-5 93.2 - - D-4 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 294 Ae-1 0.80 Ba-1 1.80 C-5 93.2 - - D-5 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 295 Ae-1 0.80 Ba-1 1.80 C-5 93.2 - - D-6 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 296 Ae-1 0.80 Ba-1 1.80 C-5 93.2 - - D-7 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 297 Ae-1 0.80 Ba-1 1.80 C-5 93.2 - - D-8 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 298 Ae-1 0.80 Ba-1 1.80 C-5 93.2 - - D-9 0.85 E-1 3.3 G-1 0.01 F-5 233 Example 299 Ae-1 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-2 3.3 G-1 0.01 F-5 233 Example 300 Ae-1 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-3 3.3 G-1 0.01 F-5 233 Example 301 Ae-1 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-4 3.3 G-1 0.01 F-5 233 Example 302 Ae-1 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-5 3.3 G-1 0.01 F-5 233 Example 303 Ae-1 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-6 3.3 G-1 0.01 F-5 233 Example 304 Ae-1 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-7 3.3 G-1 0.01 F-5 233 Example 305 Ae-1 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 E-5 1.7 1.6 G-1 0.01 F-5 233 Example 306 Ae-1 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-2 0.01 F-5 233 Example 307 Ae-1 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-3 0.01 F-5 233 Example 308 Ae-1 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-4 0.01 F-5 233 Example 309 Ae-1 0.80 Ba-1 1.80 C-5 90.2 H-1 3 D-1 0.85 E-2 3.3 G-1 0.01 F-5 233 Example 310 Ae-1 0.80 Ba-1 1.80 C-5 90.2 H-2 3 D-1 0.85 E-2 3.3 G-1 0.01 F-5 233 Example 311 Ae-1 0.80 Ba-1 1.80 C-5 90.2 H-3 3 D-1 0.85 E-2 3.3 G-1 0.01 F-5 233 Example 312 Ae-1 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-6 233 Example 313 Ae-1 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 F-7 117 116 Comparative example 2 X-1 0.80 Ba-1 1.80 C-5 93.2 - - D-1 0.85 E-1 3.3 G-1 0.01 F-5 233 [Table 9]    Infrared absorbers (specific compounds) Infrared absorber (other) Resin polymeric compound Photopolymerization initiator UV absorber Antioxidants surfactant polymerization inhibitor sealant Solvent Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Example 401 Aa-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 402 Aa-2 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 403 Aa-3 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 404 Ab-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 405 Ab-2 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 406 Ab-3 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 407 Ab-4 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 408 Ab-5 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 409 Ab-6 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 410 Ab-7 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 411 Ab-8 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 412 Ab-9 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 413 Ab-10 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 414 Ab-11 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 415 Ab-12 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 416 Ab-13 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 417 Ab-14 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 418 Ab-15 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 419 Ac-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 420 Ac-2 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 421 Ac-3 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 422 Ac-4 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 423 Ad-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 424 Ad-2 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 425 Ad-3 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 426 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 427 Ae-2 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 428 Ae-3 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 429 Ae-4 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 [Table 10]    Infrared absorbers (specific compounds) Infrared absorber (other) Resin polymeric compound Photopolymerization initiator UV absorber Antioxidants surfactant polymerization inhibitor sealant Solvent Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Example 430 Ae-5 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 431 Ae-6 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 432 Ae-7 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 433 Ae-8 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 434 Ae-9 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 435 Ae-10 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 436 Ae-11 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 437 Ae-12 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 438 Ae-13 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 439 Ae-14 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 440 Ae-15 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 441 Ae-16 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 442 Af-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 443 Af-2 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 444 Af-3 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 445 Af-4 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 446 Ag-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 447 Ag-2 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 448 Ag-3 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 449 Ag-4 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 450 Ah-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 451 Ah-2 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 452 Ai-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 453 Ai-2 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 454 Ai-3 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 455 Ai-4 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 456 Ai-5 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 457 Ai-6 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 458 Ak-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 [Table 11]    Infrared absorbers (specific compounds) Infrared absorber (other) Resin polymeric compound Photopolymerization initiator UV absorber Antioxidants surfactant polymerization inhibitor sealant Solvent Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Example 459 Ak-2 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 460 Ak-3 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 461 Ak-4 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 462 Ak-5 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 463 Ak-6 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 464 Ae-1 Ag-4 2.0 2.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 465 Ae-1 4.0 Ba-2 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 466 Ae-1 4.0 Ba-3 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 467 Ae-1 3.5 Ba-1 Bb-1 2.0 10 C-14 46.5 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 01003 F-5 400 Example 468 Ae-1 3.5 Ba-1 Bb-2 2.0 10 C-14 46.5 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 469 Ae-1 3.5 Ba-1 Bb-3 2.0 10 C-14 46.5 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 470 Ae-1 3.5 Ba-1 Bb-4 2.0 10 C-14 46.5 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 471 Ae-1 3.5 Ba-1 Bb-5 2.0 10 C-14 46.5 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 472 Ae-1 3.8 Ba-1 Bb-6 7.5 20 C-14 30.7 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 473 Ae-1 3.8 Ba-1 Bb-7 7.5 20 C-14 30.7 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 474 Ae-1 3.8 Ba-1 Bb-8 7.5 20 C-14 30.7 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 475 Ae-1 5.0 Ba-1 Bc-1 12 5.0 C-14 40.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 476 Ae-1 5.0 Ba-1 Bc-1 Bc-2 12 5.0 4.0 C-14 36.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 [Table 12]    Infrared absorbers (specific compounds) Infrared absorber (other) Resin polymeric compound Photopolymerization initiator UV absorber Antioxidants surfactant polymerization inhibitor sealant Solvent Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Example 477 Ae-1 4.0 Ba-1 Bc-3 9.0 0.5 C-14 48.5 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 478 Ae-1 6.0 Ba-1 Bd-1 7.0 4.0 C-14 45.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 479 Ae-1 6.0 Ba-1 Bd-2 7.0 4.0 C-14 45.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 480 Ae-1 6.0 Ba-1 Bd-3 7.0 5.0 C-14 44.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 481 Ae-1 6.0 Ba-1 Bd-4 7.0 5.0 C-14 44.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 482 Ae-1 4.0 Ba-1 Be-1 9.0 8.0 C-14 41.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 483 Ae-1 4.0 Ba-1 9.0 C-10 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 484 Ae-1 4.0 Ba-1 9.0 C-15 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 485 Ae-1 4.0 Ba-1 9.0 C-16 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 486 Ae-1 4.0 Ba-1 9.0 C-17 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 487 Ae-1 4.0 Ba-1 9.0 C-18 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 488 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-2 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 489 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-3 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 490 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-2 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 491 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-3 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 492 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-4 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 493 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-5 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 494 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-2 J-3 5 5 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 495 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-2 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 [Table 13]    Infrared absorbers (specific compounds) Infrared absorber (other) Resin polymeric compound Photopolymerization initiator UV absorber Antioxidants surfactant polymerization inhibitor sealant Solvent Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Kind parts by mass Example 496 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-3 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 497 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-4 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 498 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-5 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 499 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-6 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 500 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-7 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 501 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-8 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 502 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-9 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400 Example 503 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-2 3 G-1 0.01 K-1 0.003 F-5 400 Example 504 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-3 3 G-1 0.01 K-1 0.003 F-5 400 Example 505 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-4 3 G-1 0.01 K-1 0.003 F-5 400 Example 506 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-5 3 G-1 0.01 K-1 0.003 F-5 400 Example 507 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-6 3 G-1 0.01 K-1 0.003 F-5 400 Example 508 Ae-1 4.0 Ba-1 9.0 C-14 49.0 1-1 20 J-1 10 D-1 5 E-7 3 G-1 0.01 K-1 0.003 F-5 400 Example 509 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 E-5 1.5 1.5 G-1 0.01 K-1 0.003 F-5 400 Example 510 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-2 0.01 K-1 0.003 F-5 400 Example 511 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-3 0.01 K-1 0.003 F-5 400 Example 512 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-4 0.01 K-1 0.003 F-5 400 Example 513 Ae-1 4.0 Ba-1 9.0 C-14 46.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 L-1 0.003 3 F-5 400 Example 514 Ae-1 4.0 Ba-1 9.0 C-14 46.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 L-2 0.003 3 F-5 400 Example 515 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-6 400 Example 516 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 F-7 200 200 Example 517 Ae-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 F-8 200 200 Comparative example 3 X-1 4.0 Ba-1 9.0 C-14 49.0 I-1 20 J-1 10 D-1 5 E-1 3 G-1 0.01 K-1 0.003 F-5 400

上述表中記載之材料的詳細內容為如下。Details of the materials listed in the above table are as follows.

(紅外線吸收劑) A-a-1~A-a-3、A-b-1~A-b-15、A-c-1~A-c-4、A-d-1~A-d-3、A-e-1~A-e-16、A-f-1~A-f-4、A-g-1~A-g-4、A-h-1、A-h-2、A-i-1~A-i-6、A-k-1~A-k-6:上述特定化合物的具體例中例示之化合物A-a-1~A-a-3、A-b-1~A-b-15、A-c-1~A-c-4、A-d-1~A-d-3、A-e-1~A-e-16、A-f-1~A-f-4、A-g-1~A-g-4、A-h-1、A-h-2、A-i-1~A-i-6、A-k-1~A-k-6 (Infrared absorber) A-a-1~A-a-3, A-b-1~A-b-15, A-c-1~A-c-4, A-d-1~A-d-3, A-e-1~A-e-16, A-f-1~A-f-4, A-g- 1 to A-g-4, A-h-1, A-h-2, A-i-1 to A-i-6, A-k-1 to A-k-6: Compounds A-a-1 to A-a-3, A-b- exemplified in the specific examples of the above-mentioned specific compounds. 1~A-b-15, A-c-1~A-c-4, A-d-1~A-d-3, A-e-1~A-e-16, A-f-1~A-f-4, A-g-1~A-g-4, A-h-1, A-h-2, A-i-1~A-i-6, A-k-1~A-k-6

X-1:下述結構的化合物(比較化合物) [化42] X-1: Compound with the following structure (comparative compound) [Chemical 42]

B-a-1~B-a-3:下述結構的化合物(酞菁化合物) B-b-1~B-b-8:下述結構的化合物(五次甲基化合物) B-c-1~B-c-3:下述結構的化合物(方酸菁化合物) B-d-1~B-d-3:下述結構的化合物(七次甲基化合物) B-d-4:下述結構的化合物(花青化合物) B-e-1:下述結構的化合物(亞銨化合物) [化43] [化44] [化45] Ba-1 to Ba-3: Compounds with the following structure (phthalocyanine compounds) Bb-1 to Bb-8: Compounds with the following structure (pentamethyl compounds) Bc-1 to Bc-3: Compounds with the following structure Compounds (squaraine compounds) Bd-1 to Bd-3: Compounds with the following structure (heptaptine compounds) Bd-4: Compounds with the following structure (cyanine compounds) Be-1: Compounds with the following structure (immonium compound) [Chemical 43] [Chemical 44] [Chemical 45]

(樹脂) C-1:藉由日本特開2021-134350號公報的樹脂合成例1中記載之方法合成之下述結構的樹脂(重量平均分子量137000、數量平均分子量32000、玻璃轉移溫度165℃) C-2:藉由日本特開2021-134350號公報的樹脂合成例2中記載之方法合成之下述結構的樹脂(重量平均分子量188000、數量平均分子量75000、玻璃轉移溫度285℃) C-3:藉由日本特開2021-134350號公報的樹脂合成例3中記載之方法合成之下述結構的樹脂(標註於主鏈之數值表示重複單元的莫耳比。玻璃轉移溫度310℃。對數黏度0.87) C-4:ACRYVIEWA(NIPPON SHOKUBAI CO.,LTD.製丙烯酸樹脂) C-5:下述結構的樹脂(標註於主鏈之數值表示重複單元的質量比。重量平均分子量26100、數量平均分子量8600、環氧當量355g/eq、酸值163mgKOH/g、玻璃轉移溫度133℃) C-6:下述結構的樹脂(標註於主鏈之數值表示重複單元的質量比。重量平均分子量22900、數量平均分子量8800、環氧當量316g/eq、酸值130mgKOH/g、玻璃轉移溫度124℃) C-7:下述結構的樹脂(標註於主鏈之數值表示重複單元的質量比。重量平均分子量18300、數量平均分子量9100、環氧當量284g/eq、酸值98mgKOH/g、玻璃轉移溫度134℃) C-8:下述結構的樹脂(標註於主鏈之數值表示重複單元的質量比。重量平均分子量20000、數量平均分子量8300、環氧當量284g/eq、酸值130mgKOH/g、玻璃轉移溫度136℃) C-9:下述結構的樹脂(標註於主鏈之數值表示重複單元的質量比。重量平均分子量21100、數量平均分子量8500、環氧當量355g/eq、酸值157mgKOH/g、玻璃轉移溫度157℃) C-10:下述結構的樹脂(標註於主鏈之數值表示重複單元的質量比。重量平均分子量9500、數量平均分子量5800) C-11:下述結構的樹脂(標註於主鏈之數值表示重複單元的質量比。重量平均分子量23700、數量平均分子量10300、環氧當量284g/eq、玻璃轉移溫度83℃) C-12:EPICLON N-695(DIC Corporation製,酚醛清漆型環氧樹脂) C-13:下述結構的樹脂(標註於主鏈之數值表示重複單元的莫耳比。重量平均分子量30000、數量平均分子量15100、酸值113mgKOH/g) C-14:下述結構的樹脂(標註於主鏈之數值表示重複單元的重量比。重量平均分子量9700、數量平均分子量5700、酸值130mgKOH/g) C-15:下述結構的樹脂(標註於主鏈之數值表示重複單元的重量比。重量平均分子量15100、數量平均分子量7000、酸值136mgKOH/g) C-16:下述結構的樹脂(標註於主鏈之數值表示重複單元的重量比。重量平均分子量17000、數量平均分子量7700、酸值32mgKOH/g) C-17:下述結構的樹脂(標註於主鏈之數值表示重複單元的重量比。重量平均分子量16000、數量平均分子量5800、酸值101mgKOH/g) C-18:下述結構的樹脂(標註於主鏈之數值表示重複單元的莫耳比。重量平均分子量10000、數量平均分子量3900、酸值69mgKOH/g) [化46] [化47] (Resin) C-1: A resin with the following structure (weight average molecular weight 137000, number average molecular weight 32000, glass transition temperature 165°C) was synthesized by the method described in Resin Synthesis Example 1 of Japanese Patent Application Publication No. 2021-134350. C-2: A resin with the following structure (weight average molecular weight 188000, number average molecular weight 75000, glass transition temperature 285°C) was synthesized by the method described in Resin Synthesis Example 2 of Japanese Patent Application Laid-Open No. 2021-134350. : A resin having the following structure was synthesized by the method described in Resin Synthesis Example 3 of Japanese Patent Application Publication No. 2021-134350 (the numerical value indicated on the main chain represents the molar ratio of the repeating unit. Glass transition temperature: 310°C. Logarithmic viscosity 0.87) C-4: ACRYVIEWA (acrylic resin manufactured by NIPPON SHOKUBAI CO., LTD.) C-5: Resin with the following structure (the numerical value marked on the main chain indicates the mass ratio of the repeating unit. Weight average molecular weight 26100, number average molecular weight 8600, epoxy equivalent 355g/eq, acid value 163mgKOH/g, glass transition temperature 133℃) C-6: Resin with the following structure (the value marked on the main chain indicates the mass ratio of the repeating unit. Weight average molecular weight 22900, quantity Average molecular weight 8800, epoxy equivalent 316g/eq, acid value 130mgKOH/g, glass transition temperature 124℃) C-7: Resin with the following structure (the value marked on the main chain indicates the mass ratio of the repeating unit. Weight average molecular weight 18300 , number average molecular weight 9100, epoxy equivalent 284g/eq, acid value 98mgKOH/g, glass transition temperature 134℃) C-8: Resin with the following structure (the value marked on the main chain indicates the mass ratio of the repeating unit. Weight average Molecular weight 20000, number average molecular weight 8300, epoxy equivalent 284g/eq, acid value 130mgKOH/g, glass transition temperature 136°C) C-9: Resin with the following structure (the value marked on the main chain indicates the mass ratio of the repeating unit. Weight average molecular weight 21100, number average molecular weight 8500, epoxy equivalent 355g/eq, acid value 157mgKOH/g, glass transition temperature 157℃) C-10: Resin with the following structure (the value marked on the main chain indicates the mass of the repeating unit Ratio. Weight average molecular weight 9500, number average molecular weight 5800) C-11: Resin with the following structure (the value marked on the main chain indicates the mass ratio of the repeating unit. Weight average molecular weight 23700, number average molecular weight 10300, epoxy equivalent 284g/ eq, glass transition temperature 83°C) C-12: EPICLON N-695 (manufactured by DIC Corporation, novolak type epoxy resin) C-13: Resin with the following structure (the numerical value indicated on the main chain represents the mole of the repeating unit Ratio. Weight average molecular weight 30000, number average molecular weight 15100, acid value 113mgKOH/g) C-14: Resin with the following structure (the value marked on the main chain indicates the weight ratio of the repeating unit. Weight average molecular weight 9700, number average molecular weight 5700, acid value 130mgKOH/g) C-15: Resin with the following structure (the value marked on the main chain indicates the weight ratio of repeating units. Weight average molecular weight 15100, number average molecular weight 7000, acid Value 136mgKOH/g) C-16: Resin with the following structure (the value marked on the main chain indicates the weight ratio of the repeating unit. Weight average molecular weight 17000, number average molecular weight 7700, acid value 32mgKOH/g) C-17: The following Resin of the structure (the numerical value marked on the main chain indicates the weight ratio of the repeating unit. Weight average molecular weight 16000, number average molecular weight 5800, acid value 101 mgKOH/g) C-18: Resin of the following structure (the numerical value marked on the main chain indicates Molar ratio of repeating units. Weight average molecular weight 10,000, number average molecular weight 3,900, acid value 69 mgKOH/g) [Chemical 46] [Chemical 47]

(紫外線吸收劑) D-1:下述結構的化合物(二氯甲烷中的吸收極大波長394nm) D-2:Uvinul3050(BASF公司製,下述結構的化合物) D-3:Tinuvin477(BASF公司製,羥苯基三𠯤系紫外線吸收劑) D-4:Tinuvin326(BASF公司製,下述結構的化合物) D-5:國際公開第2021/131355號中記載之化合物(2)-22(下述結構的化合物) D-6:國際公開第2021/131355號中記載之化合物(1)-46(下述結構的化合物) D-7:國際公開第2021/132247號中記載之化合物A-1(下述結構的化合物) D-8:NeoHeliopan357(Symrise AG製,下述結構的化合物) D-9:下述結構的化合物 [化48] (Ultraviolet absorber) D-1: Compound with the following structure (absorption maximum wavelength in methylene chloride is 394 nm) D-2: Uvinul3050 (manufactured by BASF, compound with the following structure) D-3: Tinuvin477 (manufactured by BASF) , hydroxyphenyltrifluoroethylene-based ultraviolet absorber) D-4: Tinuvin 326 (manufactured by BASF, compound with the following structure) D-5: Compound (2)-22 (below) described in International Publication No. 2021/131355 (compound with the following structure) D-6: Compound (1)-46 described in International Publication No. 2021/131355 (compound with the following structure) D-7: Compound A-1 (compound A-1 described in International Publication No. 2021/132247 Compound with the following structure) D-8: NeoHeliopan357 (manufactured by Symrise AG, compound with the following structure) D-9: Compound with the following structure [Chemical 48]

(抗氧化劑) E-1:ADEKA STAB AO-60(ADEKA CORPORATION製,下述結構的化合物) E-2:ADEKA STAB AO-80(ADEKA CORPORATION製,下述結構的化合物) E-3:下述結構的化合物 E-4:ADEKA STAB 2112(ADEKA CORPORATION製,下述結構的化合物) E-5:ADEKA STAB PEP-36(ADEKA CORPORATION製,下述結構的化合物) E-6:ADEKA STAB HP-10(ADEKA CORPORATION製,下述結構的化合物) E-7:ADEKA STAB AO-412S(ADEKA CORPORATION製,下述結構的化合物) [化49] (Antioxidant) E-1: ADEKA STAB AO-60 (manufactured by ADEKA CORPORATION, compound with the following structure) E-2: ADEKA STAB AO-80 (manufactured by ADEKA CORPORATION, compound with the following structure) E-3: following Compound of the structure E-4: ADEKA STAB 2112 (manufactured by ADEKA CORPORATION, compound with the following structure) E-5: ADEKA STAB PEP-36 (manufactured by ADEKA CORPORATION, compound with the following structure) E-6: ADEKA STAB HP-10 (manufactured by ADEKA CORPORATION, compound with the following structure) E-7: ADEKA STAB AO-412S (manufactured by ADEKA CORPORATION, compound with the following structure) [Chemical 49]

(溶劑) F-1:二氯甲烷 F-2:N,N-二甲基乙醯胺 F-3:環己烷 F-4:二甲苯 F-5:環戊酮 F-6:環己酮 F-7:丙二醇單甲醚乙酸酯(PGMEA) F-8:丙二醇單甲醚(PGME) (solvent) F-1: Dichloromethane F-2: N,N-dimethylacetamide F-3: cyclohexane F-4: xylene F-5: cyclopentanone F-6: cyclohexanone F-7: Propylene glycol monomethyl ether acetate (PGMEA) F-8: Propylene glycol monomethyl ether (PGME)

(界面活性劑) G-1:FTX-218D(Neos Corporation製氟系界面活性劑) G-2:MEGAFACE F-554(DIC Corporation製氟系界面活性劑) G-3:KF-6001(Shin-Etsu Chemical Co.,Ltd.製聚矽氧系界面活性劑) G-4:下述結構的化合物(重量平均分子量14000,表示重複單元的比例之%的數值為莫耳%) [化50] (Surfactant) G-1: FTX-218D (fluorine-based surfactant manufactured by Neos Corporation) G-2: MEGAFACE F-554 (fluorine-based surfactant manufactured by DIC Corporation) G-3: KF-6001 (Shin- Polysilicone surfactant manufactured by Etsu Chemical Co., Ltd.) G-4: Compound with the following structure (weight average molecular weight: 14,000, the value indicating the percentage of repeating units is molar %) [Chemical 50]

(硬化劑) H-1:偏苯三甲酸 H-2:2-乙基-4-甲基咪唑 H-3:甲基四氫鄰苯二甲酸酐 (hardener) H-1: Trimellitic acid H-2: 2-ethyl-4-methylimidazole H-3: Methyltetrahydrophthalic anhydride

(聚合性化合物) I-1:KAYARAD DPHA(Nippon Kayaku Co.,Ltd.製二季戊四醇六丙烯酸酯與二季戊四醇五丙烯酸酯的混合物) I-2:KAYARAD RP-1040(Nippon Kayaku Co.,Ltd.製環氧乙烷改質新戊四醇四丙烯酸酯) I-3:ARONIX M-510(TOAGOSEI CO.,LTD.製多元酸改質丙烯酸寡聚物) (polymeric compound) I-1: KAYARAD DPHA (a mixture of dipentaerythritol hexaacrylate and dipentaerythritol pentaacrylate manufactured by Nippon Kayaku Co., Ltd.) I-2: KAYARAD RP-1040 (Ethylene oxide modified neopentaerythritol tetraacrylate manufactured by Nippon Kayaku Co., Ltd.) I-3: ARONIX M-510 (polyacid-modified acrylic oligomer manufactured by TOAGOSEI CO., LTD.)

(光聚合起始劑) J-1:Irgacure OXE01(BASF公司製肟酯化合物) J-2:國際公開第2017/169819號中記載之化合物No.1(下述結構的化合物) J-3:國際公開第2017/169819號中記載之化合物No.10(下述結構的化合物) J-4:日本特開2019-168654號公報中記載之化合物No.5(下述結構的化合物) J-5:日本特開2019-168654號公報中記載之化合物No.73(下述結構的化合物) [化51] (Photopolymerization initiator) J-1: Irgacure OXE01 (oxime ester compound manufactured by BASF) J-2: Compound No. 1 described in International Publication No. 2017/169819 (compound with the following structure) J-3: Compound No. 10 (compound with the following structure) described in International Publication No. 2017/169819 J-4: Compound No. 5 (compound with the following structure) described in Japanese Patent Application Publication No. 2019-168654 J-5 : Compound No. 73 (compound with the following structure) described in Japanese Patent Application Laid-Open No. 2019-168654 [Chemical 51]

(聚合抑制劑) K-1:對甲氧基苯酚 (密接劑) L-1、L-2:下述結構的化合物 [化52] (Polymerization inhibitor) K-1: p-methoxyphenol (adhesive agent) L-1, L-2: Compounds with the following structures [Chemical 52]

<膜的製造> (製造例1)使用了實施例1~102、比較例1的組成物之膜的製造方法 將各組成物澆鑄在玻璃基板上,以20℃乾燥8小時之後,從玻璃基板剝離。將剝離的塗膜進而在減壓下以100℃乾燥8小時,獲得了厚度0.1mm、縱60mm、橫60mm的膜。 <Manufacturing of membrane> (Manufacture Example 1) Method for producing a film using the compositions of Examples 1 to 102 and Comparative Example 1 Each composition was cast on a glass substrate, dried at 20° C. for 8 hours, and then peeled from the glass substrate. The peeled coating film was further dried at 100° C. for 8 hours under reduced pressure, and a film with a thickness of 0.1 mm, a length of 60 mm, and a width of 60 mm was obtained.

(製造例2)使用了實施例201~313、比較例2的組成物之膜的製造方法 藉由旋塗法,將各組成物塗佈於玻璃基板上,之後利用加熱板以100℃加熱2分鐘,接著以200℃加熱8分鐘而進行硬化處理,由此獲得了厚度10μm的膜。 (Manufacture Example 2) Method for producing a film using the compositions of Examples 201 to 313 and Comparative Example 2 Each composition was applied on a glass substrate by a spin coating method, and then heated at 100° C. for 2 minutes using a hot plate, and then heated at 200° C. for 8 minutes to perform hardening treatment, thereby obtaining a film with a thickness of 10 μm.

(製造例3)使用了實施例401~517、比較例3的組成物之膜的製造方法 藉由旋塗法,將各組成物塗佈於玻璃基板上,之後利用加熱板以100℃加熱2分鐘,由此獲得了組成物層。將所獲得之組成物層利用i射線步進曝光裝置FPA-3000i5+(Canon Inc.製),以500mJ/cm 2的曝光量進行了整面曝光。接著,利用加熱板,以200℃加熱曝光後的組成物層5分鐘而進行硬化處理,由此獲得了厚度1.0μm的膜。 (Manufacture Example 3) Method for producing a film using the compositions of Examples 401 to 517 and Comparative Example 3. Each composition was applied on a glass substrate by a spin coating method, and then heated at 100° C. for 2 seconds using a hot plate. minutes, thereby obtaining a composition layer. The obtained composition layer was exposed over the entire surface using an i-ray stepper exposure device FPA-3000i5+ (manufactured by Canon Inc.) at an exposure dose of 500 mJ/cm 2 . Next, the exposed composition layer was heated at 200° C. for 5 minutes using a hot plate to perform a hardening process, thereby obtaining a film with a thickness of 1.0 μm.

<性能評價> (紅外線遮蔽性的評價基準) 利用分光光度計U-4100(Hitachi High-Tech Corporation製)測定所獲得之膜在波長700~720nm的範圍內的平均透射率,按照以下基準評價了紅外線遮蔽性。 A:波長700nm~720nm的範圍內的平均透射率≤2% B:2%<波長700nm~720nm的範圍內的平均透射率≤4% C:4%<波長700nm~720nm的範圍內的平均透射率≤7% D:7%<波長700nm~720nm的範圍內的平均透射率≤10% E:10%<波長700nm~720nm範圍內的平均透射率 <Performance Evaluation> (Evaluation criteria for infrared shielding properties) The average transmittance of the obtained film in the wavelength range of 700 to 720 nm was measured using a spectrophotometer U-4100 (manufactured by Hitachi High-Tech Corporation), and the infrared shielding properties were evaluated based on the following criteria. A: The average transmittance within the wavelength range of 700nm ~ 720nm is ≤ 2% B: 2%<average transmittance within the wavelength range of 700nm to 720nm≤4% C: 4%<average transmittance within the wavelength range of 700nm to 720nm≤7% D: 7%<average transmittance within the wavelength range of 700nm to 720nm≤10% E: 10%<average transmittance within the wavelength range of 700nm~720nm

(可見光透射性的評價) 利用分光光度計U-4100(Hitachi High-Tech Corporation製)測定所獲得之膜在波長420~550nm的範圍內的平均透射率,按照以下基準評價了可見光透射性。 A:波長420nm~550nm的範圍內的平均透射率≥95% B:92%≤波長420nm~550nm的範圍內的平均透射率<95% C:89%≤波長420nm~550nm的範圍內的平均透射率<92% D:86%≤波長420nm~550nm的範圍內的平均透射率<89% E:波長420nm~550nm的範圍內的平均透射率<86% (Evaluation of visible light transmittance) The average transmittance of the obtained film in the wavelength range of 420 to 550 nm was measured using a spectrophotometer U-4100 (manufactured by Hitachi High-Tech Corporation), and the visible light transmittance was evaluated based on the following criteria. A: The average transmittance in the wavelength range of 420nm ~ 550nm is ≥95% B: 92% ≤ average transmittance within the wavelength range of 420nm ~ 550nm < 95% C: 89% ≤ average transmittance within the wavelength range of 420nm ~ 550nm < 92% D: 86% ≤ average transmittance within the wavelength range of 420nm ~ 550nm < 89% E: Average transmittance in the wavelength range of 420nm to 550nm <86%

(耐光性的評價) 利用Xe燈、通過紫外線截止濾波器對所獲得之膜照射5万勒克司的光20小時來進行了耐光性試驗,利用色度計MCPD-1000(Otsuka Electronics Co.,Ltd.製)測定了光照射前後的色差的ΔEab值。ΔEab值越小,表示耐光性越良好。再者,ΔEab值為由基於CIE1976(L*,a*,b*)空間表色系統之以下色差公式求得之值(日本色彩學會編 新編色彩科學手冊(1985年)266頁)。 ΔEab={(ΔL*) 2+(Δa*) 2+(Δb*) 2} 1/2A:ΔEab值<2.5 B:2.5≤ΔEab值<5 C:5≤ΔEab值<10 D:10≤ΔEab值<15 E:15≤ΔEab值 (Evaluation of light resistance) A light resistance test was conducted by irradiating the obtained film with 50,000 lux of light using an Xe lamp and an ultraviolet cut filter for 20 hours, using a colorimeter MCPD-1000 (Otsuka Electronics Co., Ltd. .) The ΔEab value of the color difference before and after light irradiation was measured. The smaller the ΔEab value is, the better the light resistance is. In addition, the ΔEab value is a value obtained from the following color difference formula based on the CIE1976 (L*, a*, b*) space color representation system (Japanese Color Society's newly compiled Color Science Handbook (1985), page 266). ΔEab={(ΔL*) 2 + (Δa*) 2 + (Δb*) 2 } 1/2 A: ΔEab value<2.5 B: 2.5≤ΔEab value<5 C: 5≤ΔEab value<10 D: 10≤ ΔEab value<15 E: 15≤ΔEab value

<保存穩定性的評價> 將各組成物在45℃的恆溫器中保管3天後,按照上述膜的製造方法製造了膜。利用掃描式電子顯微鏡觀察(測定倍率=10000倍)所獲得之膜,測定在10μm×15μm的範圍內存在的異物數,按照以下基準評價了保存穩定性。 A:在10μm×15μm的範圍內不存在異物 B:在10μm×15μm的範圍內存在的異物超出0個且50個以下 C:在10μm×15μm的範圍內存在的異物超出50個且100個以下 D:在10μm×15μm的範圍內存在的異物超出100個且200個以下 E:在10μm×15μm的範圍內存在的異物超出200個 <Evaluation of storage stability> Each composition was stored in a thermostat at 45° C. for 3 days, and then a film was produced according to the film production method described above. The obtained film was observed with a scanning electron microscope (measurement magnification = 10,000 times), the number of foreign matter present in the range of 10 μm × 15 μm was measured, and the storage stability was evaluated based on the following criteria. A: There is no foreign matter within the range of 10μm×15μm B: The number of foreign matter present in the range of 10 μm × 15 μm exceeds 0 and is less than 50. C: There are more than 50 and less than 100 foreign objects present in the range of 10 μm × 15 μm. D: There are more than 100 and less than 200 foreign objects in the range of 10 μm × 15 μm. E: More than 200 foreign objects exist within the range of 10μm×15μm

[表14]    評價結果 紅外線遮蔽性 可見光透射性 耐光性 保存穩定性 實施例1 A A D C 實施例2 A A D C 實施例3 A A D C 實施例4 A A D A 實施例5 A A D A 實施例6 A A D A 實施例7 D D D A 實施例8 A A D A 實施例9 C C D A 實施例10 B B D A 實施例11 D D D A 實施例12 D D D A 實施例13 D D D A 實施例14 D D D A 實施例15 D D D B 實施例16 D D D B 實施例17 D D D B 實施例18 D D D B 實施例19 A A D B 實施例20 A A D B 實施例21 A A D B 實施例22 A A D B 實施例23 A A B A 實施例24 A A B A 實施例25 A A B A 實施例26 A A A A 實施例27 A A A A 實施例28 A A A A 實施例29 A A A A 實施例30 D D A A 實施例31 A A A A 實施例32 C C A A 實施例33 B B A A 實施例34 D D A A 實施例35 D D A A 實施例36 D D A A 實施例37 D D B A 實施例38 D D C A 實施例39 D D C A 實施例40 D D C A [表15]    評價結果 紅外線遮蔽性 可見光透射性 耐光性 保存穩定性 實施例41 D D C A 實施例42 A A B A 實施例43 A A B A 實施例44 A A B A 實施例45 A A B A 實施例46 A A A A 實施例47 A A A A 實施例48 A A A A 實施例49 A A A A 實施例50 A A C A 實施例51 A A C A 實施例52 A A C A 實施例53 A A C A 實施例54 A A C A 實施例55 A A C A 實施例56 A A C A 實施例57 A A C A 實施例58 A A A A 實施例59 A A B A 實施例60 A A A A 實施例61 A A A A 實施例62 A A B A 實施例63 A A B A 實施例64 A A A A 實施例65 A A A A 實施例66 A A A A 實施例67 A A A A 實施例68 A A A A 實施例69 A A A A 實施例70 A A A A 實施例71 A A A A 實施例72 A A A A 實施例73 A A A A 實施例74 A A A A 實施例75 A A A A 實施例76 A A A A 實施例77 A A A A 實施例78 A A A A 實施例79 A A A A 實施例80 A A A A [表16]    評價結果 紅外線遮蔽性 可見光透射性 耐光性 保存穩定性 實施例81 A A A A 實施例82 A A A A 實施例83 A A A A 實施例84 A A A A 實施例85 A A A A 實施例86 A A A A 實施例87 A A A A 實施例88 A A A A 實施例89 A A A A 實施例90 A A A A 實施例91 A A A A 實施例92 A A A A 實施例93 A A A A 實施例94 A A A A 實施例95 A A A A 實施例96 A A A A 實施例97 A A A A 實施例98 A A A A 實施例99 A A A A 實施例100 A A A A 實施例101 A A A A 實施例102 A A A A 比較例1 E E E E [表17]    評價結果 紅外線遮蔽性 可見光透射性 耐光性 保存穩定性 實施例201 A A D C 實施例202 A A D C 實施例203 A A D C 實施例204 A A D A 實施例205 A A D A 實施例206 A A D A 實施例207 D D D A 實施例208 A A D A 實施例209 C C D A 實施例210 B B D A 實施例211 D D D A 實施例212 D D D A 實施例213 D D D A 實施例214 D D D A 實施例215 D D D B 實施例216 D D D B 實施例217 D D D B 實施例218 D D D B 實施例219 A A D B 實施例220 A A D B 實施例221 A A D B 實施例222 A A D B 實施例223 A A B A 實施例224 A A B A 實施例225 A A B A 實施例226 A A A A 實施例227 A A A A 實施例228 A A A A 實施例229 A A A A 實施例230 D D A A 實施例231 A A A A 實施例232 C C A A 實施例233 B B A A 實施例234 D D A A 實施例235 D D A A 實施例236 D D A A 實施例237 D D B A 實施例238 D D C A 實施例239 D D C A 實施例240 D D C A [表18]    評價結果 紅外線遮蔽性 可見光透射性 耐光性 保存穩定性 實施例241 D D C A 實施例242 A A B A 實施例243 A A B A 實施例244 A A B A 實施例245 A A B A 實施例246 A A A A 實施例247 A A A A 實施例248 A A A A 實施例249 A A A A 實施例250 A A C A 實施例251 A A C A 實施例252 A A C A 實施例253 A A C A 實施例254 A A C A 實施例255 A A C A 實施例256 A A C A 實施例257 A A C A 實施例258 A A A A 實施例259 A A B A 實施例260 A A A A 實施例261 A A A A 實施例262 A A B A 實施例263 A A B A 實施例264 A A A A 實施例265 A A A A 實施例266 A A A A 實施例267 A A A A 實施例268 A A A A 實施例269 A A A A 實施例270 A A A A 實施例271 A A A A 實施例272 A A A A 實施例273 A A A A 實施例274 A A A A 實施例275 A A A A 實施例276 A A A A 實施例277 A A A A 實施例278 A A A A 實施例279 A A A A 實施例280 A A A A [表19]    評價結果 紅外線遮蔽性 可見光透射性 耐光性 保存穩定性 實施例281 A A A A 實施例282 A A A A 實施例283 A A A A 實施例284 A A A A 實施例285 A A A A 實施例286 A A A A 實施例287 A A A A 實施例288 A A A A 實施例289 A A A A 實施例290 A A A A 實施例291 A A A A 實施例292 A A A A 實施例293 A A A A 實施例294 A A A A 實施例295 A A A A 實施例296 A A A A 實施例297 A A A A 實施例298 A A A A 實施例299 A A A A 實施例300 A A A A 實施例301 A A A A 實施例302 A A A A 實施例303 A A A A 實施例304 A A A A 實施例305 A A A A 實施例306 A A A A 實施例307 A A A A 實施例308 A A A A 實施例309 A A A A 實施例310 A A A A 實施例311 A A A A 實施例312 A A A A 實施例313 A A A A 比較例2 E E E E [表20]    評價結果 紅外線遮蔽性 可見光透射性 耐光性 保存穩定性 實施例401 A A D C 實施例402 A A D C 實施例403 A A D C 實施例404 A A D A 實施例405 A A D A 實施例406 A A D A 實施例407 D D D A 實施例408 A A D A 實施例409 C C D A 實施例410 B B D A 實施例411 D D D A 實施例412 D D D A 實施例413 D D D A 實施例414 D D D A 實施例415 D D D B 實施例416 D D D B 實施例417 D D D B 實施例418 D D D B 實施例419 A A D B 實施例420 A A D B 實施例421 A A D B 實施例422 A A D B 實施例423 A A B A 實施例424 A A B A 實施例425 A A B A 實施例426 A A A A 實施例427 A A A A 實施例428 A A A A 實施例429 A A A A 實施例430 D D A A 實施例431 A A A A 實施例432 C C A A 實施例433 B B A A 實施例434 D D A A 實施例435 D D A A 實施例436 D D A A 實施例437 D D B A 實施例438 D D C A 實施例439 D D C A 實施例440 D D C A [表21]    評價結果 紅外線遮蔽性 可見光透射性 耐光性 保存穩定性 實施例441 D D C A 實施例442 A A B A 實施例443 A A B A 實施例444 A A B A 實施例445 A A B A 實施例446 A A A A 實施例447 A A A A 實施例448 A A A A 實施例449 A A A A 實施例450 A A C A 實施例451 A A C A 實施例452 A A C A 實施例453 A A C A 實施例454 A A C A 實施例455 A A C A 實施例456 A A C A 實施例457 A A C A 實施例458 A A A A 實施例459 A A B A 實施例460 A A A A 實施例461 A A A A 實施例462 A A B A 實施例463 A A B A 實施例464 A A A A 實施例465 A A A A 實施例466 A A A A 實施例467 A A A A 實施例468 A A A A 實施例469 A A A A 實施例470 A A A A 實施例471 A A A A 實施例472 A A A A 實施例473 A A A A 實施例474 A A A A 實施例475 A A A A 實施例476 A A A A 實施例477 A A A A 實施例478 A A A A 實施例479 A A A A 實施例480 A A A A [表22]    評價結果 紅外線遮蔽性 可見光透射性 耐光性 保存穩定性 實施例481 A A A A 實施例482 A A A A 實施例483 A A A A 實施例484 A A A A 實施例485 A A A A 實施例486 A A A A 實施例487 A A A A 實施例488 A A A A 實施例489 A A A A 實施例490 A A A A 實施例491 A A A A 實施例492 A A A A 實施例493 A A A A 實施例494 A A A A 實施例495 A A A A 實施例496 A A A A 實施例497 A A A A 實施例498 A A A A 實施例499 A A A A 實施例500 A A A A 實施例501 A A A A 實施例502 A A A A 實施例503 A A A A 實施例504 A A A A 實施例505 A A A A 實施例506 A A A A 實施例507 A A A A 實施例508 A A A A 實施例509 A A A A 實施例510 A A A A 實施例511 A A A A 實施例512 A A A A 實施例513 A A A A 實施例514 A A A A 實施例515 A A A A 實施例516 A A A A 實施例517 A A A A 比較例3 E E E E [Table 14] Evaluation results Infrared shielding Visible light transmittance Lightfastness Storage stability Example 1 A A D C Example 2 A A D C Example 3 A A D C Example 4 A A D A Example 5 A A D A Example 6 A A D A Example 7 D D D A Example 8 A A D A Example 9 C C D A Example 10 B B D A Example 11 D D D A Example 12 D D D A Example 13 D D D A Example 14 D D D A Example 15 D D D B Example 16 D D D B Example 17 D D D B Example 18 D D D B Example 19 A A D B Example 20 A A D B Example 21 A A D B Example 22 A A D B Example 23 A A B A Example 24 A A B A Example 25 A A B A Example 26 A A A A Example 27 A A A A Example 28 A A A A Example 29 A A A A Example 30 D D A A Example 31 A A A A Example 32 C C A A Example 33 B B A A Example 34 D D A A Example 35 D D A A Example 36 D D A A Example 37 D D B A Example 38 D D C A Example 39 D D C A Example 40 D D C A [Table 15] Evaluation results Infrared shielding Visible light transmittance Lightfastness Storage stability Example 41 D D C A Example 42 A A B A Example 43 A A B A Example 44 A A B A Example 45 A A B A Example 46 A A A A Example 47 A A A A Example 48 A A A A Example 49 A A A A Example 50 A A C A Example 51 A A C A Example 52 A A C A Example 53 A A C A Example 54 A A C A Example 55 A A C A Example 56 A A C A Example 57 A A C A Example 58 A A A A Example 59 A A B A Example 60 A A A A Example 61 A A A A Example 62 A A B A Example 63 A A B A Example 64 A A A A Example 65 A A A A Example 66 A A A A Example 67 A A A A Example 68 A A A A Example 69 A A A A Example 70 A A A A Example 71 A A A A Example 72 A A A A Example 73 A A A A Example 74 A A A A Example 75 A A A A Example 76 A A A A Example 77 A A A A Example 78 A A A A Example 79 A A A A Example 80 A A A A [Table 16] Evaluation results Infrared shielding Visible light transmittance Lightfastness Storage stability Example 81 A A A A Example 82 A A A A Example 83 A A A A Example 84 A A A A Example 85 A A A A Example 86 A A A A Example 87 A A A A Example 88 A A A A Example 89 A A A A Example 90 A A A A Example 91 A A A A Example 92 A A A A Example 93 A A A A Example 94 A A A A Example 95 A A A A Example 96 A A A A Example 97 A A A A Example 98 A A A A Example 99 A A A A Example 100 A A A A Example 101 A A A A Example 102 A A A A Comparative example 1 E E E E [Table 17] Evaluation results Infrared shielding Visible light transmittance Lightfastness Storage stability Example 201 A A D C Example 202 A A D C Example 203 A A D C Example 204 A A D A Example 205 A A D A Example 206 A A D A Example 207 D D D A Example 208 A A D A Example 209 C C D A Example 210 B B D A Example 211 D D D A Example 212 D D D A Example 213 D D D A Example 214 D D D A Example 215 D D D B Example 216 D D D B Example 217 D D D B Example 218 D D D B Example 219 A A D B Example 220 A A D B Example 221 A A D B Example 222 A A D B Example 223 A A B A Example 224 A A B A Example 225 A A B A Example 226 A A A A Example 227 A A A A Example 228 A A A A Example 229 A A A A Example 230 D D A A Example 231 A A A A Example 232 C C A A Example 233 B B A A Example 234 D D A A Example 235 D D A A Example 236 D D A A Example 237 D D B A Example 238 D D C A Example 239 D D C A Example 240 D D C A [Table 18] Evaluation results Infrared shielding Visible light transmittance Lightfastness Storage stability Example 241 D D C A Example 242 A A B A Example 243 A A B A Example 244 A A B A Example 245 A A B A Example 246 A A A A Example 247 A A A A Example 248 A A A A Example 249 A A A A Example 250 A A C A Example 251 A A C A Example 252 A A C A Example 253 A A C A Example 254 A A C A Example 255 A A C A Example 256 A A C A Example 257 A A C A Example 258 A A A A Example 259 A A B A Example 260 A A A A Example 261 A A A A Example 262 A A B A Example 263 A A B A Example 264 A A A A Example 265 A A A A Example 266 A A A A Example 267 A A A A Example 268 A A A A Example 269 A A A A Example 270 A A A A Example 271 A A A A Example 272 A A A A Example 273 A A A A Example 274 A A A A Example 275 A A A A Example 276 A A A A Example 277 A A A A Example 278 A A A A Example 279 A A A A Example 280 A A A A [Table 19] Evaluation results Infrared shielding Visible light transmittance Lightfastness Storage stability Example 281 A A A A Example 282 A A A A Example 283 A A A A Example 284 A A A A Example 285 A A A A Example 286 A A A A Example 287 A A A A Example 288 A A A A Example 289 A A A A Example 290 A A A A Example 291 A A A A Example 292 A A A A Example 293 A A A A Example 294 A A A A Example 295 A A A A Example 296 A A A A Example 297 A A A A Example 298 A A A A Example 299 A A A A Example 300 A A A A Example 301 A A A A Example 302 A A A A Example 303 A A A A Example 304 A A A A Example 305 A A A A Example 306 A A A A Example 307 A A A A Example 308 A A A A Example 309 A A A A Example 310 A A A A Example 311 A A A A Example 312 A A A A Example 313 A A A A Comparative example 2 E E E E [Table 20] Evaluation results Infrared shielding Visible light transmittance Lightfastness Storage stability Example 401 A A D C Example 402 A A D C Example 403 A A D C Example 404 A A D A Example 405 A A D A Example 406 A A D A Example 407 D D D A Example 408 A A D A Example 409 C C D A Example 410 B B D A Example 411 D D D A Example 412 D D D A Example 413 D D D A Example 414 D D D A Example 415 D D D B Example 416 D D D B Example 417 D D D B Example 418 D D D B Example 419 A A D B Example 420 A A D B Example 421 A A D B Example 422 A A D B Example 423 A A B A Example 424 A A B A Example 425 A A B A Example 426 A A A A Example 427 A A A A Example 428 A A A A Example 429 A A A A Example 430 D D A A Example 431 A A A A Example 432 C C A A Example 433 B B A A Example 434 D D A A Example 435 D D A A Example 436 D D A A Example 437 D D B A Example 438 D D C A Example 439 D D C A Example 440 D D C A [Table 21] Evaluation results Infrared shielding Visible light transmittance Lightfastness Storage stability Example 441 D D C A Example 442 A A B A Example 443 A A B A Example 444 A A B A Example 445 A A B A Example 446 A A A A Example 447 A A A A Example 448 A A A A Example 449 A A A A Example 450 A A C A Example 451 A A C A Example 452 A A C A Example 453 A A C A Example 454 A A C A Example 455 A A C A Example 456 A A C A Example 457 A A C A Example 458 A A A A Example 459 A A B A Example 460 A A A A Example 461 A A A A Example 462 A A B A Example 463 A A B A Example 464 A A A A Example 465 A A A A Example 466 A A A A Example 467 A A A A Example 468 A A A A Example 469 A A A A Example 470 A A A A Example 471 A A A A Example 472 A A A A Example 473 A A A A Example 474 A A A A Example 475 A A A A Example 476 A A A A Example 477 A A A A Example 478 A A A A Example 479 A A A A Example 480 A A A A [Table 22] Evaluation results Infrared shielding Visible light transmittance Lightfastness Storage stability Example 481 A A A A Example 482 A A A A Example 483 A A A A Example 484 A A A A Example 485 A A A A Example 486 A A A A Example 487 A A A A Example 488 A A A A Example 489 A A A A Example 490 A A A A Example 491 A A A A Example 492 A A A A Example 493 A A A A Example 494 A A A A Example 495 A A A A Example 496 A A A A Example 497 A A A A Example 498 A A A A Example 499 A A A A Example 500 A A A A Example 501 A A A A Example 502 A A A A Example 503 A A A A Example 504 A A A A Example 505 A A A A Example 506 A A A A Example 507 A A A A Example 508 A A A A Example 509 A A A A Example 510 A A A A Example 511 A A A A Example 512 A A A A Example 513 A A A A Example 514 A A A A Example 515 A A A A Example 516 A A A A Example 517 A A A A Comparative example 3 E E E E

如上述表所示,與比較例相比,實施例的可見光透射性、紅外線遮蔽性、耐光性及保存穩定性的評價優異。As shown in the table above, the Examples were excellent in evaluation of visible light transmittance, infrared shielding properties, light resistance, and storage stability compared with the Comparative Examples.

110:固體攝像元件 111:紅外線截止濾波器 112:濾色器 114:紅外線透射濾波器 115:微透鏡 116:平坦化層 110: Solid camera element 111: Infrared cut filter 112:Color filter 114:Infrared transmission filter 115: Microlens 116: Planarization layer

圖1係表示紅外線感測器的一實施形態之概略圖。FIG. 1 is a schematic diagram showing an embodiment of an infrared sensor.

Claims (15)

一種組成物,其包含紅外線吸收劑、硬化性化合物及溶劑, 前述紅外線吸收劑包含由式(1)表示之化合物; 式(1)中,A及B分別獨立地表示芳香族烴環或芳香族雜環, R aa1及R aa2分別獨立地表示鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基、烷基、芳基、雜環基、烷氧基、醯基、烷氧基羰基、-NR a11R a12、-SR a13、-SO 2R a14或-OSO 2R a15, R a11及R a12分別獨立地表示氫原子、烷基、芳基或雜環基, R a13~R a15分別獨立地表示烷基、芳基或雜環基, R b1~R b4分別獨立地表示氫原子、鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基、烷基、芳基、雜環基、烷氧基、醯基、烷氧基羰基、-NR b11R b12、-NHCOR b13、-NHSO 2R b14、-NHCSNHR b15、-SR b16、-SO 2R b17、-OSO 2R b18、-NHCSR b19、-NHCONHR b20或-NHCOOR b21, R b11及R b12分別獨立地表示氫原子、烷基、芳基或雜環基, R b13~R b21分別獨立地表示烷基、芳基或雜環基, Y 1~Y 4分別獨立地表示氫原子、烷基、芳基、雜環基或由式(Y-1)表示之基團, m1表示0~mA的整數,mA表示R aa1可取代A之最大的整數, m2表示0~mB的整數,mB表示R aa2可取代B之最大的整數, m1為2以上時,m1個R aa1中2個R aa1可以彼此鍵結而形成環, m2為2以上時,m2個R aa2中2個R aa2可以彼此鍵結而形成環, R aa1與Y 1可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, R aa1與Y 2可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, R aa2與Y 3可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, R aa2與Y 4可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, Y 1與Y 2可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, Y 3與Y 4可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環; 其中,Y 1~Y 4中的至少一個為由式(Y-1)表示之基團,且選自R aa1與Y 1、R aa1與Y 2、R aa2與Y 3及R aa2與Y 4中之至少一個鍵結而形成包含至少一個氮原子之5員環或6員環的雜環; 式(Y-1)中,波線表示鍵結鍵, Ry 1~Ry 4分別獨立地表示氫原子、烷基或芳基, X 1為單鍵、伸烷基、伸芳基、-O-、-S-、-NRx-、-CO-、-CS-、-SO-或-SO 2-,或者表示將選自伸烷基、伸芳基、-O-、-S-、-NRx-、-CO-、-CS-、-SO-及-SO 2-中之2個以上組合而成之基團,Rx表示氫原子、烷基或芳基, Z 1表示脂環式烴基、芳香族烴基、雜環基、由式(Z-1)~(Z-6)中的任一個表示之基團; 其中,Z 1為由式(Z-1)表示之基團或由式(Z-4)表示之基團時,X 1中的與Z 1連結之部分為伸烷基或伸芳基; 式(Z-1)~式(Z-6)中,波線表示鍵結鍵; 式(Z-1)中,Rz 11表示烷基或芳基; 式(Z-2)中,Rz 12表示氫原子、-COR 100或-COOR 100,R 100表示氫原子、烷基或芳基,Rz 12a表示烷基,mz表示0~4的整數; 式(Z-3)中,Rz 13~Rz 16分別獨立地表示烷基,Rz 17表示氫原子、烷基或氧自由基; 式(Z-4)中,Rz 18及Rz 19分別獨立地表示烷基或芳基; 式(Z-6)中,W 1表示單鍵、伸烷基、伸芳基或-CO-,Rz 20表示氫原子、烷基、芳基或-COR 101,R 101表示烷基或芳基。 A composition including an infrared absorber, a curable compound and a solvent, wherein the infrared absorber includes a compound represented by formula (1); In formula (1), A and B independently represent an aromatic hydrocarbon ring or an aromatic heterocyclic ring, and R aa1 and R aa2 independently represent a halogen atom, a sulfo group, a hydroxyl group, a cyano group, a nitro group, a carboxyl group, and a phosphate group. , alkyl, aryl, heterocyclyl, alkoxy, acyl, alkoxycarbonyl, -NR a11 R a12 , -SR a13 , -SO 2 R a14 or -OSO 2 R a15 , R a11 and R a12 Each independently represents a hydrogen atom, an alkyl group, an aryl group or a heterocyclic group, R a13 to R a15 each independently represents an alkyl group, an aryl group or a heterocyclic group, R b1 to R b4 each independently represents a hydrogen atom or a halogen atom , sulfo group, hydroxyl group, cyano group, nitro group, carboxyl group, phosphate group, alkyl group, aryl group, heterocyclic group, alkoxy group, hydroxyl group, alkoxycarbonyl group, -NR b11 R b12 , -NHCOR b13 , - NHSO 2 R b14 , -NHCSNHR b15 , -SR b16 , -SO 2 R b17 , -OSO 2 R b18 , -NHCSR b19 , -NHCONHR b20 or -NHCOOR b21 , R b11 and R b12 independently represent a hydrogen atom, an alkane group, aryl group or heterocyclic group, R b13 to R b21 independently represent an alkyl group, an aryl group or a heterocyclic group, Y 1 to Y 4 independently represent a hydrogen atom, an alkyl group, an aryl group, a heterocyclic group or A group represented by formula (Y-1), m1 represents an integer from 0 to mA, mA represents the largest integer that R aa1 can replace A, m2 represents an integer from 0 to mB, and mB represents the largest integer that R aa2 can replace B. Integer, when m1 is 2 or more, 2 R aa1 out of m1 R aa1 can bond with each other to form a ring. When m2 is 2 or more, 2 R aa2 out of m2 R aa2 can bond with each other to form a ring, R aa1 It can bond with Y 1 to form a heterocyclic ring containing a 5-membered ring or a 6-membered ring containing at least one nitrogen atom. R aa1 and Y 2 can bond to form a heterocyclic ring containing a 5-membered ring or a 6-membered ring containing at least one nitrogen atom. Ring, R aa2 and Y 3 can bond to form a 5-membered ring or a 6-membered heterocyclic ring containing at least one nitrogen atom, R aa2 and Y 4 can bond to form a 5-membered ring or 6-membered ring containing at least one nitrogen atom A heterocyclic ring with 5 members, Y 1 and Y 2 can be bonded to form a 5-membered ring or a 6-membered ring containing at least one nitrogen atom, Y 3 and Y 4 can be bonded to form a 5-membered ring containing at least one nitrogen atom. A membered ring or a 6-membered heterocyclic ring; wherein, at least one of Y 1 to Y 4 is a group represented by formula (Y-1), and is selected from R aa1 and Y 1 , R aa1 and Y 2 , R aa2 and at least one of Y 3 and R aa2 and Y 4 are bonded to form a 5-membered ring or a 6-membered ring heterocyclic ring containing at least one nitrogen atom; In formula (Y-1), the wavy line represents a bond, Ry 1 to Ry 4 independently represent a hydrogen atom, an alkyl group or an aryl group, and X 1 is a single bond, an alkylene group, an aryl group, -O-, -S-, -NRx-, -CO-, -CS-, -SO- or -SO 2 -, or it will be selected from alkylene, aryl, -O-, -S-, -NRx-, A group composed of two or more of -CO-, -CS-, -SO- and -SO 2 -, Rx represents a hydrogen atom, an alkyl group or an aryl group, Z 1 represents an alicyclic hydrocarbon group or an aromatic hydrocarbon group , heterocyclic group, a group represented by any one of the formulas (Z-1) to (Z-6); wherein, Z 1 is a group represented by the formula (Z-1) or a group represented by the formula (Z-4 ) represents a group, the part in X 1 linked to Z 1 is an alkylene group or an aryl group; In formula (Z-1) to formula (Z-6), the wavy line represents a bond; in formula (Z-1), Rz 11 represents an alkyl group or an aryl group; in formula (Z-2), Rz 12 represents hydrogen atom, -COR 100 or -COOR 100 , R 100 represents a hydrogen atom, an alkyl group or an aryl group, Rz 12a represents an alkyl group, mz represents an integer from 0 to 4; in formula (Z-3), Rz 13 to Rz 16 respectively independently represents an alkyl group, and Rz 17 represents a hydrogen atom, an alkyl group or an oxygen radical; in formula (Z-4), Rz 18 and Rz 19 independently represent an alkyl group or an aryl group; in formula (Z-6), W 1 represents a single bond, an alkylene group, an aryl group or -CO-, Rz 20 represents a hydrogen atom, an alkyl group, an aryl group or -COR 101 , and R 101 represents an alkyl group or an aryl group. 如請求項1所述之組成物,其中 由前述式(1)表示之化合物為由式(2)表示之化合物; 式(2)中,R a1~R a4分別獨立地表示氫原子、鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基、烷基、芳基、雜環基、烷氧基、醯基、烷氧基羰基、-NR a11R a12、-SR a13、-SO 2R a14或-OSO 2R a15, R a11及R a12分別獨立地表示氫原子、烷基、芳基或雜環基, R a13~R a15分別獨立地表示烷基、芳基或雜環基, R b1~R b4分別獨立地表示氫原子、鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基、烷基、芳基、雜環基、烷氧基、醯基、烷氧基羰基、-NR b11R b12、-NHCOR b13、-NHSO 2R b14、-NHCSNHR b15、-SR b16、-SO 2R b17、-OSO 2R b18、-NHCSR b19、-NHCONHR b20或-NHCOOR b21, R b11及R b12分別獨立地表示氫原子、烷基、芳基或雜環基, R b13~R b21分別獨立地表示烷基、芳基或雜環基, Y 1~Y 4分別獨立地表示氫原子、烷基、芳基、雜環基或由前述式(Y-1)表示之基團, R a1與Y 1可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, R a2與Y 2可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, R a3與Y 3可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, R a4與Y 4可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, Y 1與Y 2可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, Y 3與Y 4可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環; 其中,Y 1~Y 4中的至少一個為由前述式(Y-1)表示之基團,且選自R a1與Y 1、R a2與Y 2、R a3與Y 3及R a4與Y 4中之至少一個鍵結而形成包含至少一個氮原子之5員環或6員環的雜環。 The composition as described in claim 1, wherein the compound represented by the aforementioned formula (1) is a compound represented by the formula (2); In formula (2), R a1 to R a4 each independently represent a hydrogen atom, a halogen atom, a sulfo group, a hydroxyl group, a cyano group, a nitro group, a carboxyl group, a phosphate group, an alkyl group, an aryl group, a heterocyclic group, and an alkoxy group. , acyl group, alkoxycarbonyl group, -NR a11 R a12 , -SR a13 , -SO 2 R a14 or -OSO 2 R a15 , R a11 and R a12 respectively independently represent a hydrogen atom, an alkyl group, an aryl group or a hetero Ring group, R a13 to R a15 independently represent an alkyl group, an aryl group or a heterocyclic group, R b1 to R b4 respectively independently represent a hydrogen atom, a halogen atom, a sulfo group, a hydroxyl group, a cyano group, a nitro group, a carboxyl group, Phosphate group, alkyl group, aryl group, heterocyclyl group, alkoxy group, acyl group, alkoxycarbonyl group, -NR b11 R b12 , -NHCOR b13 , -NHSO 2 R b14 , -NHCSNHR b15 , -SR b16 , - SO 2 R b17 , -OSO 2 R b18 , -NHCSR b19 , -NHCONHR b20 or -NHCOOR b21 , R b11 and R b12 independently represent a hydrogen atom, an alkyl group, an aryl group or a heterocyclic group, R b13 ~ R b21 Each independently represents an alkyl group, an aryl group or a heterocyclic group, Y 1 to Y 4 each independently represents a hydrogen atom, an alkyl group, an aryl group, a heterocyclic group or a group represented by the aforementioned formula (Y-1), R a1 and Y 1 may bond to form a 5-membered ring or 6-membered heterocyclic ring containing at least one nitrogen atom, and R a2 and Y 2 may bond to form a 5-membered ring or 6-membered ring containing at least one nitrogen atom. Heterocycle, R a3 and Y 3 can bond to form a 5-membered ring or 6-membered ring containing at least one nitrogen atom, R a4 and Y 4 can bond to form a 5-membered ring containing at least one nitrogen atom or a 6-membered ring. A 6-membered heterocyclic ring, Y 1 and Y 2 can be bonded to form a 5-membered ring or a 6-membered ring heterocyclic containing at least one nitrogen atom, Y 3 and Y 4 can be bonded to form a 5-membered ring containing at least one nitrogen atom 5-membered ring or 6-membered ring heterocycle; wherein, at least one of Y 1 to Y 4 is a group represented by the aforementioned formula (Y-1), and is selected from R a1 and Y 1 , R a2 and Y 2 , R a3 and at least one of Y 3 and R a4 and Y 4 are bonded to form a 5-membered ring or a 6-membered ring heterocyclic ring containing at least one nitrogen atom. 如請求項1所述之組成物,其中 由前述式(1)表示之化合物為由式(3)表示之化合物; 式(3)中,R 13~R 17、R 23~R 27分別獨立地表示氫原子、鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基、烷基、芳基、雜環基、烷氧基、醯基、烷氧基羰基、-NR a11R a12、-SR a13、-SO 2R a14或-OSO 2R a15, R a11及R a12分別獨立地表示氫原子、烷基、芳基或雜環基, R a13~R a15分別獨立地表示烷基、芳基或雜環基, R 11、R 12、R 21及R 22分別獨立地表示氫原子、鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基、烷基、芳基、雜環基、烷氧基、醯基、烷氧基羰基、-NR b11R b12、-NHCOR b13、-NHSO 2R b14、-NHCSNHR b15、-SR b16、-SO 2R b17、-OSO 2R b18、-NHCSR b19、-NHCONHR b20或-NHCOOR b21, R b11及R b12分別獨立地表示氫原子、烷基、芳基或雜環基, R b13~R b21分別獨立地表示烷基、芳基或雜環基, Y 11及Y 21分別獨立地表示氫原子、烷基、芳基、雜環基或由前述式(Y-1)表示之基團,Y 11及Y 21中的至少一個為由前述式(Y-1)表示之基團。 The composition as described in claim 1, wherein the compound represented by the aforementioned formula (1) is a compound represented by the formula (3); In formula (3), R 13 to R 17 and R 23 to R 27 respectively independently represent a hydrogen atom, a halogen atom, a sulfo group, a hydroxyl group, a cyano group, a nitro group, a carboxyl group, a phosphate group, an alkyl group, an aryl group, a hetero group, and a hydrogen atom. Ring group, alkoxy group, acyl group, alkoxycarbonyl group, -NR a11 R a12 , -SR a13 , -SO 2 R a14 or -OSO 2 R a15 , R a11 and R a12 independently represent a hydrogen atom, an alkane group, aryl or heterocyclic group, R a13 to R a15 independently represent an alkyl group, an aryl group or a heterocyclic group, R 11 , R 12 , R 21 and R 22 respectively independently represent a hydrogen atom, a halogen atom, a sulfonate group, hydroxyl group, cyano group, nitro group, carboxyl group, phosphate group, alkyl group, aryl group, heterocyclic group, alkoxy group, acyl group, alkoxycarbonyl group, -NR b11 R b12 , -NHCOR b13 , -NHSO 2 R b14 , -NHCSNHR b15 , -SR b16 , -SO 2 R b17 , -OSO 2 R b18 , -NHCSR b19 , -NHCONHR b20 or -NHCOOR b21 , R b11 and R b12 independently represent a hydrogen atom, an alkyl group, Aryl or heterocyclic group, R b13 ~ R b21 independently represent an alkyl group, an aryl group or a heterocyclic group, Y 11 and Y 21 independently represent a hydrogen atom, an alkyl group, an aryl group, a heterocyclic group or a combination of the above In the group represented by formula (Y-1), at least one of Y 11 and Y 21 is a group represented by the aforementioned formula (Y-1). 如請求項3所述之組成物,其中 前述式(3)的R 11及R 12中的至少一個和R 21及R 22中的至少一個分別獨立地為-NHCOR b13,R b13為烷基、芳基或雜環基。 The composition according to claim 3, wherein at least one of R 11 and R 12 and at least one of R 21 and R 22 of the aforementioned formula (3) are independently -NHCOR b13 , and R b13 is an alkyl group, Aryl or heterocyclyl. 如請求項3所述之組成物,其中 前述式(3)的R 11及R 12中的至少一個和R 21及R 22中的至少一個分別獨立地為-NHSO 2R b14,R b14為烷基、芳基或雜環基。 The composition as claimed in claim 3, wherein at least one of R 11 and R 12 and at least one of R 21 and R 22 of the aforementioned formula (3) are independently -NHSO 2 R b14 , and R b14 is an alkane. base, aryl or heterocyclic group. 如請求項1至5之任一項所述之組成物,其中 前述硬化性化合物包含樹脂。 The composition as described in any one of claims 1 to 5, wherein The aforementioned curable compound includes resin. 如請求項1至5之任一項所述之組成物,其中 前述紅外線吸收劑進一步包含由前述式(1)表示之化合物以外的紅外線吸收劑。 The composition as described in any one of claims 1 to 5, wherein The infrared absorber further includes an infrared absorber other than the compound represented by the formula (1). 如請求項1至5之任一項所述之組成物,其進一步包含選自紫外線吸收劑及抗氧化劑中之至少1種。The composition according to any one of claims 1 to 5, further comprising at least one selected from the group consisting of ultraviolet absorbers and antioxidants. 一種膜,其使用如請求項1至5之任一項所述之組成物來獲得。A film obtained using the composition according to any one of claims 1 to 5. 一種光學濾波器,其包含如請求項9所述之膜。An optical filter comprising the film according to claim 9. 一種固體攝像元件,其包含如請求項9所述之膜。A solid-state imaging element including the film according to claim 9. 一種圖像顯示裝置,其包含如請求項9所述之膜。An image display device comprising the film according to claim 9. 一種紅外線感測器,其包含如請求項9所述之膜。An infrared sensor comprising the film described in claim 9. 一種照相機膜組,其包含如請求項9所述之膜。A camera film set including the film described in claim 9. 一種化合物,其由式(1)表示; 式(1)中,A及B分別獨立地表示芳香族烴環或芳香族雜環, R aa1及R aa2分別獨立地表示鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基、烷基、芳基、雜環基、烷氧基、醯基、烷氧基羰基、-NR a11R a12、-SR a13、-SO 2R a14或-OSO 2R a15, R a11及R a12分別獨立地表示氫原子、烷基、芳基或雜環基, R a13~R a15分別獨立地表示烷基、芳基或雜環基, R b1~R b4分別獨立地表示氫原子、鹵素原子、磺基、羥基、氰基、硝基、羧基、磷酸基、烷基、芳基、雜環基、烷氧基、醯基、烷氧基羰基、-NR b11R b12、-NHCOR b13、-NHSO 2R b14、-NHCSNHR b15、-SR b16、-SO 2R b17、-OSO 2R b18、-NHCSR b19、-NHCONHR b20或-NHCOOR b21, R b11及R b12分別獨立地表示氫原子、烷基、芳基或雜環基, R b13~R b21分別獨立地表示烷基、芳基或雜環基, Y 1~Y 4分別獨立地表示氫原子、烷基、芳基、雜環基或由式(Y-1)表示之基團, m1表示0~mA的整數,mA表示R aa1可取代A之最大的整數, m2表示0~mB的整數,mB表示R aa2可取代B之最大的整數, m1為2以上時,m1個R aa1中2個R aa1可以彼此鍵結而形成環, m2為2以上時,m2個R aa2中2個R aa2可以彼此鍵結而形成環, R aa1與Y 1可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, R aa1與Y 2可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, R aa2與Y 3可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, R aa2與Y 4可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, Y 1與Y 2可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環, Y 3與Y 4可以鍵結而形成包含至少一個氮原子之5員環或6員環的雜環; 其中,Y 1~Y 4中的至少一個為由式(Y-1)表示之基團,且選自R aa1與Y 1、R aa1與Y 2、R aa2與Y 3及R aa2與Y 4中之至少一個鍵結而形成包含至少一個氮原子之5員環或6員環的雜環; 式(Y-1)中,波線表示鍵結鍵, Ry 1~Ry 4分別獨立地表示氫原子、烷基或芳基, X 1為單鍵、伸烷基、伸芳基、-O-、-S-、-NRx-、-CO-、-CS-、-SO-或-SO 2-,或者表示將選自伸烷基、伸芳基、-O-、-S-、-NRx-、-CO-、-CS-、-SO-及-SO 2-中之2個以上組合而成之基團,Rx表示氫原子、烷基或芳基, Z 1表示脂環式烴基、芳香族烴基、雜環基、由式(Z-1)~(Z-6)中的任一個表示之基團; 其中,Z 1為由式(Z-1)表示之基團或由式(Z-4)表示之基團時,X 1中的與Z 1連結之部分為伸烷基或伸芳基; 式(Z-1)~式(Z-6)中,波線表示鍵結鍵; 式(Z-1)中,Rz 11表示烷基或芳基; 式(Z-2)中,Rz 12表示氫原子、-COR 100或-COOR 100,R 100表示氫原子、烷基或芳基,Rz 12a表示烷基,mz表示0~4的整數; 式(Z-3)中,Rz 13~Rz 16分別獨立地表示烷基,Rz 17表示氫原子、烷基或氧自由基; 式(Z-4)中,Rz 18及Rz 19分別獨立地表示烷基或芳基; 式(Z-6)中,W 1表示單鍵、伸烷基、伸芳基或-CO-,Rz 20表示氫原子、烷基、芳基或-COR 101,R 101表示烷基或芳基。 A compound represented by formula (1); In formula (1), A and B independently represent an aromatic hydrocarbon ring or an aromatic heterocyclic ring, and R aa1 and R aa2 independently represent a halogen atom, a sulfo group, a hydroxyl group, a cyano group, a nitro group, a carboxyl group, and a phosphate group. , alkyl, aryl, heterocyclyl, alkoxy, acyl, alkoxycarbonyl, -NR a11 R a12 , -SR a13 , -SO 2 R a14 or -OSO 2 R a15 , R a11 and R a12 Each independently represents a hydrogen atom, an alkyl group, an aryl group or a heterocyclic group, R a13 to R a15 each independently represents an alkyl group, an aryl group or a heterocyclic group, R b1 to R b4 each independently represents a hydrogen atom or a halogen atom , sulfo group, hydroxyl group, cyano group, nitro group, carboxyl group, phosphate group, alkyl group, aryl group, heterocyclic group, alkoxy group, hydroxyl group, alkoxycarbonyl group, -NR b11 R b12 , -NHCOR b13 , - NHSO 2 R b14 , -NHCSNHR b15 , -SR b16 , -SO 2 R b17 , -OSO 2 R b18 , -NHCSR b19 , -NHCONHR b20 or -NHCOOR b21 , R b11 and R b12 independently represent a hydrogen atom, an alkane group, aryl group or heterocyclic group, R b13 to R b21 independently represent an alkyl group, an aryl group or a heterocyclic group, Y 1 to Y 4 independently represent a hydrogen atom, an alkyl group, an aryl group, a heterocyclic group or A group represented by formula (Y-1), m1 represents an integer from 0 to mA, mA represents the largest integer that R aa1 can replace A, m2 represents an integer from 0 to mB, and mB represents the largest integer that R aa2 can replace B. Integer, when m1 is 2 or more, 2 R aa1 out of m1 R aa1 can bond with each other to form a ring. When m2 is 2 or more, 2 R aa2 out of m2 R aa2 can bond with each other to form a ring, R aa1 It can bond with Y 1 to form a heterocyclic ring containing a 5-membered ring or a 6-membered ring containing at least one nitrogen atom. R aa1 and Y 2 can bond to form a heterocyclic ring containing a 5-membered ring or a 6-membered ring containing at least one nitrogen atom. Ring, R aa2 and Y 3 can bond to form a 5-membered ring or a 6-membered heterocyclic ring containing at least one nitrogen atom, R aa2 and Y 4 can bond to form a 5-membered ring or 6-membered ring containing at least one nitrogen atom A heterocyclic ring with 5 members, Y 1 and Y 2 can be bonded to form a 5-membered ring or a 6-membered ring containing at least one nitrogen atom, Y 3 and Y 4 can be bonded to form a 5-membered ring containing at least one nitrogen atom. A membered ring or a 6-membered heterocyclic ring; wherein, at least one of Y 1 to Y 4 is a group represented by formula (Y-1), and is selected from R aa1 and Y 1 , R aa1 and Y 2 , R aa2 and at least one of Y 3 and R aa2 and Y 4 are bonded to form a 5-membered ring or a 6-membered ring heterocyclic ring containing at least one nitrogen atom; In formula (Y-1), the wavy line represents a bond, Ry 1 to Ry 4 independently represent a hydrogen atom, an alkyl group or an aryl group, and X 1 is a single bond, an alkylene group, an aryl group, -O-, -S-, -NRx-, -CO-, -CS-, -SO- or -SO 2 -, or it will be selected from alkylene, aryl, -O-, -S-, -NRx-, A group composed of two or more of -CO-, -CS-, -SO- and -SO 2 -, Rx represents a hydrogen atom, an alkyl group or an aryl group, Z 1 represents an alicyclic hydrocarbon group or an aromatic hydrocarbon group , heterocyclic group, a group represented by any one of the formulas (Z-1) to (Z-6); wherein, Z 1 is a group represented by the formula (Z-1) or a group represented by the formula (Z-4 ) represents a group, the part in X 1 linked to Z 1 is an alkylene group or an aryl group; In formula (Z-1) to formula (Z-6), the wavy line represents a bond; in formula (Z-1), Rz 11 represents an alkyl group or an aryl group; in formula (Z-2), Rz 12 represents hydrogen atom, -COR 100 or -COOR 100 , R 100 represents a hydrogen atom, an alkyl group or an aryl group, Rz 12a represents an alkyl group, mz represents an integer from 0 to 4; in formula (Z-3), Rz 13 to Rz 16 respectively independently represents an alkyl group, and Rz 17 represents a hydrogen atom, an alkyl group or an oxygen radical; in formula (Z-4), Rz 18 and Rz 19 independently represent an alkyl group or an aryl group; in formula (Z-6), W 1 represents a single bond, an alkylene group, an aryl group or -CO-, Rz 20 represents a hydrogen atom, an alkyl group, an aryl group or -COR 101 , and R 101 represents an alkyl group or an aryl group.
TW112109380A 2022-03-18 2023-03-14 Composition, film, optical filter, solid-state imaging element, image display device, infrared sensor, camera module, and compound TW202342649A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022044340 2022-03-18
JP2022-044340 2022-03-18

Publications (1)

Publication Number Publication Date
TW202342649A true TW202342649A (en) 2023-11-01

Family

ID=88023254

Family Applications (1)

Application Number Title Priority Date Filing Date
TW112109380A TW202342649A (en) 2022-03-18 2023-03-14 Composition, film, optical filter, solid-state imaging element, image display device, infrared sensor, camera module, and compound

Country Status (2)

Country Link
TW (1) TW202342649A (en)
WO (1) WO2023176609A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01314250A (en) * 1988-06-13 1989-12-19 Konica Corp Electrophotographic sensitive body
JPH0213964A (en) * 1988-07-01 1990-01-18 Konica Corp Electrophotographic sensitive body
CN103858028B (en) * 2011-10-14 2016-12-28 Jsr株式会社 Solid-state image sensor light filter and use solid-state image sensor and the camera module of this light filter
JP6248945B2 (en) * 2012-12-06 2017-12-20 旭硝子株式会社 Near-infrared cut filter
KR101842495B1 (en) * 2017-03-13 2018-03-27 한국화학연구원 Novel squarylium compounds, resin composition for absorbing near infrared ray including the same and absorbing near infrared ray blocking filter manufactured by using this
CN114269556A (en) * 2019-08-29 2022-04-01 富士胶片株式会社 Composition, film, near-infrared cut filter, pattern formation method, laminate, solid-state imaging element, infrared sensor, image display device, camera module, and compound

Also Published As

Publication number Publication date
WO2023176609A1 (en) 2023-09-21

Similar Documents

Publication Publication Date Title
TWI741010B (en) Composition, film, near-infrared cut filter, pattern forming method, laminate, solid-state imaging element, image display device, camera module, and infrared sensor
TWI712607B (en) Composition, curable composition, cured film, near infrared cut filter, infrared transmission filter, solid-state imaging device, infrared sensor, and camera module
KR102536495B1 (en) Near-infrared absorbing photosensitive composition, cured film, optical filter, pattern formation method, laminate, solid-state imaging device, image display device, and infrared sensor
TWI807062B (en) Curable composition, film, near-infrared cut filter, solid-state imaging device, image display device, infrared sensor, and camera module
US20230220210A1 (en) Composition, film, optical filter, solid-state imaging element, image display device, infrared sensor, camera module, compound, and infrared absorber
TW201739804A (en) Film, method for manufacturing film, optical filter, layered body, solid-state imaging element, image display device, and infrared sensor
JP6705891B2 (en) Composition, film, optical filter, laminate, solid-state image sensor, image display device and infrared sensor
JP2024025792A (en) Infrared absorbing compositions, films, optical filters, solid-state imaging devices, image display devices, and infrared sensors
TW202212492A (en) Composition, film, optical filer, solid-state imaging element, image display device, infrared sensor, camera module, compound and infrared absorbent
TW202342649A (en) Composition, film, optical filter, solid-state imaging element, image display device, infrared sensor, camera module, and compound
TW202026317A (en) Composition, film, optical filter, solid-state imaging device, infrared sensor, method for manufacturing optical filter, camera module, compound, and dispersion composition
TW202001425A (en) Photosensitive composition, film, color filter, solid-state imaging element and image display device
TW202338010A (en) Composition, film, optical filter, solid-state imaging element, image display device, infrared sensor, camera module, and compound
WO2023162791A1 (en) Infrared absorbing composition, infrared absorber, film, optical filter and solid-state imaging element
WO2022191044A1 (en) Composition, film, optical filter, solid-state imaging element, image display device, infrared sensor, camera module, compound, and infrared absorbing agent
TW202336019A (en) Composition, film, optical filter, solid-state imaging element, image display device, infrared sensor, camera module, and compound
WO2022131191A1 (en) Composition, membrane, optical filter, solid image pickup element, image display apparatus, and infrared ray sensor
WO2023286582A1 (en) Composition, film, optical filter, solid-state imaging element, image display device, infrared sensor, camera module, and compound
TW202336045A (en) Compositions, films, optical filters, solid-state imaging devices, image display devices, infrared sensors, and camera modules wherein the composition contains an infrared absorber containing a compound represented by formula (1), a prescribed anti-fading agent, and a curable compound
TW202229233A (en) Composition, film, optical filter, solid-state imaging element, image display device, and ir sensor
TW202229286A (en) Composition, film, optical filter, solid-state imaging element, image display device, and infrared sensor
TW202413543A (en) Compositions, films, filters, solid-state imaging devices, image display devices, infrared sensors, camera modules, compounds and infrared absorbers
TW202346385A (en) Resin composition, film, optical filter, solid-state imaging element, image display device, infrared sensor, camera module, and compound
TW202336119A (en) Infrared absorbing composition, film, optical filter, solid-state imaging element, image display device, infrared sensor, and camera module
TW202311405A (en) Composition, film, optical filter, solid-state imaging element, image display device, and infrared sensor